data_1i4v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i4v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 12.6 tt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.212 0.529 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' ND2' ' OD1' ' A' ' 39' ' ' ASP . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' CD2' ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' HD11 ' A' ' 62' ' ' ILE . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.402 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.433 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' O ' ' CG1' ' A' ' 134' ' ' VAL . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 62' ' ' ILE . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 32.1 m-70 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.468 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 94' ' ' PHE . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.492 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.433 ' OD1' ' CD1' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.419 ' CG2' HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 133' ' ' HIS . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.475 ' CD2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 64' ' ' GLY . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.318 0.58 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.441 ' CD1' ' CD2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.425 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.443 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.428 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.401 ' HG3' ' HE3' ' B' ' 97' ' ' LYS . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.435 ' CG1' ' OD1' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 134' ' ' VAL . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.447 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.423 ' HA ' HG12 ' B' ' 62' ' ' ILE . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.429 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.467 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 31.0 m-70 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.463 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.432 HG22 ' CD2' ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 93' ' ' GLU . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.429 HG11 ' CA ' ' B' ' 64' ' ' GLY . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' B' ' 96' ' ' VAL . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.479 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.487 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' B' ' 118' ' ' THR . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.498 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.435 ' OD1' ' CG1' ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' B' ' 106' ' ' GLN . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.432 ' CD2' HG22 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.426 HG13 ' N ' ' B' ' 128' ' ' PHE . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' ' 133' ' ' HIS . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 tp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' B' ' 41' ' ' ASN . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 39' ' ' ASP . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' CA ' HD13 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.423 HD13 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' CB ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.441 ' CD1' HG21 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' B' ' 43' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.427 ' CB ' HG12 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.3 m-70 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 80' ' ' ALA . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG2' HD23 ' A' ' 125' ' ' LEU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.478 ' CG2' ' CB ' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 ' CA ' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.504 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.442 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.426 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 128' ' ' PHE . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.413 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.522 ' CD2' ' CG1' ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.486 ' N ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.233 0.539 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 41' ' ' ASN . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' B' ' 39' ' ' ASP . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.403 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 44' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.454 ' CB ' ' CG1' ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.428 ' CA ' HD13 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.428 HD13 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.413 ' HA3' HG12 ' B' ' 96' ' ' VAL . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.429 ' CB ' ' HB ' ' B' ' 135' ' ' VAL . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.44 ' CD1' HG21 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.426 ' CD1' HD11 ' A' ' 43' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.454 ' CG1' ' CB ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.446 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 94.4 m-70 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.414 HG12 ' CB ' ' B' ' 80' ' ' ALA . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.439 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.445 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.488 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.494 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.414 ' CD1' HD12 ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.425 HG13 ' O ' ' B' ' 108' ' ' ILE . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.422 ' N ' HD12 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.438 HD23 ' CG2' ' B' ' 90' ' ' VAL . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 128' ' ' PHE . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.407 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.507 ' CD2' ' CG1' ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.38 0.61 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' C ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.42 HG13 ' CB ' ' B' ' 40' ' ' LEU . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' ' CD2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' GLN . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' CA ' HD12 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.427 HD12 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' MET . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 68' ' ' ASP . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 73' ' ' ILE . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.469 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 53' ' ' PHE . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' CG1' ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.423 HD11 ' CG1' ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.9 m-70 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' CD1' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 85' ' ' ILE . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.431 ' CD ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.433 HG23 ' CA ' ' A' ' 122' ' ' GLU . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 108' ' ' ILE . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 110' ' ' MET . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.431 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.414 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.433 ' CA ' HG23 ' A' ' 105' ' ' VAL . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.407 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.413 ' N ' HG11 ' A' ' 127' ' ' VAL . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 78' ' ' ILE . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.477 ' CG1' ' CB ' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 131' ' ' VAL . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.45 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.322 0.582 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.485 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.445 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 40' ' ' LEU . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.462 ' O ' ' CD2' ' B' ' 47' ' ' HIS . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' B' ' 46' ' ' GLN . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.431 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.446 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.414 ' O ' ' C ' ' B' ' 68' ' ' ASP . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' B' ' 73' ' ' ILE . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' B' ' 54' ' ' VAL . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' B' ' 53' ' ' PHE . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.479 ' CB ' ' CG1' ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.8 m-70 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.459 HG21 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 127' ' ' VAL . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.43 ' CG2' ' CG ' ' B' ' 109' ' ' PRO . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.421 ' CB ' HD11 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.476 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.524 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.421 HD11 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.433 HG13 ' O ' ' B' ' 108' ' ' ILE . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' B' ' 110' ' ' MET . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.425 ' N ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 128' ' ' PHE . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.431 ' N ' HG11 ' B' ' 127' ' ' VAL . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.431 ' CG1' HD11 ' B' ' 78' ' ' ILE . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.479 ' CG1' ' CB ' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' B' ' 131' ' ' VAL . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.446 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' ' CG2' ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.466 ' CG ' HD12 ' B' ' 43' ' ' LEU . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.428 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.434 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.509 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.472 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.409 ' CB ' ' OD2' ' A' ' 123' ' ' ASP . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 86' ' ' VAL . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.437 ' ND1' ' HA ' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.432 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.423 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 6.5 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.453 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.475 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.443 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.476 ' CG ' HD12 ' A' ' 43' ' ' LEU . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.404 ' HB3' HG12 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.426 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.425 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.411 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.441 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.437 ' O ' ' CD1' ' B' ' 94' ' ' PHE . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.439 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.526 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' B' ' 108' ' ' ILE . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.458 HD12 ' N ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.4 t30 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.458 ' N ' HD12 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.413 ' O ' ' N ' ' B' ' 122' ' ' GLU . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.422 ' CD2' ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.421 ' CG2' HG22 ' B' ' 86' ' ' VAL . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.432 ' ND1' ' HA ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.437 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.177 0.513 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.443 ' CB ' ' CD1' ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' B' ' 43' ' ' LEU . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.7 m-70 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.486 HD12 ' CE2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.486 ' CE2' HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' B' ' 139' ' ' ARG . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 44.5 m170 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HB3' ' CG2' ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.407 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.531 . . . . 0.0 110.13 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.46 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.423 HG22 ' CG2' ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.443 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.48 ' CG ' HD23 ' A' ' 43' ' ' LEU . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.449 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.401 ' HB2' HG22 ' B' ' 62' ' ' ILE . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.447 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.449 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.438 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.456 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.7 m-70 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.422 ' CD1' ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.456 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.422 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 88' ' ' ALA . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.508 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.445 HD13 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.441 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 7.5 t30 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.445 ' N ' HD13 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.408 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.406 ' CB ' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.409 ' O ' ' CG2' ' B' ' 130' ' ' VAL . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.459 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 44.0 m170 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.471 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . 0.424 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.084 0.469 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.455 ' CD1' ' CB ' ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.412 ' N ' HG23 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CD1' HD23 ' B' ' 43' ' ' LEU . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.419 ' CA ' HD13 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CA ' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.458 ' HA3' ' CG1' ' A' ' 96' ' ' VAL . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' B' ' 44' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.471 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLU . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.458 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 6.1 t30 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' CA ' HG21 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.247 0.546 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.465 ' CD1' ' CB ' ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.408 ' N ' HG23 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.416 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 43' ' ' LEU . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.434 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.423 ' CA ' HD13 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.423 HD13 ' CA ' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.434 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.462 ' CD1' HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.469 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.458 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.3 m-70 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.402 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.458 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.427 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.427 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.428 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.426 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.505 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.402 HG23 ' N ' ' B' ' 105' ' ' VAL . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' B' ' 115' ' ' SER . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.431 ' CG2' HG21 ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.426 HG21 ' CA ' ' A' ' 139' ' ' ARG . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . 0.412 ' CA ' HG21 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 109.902 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.477 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.433 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CE1' HD23 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HB3' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.431 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.444 ' CG1' HD13 ' A' ' 71' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.417 ' N ' HG23 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CE1' ' CD1' ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.422 ' O ' ' CD1' ' A' ' 132' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' VAL . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.42 ' CB ' HD23 ' A' ' 107' ' ' LEU . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD2' ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 82' ' ' HIS . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.509 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.417 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.42 HD23 ' CB ' ' A' ' 95' ' ' THR . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.442 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 2.5 t-20 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 122' ' ' GLU . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.47 HG22 ' CE1' ' A' ' 133' ' ' HIS . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.47 ' CE1' HG22 ' A' ' 131' ' ' VAL . 15.5 m-70 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.199 0.523 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.437 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.482 ' CE1' HD23 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.434 ' HB3' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.446 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' B' ' 67' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.423 ' N ' HD22 ' B' ' 71' ' ' LEU . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.445 ' CG1' HD13 ' B' ' 71' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.429 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.42 HG23 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.42 ' N ' HG23 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.465 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 39.2 m-70 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.402 ' N ' ' HB2' ' B' ' 98' ' ' LYS . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.427 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.429 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.415 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 97' ' ' LYS . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' B' ' 107' ' ' LEU . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' B' ' 119' ' ' ILE . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' B' ' 108' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.409 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' B' ' 105' ' ' VAL . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.424 ' O ' ' N ' ' B' ' 122' ' ' GLU . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.446 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.471 HG22 ' CE1' ' B' ' 133' ' ' HIS . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.471 ' CE1' HG22 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . 0.426 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.6 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 45' ' ' ILE . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 ' CD1' ' CD2' ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' CG2' ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.444 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' HD22 ' B' ' 43' ' ' LEU . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.418 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 59' ' ' ASP . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 62' ' ' ILE . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 71' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.42 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.6 m-70 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.448 ' CG2' ' CD2' ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.506 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.448 ' CD2' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG2' HG21 ' A' ' 86' ' ' VAL . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.401 HG23 ' O ' ' B' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.438 HG23 ' CG2' ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.447 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.457 ' CD1' HD22 ' A' ' 43' ' ' LEU . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.448 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' B' ' 71' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.42 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.472 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.436 ' CE ' HG21 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' B' ' 84' ' ' ASP . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.547 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.486 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.502 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.437 ' OD1' ' CG1' ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.427 ' HA ' ' CD ' ' B' ' 109' ' ' PRO . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.427 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.439 ' CD2' ' CG2' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' B' ' 86' ' ' VAL . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' B' ' 127' ' ' VAL . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.215 0.531 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD11 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 47' ' ' HIS . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CG ' HD22 ' B' ' 43' ' ' LEU . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' CD1' HG12 ' A' ' 73' ' ' ILE . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 71' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.419 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.42 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 17.3 m-70 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.426 ' CB ' HD22 ' A' ' 107' ' ' LEU . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 98' ' ' LYS . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.407 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.41 ' N ' HD11 ' A' ' 108' ' ' ILE . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.418 HG21 ' CD2' ' A' ' 125' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.418 ' CE1' ' CG2' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.37 0.605 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' B' ' 44' ' ' LEU . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' B' ' 45' ' ' ILE . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.492 HD22 ' CG ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.489 ' N ' HD11 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' B' ' 41' ' ' ASN . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.433 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.431 ' HB1' ' CB ' ' B' ' 47' ' ' HIS . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.434 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.467 ' CG ' HD22 ' A' ' 43' ' ' LEU . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.432 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.409 HD11 ' ND2' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' B' ' 73' ' ' ILE . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' B' ' 71' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.411 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.426 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.537 ' CE1' ' CD1' ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' B' ' 98' ' ' LYS . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.417 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.465 ' CG ' ' HB2' ' B' ' 63' ' ' ASP . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.452 ' CD2' ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.537 ' CD1' ' CE1' ' B' ' 82' ' ' HIS . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.467 ' CD2' ' CG2' ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.424 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.409 ' ND2' HD11 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' B' ' 119' ' ' ILE . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.452 ' CG2' ' CD2' ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.411 ' O ' ' CG2' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.422 ' CE1' ' CG2' ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.318 0.58 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' B' ' 45' ' ' ILE . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 ' CD1' ' HG ' ' B' ' 40' ' ' LEU . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CG ' ' C ' ' A' ' 46' ' ' GLN . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CG ' HD22 ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' HG12 ' A' ' 73' ' ' ILE . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.441 ' CD2' HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.442 HG12 ' CD1' ' A' ' 71' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' OD2' ' CG1' ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.424 HD11 ' NE2' ' A' ' 47' ' ' HIS . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.414 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 96.3 m-70 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.419 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.419 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.435 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 ' CB ' HD12 ' A' ' 107' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 119' ' ' ILE . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.468 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.46 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 90' ' ' VAL . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' CG1' ' OD2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' B' ' 137' ' ' ALA . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.325 0.583 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 45' ' ' ILE . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.438 ' O ' ' CG1' ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.516 HD11 ' N ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.516 ' N ' HD11 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.486 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.438 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.438 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.436 ' CB ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.476 ' CG ' HD22 ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.45 ' CD1' HG12 ' B' ' 73' ' ' ILE . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.45 HG12 ' CD1' ' B' ' 71' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.431 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.428 HD11 ' NE2' ' B' ' 47' ' ' HIS . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.42 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.45 HG21 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.449 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.426 HD22 ' N ' ' B' ' 99' ' ' LEU . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.497 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 108' ' ' ILE . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' B' ' 86' ' ' VAL . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 137' ' ' ALA . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.093 0.473 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.42 ' CB ' HG21 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' HG ' ' B' ' 43' ' ' LEU . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.485 ' CG1' ' CD1' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.434 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 HD13 ' ND2' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 110' ' ' MET . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.421 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 72' ' ' LEU . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.425 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 132' ' ' ILE . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.42 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 118' ' ' THR . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 108' ' ' ILE . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' HD13 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.451 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 107' ' ' LEU . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.412 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HD22 ' A' ' 99' ' ' LEU . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.421 ' N ' HG11 ' A' ' 127' ' ' VAL . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' LEU . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.496 ' CB ' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' B' ' 45' ' ' ILE . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' B' ' 41' ' ' ASN . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.489 ' CD1' ' HG ' ' A' ' 43' ' ' LEU . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.477 ' CG1' ' CD1' ' B' ' 72' ' ' LEU . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' B' ' 66' ' ' ILE . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.417 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.44 HD11 ' N ' ' B' ' 72' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 51' ' ' THR . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.417 ' HA ' HD11 ' B' ' 132' ' ' ILE . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.437 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.437 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' B' ' 97' ' ' LYS . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.438 ' CB ' ' HB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' B' ' 127' ' ' VAL . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.535 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.453 ' HA ' ' HB ' ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.42 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.423 ' CG2' HD21 ' B' ' 99' ' ' LEU . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.41 ' N ' HG11 ' B' ' 127' ' ' VAL . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 74' ' ' VAL . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 74' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.496 ' CE1' ' CB ' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.495 ' CB ' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.407 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' CD1' ' CD1' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.43 HD13 ' CD2' ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' B' ' 43' ' ' LEU . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 127' ' ' VAL . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.409 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' CD ' HG21 ' A' ' 108' ' ' ILE . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 107' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.51 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD13 ' A' ' 99' ' ' LEU . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HG21 ' CD ' ' A' ' 97' ' ' LYS . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.502 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 120' ' ' SER . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' N ' HG23 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' CG2' HG21 ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 133' ' ' HIS . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.42 ' CD1' HD23 ' B' ' 40' ' ' LEU . 1.2 pt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.421 0.629 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.432 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.449 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.467 ' CG ' HD13 ' A' ' 43' ' ' LEU . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HB ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.443 ' CD1' ' ND2' ' B' ' 111' ' ' ASN . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.432 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.409 HG21 HG23 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.457 ' O ' ' CD1' ' B' ' 94' ' ' PHE . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.44 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.424 HG23 ' CD ' ' B' ' 97' ' ' LYS . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' B' ' 108' ' ' ILE . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.46 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.443 ' ND2' ' CD1' ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.405 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.479 HG22 ' CD2' ' B' ' 133' ' ' HIS . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.479 ' CD2' HG22 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 12.1 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' B' ' 41' ' ' ASN . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.463 ' CB ' ' CD2' ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' ' CG ' ' A' ' 47' ' ' HIS . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.424 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' ' HG ' ' B' ' 43' ' ' LEU . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' N ' ' HE2' ' A' ' 55' ' ' LYS . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.41 ' CG ' HG21 ' A' ' 96' ' ' VAL . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.425 HD13 ' ND2' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.425 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG12 ' A' ' 73' ' ' ILE . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 HG12 ' CD1' ' A' ' 71' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 84' ' ' ASP . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 61' ' ' MET . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 125' ' ' LEU . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 118' ' ' THR . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.429 HG22 ' CG2' ' A' ' 95' ' ' THR . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' ND2' HD13 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 122' ' ' GLU . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.457 ' CG2' ' CE1' ' A' ' 133' ' ' HIS . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.308 0.575 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.463 ' CD2' ' CB ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.47 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 47' ' ' HIS . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 43' ' ' LEU . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.424 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.424 ' N ' ' HE2' ' B' ' 55' ' ' LYS . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' CD1' ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' B' ' 96' ' ' VAL . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.42 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG12 ' B' ' 73' ' ' ILE . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.451 HG12 ' CD1' ' B' ' 71' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.465 ' CB ' ' CG1' ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' B' ' 85' ' ' ILE . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 84' ' ' ASP . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.424 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.405 ' HB2' HG13 ' B' ' 108' ' ' ILE . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' B' ' 127' ' ' VAL . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' B' ' 125' ' ' LEU . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.477 HD13 ' N ' ' B' ' 110' ' ' MET . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.501 ' HA ' ' HB ' ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.409 ' O ' ' N ' ' B' ' 122' ' ' GLU . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.453 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.465 ' CG1' ' CB ' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.415 ' HA ' ' CB ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 52' ' ' TYR . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.422 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' B' ' 43' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.474 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' CD1' ' HG2' ' B' ' 138' ' ' MET . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 96' ' ' VAL . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 107' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.45 HD11 ' CB ' ' A' ' 99' ' ' LEU . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 59' ' ' ASP . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 122' ' ' GLU . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 120' ' ' SER . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.404 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.429 HD22 ' CG2' ' A' ' 90' ' ' VAL . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 133' ' ' HIS . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.327 0.584 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' CD2' ' B' ' 44' ' ' LEU . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 40' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.409 HG21 ' N ' ' B' ' 52' ' ' TYR . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.436 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.448 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.438 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.427 HD22 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.434 ' CD1' HD11 ' A' ' 43' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 94' ' ' PHE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.425 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.439 ' CG2' HD22 ' B' ' 125' ' ' LEU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.425 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' B' ' 106' ' ' GLN . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . 0.421 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' B' ' 108' ' ' ILE . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.443 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.424 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.472 ' HB ' ' CG2' ' B' ' 105' ' ' VAL . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.4 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.439 HD22 ' CG2' ' B' ' 90' ' ' VAL . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.439 ' CG2' HG22 ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.455 ' CG2' ' NE2' ' B' ' 133' ' ' HIS . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' MET . . . . . 0.431 ' HG2' ' CD1' ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.282 0.563 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.478 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD12 ' CB ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.43 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.43 ' CG ' ' C ' ' A' ' 46' ' ' GLN . 48.0 m80 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.421 HG23 ' CG2' ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.445 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.431 ' CA ' HD13 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 59' ' ' ASP . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 68' ' ' ASP . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.425 ' CD1' HD13 ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' N ' HD21 ' A' ' 72' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 95.6 m-70 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' C ' ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 109' ' ' PRO . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG13 ' CA ' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' A' ' 86' ' ' VAL . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.505 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 110' ' ' MET . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.431 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 128' ' ' PHE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.415 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.414 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.475 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.452 HD12 ' CB ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 40' ' ' LEU . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.432 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.419 HG23 ' CG2' ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.445 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.463 ' CB ' HD12 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.43 ' CA ' HD13 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.43 HD13 ' CA ' ' B' ' 59' ' ' ASP . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.425 ' O ' ' C ' ' B' ' 68' ' ' ASP . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.431 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.422 ' N ' HD21 ' B' ' 72' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 95.7 m-70 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.429 ' C ' ' CD1' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.43 ' CB ' HD21 ' B' ' 107' ' ' LEU . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' B' ' 107' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.43 HD21 ' CB ' ' B' ' 95' ' ' THR . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.424 ' N ' ' HD3' ' B' ' 109' ' ' PRO . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' B' ' 110' ' ' MET . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' HB ' ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.435 HD11 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.435 ' N ' HD11 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.423 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.424 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' B' ' 119' ' ' ILE . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.415 HG13 ' N ' ' B' ' 128' ' ' PHE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.415 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.414 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.415 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 HD13 ' CG ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.428 HG21 ' CG2' ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.452 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CG ' HD13 ' B' ' 43' ' ' LEU . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 59' ' ' ASP . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' CA ' HG12 ' A' ' 96' ' ' VAL . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' B' ' 43' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.4 HG22 ' CG ' ' A' ' 109' ' ' PRO . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.435 HG12 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.516 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 122' ' ' GLU . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.407 ' CD1' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.435 ' CB ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.441 ' CD1' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.49 HD13 ' CG ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.444 HD13 ' CD1' ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.435 ' CB ' HG22 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.447 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.482 ' CG ' HD13 ' A' ' 43' ' ' LEU . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' B' ' 59' ' ' ASP . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' B' ' 59' ' ' ASP . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.442 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.476 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' A' ' 43' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.458 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.458 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' B' ' 99' ' ' LEU . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.433 ' CB ' HG22 ' B' ' 108' ' ' ILE . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.442 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' CD ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.412 ' CD1' ' HB3' ' B' ' 88' ' ' ALA . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' B' ' 108' ' ' ILE . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.443 ' CD1' ' OD2' ' B' ' 63' ' ' ASP . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.439 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' B' ' 114' ' ' TYR . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 113' ' ' ALA . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.421 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.252 0.549 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' B' ' 40' ' ' LEU . 9.6 p30 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' CD1' HD13 ' B' ' 71' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.535 ' N ' ' CD2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.469 ' CG2' ' CD1' ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.437 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' B' ' 44' ' ' LEU . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.428 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.496 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.417 ' CD2' ' HD3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.431 ' N ' HG23 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' ILE . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 72' ' ' LEU . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 38' ' ' ILE . 6.3 tp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.267 0.556 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.412 ' ND2' ' OD1' ' B' ' 39' ' ' ASP . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.441 HD23 HD11 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.441 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' B' ' 47' ' ' HIS . 0.3 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' B' ' 46' ' ' GLN . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.497 ' HB1' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.466 ' CG2' ' CD1' ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.442 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.429 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.407 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' B' ' 96' ' ' VAL . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.413 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.445 HD13 ' CD1' ' A' ' 44' ' ' LEU . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.436 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.472 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.416 ' CG2' ' HG3' ' B' ' 109' ' ' PRO . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.434 HG12 ' CA ' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.491 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.416 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.432 HG22 ' CD2' ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.429 ' N ' HG21 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.432 ' CD2' HG22 ' B' ' 119' ' ' ILE . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.439 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' B' ' 72' ' ' LEU . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.505 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.462 HG13 HD22 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.414 ' OG1' ' CG2' ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' B' ' 43' ' ' LEU . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.474 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.482 ' CA ' ' CG1' ' A' ' 96' ' ' VAL . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD1' HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.424 ' CD1' HG23 ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 71' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.7 m-70 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.434 HG12 ' CG1' ' A' ' 96' ' ' VAL . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 125' ' ' LEU . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.482 ' CG1' ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' CE ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 82' ' ' HIS . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.464 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.496 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.474 ' ND2' ' CD1' ' A' ' 62' ' ' ILE . 1.5 t-20 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.424 ' CD2' HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 86' ' ' VAL . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.494 ' CE1' ' CB ' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.484 ' CB ' ' CE1' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.407 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.497 ' CD1' HD23 ' A' ' 43' ' ' LEU . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.405 ' O ' ' NZ ' ' B' ' 97' ' ' LYS . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.465 ' CD1' ' ND2' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.473 ' CA ' ' CG1' ' B' ' 96' ' ' VAL . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' B' ' 66' ' ' ILE . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' B' ' 71' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.437 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.4 m-70 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.425 HG12 ' CG1' ' B' ' 96' ' ' VAL . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' B' ' 60' ' ' SER . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.508 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . 0.428 ' CA ' HD11 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.455 ' O ' ' CD1' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.491 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.465 ' ND2' ' CD1' ' B' ' 62' ' ' ILE . 2.2 t-20 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.436 ' HB ' ' CG2' ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' B' ' 86' ' ' VAL . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.408 ' N ' HG13 ' B' ' 127' ' ' VAL . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.484 ' CE1' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CE1' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' B' ' 73' ' ' ILE . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' HB ' ' ND2' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' ' CE ' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.431 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.433 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ASP . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' B' ' 44' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 89.2 m-70 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ASP . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.418 HG23 ' CD2' ' A' ' 107' ' ' LEU . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' CG ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' CD2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.436 HG23 ' CG ' ' A' ' 97' ' ' LYS . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.454 ' HG2' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.407 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.434 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' A' ' 87' ' ' ILE . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.335 0.588 . . . . 0.0 110.123 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.409 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.452 HD11 ' CD1' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.448 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' MET . . . . . 0.413 ' HG2' ' CD1' ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' B' ' 96' ' ' VAL . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.447 ' CD1' HD11 ' A' ' 44' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.418 ' O ' HD13 ' B' ' 132' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 84' ' ' ASP . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.449 ' CG2' HD22 ' B' ' 125' ' ' LEU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.452 ' CB ' ' HD2' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' B' ' 88' ' ' ALA . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' B' ' 106' ' ' GLN . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.514 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' B' ' 108' ' ' ILE . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' B' ' 95' ' ' THR . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . 0.417 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.449 HD22 ' CG2' ' B' ' 90' ' ' VAL . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' B' ' 88' ' ' ALA . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.162 0.506 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 ' CG2' HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.478 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' B' ' 43' ' ' LEU . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.433 ' HB ' ' CB ' ' A' ' 111' ' ' ASN . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD2' ' N ' ' A' ' 110' ' ' MET . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.447 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.43 ' CD1' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' A' ' 131' ' ' VAL . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' CB ' ' A' ' 133' ' ' HIS . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 52' ' ' TYR . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 80' ' ' ALA . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.434 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CE ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.415 ' O ' ' CD2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.412 HD11 ' NZ ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.457 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.434 ' N ' HD11 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.413 ' N ' HG21 ' A' ' 119' ' ' ILE . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.406 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' B' ' 139' ' ' ARG . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.488 HG21 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.496 ' O ' HG21 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' B' ' 133' ' ' HIS . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' B' ' 38' ' ' ILE . 2.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.187 0.518 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.438 ' CD2' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.443 ' CB ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.431 HD13 ' CG2' ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.431 ' CG2' HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.474 ' CB ' ' CG1' ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 43' ' ' LEU . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.429 ' CA ' HD12 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' B' ' 63' ' ' ASP . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.439 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.444 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' LEU . . . . . 0.439 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' B' ' 133' ' ' HIS . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' B' ' 52' ' ' TYR . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' B' ' 80' ' ' ALA . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' B' ' 109' ' ' PRO . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA2' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' B' ' 107' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.438 HD13 ' N ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.438 ' N ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 128' ' ' PHE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' PHE . . . . . 0.413 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 139' ' ' ARG . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' HIS . . . . . 0.522 ' CB ' ' HB ' ' B' ' 73' ' ' ILE . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' MET . . . . . 0.488 ' O ' HG21 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' A' ' 133' ' ' HIS . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.71 82.62 17.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.86 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.418 1.22 . . . . 0.0 110.605 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -115.93 152.56 47.7 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.9 -63.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.218 1.115 . . . . 0.0 110.555 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.8 -80.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 110.171 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.99 67.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.321 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.82 120.31 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -123.79 30.93 6.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.97 148.15 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.06 88.09 1.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -27.26 51.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -81.45 134.38 35.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 12.6 tt -103.74 78.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 110.356 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' ND2' ' OD1' ' A' ' 39' ' ' ASP . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' CD2' ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' HD11 ' A' ' 62' ' ' ILE . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.402 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.433 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' O ' ' CG1' ' A' ' 134' ' ' VAL . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 62' ' ' ILE . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.443 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 32.1 m-70 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' CD2' ' A' ' 94' ' ' PHE . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.492 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.433 ' OD1' ' CD1' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.419 ' CG2' HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.421 ' CG2' HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 133' ' ' HIS . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.475 ' CD2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 64' ' ' GLY . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.235 0.54 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.48 157.6 45.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 -26.5 82.23 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.339 1.178 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.71 73.55 0.31 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.158 -0.964 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.85 126.65 19.39 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.202 1.106 . . . . 0.0 110.444 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.15 -23.83 11.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -155.96 144.62 20.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.89 83.21 1.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.19 86.97 2.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.315 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -120.41 -31.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.16 6.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.212 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -153.55 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.61 164.07 38.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 110.295 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.69 109.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.866 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.441 ' CD1' ' CD2' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.425 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.426 HD13 ' CD2' ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.443 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.428 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.401 ' HG3' ' HE3' ' B' ' 97' ' ' LYS . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.435 ' CG1' ' OD1' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 134' ' ' VAL . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.447 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.423 ' HA ' HG12 ' B' ' 62' ' ' ILE . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.429 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.467 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 31.0 m-70 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.463 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.432 HG22 ' CD2' ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 93' ' ' GLU . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.429 HG11 ' CA ' ' B' ' 64' ' ' GLY . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' B' ' 96' ' ' VAL . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.479 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.487 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' B' ' 118' ' ' THR . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.498 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.435 ' OD1' ' CG1' ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' B' ' 106' ' ' GLN . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.432 ' CD2' HG22 ' B' ' 90' ' ' VAL . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.426 HG13 ' N ' ' B' ' 128' ' ' PHE . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' ' 133' ' ' HIS . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.15 165.22 14.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.24 178.34 0.6 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.322 1.17 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 67.19 3.97 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.64 117.32 4.13 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.263 1.139 . . . . 0.0 110.515 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.51 59.89 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.27 151.44 51.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -39.67 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 34.6 p90 -90.66 144.39 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.14 -41.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.94 -155.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.69 -159.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.75 51.89 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 tp -57.88 126.2 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' B' ' 41' ' ' ASN . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 39' ' ' ASP . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' CA ' HD13 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD13 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.457 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' CB ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.441 ' CD1' HG21 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' CD1' HD11 ' B' ' 43' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.457 ' CG1' ' CB ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.427 ' CB ' HG12 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.3 m-70 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 80' ' ' ALA . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG2' HD23 ' A' ' 125' ' ' LEU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.478 ' CG2' ' CB ' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 ' CA ' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.504 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.442 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 128' ' ' PHE . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.413 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.522 ' CD2' ' CG1' ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.486 ' N ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.192 0.52 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.36 156.52 91.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.39 -72.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.317 1.167 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -118.42 90.51 39.04 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.07 108.4 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.5 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 147.29 45.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.296 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' B' ' 34' ' ' VAL . 31.2 t0 -97.01 75.43 2.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.86 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.413 -0.804 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' B' ' 32' ' ' ASP . 57.7 t -112.39 138.36 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.33 166.72 17.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -63.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -127.25 108.46 10.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 110.16 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -60.99 144.76 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 41' ' ' ASN . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' B' ' 39' ' ' ASP . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.403 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 44' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.454 ' CB ' ' CG1' ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.48 ' CD2' HD13 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.428 ' CA ' HD13 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.428 HD13 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.413 ' HA3' HG12 ' B' ' 96' ' ' VAL . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.458 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.429 ' CB ' ' HB ' ' B' ' 135' ' ' VAL . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.44 ' CD1' HG21 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.426 ' CD1' HD11 ' A' ' 43' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.454 ' CG1' ' CB ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.446 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.488 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 94.4 m-70 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.414 HG12 ' CB ' ' B' ' 80' ' ' ALA . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.439 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.445 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.488 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.494 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.414 ' CD1' HD12 ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.425 HG13 ' O ' ' B' ' 108' ' ' ILE . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.422 ' N ' HD12 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.438 HD23 ' CG2' ' B' ' 90' ' ' VAL . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 128' ' ' PHE . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.407 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.507 ' CD2' ' CG1' ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.207 0.527 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -106.85 173.0 3.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.346 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.87 170.45 5.96 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.325 1.171 . . . . 0.0 110.678 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.421 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 52.63 61.82 11.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.447 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.16 127.67 21.81 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.266 1.14 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 99.57 7.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.287 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.1 96.25 5.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -70.05 95.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.149 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.74 89.03 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.58 -31.24 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -95.69 130.69 42.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.52 -54.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -77.06 -18.89 57.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.379 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -144.09 85.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.171 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' C ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.42 HG13 ' CB ' ' B' ' 40' ' ' LEU . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' ' CD2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' GLN . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' CG1' ' CD2' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' CA ' HD12 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.427 HD12 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' MET . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 68' ' ' ASP . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 73' ' ' ILE . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 53' ' ' PHE . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' CG1' ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.423 HD11 ' CG1' ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.9 m-70 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' CD1' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 85' ' ' ILE . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' CD ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.486 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.433 HG23 ' CA ' ' A' ' 122' ' ' GLU . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 108' ' ' ILE . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 110' ' ' MET . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.431 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.414 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.433 ' CA ' HG23 ' A' ' 105' ' ' VAL . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.407 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.413 ' N ' HG11 ' A' ' 127' ' ' VAL . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 78' ' ' ILE . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.477 ' CG1' ' CB ' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.459 ' CE1' ' CG2' ' A' ' 131' ' ' VAL . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.45 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.265 0.555 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.49 154.15 85.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.36 127.07 20.85 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.286 1.151 . . . . 0.0 110.491 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.8 155.55 88.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 107.44 0.52 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.26 1.137 . . . . 0.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.91 31.73 6.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.031 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.96 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.364 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.19 114.83 8.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 52.66 95.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.924 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' B' ' 34' ' ' VAL . 9.3 p -139.95 111.57 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.344 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -135.63 87.22 2.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.081 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -149.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.906 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -42.91 11.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 110.303 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.69 70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.485 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.445 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 40' ' ' LEU . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.462 ' O ' ' CD2' ' B' ' 47' ' ' HIS . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' B' ' 46' ' ' GLN . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.431 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.446 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.414 ' O ' ' C ' ' B' ' 68' ' ' ASP . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' B' ' 73' ' ' ILE . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' B' ' 54' ' ' VAL . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' B' ' 53' ' ' PHE . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.479 ' CB ' ' CG1' ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' CG1' ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.8 m-70 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.459 HG21 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.442 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' B' ' 127' ' ' VAL . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.43 ' CG2' ' CG ' ' B' ' 109' ' ' PRO . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.421 ' CB ' HD11 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.476 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.524 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.421 HD11 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.433 HG13 ' O ' ' B' ' 108' ' ' ILE . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' B' ' 110' ' ' MET . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.425 ' N ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.431 HG11 ' N ' ' B' ' 128' ' ' PHE . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.431 ' N ' HG11 ' B' ' 127' ' ' VAL . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.431 ' CG1' HD11 ' B' ' 78' ' ' ILE . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.479 ' CG1' ' CB ' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.442 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.455 ' CE1' ' CG2' ' B' ' 131' ' ' VAL . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.446 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.78 161.94 61.93 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.33 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.52 175.34 1.66 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.29 1.153 . . . . 0.0 110.508 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.25 169.29 8.2 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 106.02 0.38 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.313 1.165 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.35 170.87 8.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.21 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.31 52.15 14.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.316 -0.865 . . . . 0.0 110.394 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.11 116.78 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.174 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 53.25 46.03 27.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.77 21.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 110.311 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.66 176.18 7.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -160.21 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 110.023 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.9 -46.49 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 110.043 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 tp -163.65 66.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' ' CG2' ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.466 ' CG ' HD12 ' B' ' 43' ' ' LEU . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.443 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.424 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.428 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.509 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 108' ' ' ILE . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.406 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.472 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' CB ' ' OD2' ' A' ' 123' ' ' ASP . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.427 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 86' ' ' VAL . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.437 ' ND1' ' HA ' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.432 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.185 0.516 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -125.81 71.57 67.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.26 -160.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.308 1.162 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.2 m -155.4 81.55 4.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.66 105.58 0.37 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.278 1.147 . . . . 0.0 110.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.77 149.55 26.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.225 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 167.42 22.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.4 -30.66 23.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.233 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -77.29 75.82 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 110.279 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.64 154.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.59 151.34 38.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 110.379 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -104.88 -141.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.704 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -174.24 -179.98 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.795 -1.191 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.423 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 6.5 tt -121.03 31.59 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.084 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.453 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.475 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.443 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.476 ' CG ' HD12 ' A' ' 43' ' ' LEU . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.413 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.428 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.404 ' HB3' HG12 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.439 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.426 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.425 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.483 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.411 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.441 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.437 ' O ' ' CD1' ' B' ' 94' ' ' PHE . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.439 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.483 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.526 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' B' ' 108' ' ' ILE . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.458 HD12 ' N ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.42 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.4 t30 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.458 ' N ' HD12 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.413 ' O ' ' N ' ' B' ' 122' ' ' GLU . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.422 ' CD2' ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.421 ' CG2' HG22 ' B' ' 86' ' ' VAL . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.432 ' ND1' ' HA ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.437 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -56.66 148.86 44.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.78 119.25 6.24 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 O-C-N 123.109 1.057 . . . . 0.0 110.394 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -63.62 -53.83 47.89 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.49 104.07 0.35 Allowed 'Trans proline' 0 N--CA 1.484 0.914 0 O-C-N 122.939 0.968 . . . . 0.0 110.541 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.23 -80.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.03 73.31 0.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.938 . . . . 0.0 110.222 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.55 148.22 30.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.53 164.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.124 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.59 51.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -96.26 -57.94 2.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -174.19 127.76 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp -86.68 145.49 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.443 ' CB ' ' CD1' ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.432 ' CD1' ' HG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.416 HG22 ' CG2' ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' CD1' HD23 ' B' ' 43' ' ' LEU . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.438 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.492 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.7 m-70 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' CD1' ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.486 HD12 ' CE2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.486 ' CE2' HD12 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 59' ' ' ASP . 0.6 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' B' ' 139' ' ' ARG . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 44.5 m170 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HB3' ' CG2' ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -80.68 159.53 68.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.16 171.37 4.04 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.288 1.152 . . . . 0.0 110.491 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -143.02 71.8 18.54 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.58 123.52 12.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.285 1.15 . . . . 0.0 110.496 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 49.73 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.81 152.89 32.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.239 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.94 28.87 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -114.4 56.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.08 -67.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.179 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.15 71.78 10.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.141 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -95.36 -39.8 9.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -104.15 110.47 22.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.407 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER -72.91 150.21 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.46 ' CB ' ' CD1' ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.423 HG22 ' CG2' ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.443 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.48 ' CG ' HD23 ' A' ' 43' ' ' LEU . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.449 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.463 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.401 ' HB2' HG22 ' B' ' 62' ' ' ILE . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.447 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.449 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.438 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.456 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.7 m-70 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.451 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.422 ' CD1' ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.456 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.422 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' B' ' 88' ' ' ALA . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.451 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.508 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.445 HD13 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.441 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 7.5 t30 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.445 ' N ' HD13 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.408 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.406 ' CB ' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.435 ' CD2' HG21 ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.409 ' O ' ' CG2' ' B' ' 130' ' ' VAL . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.459 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 44.0 m170 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.471 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . 0.424 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.163 0.506 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 53.38 78.14 0.41 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.349 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.4 166.13 11.84 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.305 1.161 . . . . 0.0 110.46 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -55.85 -54.42 52.21 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.545 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -61.28 114.17 2.09 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 O-C-N 122.766 0.877 . . . . 0.0 110.513 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.93 98.18 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.27 110.01 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 108.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -163.72 46.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.8 117.96 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.33 166.92 20.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.34 -148.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtp85 -141.48 -174.76 4.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.025 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.46 103.89 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -0.815 . . . . 0.0 109.924 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.455 ' CD1' ' CB ' ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.412 ' N ' HG23 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CD1' HD23 ' B' ' 43' ' ' LEU . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.419 ' CA ' HD13 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD13 ' CA ' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.458 ' HA3' ' CG1' ' A' ' 96' ' ' VAL . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' B' ' 44' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.471 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 93' ' ' GLU . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.458 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.519 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.437 ' CD1' ' N ' ' A' ' 115' ' ' SER . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 6.1 t30 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' N ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' CG2' HG21 ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' CA ' HG21 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.225 0.536 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 53.46 65.42 5.68 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.54 80.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.304 1.16 . . . . 0.0 110.635 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p -117.77 154.32 51.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.019 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.48 -69.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.284 1.15 . . . . 0.0 110.45 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.34 -156.6 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.58 71.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.31 -1.77 32.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.694 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.57 -11.31 9.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.014 -1.053 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.77 -67.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -73.68 173.37 9.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.55 -62.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -155.84 -164.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 tt -174.23 71.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.962 . . . . 0.0 110.368 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.456 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.465 ' CD1' ' CB ' ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.408 ' N ' HG23 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.416 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' CB ' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 43' ' ' LEU . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.434 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.423 ' CA ' HD13 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.423 HD13 ' CA ' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.434 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.462 ' CD1' HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.469 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.458 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.3 m-70 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.402 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.458 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.427 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.427 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.428 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.426 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.505 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.402 HG23 ' N ' ' B' ' 105' ' ' VAL . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' B' ' 115' ' ' SER . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.431 ' CG2' HG21 ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.426 HG21 ' CA ' ' A' ' 139' ' ' ARG . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . 0.412 ' CA ' HG21 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -77.18 162.42 69.55 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 143.56 98.92 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.282 1.148 . . . . 0.0 110.461 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.419 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER 54.47 176.25 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.63 -40.91 43.02 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.201 1.106 . . . . 0.0 110.499 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.56 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.168 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.14 149.54 26.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.147 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -158.24 105.78 1.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 0.0 110.172 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 52.97 35.2 18.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.902 . . . . 0.0 110.235 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.73 123.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.49 23.35 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.938 . . . . 0.0 110.202 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 51.6 tt0 -152.71 169.43 22.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 36' ' ' GLN . 2.3 ttp180 -124.38 115.19 20.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -142.03 43.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 109.902 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.477 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.433 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CE1' HD23 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HB3' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.431 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.444 ' CG1' HD13 ' A' ' 71' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.417 ' N ' HG23 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.542 ' CE1' ' CD1' ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.422 ' O ' ' CD1' ' A' ' 132' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 127' ' ' VAL . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.42 ' CB ' HD23 ' A' ' 107' ' ' LEU . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD2' ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 82' ' ' HIS . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.509 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.417 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.42 HD23 ' CB ' ' A' ' 95' ' ' THR . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.442 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 2.5 t-20 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 122' ' ' GLU . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.423 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG22 ' CE1' ' A' ' 133' ' ' HIS . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.47 ' CE1' HG22 ' A' ' 131' ' ' VAL . 15.5 m-70 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.19 0.519 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.536 ' N ' ' CD1' ' B' ' 26' ' ' PHE . 14.7 p90 -158.69 77.85 3.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.216 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 102.3 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.146 1.077 . . . . 0.0 110.504 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 85.5 p -150.47 81.31 6.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.46 -44.83 20.57 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.321 1.169 . . . . 0.0 110.527 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.98 84.88 2.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.134 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.09 116.82 11.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.99 157.34 43.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 21.26 15.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.94 148.32 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -151.53 79.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -138.98 -146.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.903 . . . . 0.0 109.942 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.26 -157.86 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt -150.69 71.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.434 HD11 ' CD2' ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.437 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.482 ' CE1' HD23 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.434 ' HB3' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.446 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' B' ' 67' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.458 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.423 ' N ' HD22 ' B' ' 71' ' ' LEU . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.445 ' CG1' HD13 ' B' ' 71' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.429 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.42 HG23 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.42 ' N ' HG23 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.465 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 39.2 m-70 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.402 ' N ' ' HB2' ' B' ' 98' ' ' LYS . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.427 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.429 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.415 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' B' ' 97' ' ' LYS . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' B' ' 107' ' ' LEU . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' B' ' 119' ' ' ILE . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' B' ' 108' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.409 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' B' ' 105' ' ' VAL . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.424 ' O ' ' N ' ' B' ' 122' ' ' GLU . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.446 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.471 HG22 ' CE1' ' B' ' 133' ' ' HIS . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.471 ' CE1' HG22 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . 0.426 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.24 0.543 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 12.2 p90 -146.92 64.97 9.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.38 174.08 2.26 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.327 1.172 . . . . 0.0 110.56 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.97 75.12 9.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 94.11 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.236 1.124 . . . . 0.0 110.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.48 11.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.26 126.31 44.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.31 126.64 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -86.54 -170.02 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 m -151.07 43.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.179 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.91 90.63 2.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -154.26 -46.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.353 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 55.12 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 109.779 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.6 tt -76.39 57.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 110.672 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 45' ' ' ILE . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' CD1' ' CD2' ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.441 HG23 ' CG2' ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.444 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD1' HD22 ' B' ' 43' ' ' LEU . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.418 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 59' ' ' ASP . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 62' ' ' ILE . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 71' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.42 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.6 m-70 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.448 ' CG2' ' CD2' ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.506 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' HB ' ' CG1' ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.448 ' CD2' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.438 ' CG2' HG21 ' A' ' 86' ' ' VAL . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.2 0.524 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -148.32 83.25 7.21 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -69.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.324 1.171 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 8.3 p -171.53 160.76 5.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.88 -28.45 81.28 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.236 1.124 . . . . 0.0 110.489 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.13 102.12 13.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 48.13 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -73.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -135.98 19.65 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 110.439 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.38 58.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.299 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.47 -75.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.183 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -58.27 8.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.105 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' B' ' 38' ' ' ILE . 3.0 ttt-85 53.13 53.62 11.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.302 -0.874 . . . . 0.0 110.454 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' B' ' 37' ' ' ARG . 0.7 OUTLIER 36.36 60.8 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.438 HG23 ' CG2' ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.447 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.457 ' CD1' HD22 ' A' ' 43' ' ' LEU . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.437 ' CG1' ' OD1' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.448 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' B' ' 71' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.42 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.478 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.447 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.472 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.436 ' CE ' HG21 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' B' ' 84' ' ' ASP . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.547 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.486 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.502 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.437 ' OD1' ' CG1' ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.427 ' HA ' ' CD ' ' B' ' 109' ' ' PRO . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.427 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.439 ' CD2' ' CG2' ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' B' ' 86' ' ' VAL . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' B' ' 127' ' ' VAL . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 23.5 p90 -139.19 61.33 20.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.51 -157.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.171 1.09 . . . . 0.0 110.459 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 11.8 m -144.92 61.72 8.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.37 81.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.289 1.152 . . . . 0.0 110.526 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 28' ' ' SER . . . -117.99 101.97 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 -44.04 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.46 34.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.55 66.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.63 135.29 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 110.14 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -120.65 169.64 10.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.943 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -174.51 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 113.7 2.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.35 148.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' N ' HD11 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 47' ' ' HIS . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.492 ' CG ' HD22 ' B' ' 43' ' ' LEU . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' CD1' HG12 ' A' ' 73' ' ' ILE . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 71' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.419 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.42 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 17.3 m-70 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.426 ' CB ' HD22 ' A' ' 107' ' ' LEU . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 98' ' ' LYS . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.407 ' OE1' ' CG ' ' A' ' 103' ' ' PRO . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.41 ' N ' HD11 ' A' ' 108' ' ' ILE . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.418 HG21 ' CD2' ' A' ' 125' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.421 ' CD2' HG21 ' A' ' 90' ' ' VAL . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.418 ' CE1' ' CG2' ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.47 ' N ' ' CD ' ' B' ' 27' ' ' PRO . 0.1 OUTLIER -52.77 -52.16 67.16 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.904 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' B' ' 26' ' ' PHE . 3.1 Cg_exo -62.62 178.01 1.1 Allowed 'Trans proline' 0 N--CA 1.484 0.948 0 O-C-N 122.833 0.912 . . . . 0.0 110.586 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m 53.77 72.72 1.06 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.153 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.42 121.43 9.58 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.374 1.197 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.16 47.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -172.4 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.53 91.95 8.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.418 HG23 ' N ' ' B' ' 35' ' ' GLU . 7.1 p -172.24 155.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.418 ' N ' HG23 ' B' ' 34' ' ' VAL . 5.0 tp10 -55.19 -64.46 0.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.24 -151.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 71.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 38' ' ' ILE . 0.1 OUTLIER -146.81 138.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' B' ' 44' ' ' LEU . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' B' ' 45' ' ' ILE . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.492 HD22 ' CG ' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.489 ' N ' HD11 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' B' ' 41' ' ' ASN . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.433 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.433 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.431 ' HB1' ' CB ' ' B' ' 47' ' ' HIS . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.434 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.467 ' CG ' HD22 ' A' ' 43' ' ' LEU . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.432 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.409 HD11 ' ND2' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.441 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' B' ' 73' ' ' ILE . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.452 HG12 ' CD1' ' B' ' 71' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.411 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.426 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.537 ' CE1' ' CD1' ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' B' ' 98' ' ' LYS . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.417 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.467 ' CG2' ' CD2' ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.465 ' CG ' ' HB2' ' B' ' 63' ' ' ASP . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.452 ' CD2' ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.537 ' CD1' ' CE1' ' B' ' 82' ' ' HIS . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.467 ' CD2' ' CG2' ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.424 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.409 ' ND2' HD11 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' B' ' 119' ' ' ILE . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.452 ' CG2' ' CD2' ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.411 ' O ' ' CG2' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.422 ' CE1' ' CG2' ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.228 0.537 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -127.02 87.44 56.67 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.228 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.65 -28.71 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.356 1.187 . . . . 0.0 110.597 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.7 90.51 7.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.37 107.6 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.239 1.126 . . . . 0.0 110.536 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.52 159.16 18.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.201 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.34 141.58 58.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 110.45 2.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.15 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 52.77 -167.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.66 176.97 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -61.01 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.04 -64.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 0.0 110.279 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 54.38 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.079 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 tt -64.58 85.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.883 . . . . 0.0 110.281 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HG ' ' CD1' ' B' ' 45' ' ' ILE . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 ' CD1' ' HG ' ' B' ' 40' ' ' LEU . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.428 ' CG ' ' C ' ' A' ' 46' ' ' GLN . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CG ' HD22 ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' CD1' HG12 ' A' ' 73' ' ' ILE . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.441 ' CD2' HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.442 HG12 ' CD1' ' A' ' 71' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' OD2' ' CG1' ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.424 HD11 ' NE2' ' A' ' 47' ' ' HIS . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.414 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.46 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 96.3 m-70 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.45 ' O ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.419 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.419 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.435 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 ' CB ' HD12 ' A' ' 107' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 119' ' ' ILE . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.468 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.46 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.445 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 90' ' ' VAL . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' CG1' ' OD2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' B' ' 137' ' ' ALA . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.302 0.572 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.7 168.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.05 161.39 22.63 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.319 1.168 . . . . 0.0 110.653 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.422 ' O ' ' N ' ' B' ' 30' ' ' ALA . 23.3 p -118.39 95.5 48.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 80.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.179 1.094 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 28' ' ' SER . . . -175.88 86.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.113 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.99 -61.5 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -174.98 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.92 60.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.269 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.62 60.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.039 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.07 117.97 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -52.91 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.935 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.23 110.66 3.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.886 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt -122.63 150.49 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 45' ' ' ILE . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.438 ' O ' ' CG1' ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.516 HD11 ' N ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.516 ' N ' HD11 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.486 ' CD1' ' HG ' ' A' ' 40' ' ' LEU . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.438 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.438 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.436 ' CB ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.476 ' CG ' HD22 ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.449 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.45 ' CD1' HG12 ' B' ' 73' ' ' ILE . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.445 ' CD2' HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.45 HG12 ' CD1' ' B' ' 71' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.431 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.428 HD11 ' NE2' ' B' ' 47' ' ' HIS . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.42 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.45 HG21 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.449 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.487 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.426 HD22 ' N ' ' B' ' 99' ' ' LEU . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.43 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.497 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 108' ' ' ILE . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.427 HG23 ' CG2' ' B' ' 86' ' ' VAL . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 137' ' ' ALA . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.297 0.57 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -128.61 68.19 77.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 132.22 39.68 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.257 1.135 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 m -142.74 64.32 15.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.931 . . . . 0.0 110.46 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.38 -72.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.302 1.159 . . . . 0.0 110.497 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 64' ' ' GLY . . . -167.73 154.84 8.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.882 . . . . 0.0 110.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' ' CG1' ' B' ' 96' ' ' VAL . . . -114.91 -142.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 0.0 110.515 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' N ' HG11 ' B' ' 96' ' ' VAL . 16.7 t0 -175.53 54.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.995 -1.066 . . . . 0.0 109.991 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.64 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.0 110.491 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 m -103.44 -170.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.15 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -170.79 79.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 110.166 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 -166.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' CZ ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER 62.71 131.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 0.0 109.8 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.35 12.07 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 110.657 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 41' ' ' ASN . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.42 ' CB ' HG21 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD1' ' HG ' ' B' ' 43' ' ' LEU . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.485 ' CG1' ' CD1' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.434 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 HD13 ' ND2' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' A' ' 110' ' ' MET . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.421 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 72' ' ' LEU . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.425 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 132' ' ' ILE . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.42 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 61' ' ' MET . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 125' ' ' LEU . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 118' ' ' THR . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 108' ' ' ILE . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' ND2' HD13 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.451 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 107' ' ' LEU . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.412 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HD22 ' A' ' 99' ' ' LEU . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.421 ' N ' HG11 ' A' ' 127' ' ' VAL . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' LEU . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.496 ' CB ' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.27 0.557 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.482 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -74.01 -52.62 4.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.783 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.1 99.83 0.2 Allowed 'Trans proline' 0 N--CA 1.483 0.892 0 O-C-N 122.809 0.9 . . . . 0.0 110.518 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.6 m -127.19 81.7 69.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.53 -70.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.309 1.162 . . . . 0.0 110.533 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.84 84.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.16 171.24 14.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 110.314 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -103.99 -177.71 3.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.11 29.49 7.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.413 HG22 ' N ' ' B' ' 35' ' ' GLU . 34.9 m -116.17 -21.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.413 ' N ' HG22 ' B' ' 34' ' ' VAL . 4.2 mt-10 -106.43 -166.77 1.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.167 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.94 -148.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 21.97 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.244 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -125.03 96.08 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.083 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' B' ' 45' ' ' ILE . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' B' ' 41' ' ' ASN . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.44 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.489 ' CD1' ' HG ' ' A' ' 43' ' ' LEU . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.477 ' CG1' ' CD1' ' B' ' 72' ' ' LEU . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 31' ' ' ALA . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.417 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.44 HD11 ' N ' ' B' ' 72' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' B' ' 72' ' ' LEU . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' B' ' 51' ' ' THR . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.417 ' HA ' HD11 ' B' ' 132' ' ' ILE . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.437 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.437 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 31' ' ' ALA . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.438 ' CB ' ' HB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' B' ' 127' ' ' VAL . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.535 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.453 ' HA ' ' HB ' ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.42 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.431 HD11 ' CD1' ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.409 ' O ' ' CG1' ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.423 ' CG2' HD21 ' B' ' 99' ' ' LEU . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.41 ' N ' HG11 ' B' ' 127' ' ' VAL . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 74' ' ' VAL . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' B' ' 74' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.496 ' CE1' ' CB ' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.495 ' CB ' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.462 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 44.4 p90 -161.34 135.82 5.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.92 -159.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.484 0.95 0 O-C-N 123.042 1.022 . . . . 0.0 110.5 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.59 68.26 3.23 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 94.5 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.348 1.183 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.67 84.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.309 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -161.4 42.1 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -113.59 -24.99 8.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.087 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -129.92 149.52 51.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.31 169.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.26 118.88 37.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -135.34 -63.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -138.19 96.25 3.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt -162.37 43.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.907 . . . . 0.0 110.276 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.407 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' CD1' ' CD1' ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' B' ' 71' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.43 HD13 ' CD2' ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' B' ' 43' ' ' LEU . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' CB ' ' HB2' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 127' ' ' VAL . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG21 HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.409 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' CD ' HG21 ' A' ' 108' ' ' ILE . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 107' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.51 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD13 ' A' ' 99' ' ' LEU . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HG21 ' CD ' ' A' ' 97' ' ' LYS . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.502 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.502 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 120' ' ' SER . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' N ' HG23 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.426 ' CD2' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' CG2' HG21 ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 133' ' ' HIS . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.475 ' CD2' HG22 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -71.19 -52.9 8.7 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.81 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_exo -61.72 99.18 0.17 Allowed 'Trans proline' 0 N--CA 1.483 0.886 0 O-C-N 122.803 0.897 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -143.31 164.66 29.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.38 -60.95 0.19 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.323 1.17 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.89 126.52 10.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 110.066 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.04 37.41 2.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.317 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.37 -70.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.39 64.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.061 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.34 155.71 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.298 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.43 19.35 6.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.438 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -174.45 -148.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.014 . . . . 0.0 110.085 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.34 -49.04 1.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.42 ' CD1' HD23 ' B' ' 40' ' ' LEU . 1.2 pt -114.98 126.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.463 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.432 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.449 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.467 ' CG ' HD13 ' A' ' 43' ' ' LEU . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HB ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.443 ' CD1' ' ND2' ' B' ' 111' ' ' ASN . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.444 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.456 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.432 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.409 HG21 HG23 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.457 ' O ' ' CD1' ' B' ' 94' ' ' PHE . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.44 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.424 HG23 ' CD ' ' B' ' 97' ' ' LYS . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' B' ' 108' ' ' ILE . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.46 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.443 ' ND2' ' CD1' ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.405 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.421 ' CD2' ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.479 HG22 ' CD2' ' B' ' 133' ' ' HIS . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.479 ' CD2' HG22 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.303 0.573 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.483 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 1.1 m-85 -69.76 -52.68 13.27 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.94 92.44 0.12 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 O-C-N 122.805 0.897 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.52 171.72 7.56 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.369 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.35 81.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.391 1.206 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.81 -58.27 3.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.26 137.0 36.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.52 122.92 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -101.01 110.4 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.98 156.31 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -85.66 103.59 14.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.46 -159.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 109.971 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -146.11 28.18 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 12.1 tt -71.07 96.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 110.331 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' B' ' 41' ' ' ASN . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.463 ' CB ' ' CD2' ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.464 ' O ' ' CG ' ' A' ' 47' ' ' HIS . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.424 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' ' HG ' ' B' ' 43' ' ' LEU . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' N ' ' HE2' ' A' ' 55' ' ' LYS . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.41 ' CG ' HG21 ' A' ' 96' ' ' VAL . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.425 HD13 ' ND2' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.425 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG12 ' A' ' 73' ' ' ILE . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 HG12 ' CD1' ' A' ' 71' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 84' ' ' ASP . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.41 HG21 ' CG ' ' A' ' 61' ' ' MET . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' HD2' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 125' ' ' LEU . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.573 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 118' ' ' THR . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 117' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.429 HG22 ' CG2' ' A' ' 95' ' ' THR . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' ND2' HD13 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 122' ' ' GLU . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.457 ' CG2' ' CE1' ' A' ' 133' ' ' HIS . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.482 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.477 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.262 0.553 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -158.34 85.39 2.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.76 132.03 38.13 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.285 1.15 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 41.6 p -69.59 156.85 90.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.145 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.74 81.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.273 1.144 . . . . 0.0 110.597 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.41 33.06 5.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.96 -30.22 10.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 110.165 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 177.54 3.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.43 122.97 40.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.93 -44.57 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -113.94 92.4 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.57 -50.67 4.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 110.256 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.21 139.83 21.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.25 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt -174.23 144.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.463 ' CD2' ' CB ' ' A' ' 41' ' ' ASN . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.47 ' CB ' ' CD2' ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.473 ' O ' ' CG ' ' B' ' 47' ' ' HIS . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 43' ' ' LEU . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.424 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.424 ' N ' ' HE2' ' B' ' 55' ' ' LYS . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.417 ' OD2' ' CD1' ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' B' ' 96' ' ' VAL . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.42 ' O ' ' CG1' ' B' ' 66' ' ' ILE . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.451 ' CD1' HG12 ' B' ' 73' ' ' ILE . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.451 HG12 ' CD1' ' B' ' 71' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.465 ' CB ' ' CG1' ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' B' ' 85' ' ' ILE . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 84' ' ' ASP . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.424 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.405 ' HB2' HG13 ' B' ' 108' ' ' ILE . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' B' ' 127' ' ' VAL . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' B' ' 125' ' ' LEU . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.477 HD13 ' N ' ' B' ' 110' ' ' MET . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.501 ' HA ' ' HB ' ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.409 ' O ' ' N ' ' B' ' 122' ' ' GLU . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.453 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.465 ' CG1' ' CB ' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.482 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . 0.437 ' CB ' ' HA ' ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.196 0.522 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.2 155.95 36.02 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.114 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 -66.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.318 1.167 . . . . 0.0 110.446 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -130.96 71.58 82.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.32 130.73 33.22 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 O-C-N 123.33 1.174 . . . . 0.0 110.439 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.68 -178.07 5.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -158.68 97.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.158 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.17 171.77 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 53.17 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.8 m -144.24 56.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.18 139.18 38.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.89 -62.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.285 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.2 68.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 tp -159.34 54.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.415 ' HA ' ' CB ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' CB ' ' HA ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 52' ' ' TYR . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.405 ' HG2' ' HB ' ' A' ' 96' ' ' VAL . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 ' CD1' ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' B' ' 43' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.474 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' CD1' ' HG2' ' B' ' 138' ' ' MET . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 96' ' ' VAL . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 107' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.523 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.45 HD11 ' CB ' ' A' ' 99' ' ' LEU . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 59' ' ' ASP . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 122' ' ' GLU . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 120' ' ' SER . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.404 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.429 HD22 ' CG2' ' A' ' 90' ' ' VAL . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 133' ' ' HIS . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.478 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.179 0.514 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.482 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.6 m-85 -62.4 -53.18 60.25 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 110.669 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 2.9 Cg_endo -62.03 153.79 66.49 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 122.825 0.908 . . . . 0.0 110.442 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' B' ' 29' ' ' PRO . 98.7 p -149.34 60.46 4.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.367 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' B' ' 28' ' ' SER . 2.9 Cg_endo -61.86 111.06 1.1 Allowed 'Trans proline' 0 C--N 1.32 -0.955 0 O-C-N 123.262 1.138 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.41 163.27 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 -56.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -92.06 160.73 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 110.051 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -120.59 142.13 49.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.11 153.98 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.136 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.04 -77.69 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.53 -151.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -127.44 74.18 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt -160.97 52.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' CD2' ' B' ' 44' ' ' LEU . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.404 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' B' ' 40' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.409 HG21 ' N ' ' B' ' 52' ' ' TYR . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.436 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.448 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.438 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.427 HD22 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.434 ' CD1' HD11 ' A' ' 43' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 94' ' ' PHE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.425 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.439 ' CG2' HD22 ' B' ' 125' ' ' LEU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.425 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' B' ' 61' ' ' MET . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' B' ' 106' ' ' GLN . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.603 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . 0.421 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' B' ' 108' ' ' ILE . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.443 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.424 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.472 ' HB ' ' CG2' ' B' ' 105' ' ' VAL . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.4 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.439 HD22 ' CG2' ' B' ' 90' ' ' VAL . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.439 ' CG2' HG22 ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.455 ' CG2' ' NE2' ' B' ' 133' ' ' HIS . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.431 ' HG2' ' CD1' ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.23 65.8 69.57 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 110.058 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.96 130.92 32.69 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.271 1.143 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 p -163.15 156.16 16.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.46 -27.11 76.82 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.319 1.168 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.17 135.94 8.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.068 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.6 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -91.92 -175.6 4.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.425 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 39.4 p90 -156.19 25.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -0.84 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 m -105.48 -22.71 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.305 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -89.96 57.27 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -155.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -115.2 -176.3 2.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -169.83 62.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.192 -0.943 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.478 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD12 ' CB ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' CG2' HG23 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.43 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.43 ' CG ' ' C ' ' A' ' 46' ' ' GLN . 48.0 m80 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.421 HG23 ' CG2' ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.445 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' CA ' HD13 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 111' ' ' ASN . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 59' ' ' ASP . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 68' ' ' ASP . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.425 ' CD1' HD13 ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' N ' HD21 ' A' ' 72' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 95.6 m-70 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' C ' ' CD1' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 109' ' ' PRO . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG13 ' CA ' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD21 ' CG2' ' A' ' 86' ' ' VAL . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.505 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 110' ' ' MET . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.431 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 128' ' ' PHE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.415 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.414 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -53.82 153.48 8.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 110.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.32 144.05 94.71 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.262 1.138 . . . . 0.0 110.675 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 88.6 p -143.03 92.18 6.92 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.112 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.04 124.74 15.9 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 O-C-N 123.155 1.082 . . . . 0.0 110.61 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.93 119.37 19.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.97 68.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -89.74 47.32 1.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 102.24 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.52 -177.86 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.105 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -143.41 68.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 110.224 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' B' ' 38' ' ' ILE . 1.0 OUTLIER -100.28 -54.86 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.23 -71.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.395 -0.816 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -160.98 72.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.059 -1.026 . . . . 0.0 110.561 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.475 ' N ' ' CD1' ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.452 HD12 ' CB ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.425 HG13 ' CB ' ' A' ' 40' ' ' LEU . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.432 ' C ' ' CG ' ' B' ' 47' ' ' HIS . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.432 ' CG ' ' C ' ' B' ' 46' ' ' GLN . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.419 HG23 ' CG2' ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.445 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.463 ' CB ' HD12 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.43 ' CA ' HD13 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.43 HD13 ' CA ' ' B' ' 59' ' ' ASP . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.42 ' CA ' HG12 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.425 ' O ' ' C ' ' B' ' 68' ' ' ASP . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.409 ' CD1' HD13 ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.431 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.422 ' N ' HD21 ' B' ' 72' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.428 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 95.7 m-70 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.429 ' C ' ' CD1' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.43 ' CB ' HD21 ' B' ' 107' ' ' LEU . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 87' ' ' ILE . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' B' ' 107' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.43 HD21 ' CB ' ' B' ' 95' ' ' THR . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.424 ' N ' ' HD3' ' B' ' 109' ' ' PRO . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' B' ' 110' ' ' MET . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.434 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' HB ' ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.435 HD11 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.435 ' N ' HD11 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.423 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.424 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' B' ' 119' ' ' ILE . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.415 HG13 ' N ' ' B' ' 128' ' ' PHE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.415 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.414 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.415 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.206 0.527 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.35 155.2 48.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.78 161.23 25.89 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.211 1.111 . . . . 0.0 110.501 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 t -141.51 73.19 24.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.301 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.63 -39.42 54.29 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.29 1.152 . . . . 0.0 110.572 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 107.02 9.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.53 41.26 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.54 111.55 2.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.856 . . . . 0.0 110.267 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 52.5 67.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.76 -27.73 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.83 124.08 48.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.164 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -96.48 -160.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.186 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 -59.01 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.31 57.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 HD13 ' CG ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.428 HG21 ' CG2' ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.452 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CG ' HD13 ' B' ' 43' ' ' LEU . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 59' ' ' ASP . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' CA ' HG12 ' A' ' 96' ' ' VAL . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.481 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.45 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' B' ' 43' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' ' CG1' ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.4 HG22 ' CG ' ' A' ' 109' ' ' PRO . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.435 HG12 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.516 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 122' ' ' GLU . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.407 ' CD1' HD11 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.435 ' CB ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.471 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 86.18 51.63 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.67 -164.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.326 1.172 . . . . 0.0 110.551 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -162.47 78.48 1.92 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.18 -54.3 1.9 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.252 1.133 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.95 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.343 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.2 -69.11 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.77 106.87 18.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.13 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.83 118.62 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -178.62 5.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.02 -149.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 154.47 29.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt -141.53 49.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.946 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.441 ' CD1' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.49 HD13 ' CG ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.444 HD13 ' CD1' ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.435 ' CB ' HG22 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.447 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.482 ' CG ' HD13 ' A' ' 43' ' ' LEU . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.439 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' B' ' 59' ' ' ASP . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.409 ' CD1' ' HB2' ' B' ' 59' ' ' ASP . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.442 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.476 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.439 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' A' ' 43' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.458 ' CB ' ' CG1' ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.458 ' CG1' ' CB ' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.412 ' HB3' ' CD1' ' B' ' 99' ' ' LEU . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.433 ' CB ' HG22 ' B' ' 108' ' ' ILE . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.442 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' CD ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.412 ' CD1' ' HB3' ' B' ' 88' ' ' ALA . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' B' ' 108' ' ' ILE . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.443 ' CD1' ' OD2' ' B' ' 63' ' ' ASP . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.439 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' B' ' 114' ' ' TYR . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' B' ' 113' ' ' ALA . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.421 HG21 ' CD2' ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' B' ' 101' ' ' LEU . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.434 ' CG2' HG22 ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.474 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.185 0.516 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 19.0 p90 -53.97 154.29 7.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.76 103.21 0.27 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.274 1.144 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.474 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -54.2 -52.81 65.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.78 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -62.43 119.86 7.14 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 122.886 0.94 . . . . 0.0 110.558 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.2 -162.93 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.272 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.04 -160.79 1.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.91 -47.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -93.7 47.62 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.6 t -54.79 -40.97 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 110.284 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.417 ' HG3' ' ND2' ' A' ' 41' ' ' ASN . 1.1 tt0 -148.17 37.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.28 -55.45 2.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.319 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -49.11 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.93 95.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.5 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' B' ' 40' ' ' LEU . 9.6 p30 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' CD1' HD13 ' B' ' 71' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.535 ' N ' ' CD2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 46' ' ' GLN . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.469 ' CG2' ' CD1' ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.437 ' O ' ' CG1' ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD13 ' CD1' ' B' ' 44' ' ' LEU . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.428 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.496 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.417 ' CD2' ' HD3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.431 ' N ' HG23 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' ILE . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 72' ' ' LEU . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.472 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.1 m-85 -64.29 -52.36 54.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.73 -155.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.942 0 O-C-N 122.785 0.887 . . . . 0.0 110.606 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ALA . 0.4 OUTLIER -147.54 155.34 45.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 75.18 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.313 1.165 . . . . 0.0 110.635 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 28' ' ' SER . . . 51.28 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.3 114.66 14.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.02 -51.04 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.08 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.72 63.45 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.24 77.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.287 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.41 145.36 20.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.83 -150.15 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 110.053 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -52.74 3.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' B' ' 38' ' ' ILE . 6.3 tp -155.21 85.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 110.391 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.412 ' ND2' ' OD1' ' B' ' 39' ' ' ASP . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.441 HD23 HD11 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.441 ' HG ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' B' ' 47' ' ' HIS . 0.3 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' B' ' 46' ' ' GLN . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.497 ' HB1' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.466 ' CG2' ' CD1' ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.442 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.429 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.407 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' B' ' 96' ' ' VAL . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.438 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.413 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.445 HD13 ' CD1' ' A' ' 44' ' ' LEU . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.436 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.472 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 96' ' ' VAL . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.416 ' CG2' ' HG3' ' B' ' 109' ' ' PRO . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.434 HG12 ' CA ' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.491 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.416 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.4 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.432 HG22 ' CD2' ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.429 ' N ' HG21 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.432 ' CD2' HG22 ' B' ' 119' ' ' ILE . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.438 HG23 ' CD2' ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.439 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' B' ' 72' ' ' LEU . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.422 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.298 0.57 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -144.32 107.92 4.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.855 . . . . 0.0 110.091 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.11 -26.42 75.64 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 O-C-N 122.946 0.972 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m 52.56 69.07 2.57 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.432 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.09 -46.88 14.0 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.314 1.166 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -67.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.49 83.86 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -144.44 123.06 12.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.297 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 52.64 58.57 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.885 . . . . 0.0 110.342 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.46 72.89 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.69 93.46 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 53.42 -149.25 0.41 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.58 146.51 49.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 110.192 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt -163.28 50.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.505 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' CD1' ' CD1' ' A' ' 43' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG13 HD22 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.414 ' OG1' ' CG2' ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' B' ' 43' ' ' LEU . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.474 ' CD1' ' ND2' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.482 ' CA ' ' CG1' ' A' ' 96' ' ' VAL . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.448 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD1' HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.424 ' CD1' HG23 ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 71' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.7 m-70 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.434 HG12 ' CG1' ' A' ' 96' ' ' VAL . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 132' ' ' ILE . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 125' ' ' LEU . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.482 ' CG1' ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' CE ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.408 HD13 ' CD1' ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 82' ' ' HIS . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.464 ' CD1' ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.496 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.474 ' ND2' ' CD1' ' A' ' 62' ' ' ILE . 1.5 t-20 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.424 ' CD2' HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 86' ' ' VAL . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 127' ' ' VAL . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 86' ' ' VAL . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.494 ' CE1' ' CB ' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.484 ' CB ' ' CE1' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.293 0.568 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -125.26 170.71 8.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 -48.84 9.28 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.232 1.122 . . . . 0.0 110.414 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.69 173.64 7.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 113.34 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.349 1.183 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.99 155.51 4.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.18 44.74 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.28 -41.53 89.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -154.93 86.43 1.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.048 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 53.2 t -86.29 80.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.269 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -170.06 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.206 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.33 -60.45 1.92 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.49 80.36 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.78 84.77 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.483 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' B' ' 43' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.469 HG13 HD22 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.407 ' OG1' ' CG2' ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.497 ' CD1' HD23 ' A' ' 43' ' ' LEU . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.405 ' O ' ' NZ ' ' B' ' 97' ' ' LYS . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.465 ' CD1' ' ND2' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.473 ' CA ' ' CG1' ' B' ' 96' ' ' VAL . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' B' ' 66' ' ' ILE . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' B' ' 71' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.437 ' HB2' ' CG1' ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.4 m-70 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.425 HG12 ' CG1' ' B' ' 96' ' ' VAL . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' B' ' 132' ' ' ILE . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.426 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' B' ' 60' ' ' SER . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' B' ' 82' ' ' HIS . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.508 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' B' ' 105' ' ' VAL . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . 0.428 ' CA ' HD11 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.455 ' O ' ' CD1' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.48 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.491 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.465 ' ND2' ' CD1' ' B' ' 62' ' ' ILE . 2.2 t-20 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.436 ' HB ' ' CG2' ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.426 ' CD2' HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' B' ' 86' ' ' VAL . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.408 ' N ' HG13 ' B' ' 127' ' ' VAL . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' B' ' 86' ' ' VAL . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.484 ' CE1' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CE1' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -157.88 82.77 2.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.34 177.12 0.88 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.306 1.161 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -162.78 84.14 1.5 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.43 109.98 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.28 1.147 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.41 59.25 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.282 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.77 -153.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -135.88 162.27 33.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.11 -0.993 . . . . 0.0 110.208 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 74.4 m-85 -101.54 132.19 47.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.179 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 27.0 m -59.67 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.98 178.93 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.19 -64.97 1.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.15 108.05 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -157.3 39.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.14 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' B' ' 73' ' ' ILE . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' CD1' ' CD1' ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' HB ' ' ND2' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' ' CE ' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.431 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.433 ' O ' ' CD1' ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ASP . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 135' ' ' VAL . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' B' ' 44' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 129' ' ' GLY . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 89.2 m-70 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ASP . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.418 HG23 ' CD2' ' A' ' 107' ' ' LEU . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' CG ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' CD2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.513 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.436 HG23 ' CG ' ' A' ' 97' ' ' LYS . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.454 ' HG2' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.407 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.434 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' A' ' 87' ' ' ILE . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.474 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 52.68 77.43 0.45 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.881 . . . . 0.0 110.337 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 -65.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.367 1.193 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.7 m -69.11 154.9 94.54 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.73 82.2 0.11 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.262 1.138 . . . . 0.0 110.52 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 150.53 43.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.27 84.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.52 98.1 10.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 110.3 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.62 58.67 5.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 110.114 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.97 152.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.77 131.86 44.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -67.94 -67.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.18 0.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 0.0 110.112 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER -154.61 33.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.123 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.484 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.409 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.452 HD11 ' CD1' ' A' ' 73' ' ' ILE . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.448 ' O ' ' CG1' ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' MET . . . . . 0.413 ' HG2' ' CD1' ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.416 ' HA3' HG23 ' B' ' 96' ' ' VAL . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' B' ' 135' ' ' VAL . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.447 ' CD1' HD11 ' A' ' 44' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CA ' ' B' ' 129' ' ' GLY . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.418 ' O ' HD13 ' B' ' 132' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 84' ' ' ASP . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.435 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.449 ' CG2' HD22 ' B' ' 125' ' ' LEU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.435 ' OG1' ' CB ' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.452 ' CB ' ' HD2' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' B' ' 88' ' ' ALA . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' B' ' 106' ' ' GLN . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.514 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' B' ' 108' ' ' ILE . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' B' ' 95' ' ' THR . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . 0.417 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.449 HD22 ' CG2' ' B' ' 90' ' ' VAL . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' B' ' 88' ' ' ALA . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.474 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.22 0.533 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.03 78.87 0.72 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.41 169.8 6.14 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.311 1.164 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -149.14 74.69 9.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.48 -29.16 88.07 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 123.3 1.158 . . . . 0.0 110.593 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.65 81.23 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.259 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.65 107.96 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.336 -0.852 . . . . 0.0 110.165 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -134.58 -62.16 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 t80 53.05 89.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.29 61.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.905 . . . . 0.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.65 78.17 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.83 -53.78 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -174.86 142.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 109.973 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.24 60.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' B' ' 41' ' ' ASN . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.443 ' HG ' ' CB ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 ' CG2' HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.478 ' CB ' ' CG1' ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' B' ' 43' ' ' LEU . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.433 ' HB ' ' CB ' ' A' ' 111' ' ' ASN . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD2' ' N ' ' A' ' 110' ' ' MET . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.447 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.43 ' CD1' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' A' ' 131' ' ' VAL . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' CB ' ' A' ' 133' ' ' HIS . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 52' ' ' TYR . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 80' ' ' ALA . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' CB ' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' CG2' ' HG3' ' A' ' 109' ' ' PRO . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' CE ' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.415 ' O ' ' CD2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD11 ' NZ ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.457 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.434 ' N ' HD11 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.413 ' N ' HG21 ' A' ' 119' ' ' ILE . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.406 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' B' ' 139' ' ' ARG . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.444 ' HB ' ' CG2' ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.488 HG21 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 71' ' ' LEU . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.496 ' O ' HG21 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' B' ' 133' ' ' HIS . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.245 0.545 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.83 68.65 6.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.157 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.58 -47.46 11.4 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.339 1.178 . . . . 0.0 110.567 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -142.5 79.7 15.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.203 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -21.98 73.33 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.314 1.165 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 7.37 44.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.61 80.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.957 -1.089 . . . . 0.0 110.318 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.08 24.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.32 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' TYR . . . . . 0.455 ' CD2' HG23 ' B' ' 34' ' ' VAL . 16.1 t80 -152.64 -55.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' B' ' 33' ' ' TYR . 97.0 t -128.43 116.7 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.245 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.3 -62.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -112.62 -64.3 1.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.32 -44.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' B' ' 38' ' ' ILE . 2.0 tt -164.14 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.438 ' CD2' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . 0.456 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' N ' ' OD1' ' B' ' 41' ' ' ASN . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.443 ' CB ' ' HG ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.431 HD13 ' CG2' ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.431 ' CG2' HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.474 ' CB ' ' CG1' ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' PHE . . . . . 0.485 ' CD1' HD12 ' A' ' 43' ' ' LEU . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.429 ' CA ' HD12 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.429 HD12 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' B' ' 63' ' ' ASP . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.439 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.444 ' HA ' ' CB ' ' B' ' 56' ' ' ALA . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.439 ' CD1' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.434 ' HB3' ' CG1' ' B' ' 54' ' ' VAL . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' B' ' 133' ' ' HIS . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' B' ' 52' ' ' TYR . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' B' ' 85' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' B' ' 80' ' ' ALA . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.415 ' CB ' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' B' ' 109' ' ' PRO . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA2' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.404 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' B' ' 107' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' B' ' 125' ' ' LEU . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' B' ' 105' ' ' VAL . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.438 HD13 ' N ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.433 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.438 ' N ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' THR . . . . . . . . . . . . . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 128' ' ' PHE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' PHE . . . . . 0.413 ' N ' HG13 ' B' ' 127' ' ' VAL . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 139' ' ' ARG . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' HIS . . . . . 0.522 ' CB ' ' HB ' ' B' ' 73' ' ' ILE . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 71' ' ' LEU . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.488 ' O ' HG21 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' A' ' 133' ' ' HIS . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 38' ' ' ILE . 12.6 tt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.212 0.529 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.785 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 45' ' ' ILE . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.737 HD12 ' ND2' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.859 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.869 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.948 ' N ' HD23 ' A' ' 72' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.501 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 79' ' ' THR . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 78' ' ' ILE . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.943 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.645 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 32.0 m170 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.859 HD11 ' HA2' ' A' ' 64' ' ' GLY . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.943 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 96' ' ' VAL . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 87' ' ' ILE . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.857 HD12 HD21 ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 99' ' ' LEU . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.645 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 120' ' ' SER . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 107' ' ' LEU . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.679 ' C ' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.737 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' THR . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.709 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.771 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.708 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 134' ' ' VAL . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 135' ' ' VAL . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.631 ' HB3' HG23 ' B' ' 131' ' ' VAL . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.519 HD12 HD23 ' B' ' 40' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.318 0.58 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.761 HD21 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.449 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.764 HD11 HD21 ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.494 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.798 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.614 ' OG1' HG21 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.647 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.868 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.732 HD12 ' ND2' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.833 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.868 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.629 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.945 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.945 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.776 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.798 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.511 HG22 ' N ' ' B' ' 79' ' ' THR . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.511 ' N ' HG22 ' B' ' 78' ' ' ILE . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.572 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 31.8 m170 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.833 HD11 ' HA2' ' B' ' 64' ' ' GLY . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.557 ' O ' HG23 ' B' ' 95' ' ' THR . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.557 HG23 ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.403 ' O ' ' CG ' ' B' ' 97' ' ' LYS . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.432 ' O ' HD23 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 1.001 HD12 HD21 ' B' ' 101' ' ' LEU . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.434 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 1.001 HD21 HD12 ' B' ' 99' ' ' LEU . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.572 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.787 HG11 ' O ' ' B' ' 120' ' ' SER . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.755 ' O ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.497 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.732 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.413 ' H ' HG22 ' B' ' 118' ' ' THR . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 107' ' ' LEU . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.787 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 90' ' ' VAL . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.654 HD21 HG21 ' B' ' 119' ' ' ILE . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 86' ' ' VAL . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.754 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.76 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.716 ' NE2' HG21 ' B' ' 131' ' ' VAL . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 134' ' ' VAL . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 135' ' ' VAL . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.679 ' HB3' HG23 ' A' ' 131' ' ' VAL . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.3 tp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.023 HD12 HD13 ' B' ' 45' ' ' ILE . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.934 ' HB3' HD21 ' B' ' 40' ' ' LEU . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.723 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.072 HD13 HD12 ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' ILE . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.72 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CA ' HD11 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' MET . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.64 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.614 HD11 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.668 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.64 HD11 ' H ' ' A' ' 61' ' ' MET . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 62' ' ' ILE . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 72' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG12 ' A' ' 131' ' ' VAL . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' THR . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.646 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 42.1 m80 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 127' ' ' VAL . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.019 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 1.019 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.668 HG11 ' HA3' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.776 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.796 ' O ' HD23 ' A' ' 101' ' ' LEU . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.646 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.742 HD13 ' N ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' C ' HD13 ' A' ' 108' ' ' ILE . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.742 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 118' ' ' THR . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.879 HD13 ' HG ' ' A' ' 125' ' ' LEU . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 125' ' ' LEU . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.879 ' HG ' HD13 ' A' ' 119' ' ' ILE . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 86' ' ' VAL . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 130' ' ' VAL . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD11 ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 1.048 ' CD2' HG12 ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 1.05 HG12 ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.768 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' B' ' 85' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.233 0.539 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.072 HD12 HD13 ' A' ' 45' ' ' ILE . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.912 ' HB3' HD21 ' A' ' 40' ' ' LEU . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HB3' ' CG ' ' B' ' 39' ' ' ASP . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 40' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.517 ' N ' HG22 ' B' ' 45' ' ' ILE . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.722 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.514 ' HB3' HD11 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.597 ' CA ' HD11 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 110' ' ' MET . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.656 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.644 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.656 HD11 ' H ' ' B' ' 61' ' ' MET . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.571 ' OG ' HG23 ' B' ' 62' ' ' ILE . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.723 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.588 ' N ' HD13 ' B' ' 72' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.722 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.714 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.412 HG22 ' N ' ' B' ' 79' ' ' THR . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.412 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 42.1 m80 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.669 HG23 ' O ' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 127' ' ' VAL . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.684 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.628 HG11 ' HA3' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.472 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.4 pm0 -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.649 HD23 ' O ' ' B' ' 100' ' ' GLN . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.79 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.597 HD13 ' N ' ' B' ' 116' ' ' PRO . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.569 ' C ' HD13 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.597 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.712 HD13 ' HG ' ' B' ' 125' ' ' LEU . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.633 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.634 ' N ' HG11 ' B' ' 105' ' ' VAL . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.619 ' O ' HD22 ' B' ' 125' ' ' LEU . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' B' ' 119' ' ' ILE . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 86' ' ' VAL . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 130' ' ' VAL . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.755 HG23 HD11 ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 1.05 ' CD2' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 1.048 HG12 ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.758 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.38 0.61 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.978 HD21 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.911 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.666 HG23 HG21 ' A' ' 51' ' ' THR . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 45' ' ' ILE . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.655 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.68 HG12 ' HG ' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.777 ' CA ' HD11 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.939 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' HG23 ' A' ' 62' ' ' ILE . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.976 HD11 HD21 ' B' ' 43' ' ' LEU . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 72' ' ' LEU . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.835 ' HB3' HG12 ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.551 ' HB ' HG11 ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 42.0 m80 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.915 HG11 ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.803 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.803 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.939 HG11 ' O ' ' A' ' 64' ' ' GLY . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CD ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.792 ' O ' HD23 ' A' ' 101' ' ' LEU . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 119' ' ' ILE . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' A' ' 95' ' ' THR . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.482 HG23 ' CD ' ' A' ' 97' ' ' LYS . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HG3' HG21 ' A' ' 95' ' ' THR . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.44 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 118' ' ' THR . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 119' ' ' ILE . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.629 ' O ' HD22 ' A' ' 125' ' ' LEU . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 124' ' ' THR . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 130' ' ' VAL . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 72' ' ' LEU . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 134' ' ' VAL . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.322 0.582 . . . . 0.0 110.203 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.88 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.88 ' N ' HD12 ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.917 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.665 HG23 HG21 ' B' ' 51' ' ' THR . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.488 ' H ' HG22 ' B' ' 45' ' ' ILE . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.665 HG21 HG23 ' B' ' 45' ' ' ILE . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.707 HG12 ' HG ' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.779 ' CA ' HD11 ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.779 HD11 ' CA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.87 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 96' ' ' VAL . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.559 ' CB ' HG23 ' B' ' 62' ' ' ILE . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.978 HD11 HD21 ' A' ' 43' ' ' LEU . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 73' ' ' ILE . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.929 ' N ' HD12 ' B' ' 72' ' ' LEU . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.861 ' HB3' HG12 ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 41.5 m80 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' B' ' 80' ' ' ALA . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.87 HG11 ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.698 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.698 HD23 ' O ' ' B' ' 100' ' ' GLN . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.65 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.58 HG12 HD13 ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.534 HD13 ' C ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' B' ' 118' ' ' THR . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.58 HD13 HG12 ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' B' ' 119' ' ' ILE . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.502 ' CA ' HG21 ' B' ' 105' ' ' VAL . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' OG ' ' B' ' 120' ' ' SER . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.682 ' O ' HD13 ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.537 HG21 HG21 ' B' ' 86' ' ' VAL . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.656 HG22 ' O ' ' B' ' 130' ' ' VAL . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.766 HG23 HD13 ' B' ' 72' ' ' LEU . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.605 ' O ' HG23 ' B' ' 134' ' ' VAL . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.539 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HB3' HG23 ' A' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.9 tp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.07 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.874 ' HA ' HD22 ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.718 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.75 ' CD1' HD12 ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.042 HD11 HD13 ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' HD11 ' B' ' 38' ' ' ILE . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.794 ' OG1' HG21 ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.739 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.709 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.502 ' CB ' HD11 ' A' ' 66' ' ' ILE . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.67 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.033 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.748 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 66' ' ' ILE . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.708 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG11 ' A' ' 130' ' ' VAL . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 78' ' ' ILE . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.829 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.949 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.849 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.869 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.455 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 101' ' ' LEU . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.669 ' O ' HD23 ' A' ' 101' ' ' LEU . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 99' ' ' LEU . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.598 HD11 ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.418 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.511 ' C ' HD11 ' A' ' 108' ' ' ILE . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.598 ' N ' HD11 ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 117' ' ' ILE . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 120' ' ' SER . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 80' ' ' ALA . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.829 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.762 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 65' ' ' GLY . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' B' ' 135' ' ' VAL . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.711 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 49' ' ' SER . 6.5 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.864 ' HA ' HD22 ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.748 ' CD1' HD12 ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.455 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.793 ' OG1' HG21 ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.718 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.712 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.483 ' CB ' HD11 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.712 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 1.035 HG23 HD12 ' B' ' 72' ' ' LEU . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 1.035 HD12 HG23 ' B' ' 66' ' ' ILE . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.724 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.677 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.531 ' HB ' HG11 ' B' ' 130' ' ' VAL . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.929 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.638 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 48.2 m80 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.473 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.846 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.929 HG11 ' HB1' ' B' ' 80' ' ' ALA . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.75 HG21 HD21 ' B' ' 107' ' ' LEU . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.841 HD12 HD21 ' B' ' 101' ' ' LEU . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.673 ' O ' HD23 ' B' ' 101' ' ' LEU . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.841 HD21 HD12 ' B' ' 99' ' ' LEU . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.638 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.75 HD21 HG21 ' B' ' 95' ' ' THR . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 8.0 t-20 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.459 ' C ' HD13 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.425 ' H ' HG22 ' B' ' 118' ' ' THR . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.513 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.513 ' N ' HG22 ' B' ' 119' ' ' ILE . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.663 ' O ' HG23 ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' B' ' 80' ' ' ALA . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.854 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' B' ' 132' ' ' ILE . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.846 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.441 HG22 ' HA3' ' B' ' 65' ' ' GLY . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 135' ' ' VAL . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.466 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.718 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.177 0.513 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.922 ' CB ' HD13 ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' B' ' 44' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.565 HG21 HG21 ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.663 ' CB ' HD11 ' A' ' 62' ' ' ILE . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.458 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.901 HD12 ' ND2' ' A' ' 111' ' ' ASN . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.877 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.037 HG23 HD12 ' A' ' 72' ' ' LEU . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 66' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 79' ' ' THR . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 78' ' ' ILE . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 55.5 m80 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.877 HD11 ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.74 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.728 HD11 ' CD2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.866 ' HB ' HD22 ' A' ' 125' ' ' LEU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.728 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.825 HG11 ' HA3' ' A' ' 64' ' ' GLY . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HD3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 97' ' ' LYS . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.901 ' ND2' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 120' ' ' SER . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 119' ' ' ILE . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.604 ' CB ' HG11 ' A' ' 105' ' ' VAL . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 133' ' ' HIS . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.843 ' CE1' HG21 ' A' ' 131' ' ' VAL . 11.5 m-70 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 1.1 HG13 HG22 ' B' ' 135' ' ' VAL . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.777 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.531 . . . . 0.0 110.13 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.446 ' O ' HD23 ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.922 HD13 ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.927 ' CB ' HD13 ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 44' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.438 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.716 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.57 HG21 HG21 ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.678 ' CB ' HD11 ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 110' ' ' MET . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.469 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.678 HD11 ' CB ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 1.038 HG23 HD12 ' B' ' 72' ' ' LEU . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.713 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 1.038 HD12 HG23 ' B' ' 66' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.838 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 79' ' ' THR . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 78' ' ' ILE . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 53.2 m80 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.752 HG11 ' HB1' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.952 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' THR . . . . . 1.022 HG21 HD11 ' B' ' 107' ' ' LEU . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' B' ' 64' ' ' GLY . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.444 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.67 HD21 HD12 ' B' ' 99' ' ' LEU . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 1.022 HD11 HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.6 HD11 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.776 ' HG3' HG23 ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' B' ' 60' ' ' SER . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.432 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 25.1 t-20 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.6 ' N ' HD11 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.464 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.421 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 118' ' ' THR . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.416 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.64 ' HB2' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' B' ' 133' ' ' HIS . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.765 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.843 ' CE1' HG21 ' B' ' 131' ' ' VAL . 11.7 m-70 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.44 ' H ' HG12 ' B' ' 134' ' ' VAL . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 135' ' ' VAL . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 134' ' ' VAL . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.785 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.807 HG23 ' HE2' ' B' ' 53' ' ' PHE . 43.7 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.084 0.469 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.803 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.627 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD11 ' B' ' 73' ' ' ILE . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.72 HD12 HD22 ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.534 ' N ' HG22 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.819 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.819 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.676 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HB3' HD13 ' A' ' 73' ' ' ILE . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' N ' ' HE3' ' A' ' 55' ' ' LYS . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.435 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.992 HG23 HD12 ' A' ' 72' ' ' LEU . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.992 HD12 HG23 ' A' ' 66' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 79' ' ' THR . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 78' ' ' ILE . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.866 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.454 ' HE1' HD12 ' A' ' 101' ' ' LEU . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' A' ' 64' ' ' GLY . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.863 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.862 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 87' ' ' ILE . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.862 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' A' ' 101' ' ' LEU . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 100' ' ' GLN . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 105' ' ' VAL . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 ' N ' ' A' ' 122' ' ' GLU . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 95' ' ' THR . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 23.5 t-20 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.517 ' CA ' HD11 ' A' ' 108' ' ' ILE . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.6 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 117' ' ' ILE . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 105' ' ' VAL . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 125' ' ' LEU . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.745 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.701 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 124' ' ' THR . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.866 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.466 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.613 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.9 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.247 0.546 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.807 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.807 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 73' ' ' ILE . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.537 ' N ' HG22 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.822 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.664 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.807 ' HE2' HG23 ' A' ' 38' ' ' ILE . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.451 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.591 ' HB2' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.442 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.974 HG23 HD12 ' B' ' 72' ' ' LEU . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.978 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.978 ' N ' HD23 ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.664 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.757 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.477 HG22 ' N ' ' B' ' 79' ' ' THR . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.477 ' N ' HG22 ' B' ' 78' ' ' ILE . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 65.4 m80 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.47 ' O ' HG22 ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' B' ' 64' ' ' GLY . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.845 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.845 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.452 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.586 ' HD2' HG23 ' B' ' 108' ' ' ILE . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.632 HD21 HG21 ' B' ' 95' ' ' THR . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.495 ' CA ' HD11 ' B' ' 108' ' ' ILE . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.508 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.508 ' N ' HG22 ' B' ' 119' ' ' ILE . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.603 ' N ' HG11 ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.702 ' O ' HD22 ' B' ' 125' ' ' LEU . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.702 HD22 ' O ' ' B' ' 124' ' ' THR . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.877 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.831 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.466 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.595 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 109.902 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.061 HD11 HD11 ' B' ' 45' ' ' ILE . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.443 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' B' ' 44' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.043 HD11 HD11 ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.704 HG21 HG21 ' A' ' 45' ' ' ILE . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CZ ' HD22 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 72' ' ' LEU . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.472 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.875 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.793 HD12 ' CG ' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.671 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 73' ' ' ILE . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.884 ' N ' HD23 ' A' ' 72' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.75 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.661 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 84' ' ' ASP . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 124' ' ' THR . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 95' ' ' THR . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.875 HG21 ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.715 HD22 ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.911 HD12 ' N ' ' A' ' 102' ' ' ARG . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.911 ' N ' HD12 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.912 ' O ' HD12 ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 106' ' ' GLN . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.793 ' CG ' HD12 ' A' ' 62' ' ' ILE . 24.0 t30 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 118' ' ' THR . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.724 ' O ' HG11 ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.575 ' O ' HG21 ' A' ' 105' ' ' VAL . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 124' ' ' THR . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' CG2' HD22 ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HB3' HG23 ' A' ' 87' ' ' ILE . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 131' ' ' VAL . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.772 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.437 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.9 m170 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 136' ' ' LYS . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.875 HG22 HG13 ' B' ' 135' ' ' VAL . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' O ' HG12 ' B' ' 134' ' ' VAL . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.586 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.6 tt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.199 0.523 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.043 HD11 HD11 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.447 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' A' ' 44' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.719 HG21 HG21 ' B' ' 45' ' ' ILE . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.536 ' CE1' HD22 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' B' ' 72' ' ' LEU . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.483 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.799 ' HG2' HG21 ' B' ' 96' ' ' VAL . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' B' ' 111' ' ' ASN . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.596 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.669 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.858 HD23 ' N ' ' B' ' 73' ' ' ILE . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.858 ' N ' HD23 ' B' ' 72' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.605 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.676 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.527 HG22 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.527 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.637 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 31.6 m170 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 86' ' ' VAL . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.686 HG23 ' O ' ' B' ' 85' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 84' ' ' ASP . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.633 ' O ' HG23 ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.918 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 88' ' ' ALA . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.918 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.799 HG21 ' HG2' ' B' ' 61' ' ' MET . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.502 ' N ' HG12 ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' B' ' 88' ' ' ALA . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.693 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.71 HD21 HD12 ' B' ' 99' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.637 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.488 HG22 ' N ' ' B' ' 105' ' ' VAL . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.766 HG11 ' O ' ' B' ' 120' ' ' SER . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.831 ' O ' HD12 ' B' ' 107' ' ' LEU . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 1.037 HD13 HD12 ' B' ' 119' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.689 ' O ' HG23 ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' B' ' 62' ' ' ILE . 6.7 t-20 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.528 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.556 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.575 ' O ' HG23 ' B' ' 118' ' ' THR . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 1.037 HD12 HD13 ' B' ' 107' ' ' LEU . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.766 ' O ' HG11 ' B' ' 105' ' ' VAL . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.524 ' O ' HD22 ' B' ' 125' ' ' LEU . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.676 HD12 HD21 ' B' ' 107' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' B' ' 87' ' ' ILE . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.475 HG13 ' N ' ' B' ' 131' ' ' VAL . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.778 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.778 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.631 ' CE1' HG21 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' LYS . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.875 HG13 HG22 ' A' ' 135' ' ' VAL . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' LYS . . . . . 0.501 ' O ' HG12 ' A' ' 134' ' ' VAL . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.621 ' HB3' HG23 ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 38' ' ' ILE . 7.6 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.991 ' CD1' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' B' ' 44' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.91 HD11 HD11 ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.733 ' H ' HD11 ' A' ' 66' ' ' ILE . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.733 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD11 HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 66' ' ' ILE . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.972 HD11 HD11 ' B' ' 44' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.788 ' HB2' HG12 ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.817 HG22 ' OXT' ' B' ' 139' ' ' ARG . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 80' ' ' ALA . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.68 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.814 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.814 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HA3' ' A' ' 64' ' ' GLY . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.852 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 100' ' ' GLN . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 118' ' ' THR . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 HG12 ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' HD22 ' A' ' 125' ' ' LEU . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.656 HD21 HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 87' ' ' ILE . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.765 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.833 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG22 HG13 ' B' ' 135' ' ' VAL . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.84 ' OXT' HG22 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.406 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.976 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' A' ' 44' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.905 HD11 HD11 ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.71 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.644 HG21 HG21 ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.686 ' O ' HG12 ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' B' ' 73' ' ' ILE . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.742 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.704 HD12 ' ND2' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.742 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.673 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.955 HD11 HD11 ' A' ' 44' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.686 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.797 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.406 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.406 ' N ' HG22 ' B' ' 78' ' ' ILE . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.854 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.84 HG22 ' OXT' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.854 HG11 ' HB1' ' B' ' 80' ' ' ALA . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.684 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.665 HG21 HD21 ' B' ' 125' ' ' LEU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.608 ' HB3' HD11 ' B' ' 87' ' ' ILE . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.638 HG21 HD12 ' B' ' 107' ' ' LEU . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' B' ' 64' ' ' GLY . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HE2' HD12 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.435 ' N ' HD23 ' B' ' 99' ' ' LEU . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.717 ' O ' HD23 ' B' ' 101' ' ' LEU . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.717 HD23 ' O ' ' B' ' 100' ' ' GLN . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.642 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.638 HD12 HG21 ' B' ' 95' ' ' THR . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.642 ' C ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.505 ' HG3' ' CE2' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.533 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.704 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.407 ' H ' HG22 ' B' ' 118' ' ' THR . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.565 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.593 ' O ' HD22 ' B' ' 125' ' ' LEU . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.665 HD21 HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 87' ' ' ILE . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.841 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.841 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 135' ' ' VAL . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.817 ' OXT' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.62 HG12 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.215 0.531 . . . . 0.0 110.269 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.759 HD13 HG13 ' B' ' 45' ' ' ILE . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG13 HD13 ' B' ' 40' ' ' LEU . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.653 HG21 HG23 ' A' ' 45' ' ' ILE . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' HD11 ' A' ' 62' ' ' ILE . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' MET . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.743 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD12 ' OD1' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.743 HD11 ' H ' ' A' ' 61' ' ' MET . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD12 HD11 ' B' ' 44' ' ' LEU . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 73' ' ' ILE . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.646 HG13 HD21 ' B' ' 44' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.777 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 36.7 m170 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 86' ' ' VAL . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 64' ' ' GLY . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 84' ' ' ASP . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.709 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.605 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.709 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 108' ' ' ILE . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 125' ' ' LEU . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.799 HG11 ' H ' ' A' ' 122' ' ' GLU . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.657 ' HB2' HD11 ' A' ' 119' ' ' ILE . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.68 ' OD1' HD12 ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 107' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.799 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.723 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' B' ' 135' ' ' VAL . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.584 ' HE ' HG22 ' B' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.557 HD13 ' N ' ' B' ' 38' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.37 0.605 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.764 HD13 HG13 ' A' ' 45' ' ' ILE . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.57 ' N ' HD12 ' B' ' 40' ' ' LEU . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 40' ' ' LEU . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.877 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.626 HG21 HG23 ' B' ' 45' ' ' ILE . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 54' ' ' VAL . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.531 ' HB2' HD11 ' B' ' 62' ' ' ILE . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.802 ' HG2' HG21 ' B' ' 96' ' ' VAL . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.929 HD12 ' CG ' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.724 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.739 HD11 ' H ' ' B' ' 61' ' ' MET . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.813 HD12 HD11 ' A' ' 44' ' ' LEU . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.523 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.632 HG13 HD21 ' A' ' 44' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.796 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.877 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.491 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' HD11 ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.736 ' O ' HG22 ' B' ' 86' ' ' VAL . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.724 HD11 ' O ' ' B' ' 64' ' ' GLY . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 84' ' ' ASP . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.578 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.621 ' HB ' HD22 ' B' ' 125' ' ' LEU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' THR . . . . . 1.023 HG21 HD23 ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' B' ' 61' ' ' MET . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.605 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' B' ' 85' ' ' ILE . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' B' ' 106' ' ' GLN . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.757 HD23 ' HB3' ' B' ' 125' ' ' LEU . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.677 ' N ' HD12 ' B' ' 101' ' ' LEU . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.76 HG11 ' O ' ' B' ' 120' ' ' SER . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' B' ' 100' ' ' GLN . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 1.023 HD23 HG21 ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.673 ' O ' HG23 ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' B' ' 113' ' ' ALA . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.929 ' CG ' HD12 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.509 ' HB3' ' SD ' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.601 ' O ' HG21 ' B' ' 105' ' ' VAL . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.76 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.57 ' O ' HG23 ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.757 ' HB3' HD23 ' B' ' 101' ' ' LEU . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.669 ' CG2' HD22 ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.796 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.716 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.531 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' A' ' 135' ' ' VAL . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.53 ' HE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 38' ' ' ILE . 11.9 tt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.318 0.58 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 43' ' ' LEU . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.545 ' HB2' HD12 ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 41' ' ' ASN . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' ILE . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.463 ' H ' HG22 ' A' ' 45' ' ' ILE . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 45' ' ' ILE . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.634 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.581 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 59' ' ' ASP . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.807 HD12 HD11 ' B' ' 44' ' ' LEU . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.893 ' N ' HD13 ' A' ' 72' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.886 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.492 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 60.5 m80 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.647 ' C ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.886 HG11 ' CB ' ' A' ' 80' ' ' ALA . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.606 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 122' ' ' GLU . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD23 ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 97' ' ' LYS . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD3' HD23 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' HB2' HD11 ' A' ' 108' ' ' ILE . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.505 ' C ' HD13 ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 117' ' ' ILE . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.716 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.74 ' HA ' HG21 ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.698 ' O ' HD22 ' A' ' 125' ' ' LEU . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 124' ' ' THR . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.751 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CE1' HG21 ' A' ' 131' ' ' VAL . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' B' ' 135' ' ' VAL . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' B' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.325 0.583 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.706 ' HA ' HD11 ' B' ' 43' ' ' LEU . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.542 ' HB2' HD12 ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' B' ' 41' ' ' ASN . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.48 ' H ' HG22 ' B' ' 45' ' ' ILE . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.471 ' H ' HG22 ' B' ' 45' ' ' ILE . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.504 HG21 HG23 ' B' ' 45' ' ' ILE . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.615 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.419 ' O ' HG13 ' B' ' 54' ' ' VAL . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.479 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.586 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.645 HD11 ' CB ' ' B' ' 59' ' ' ASP . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.505 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.608 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 44' ' ' LEU . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 1.054 HD11 HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.907 ' N ' HD13 ' B' ' 72' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.431 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.892 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.402 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.653 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.892 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.605 HD11 HG23 ' B' ' 127' ' ' VAL . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.799 ' O ' HD23 ' B' ' 101' ' ' LEU . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.799 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.682 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' B' ' 99' ' ' LEU . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.464 HG23 ' HG2' ' B' ' 97' ' ' LYS . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.463 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 118' ' ' THR . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.526 HG21 HD23 ' B' ' 125' ' ' LEU . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.713 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.713 HD22 ' O ' ' B' ' 124' ' ' THR . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.605 HG23 HD11 ' B' ' 99' ' ' LEU . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.585 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.77 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 1.054 HG23 HD11 ' B' ' 72' ' ' LEU . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.53 ' CE1' HG21 ' B' ' 131' ' ' VAL . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 135' ' ' VAL . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.452 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.093 0.473 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.096 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.816 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.02 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD22 HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.009 HD11 HD13 ' B' ' 40' ' ' LEU . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' N ' HG22 ' A' ' 45' ' ' ILE . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.723 HG21 HG23 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.629 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.943 ' HB3' HD13 ' A' ' 73' ' ' ILE . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.607 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 ' CG ' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 96' ' ' VAL . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.646 HD23 ' HG2' ' A' ' 55' ' ' LYS . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.7 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 79' ' ' THR . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 78' ' ' ILE . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 86' ' ' VAL . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 127' ' ' VAL . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 124' ' ' THR . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.804 ' H ' HD12 ' A' ' 108' ' ' ILE . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 100' ' ' GLN . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.567 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 120' ' ' SER . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.033 HD13 HD11 ' A' ' 119' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.804 HD12 ' H ' ' A' ' 96' ' ' VAL . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.766 ' CG ' HD12 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 110' ' ' MET . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 117' ' ' ILE . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 118' ' ' THR . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.033 HD11 HD13 ' A' ' 107' ' ' LEU . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.815 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.62 ' H ' HG11 ' A' ' 105' ' ' VAL . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 86' ' ' VAL . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 130' ' ' VAL . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.873 ' C ' HD12 ' A' ' 132' ' ' ILE . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.559 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' B' ' 135' ' ' VAL . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' B' ' 134' ' ' VAL . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.009 HD13 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.81 ' HA ' HD22 ' A' ' 40' ' ' LEU . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.992 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.992 HD22 ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 1.096 HD11 HD13 ' A' ' 40' ' ' LEU . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.491 ' N ' HG22 ' B' ' 45' ' ' ILE . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.713 HG21 HG23 ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.638 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.96 ' HB3' HD13 ' B' ' 73' ' ' ILE . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.482 HG12 ' HG ' ' B' ' 72' ' ' LEU . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.626 ' HG2' HD23 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.612 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.843 HD12 ' OD1' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.665 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.636 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.431 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.642 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.672 ' N ' HD23 ' B' ' 72' ' ' LEU . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.96 HD13 ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.638 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.425 HG22 ' N ' ' B' ' 79' ' ' THR . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.425 ' N ' HG22 ' B' ' 78' ' ' ILE . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.414 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 70.0 m80 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.459 ' O ' HG22 ' B' ' 86' ' ' VAL . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.731 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 127' ' ' VAL . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.56 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.984 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 124' ' ' THR . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.984 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' B' ' 61' ' ' MET . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' CB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.496 ' N ' HD23 ' B' ' 99' ' ' LEU . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.868 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.868 HD23 ' O ' ' B' ' 100' ' ' GLN . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.561 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 105' ' ' VAL . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.837 HG11 ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' B' ' 100' ' ' GLN . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 1.008 HD13 HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.665 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.515 ' C ' HD13 ' B' ' 108' ' ' ILE . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.843 ' OD1' HD12 ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.408 ' OG1' HG23 ' B' ' 105' ' ' VAL . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 1.008 HD11 HD13 ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.837 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.722 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.66 ' HB3' HD11 ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 86' ' ' VAL . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 130' ' ' VAL . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.874 ' C ' HD12 ' B' ' 132' ' ' ILE . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.874 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.557 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 136' ' ' LYS . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 135' ' ' VAL . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.633 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.675 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.672 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 59' ' ' ASP . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.869 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' A' ' 61' ' ' MET . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.926 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.926 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 131' ' ' VAL . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.857 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.875 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.832 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.878 ' HB ' HD22 ' A' ' 125' ' ' LEU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.832 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.869 HG11 ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.794 HD12 HD21 ' A' ' 101' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' HD23 ' A' ' 101' ' ' LEU . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 99' ' ' LEU . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 119' ' ' ILE . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.482 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.609 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' ILE . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 117' ' ' ILE . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' LEU . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.488 ' H ' HG11 ' A' ' 105' ' ' VAL . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.878 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' A' ' 75' ' ' ASP . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.656 ' NE2' HG21 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 64' ' ' GLY . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HG22 ' B' ' 135' ' ' VAL . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 1.025 HD12 HD23 ' B' ' 40' ' ' LEU . 1.2 pt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.421 0.629 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.025 HD23 HD12 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.673 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.421 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.674 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' B' ' 73' ' ' ILE . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' B' ' 62' ' ' ILE . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' B' ' 59' ' ' ASP . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.823 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.669 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.932 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.932 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.674 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.889 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.454 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.819 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.885 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.672 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.883 HG23 ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.823 HG11 ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.784 HD12 HD21 ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.761 ' O ' HD23 ' B' ' 101' ' ' LEU . 4.1 mm-40 -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.81 HD13 ' O ' ' B' ' 125' ' ' LEU . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 108' ' ' ILE . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.883 ' HB3' HG23 ' B' ' 95' ' ' THR . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.626 ' CG ' HD12 ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 117' ' ' ILE . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.426 ' H ' HG22 ' B' ' 118' ' ' THR . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.728 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 105' ' ' VAL . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.819 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.889 HG12 ' HB2' ' B' ' 75' ' ' ASP . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.885 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.518 HG21 ' O ' ' B' ' 64' ' ' GLY . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 135' ' ' VAL . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.747 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 38' ' ' ILE . 12.1 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.988 HD13 HD12 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.662 ' CB ' HD21 ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.009 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.039 HD12 HD13 ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 45' ' ' ILE . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.809 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 70' ' ' ASP . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.725 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' CG ' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.725 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.95 ' N ' HD23 ' A' ' 72' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.755 ' HB3' HG12 ' A' ' 131' ' ' VAL . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.694 HD13 HG11 ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 78' ' ' ILE . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' B' ' 138' ' ' MET . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 80' ' ' ALA . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.966 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.966 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.797 ' H ' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' H ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 127' ' ' VAL . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.771 ' O ' HD23 ' A' ' 101' ' ' LEU . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 105' ' ' VAL . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' VAL . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.787 ' HB2' HD11 ' A' ' 119' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.797 HD12 ' H ' ' A' ' 96' ' ' VAL . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.844 ' CG ' HD12 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.532 ' OG1' HG23 ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' ' 107' ' ' LEU . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.63 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 125' ' ' LEU . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 99' ' ' LEU . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.694 HG11 HD13 ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.83 ' HB3' HD13 ' B' ' 85' ' ' ILE . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.308 0.575 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.764 ' O ' HD12 ' B' ' 43' ' ' LEU . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.039 HD13 HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.675 ' CB ' HD21 ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 1.014 HD13 ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.014 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.988 HD12 HD13 ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.52 ' N ' HG22 ' B' ' 45' ' ' ILE . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.642 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.804 ' HB3' HD13 ' B' ' 73' ' ' ILE . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.432 ' O ' HG13 ' B' ' 54' ' ' VAL . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 70' ' ' ASP . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.718 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.883 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.718 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 56' ' ' ALA . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.66 ' C ' HD13 ' B' ' 71' ' ' LEU . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.953 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.642 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.733 ' HB3' HG12 ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.683 HD13 HG11 ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.428 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.46 ' O ' HG22 ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 138' ' ' MET . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' B' ' 80' ' ' ALA . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.461 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.887 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.887 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.467 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.429 ' HD3' ' HE3' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.795 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.795 HD23 ' O ' ' B' ' 100' ' ' GLN . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 105' ' ' VAL . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.686 HD13 HD11 ' B' ' 119' ' ' ILE . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.883 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.875 ' CG ' HD12 ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.434 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.518 ' OG1' HG23 ' B' ' 105' ' ' VAL . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.688 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.5 ' O ' HD22 ' B' ' 125' ' ' LEU . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.739 HG22 HD21 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.683 HG11 HD13 ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.733 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.481 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 135' ' ' VAL . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' MET . . . . . 0.845 ' HB3' HD13 ' A' ' 85' ' ' ILE . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.471 ' HB3' HG23 ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 38' ' ' ILE . 1.8 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD11 ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.433 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' GLN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' B' ' 44' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.879 HD11 HD11 ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 45' ' ' ILE . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.804 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.706 HD12 ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.804 HD11 ' N ' ' A' ' 61' ' ' MET . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.904 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 79' ' ' THR . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.791 ' O ' HD13 ' A' ' 132' ' ' ILE . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 64' ' ' GLY . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.868 ' HD2' HD12 ' A' ' 107' ' ' LEU . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.734 ' O ' HD23 ' A' ' 101' ' ' LEU . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.645 ' C ' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.489 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.706 ' OD1' HD12 ' A' ' 62' ' ' ILE . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 107' ' ' LEU . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 105' ' ' VAL . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.843 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.791 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.691 ' NE2' HG21 ' A' ' 131' ' ' VAL . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG13 HG22 ' B' ' 135' ' ' VAL . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.508 ' CG ' HD13 ' B' ' 85' ' ' ILE . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HB3' HG23 ' B' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.327 0.584 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 45' ' ' ILE . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.48 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' B' ' 46' ' ' GLN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.9 HD11 HD11 ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.461 ' OG1' HG21 ' B' ' 45' ' ' ILE . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.602 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.808 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.832 HD12 ' OD1' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.808 HD11 ' N ' ' B' ' 61' ' ' MET . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.634 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.896 ' N ' HD23 ' B' ' 72' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.442 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.81 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.404 HG22 ' N ' ' B' ' 79' ' ' THR . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.404 ' N ' HG22 ' B' ' 78' ' ' ILE . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.721 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.409 ' HE1' HD12 ' B' ' 101' ' ' LEU . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.793 ' O ' HD13 ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.963 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.963 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.628 HG12 ' H ' ' B' ' 97' ' ' LYS . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.628 ' H ' HG12 ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.778 ' HB2' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.67 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.722 HD21 HD12 ' B' ' 99' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.624 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 105' ' ' VAL . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.708 ' O ' HG13 ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.686 HD13 ' N ' ' B' ' 110' ' ' MET . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HG2' ' HG2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.686 ' N ' HD13 ' B' ' 108' ' ' ILE . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.832 ' OD1' HD12 ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.618 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.525 ' O ' HG23 ' B' ' 118' ' ' THR . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.889 HD13 ' HG ' ' B' ' 125' ' ' LEU . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' B' ' 120' ' ' SER . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.677 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.889 ' HG ' HD13 ' B' ' 119' ' ' ILE . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 130' ' ' VAL . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.823 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.793 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.702 ' NE2' HG21 ' B' ' 131' ' ' VAL . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 135' ' ' VAL . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 138' ' ' MET . . . . . 0.553 ' CG ' HD13 ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.282 0.563 . . . . 0.0 110.15 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.907 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 90.8 m-70 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.91 HG21 HG23 ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HD11 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.782 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' A' ' 67' ' ' SER . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 61' ' ' MET . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.847 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.782 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' A' ' 62' ' ' ILE . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 132' ' ' ILE . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.742 HD11 HD13 ' B' ' 43' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 131' ' ' VAL . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.791 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 53.7 m80 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.791 HG11 ' HB1' ' A' ' 80' ' ' ALA . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 124' ' ' THR . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 88' ' ' ALA . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.847 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' O ' HD23 ' A' ' 101' ' ' LEU . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 100' ' ' GLN . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 105' ' ' VAL . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 99' ' ' LEU . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' SER . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.647 ' N ' HD11 ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 118' ' ' THR . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.624 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 124' ' ' THR . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 87' ' ' ILE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.716 HG23 HD21 ' A' ' 72' ' ' LEU . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.42 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' HA3' ' A' ' 65' ' ' GLY . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.646 HG22 HG13 ' B' ' 135' ' ' VAL . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.606 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.902 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.902 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.792 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.923 HG23 HG21 ' B' ' 51' ' ' THR . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.492 ' H ' HG22 ' B' ' 45' ' ' ILE . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.923 HG21 HG23 ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.585 ' CB ' HD11 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.561 ' CA ' HD11 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' B' ' 67' ' ' SER . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' B' ' 61' ' ' MET . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.908 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' B' ' 62' ' ' ILE . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.735 HD21 HG23 ' B' ' 132' ' ' ILE . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 44' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.828 ' HB2' HG12 ' B' ' 131' ' ' VAL . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.723 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.79 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.587 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 55.1 m80 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.79 HG11 ' HB1' ' B' ' 80' ' ' ALA . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.688 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 124' ' ' THR . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.908 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.736 ' HG2' HG23 ' B' ' 108' ' ' ILE . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.714 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' B' ' 101' ' ' LEU . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.587 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.679 HG11 ' H ' ' B' ' 122' ' ' GLU . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.633 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' B' ' 97' ' ' LYS . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.533 ' CB ' HD12 ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.589 HD13 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.589 ' N ' HD13 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.518 HG22 ' N ' ' B' ' 120' ' ' SER . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.679 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' B' ' 124' ' ' THR . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 87' ' ' ILE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.554 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.828 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.735 HG23 HD21 ' B' ' 72' ' ' LEU . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.409 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.644 HG22 ' HA3' ' B' ' 65' ' ' GLY . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.646 HG13 HG22 ' A' ' 135' ' ' VAL . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.941 HD11 HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.71 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.653 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.94 HD12 HD11 ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 45' ' ' ILE . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.701 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.727 ' HB2' HD11 ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.935 HG23 ' OG ' ' A' ' 67' ' ' SER . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.935 ' OG ' HG23 ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.837 ' HB2' HG12 ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 79' ' ' THR . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 78' ' ' ILE . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.725 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.499 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 86' ' ' VAL . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.74 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.725 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 124' ' ' THR . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG11 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 108' ' ' ILE . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.832 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 100' ' ' GLN . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 105' ' ' VAL . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 122' ' ' GLU . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.806 ' CG ' HD12 ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 108' ' ' ILE . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.852 ' HG1' HG23 ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 125' ' ' LEU . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.852 ' N ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 124' ' ' THR . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.773 HG23 HD21 ' A' ' 72' ' ' LEU . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 HG13 ' B' ' 135' ' ' VAL . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.94 HD11 HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.725 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.941 HD12 HD11 ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.507 ' N ' HG22 ' B' ' 45' ' ' ILE . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.562 HG21 HD13 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.7 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.798 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.743 ' HB2' HD11 ' B' ' 62' ' ' ILE . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.919 HG23 ' OG ' ' B' ' 67' ' ' SER . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.74 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.488 ' O ' HD11 ' B' ' 85' ' ' ILE . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.592 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.62 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.919 ' OG ' HG23 ' B' ' 62' ' ' ILE . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.941 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.941 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.7 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.851 ' HB2' HG12 ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.709 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.507 HG22 ' N ' ' B' ' 79' ' ' THR . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.507 ' N ' HG22 ' B' ' 78' ' ' ILE . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.72 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.742 ' O ' HD13 ' B' ' 132' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.72 HG11 ' HB1' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.658 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.875 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 124' ' ' THR . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.875 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.808 ' H ' HD12 ' B' ' 108' ' ' ILE . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.588 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HG2' ' HD3' ' B' ' 97' ' ' LYS . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.693 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.858 ' O ' HD23 ' B' ' 101' ' ' LEU . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.858 HD23 ' O ' ' B' ' 100' ' ' GLN . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.554 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 105' ' ' VAL . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.808 HD12 ' H ' ' B' ' 96' ' ' VAL . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.436 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.566 ' CG ' HD12 ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.438 ' CE2' ' SD ' ' B' ' 110' ' ' MET . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.629 ' OG1' HG23 ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.642 HG21 HD23 ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' B' ' 119' ' ' ILE . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.663 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.699 ' O ' HD22 ' B' ' 125' ' ' LEU . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.699 HD22 ' O ' ' B' ' 124' ' ' THR . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.469 HG11 ' HB ' ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.604 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.851 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.781 HG23 HD21 ' B' ' 72' ' ' LEU . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.472 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 135' ' ' VAL . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.532 ' HB2' HG23 ' A' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.252 0.549 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.834 HD21 HG13 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HA ' HD13 ' B' ' 40' ' ' LEU . 9.6 p30 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.961 HD13 HG21 ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.961 HG21 HD13 ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.648 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' CB ' HD11 ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.607 HD11 ' CB ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.804 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.419 ' CG ' ' HB3' ' A' ' 56' ' ' ALA . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 73' ' ' ILE . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.986 ' N ' HD13 ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.623 ' HB2' HG12 ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 79' ' ' THR . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' HG22 ' A' ' 78' ' ' ILE . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.749 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.453 ' NE2' ' HD2' ' A' ' 102' ' ' ARG . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 64' ' ' GLY . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.749 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 124' ' ' THR . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.747 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.703 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.657 HD21 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.518 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.838 HG11 ' H ' ' A' ' 122' ' ' GLU . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.492 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.684 HG21 HD23 ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.838 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.717 ' O ' HD22 ' A' ' 125' ' ' LEU . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 132' ' ' ILE . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.548 HG22 ' HA3' ' A' ' 65' ' ' GLY . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.566 HG13 HG22 ' B' ' 135' ' ' VAL . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.655 ' O ' HG23 ' B' ' 38' ' ' ILE . 6.3 tp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.267 0.556 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.699 ' HA ' HD13 ' A' ' 40' ' ' LEU . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.983 HD13 HG21 ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.457 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.983 HG21 HD13 ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.642 ' HB3' HG13 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.414 ' O ' HG13 ' B' ' 54' ' ' VAL . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.61 ' CB ' HD11 ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.61 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.794 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.558 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.427 ' CG ' ' HB3' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.741 HD11 HD11 ' B' ' 73' ' ' ILE . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.961 HD13 ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.961 ' N ' HD13 ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.636 ' HB2' HG12 ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.498 HG22 ' N ' ' B' ' 79' ' ' THR . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 64' ' ' GLY . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.714 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.57 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.893 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 124' ' ' THR . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.893 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.725 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.688 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.751 HG11 ' H ' ' B' ' 122' ' ' GLU . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.75 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.551 HD11 ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.412 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.551 ' N ' HD11 ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.419 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.66 HG21 HD23 ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.751 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' B' ' 125' ' ' LEU . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 124' ' ' THR . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.643 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.725 ' C ' HD12 ' B' ' 132' ' ' ILE . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.846 HG23 HD11 ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.532 HG22 ' HA3' ' B' ' 65' ' ' GLY . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 135' ' ' VAL . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.941 ' HA ' HD22 ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' B' ' 44' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.897 HD11 HD13 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 45' ' ' ILE . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.844 HG21 HG23 ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.65 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HE2' HG23 ' B' ' 38' ' ' ILE . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 72' ' ' LEU . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.609 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.698 ' HB2' HD22 ' A' ' 111' ' ' ASN . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' OD1' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 72' ' ' LEU . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.709 HD11 HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.962 HD11 HD11 ' B' ' 44' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.836 ' HB2' HG12 ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 45.7 m80 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 132' ' ' ILE . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 124' ' ' THR . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.791 HG11 ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.796 HD12 HD21 ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 101' ' ' LEU . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.796 HD21 HD12 ' A' ' 99' ' ' LEU . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.521 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.844 ' OD1' HD12 ' A' ' 62' ' ' ILE . 15.9 t30 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 125' ' ' LEU . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.558 ' O ' HG21 ' A' ' 105' ' ' VAL . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' CA ' HG11 ' A' ' 105' ' ' VAL . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 90' ' ' VAL . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 87' ' ' ILE . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.836 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 20.7 m170 -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.863 HG13 HG22 ' B' ' 135' ' ' VAL . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.412 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HG23 ' B' ' 131' ' ' VAL . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.689 HG23 ' HE2' ' A' ' 53' ' ' PHE . 4.5 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.926 ' HA ' HD22 ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' A' ' 44' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.528 ' H ' HG22 ' B' ' 45' ' ' ILE . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.786 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.857 HG21 HG23 ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.654 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' B' ' 73' ' ' ILE . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.502 HG12 HD22 ' B' ' 72' ' ' LEU . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.611 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.664 ' HB2' HD22 ' B' ' 111' ' ' ASN . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.75 ' SD ' HG22 ' B' ' 95' ' ' THR . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.833 HD12 ' OD1' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.831 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.771 ' CG2' HD12 ' B' ' 72' ' ' LEU . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.771 HD12 ' CG2' ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.969 HD11 HD11 ' A' ' 44' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.654 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.799 ' HB2' HG12 ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.786 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.641 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 45.7 m80 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.859 ' O ' HD13 ' B' ' 132' ' ' ILE . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.768 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.523 ' O ' HG23 ' B' ' 87' ' ' ILE . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 124' ' ' THR . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.75 HG22 ' SD ' ' B' ' 61' ' ' MET . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.757 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' B' ' 109' ' ' PRO . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.721 HD12 HD21 ' B' ' 101' ' ' LEU . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 125' ' ' LEU . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.641 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' B' ' 119' ' ' ILE . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.536 ' CA ' HD12 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.423 ' HB2' HD11 ' B' ' 119' ' ' ILE . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.679 ' C ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.507 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.538 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.833 ' OD1' HD12 ' B' ' 62' ' ' ILE . 24.0 t30 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 118' ' ' THR . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.788 ' HB ' HG22 ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.527 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.616 ' O ' HG23 ' B' ' 90' ' ' VAL . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.736 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 87' ' ' ILE . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.799 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.799 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.859 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 20.6 m170 -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.863 HG22 HG13 ' A' ' 135' ' ' VAL . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 138' ' ' MET . . . . . 0.444 ' HG3' HG21 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 131' ' ' VAL . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.027 HD11 HD11 ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG3' ' HG2' ' A' ' 46' ' ' GLN . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' B' ' 44' ' ' LEU . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.999 HD11 HD11 ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 45' ' ' ILE . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.736 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' ' HE1' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.619 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 62' ' ' ILE . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 72' ' ' LEU . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 71' ' ' LEU . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.795 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 79' ' ' THR . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 64.3 m80 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 95' ' ' THR . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' PRO . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.88 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.857 HG11 ' H ' ' A' ' 122' ' ' GLU . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.739 ' HB3' HG23 ' A' ' 95' ' ' THR . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.497 ' HE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.8 t30 -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 108' ' ' ILE . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.857 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.624 ' O ' HD22 ' A' ' 125' ' ' LEU . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 134' ' ' VAL . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.734 HG22 HG13 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.459 ' HB3' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.499 ' O ' HD13 ' B' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.335 0.588 . . . . 0.0 110.123 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.999 HD11 HD11 ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 46' ' ' GLN . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' B' ' 45' ' ' ILE . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.682 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.72 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.439 ' HG2' HD11 ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.72 HD11 ' CB ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.798 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.657 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.709 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.799 HD13 ' N ' ' B' ' 72' ' ' LEU . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.799 ' N ' HD13 ' B' ' 71' ' ' LEU . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.794 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.806 ' N ' HG12 ' B' ' 131' ' ' VAL . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' B' ' 77' ' ' ALA . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.454 HG22 ' N ' ' B' ' 79' ' ' THR . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' HG22 ' B' ' 78' ' ' ILE . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.869 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 64.6 m80 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.666 HG23 ' O ' ' B' ' 85' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.869 HG11 ' HB1' ' B' ' 80' ' ' ALA . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.46 HG21 HG21 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.98 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' B' ' 128' ' ' PHE . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.98 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.798 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.554 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.762 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.686 ' O ' HD23 ' B' ' 101' ' ' LEU . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 105' ' ' VAL . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.675 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' B' ' 88' ' ' ALA . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.591 ' O ' HG23 ' B' ' 108' ' ' ILE . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 97' ' ' LYS . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.645 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.839 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.489 HG22 HD21 ' B' ' 99' ' ' LEU . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' B' ' 89' ' ' ALA . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.485 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.806 HG12 ' N ' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.691 ' N ' HD12 ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 134' ' ' VAL . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.734 HG13 HG22 ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 138' ' ' MET . . . . . 0.443 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.486 ' O ' HD13 ' A' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.162 0.506 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.76 ' CG ' HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.704 ' HA ' HD22 ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.907 HD13 HG21 ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.566 ' H ' HG22 ' A' ' 45' ' ' ILE . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.907 HG21 HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HB2' HG13 ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' CA ' HD11 ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.75 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 59' ' ' ASP . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 85' ' ' ILE . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.551 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.75 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.719 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 73' ' ' ILE . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' HB ' ' A' ' 131' ' ' VAL . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.669 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 86' ' ' VAL . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.679 HG21 HD12 ' A' ' 132' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 130' ' ' VAL . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.979 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 124' ' ' THR . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.979 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.551 HG11 ' CA ' ' A' ' 64' ' ' GLY . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' NZ ' HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.928 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.928 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 119' ' ' ILE . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.469 HD13 ' C ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HG3' ' CG2' ' A' ' 95' ' ' THR . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 110' ' ' MET . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.469 ' C ' HD13 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 118' ' ' THR . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.757 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.664 ' O ' HD22 ' A' ' 125' ' ' LEU . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 119' ' ' ILE . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 86' ' ' VAL . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.786 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 135' ' ' VAL . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.797 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.895 ' O ' HG23 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' B' ' 130' ' ' VAL . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.672 ' O ' HG23 ' B' ' 38' ' ' ILE . 2.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.187 0.518 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.765 ' CG ' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.926 HD13 HG21 ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLN . . . . . 0.549 ' H ' HG22 ' B' ' 45' ' ' ILE . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.926 HG21 HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.657 ' HB2' HG13 ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.545 ' CA ' HD11 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 61' ' ' MET . . . . . 0.738 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.545 HD11 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.597 ' O ' HD11 ' B' ' 85' ' ' ILE . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.55 ' CA ' HG11 ' B' ' 96' ' ' VAL . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.638 ' C ' HD23 ' B' ' 72' ' ' LEU . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.738 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.734 HD13 ' N ' ' B' ' 73' ' ' ILE . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.734 ' N ' HD13 ' B' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' B' ' 131' ' ' VAL . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.672 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ASP . . . . . 0.519 ' O ' HG13 ' B' ' 86' ' ' VAL . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.683 HG21 HD12 ' B' ' 132' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' VAL . . . . . 0.916 HG12 HG13 ' B' ' 130' ' ' VAL . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.833 ' O ' HG13 ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.953 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 124' ' ' THR . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' THR . . . . . 0.953 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' VAL . . . . . 0.55 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.471 ' HD3' ' HB2' ' B' ' 63' ' ' ASP . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' GLN . . . . . 0.865 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.865 HD23 ' O ' ' B' ' 100' ' ' GLN . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' VAL . . . . . 0.752 HG21 ' O ' ' B' ' 120' ' ' SER . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' LEU . . . . . 0.608 HD12 ' CB ' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ILE . . . . . 0.537 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.459 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' B' ' 60' ' ' SER . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ASN . . . . . 0.514 ' HB3' HD12 ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.537 ' C ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' PRO . . . . . 0.473 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.404 HG23 ' O ' ' B' ' 117' ' ' ILE . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' B' ' 125' ' ' LEU . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.752 ' O ' HG21 ' B' ' 105' ' ' VAL . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.634 ' CA ' HG11 ' B' ' 105' ' ' VAL . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.65 ' O ' HD22 ' B' ' 125' ' ' LEU . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.8 ' HB3' HD13 ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.833 HG13 ' O ' ' B' ' 87' ' ' ILE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' GLY . . . . . 0.607 ' O ' HG22 ' B' ' 87' ' ' ILE . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.916 HG13 HG12 ' B' ' 86' ' ' VAL . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 133' ' ' HIS . . . . . 0.797 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 135' ' ' VAL . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 137' ' ' ALA . . . . . 0.786 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' MET . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.71 82.62 17.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.86 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.418 1.22 . . . . 0.0 110.605 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -115.93 152.56 47.7 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.9 -63.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.218 1.115 . . . . 0.0 110.555 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.8 -80.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 110.171 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.99 67.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.321 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.82 120.31 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -123.79 30.93 6.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.97 148.15 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.06 88.09 1.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -27.26 51.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -81.45 134.38 35.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 38' ' ' ILE . 12.6 tt -103.74 78.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 110.356 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.785 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 45' ' ' ILE . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.737 HD12 ' ND2' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.859 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.869 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.948 ' N ' HD23 ' A' ' 72' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.501 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 79' ' ' THR . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 78' ' ' ILE . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.943 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.645 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 32.0 m170 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.859 HD11 ' HA2' ' A' ' 64' ' ' GLY . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.943 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 96' ' ' VAL . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 87' ' ' ILE . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.857 HD12 HD21 ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 99' ' ' LEU . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.645 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 120' ' ' SER . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 107' ' ' LEU . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.679 ' C ' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.737 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' THR . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.709 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.771 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.708 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 134' ' ' VAL . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 135' ' ' VAL . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.631 ' HB3' HG23 ' B' ' 131' ' ' VAL . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.235 0.54 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.48 157.6 45.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 -26.5 82.23 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.339 1.178 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.71 73.55 0.31 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.158 -0.964 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.85 126.65 19.39 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.202 1.106 . . . . 0.0 110.444 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.15 -23.83 11.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -155.96 144.62 20.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.89 83.21 1.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.19 86.97 2.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.315 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -120.41 -31.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.16 6.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.212 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -153.55 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.439 ' C ' HG23 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -152.61 164.07 38.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 110.295 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.519 HD12 HD23 ' B' ' 40' ' ' LEU . 1.0 OUTLIER -149.69 109.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.866 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.761 HD21 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.449 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.764 HD11 HD21 ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.494 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.798 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.614 ' OG1' HG21 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.647 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.868 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.732 HD12 ' ND2' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.833 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.868 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.629 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.945 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.945 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.776 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.798 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.511 HG22 ' N ' ' B' ' 79' ' ' THR . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.511 ' N ' HG22 ' B' ' 78' ' ' ILE . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.572 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 31.8 m170 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.833 HD11 ' HA2' ' B' ' 64' ' ' GLY . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.557 ' O ' HG23 ' B' ' 95' ' ' THR . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.557 HG23 ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.403 ' O ' ' CG ' ' B' ' 97' ' ' LYS . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.432 ' O ' HD23 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 1.001 HD12 HD21 ' B' ' 101' ' ' LEU . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.434 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 1.001 HD21 HD12 ' B' ' 99' ' ' LEU . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.572 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.787 HG11 ' O ' ' B' ' 120' ' ' SER . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.755 ' O ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.497 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.732 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.413 ' H ' HG22 ' B' ' 118' ' ' THR . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 107' ' ' LEU . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.787 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 90' ' ' VAL . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.654 HD21 HG21 ' B' ' 119' ' ' ILE . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 86' ' ' VAL . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.754 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.76 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.716 ' NE2' HG21 ' B' ' 131' ' ' VAL . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 134' ' ' VAL . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 135' ' ' VAL . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.679 ' HB3' HG23 ' A' ' 131' ' ' VAL . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.15 165.22 14.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.24 178.34 0.6 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.322 1.17 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 67.19 3.97 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.64 117.32 4.13 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.263 1.139 . . . . 0.0 110.515 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.51 59.89 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.27 151.44 51.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -39.67 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 34.6 p90 -90.66 144.39 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.14 -41.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.94 -155.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.69 -159.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.75 51.89 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.3 tp -57.88 126.2 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.023 HD12 HD13 ' B' ' 45' ' ' ILE . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.934 ' HB3' HD21 ' B' ' 40' ' ' LEU . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.723 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.072 HD13 HD12 ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' ILE . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.72 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CA ' HD11 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' MET . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.64 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.614 HD11 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.668 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.64 HD11 ' H ' ' A' ' 61' ' ' MET . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 62' ' ' ILE . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 72' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG12 ' A' ' 131' ' ' VAL . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' THR . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.646 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 42.1 m80 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.659 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 127' ' ' VAL . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.019 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.019 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.668 HG11 ' HA3' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.776 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.796 ' O ' HD23 ' A' ' 101' ' ' LEU . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.646 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.742 HD13 ' N ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' C ' HD13 ' A' ' 108' ' ' ILE . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.742 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 118' ' ' THR . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.879 HD13 ' HG ' ' A' ' 125' ' ' LEU . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 125' ' ' LEU . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.879 ' HG ' HD13 ' A' ' 119' ' ' ILE . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 86' ' ' VAL . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 130' ' ' VAL . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD11 ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 1.048 ' CD2' HG12 ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.05 HG12 ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.768 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' B' ' 85' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.192 0.52 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.36 156.52 91.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.39 -72.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.317 1.167 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -118.42 90.51 39.04 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.07 108.4 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.5 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 147.29 45.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.296 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' B' ' 34' ' ' VAL . 31.2 t0 -97.01 75.43 2.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.86 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.413 -0.804 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' B' ' 32' ' ' ASP . 57.7 t -112.39 138.36 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.33 166.72 17.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -63.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -127.25 108.46 10.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 110.16 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -60.99 144.76 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.072 HD12 HD13 ' A' ' 45' ' ' ILE . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.912 ' HB3' HD21 ' A' ' 40' ' ' LEU . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HB3' ' CG ' ' B' ' 39' ' ' ASP . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 40' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.517 ' N ' HG22 ' B' ' 45' ' ' ILE . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.722 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.514 ' HB3' HD11 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.597 ' CA ' HD11 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 110' ' ' MET . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.656 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.644 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.656 HD11 ' H ' ' B' ' 61' ' ' MET . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.571 ' OG ' HG23 ' B' ' 62' ' ' ILE . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.723 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.588 ' N ' HD13 ' B' ' 72' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.722 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.714 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.412 HG22 ' N ' ' B' ' 79' ' ' THR . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.412 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 42.1 m80 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.669 HG23 ' O ' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 127' ' ' VAL . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.684 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.628 HG11 ' HA3' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.472 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.4 pm0 -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.649 HD23 ' O ' ' B' ' 100' ' ' GLN . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.79 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.597 HD13 ' N ' ' B' ' 116' ' ' PRO . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.569 ' C ' HD13 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.597 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.712 HD13 ' HG ' ' B' ' 125' ' ' LEU . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.633 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.634 ' N ' HG11 ' B' ' 105' ' ' VAL . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.619 ' O ' HD22 ' B' ' 125' ' ' LEU . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' B' ' 119' ' ' ILE . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 86' ' ' VAL . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 130' ' ' VAL . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.755 HG23 HD11 ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 1.05 ' CD2' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 1.048 HG12 ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.758 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.207 0.527 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -106.85 173.0 3.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.346 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.87 170.45 5.96 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.325 1.171 . . . . 0.0 110.678 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 52.63 61.82 11.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.447 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.16 127.67 21.81 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.266 1.14 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 99.57 7.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.287 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.1 96.25 5.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -70.05 95.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.149 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.74 89.03 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.58 -31.24 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -95.69 130.69 42.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.52 -54.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -77.06 -18.89 57.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.379 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -144.09 85.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.171 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.978 HD21 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.911 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.666 HG23 HG21 ' A' ' 51' ' ' THR . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 45' ' ' ILE . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.655 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.68 HG12 ' HG ' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.777 ' CA ' HD11 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.939 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' HG23 ' A' ' 62' ' ' ILE . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.976 HD11 HD21 ' B' ' 43' ' ' LEU . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 72' ' ' LEU . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.835 ' HB3' HG12 ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.551 ' HB ' HG11 ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 42.0 m80 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.915 HG11 ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.803 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.803 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.939 HG11 ' O ' ' A' ' 64' ' ' GLY . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CD ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.792 ' O ' HD23 ' A' ' 101' ' ' LEU . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 119' ' ' ILE . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' A' ' 95' ' ' THR . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.482 HG23 ' CD ' ' A' ' 97' ' ' LYS . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HG3' HG21 ' A' ' 95' ' ' THR . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.44 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 118' ' ' THR . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 119' ' ' ILE . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.629 ' O ' HD22 ' A' ' 125' ' ' LEU . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 124' ' ' THR . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 130' ' ' VAL . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 72' ' ' LEU . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 134' ' ' VAL . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.265 0.555 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.49 154.15 85.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.36 127.07 20.85 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.286 1.151 . . . . 0.0 110.491 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.8 155.55 88.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 107.44 0.52 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.26 1.137 . . . . 0.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.91 31.73 6.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.031 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.96 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.364 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.19 114.83 8.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 52.66 95.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.924 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.665 ' O ' HG13 ' B' ' 34' ' ' VAL . 9.3 p -139.95 111.57 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.344 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -135.63 87.22 2.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.081 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -149.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.906 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -42.91 11.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 110.303 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -68.69 70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.88 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.88 ' N ' HD12 ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.917 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.665 HG23 HG21 ' B' ' 51' ' ' THR . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.488 ' H ' HG22 ' B' ' 45' ' ' ILE . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.665 HG21 HG23 ' B' ' 45' ' ' ILE . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.707 HG12 ' HG ' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.779 ' CA ' HD11 ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.779 HD11 ' CA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.87 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 96' ' ' VAL . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.559 ' CB ' HG23 ' B' ' 62' ' ' ILE . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.978 HD11 HD21 ' A' ' 43' ' ' LEU . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 73' ' ' ILE . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.929 ' N ' HD12 ' B' ' 72' ' ' LEU . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.861 ' HB3' HG12 ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 41.5 m80 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' B' ' 80' ' ' ALA . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.87 HG11 ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.698 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.698 HD23 ' O ' ' B' ' 100' ' ' GLN . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.65 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.58 HG12 HD13 ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.534 HD13 ' C ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' B' ' 118' ' ' THR . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.58 HD13 HG12 ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' B' ' 119' ' ' ILE . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.502 ' CA ' HG21 ' B' ' 105' ' ' VAL . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' OG ' ' B' ' 120' ' ' SER . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.682 ' O ' HD13 ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.537 HG21 HG21 ' B' ' 86' ' ' VAL . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.656 HG22 ' O ' ' B' ' 130' ' ' VAL . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.766 HG23 HD13 ' B' ' 72' ' ' LEU . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.605 ' O ' HG23 ' B' ' 134' ' ' VAL . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.539 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HB3' HG23 ' A' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.78 161.94 61.93 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.33 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.52 175.34 1.66 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.29 1.153 . . . . 0.0 110.508 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.25 169.29 8.2 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 106.02 0.38 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.313 1.165 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.35 170.87 8.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.21 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.31 52.15 14.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.316 -0.865 . . . . 0.0 110.394 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -143.11 116.78 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.174 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 53.25 46.03 27.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 32' ' ' ASP . 34.7 m -123.77 21.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 110.311 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.66 176.18 7.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -160.21 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 110.023 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.9 -46.49 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 110.043 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' ILE . 4.9 tp -163.65 66.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.07 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.874 ' HA ' HD22 ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.718 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.75 ' CD1' HD12 ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.042 HD11 HD13 ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' HD11 ' B' ' 38' ' ' ILE . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.794 ' OG1' HG21 ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.739 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.709 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.502 ' CB ' HD11 ' A' ' 66' ' ' ILE . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.67 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.033 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.748 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 66' ' ' ILE . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.708 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG11 ' A' ' 130' ' ' VAL . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 78' ' ' ILE . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.829 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.949 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.849 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.869 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.455 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 101' ' ' LEU . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.669 ' O ' HD23 ' A' ' 101' ' ' LEU . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 99' ' ' LEU . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.598 HD11 ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.418 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.511 ' C ' HD11 ' A' ' 108' ' ' ILE . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.598 ' N ' HD11 ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 117' ' ' ILE . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 120' ' ' SER . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 80' ' ' ALA . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.829 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.762 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 65' ' ' GLY . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' B' ' 135' ' ' VAL . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.711 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.185 0.516 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -125.81 71.57 67.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.26 -160.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.308 1.162 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.2 m -155.4 81.55 4.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.66 105.58 0.37 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.278 1.147 . . . . 0.0 110.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.77 149.55 26.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.225 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 167.42 22.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.4 -30.66 23.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.233 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -77.29 75.82 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 110.279 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 34' ' ' VAL . 34.1 m -72.64 154.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.59 151.34 38.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 110.379 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -104.88 -141.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.704 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -174.24 -179.98 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.795 -1.191 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 49' ' ' SER . 6.5 tt -121.03 31.59 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.084 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.864 ' HA ' HD22 ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.748 ' CD1' HD12 ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.455 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.793 ' OG1' HG21 ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.718 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.712 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.483 ' CB ' HD11 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.712 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 1.035 HG23 HD12 ' B' ' 72' ' ' LEU . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 1.035 HD12 HG23 ' B' ' 66' ' ' ILE . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.724 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.677 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.531 ' HB ' HG11 ' B' ' 130' ' ' VAL . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.929 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.638 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 48.2 m80 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.473 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.846 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.929 HG11 ' HB1' ' B' ' 80' ' ' ALA . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.75 HG21 HD21 ' B' ' 107' ' ' LEU . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.841 HD12 HD21 ' B' ' 101' ' ' LEU . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.673 ' O ' HD23 ' B' ' 101' ' ' LEU . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.841 HD21 HD12 ' B' ' 99' ' ' LEU . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.638 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.75 HD21 HG21 ' B' ' 95' ' ' THR . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 8.0 t-20 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.459 ' C ' HD13 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.425 ' H ' HG22 ' B' ' 118' ' ' THR . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.513 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.513 ' N ' HG22 ' B' ' 119' ' ' ILE . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.663 ' O ' HG23 ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' B' ' 80' ' ' ALA . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.854 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' B' ' 132' ' ' ILE . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.846 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.441 HG22 ' HA3' ' B' ' 65' ' ' GLY . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 135' ' ' VAL . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.466 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.718 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -56.66 148.86 44.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.78 119.25 6.24 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 O-C-N 123.109 1.057 . . . . 0.0 110.394 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.499 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -63.62 -53.83 47.89 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.49 104.07 0.35 Allowed 'Trans proline' 0 N--CA 1.484 0.914 0 O-C-N 122.939 0.968 . . . . 0.0 110.541 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.23 -80.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.03 73.31 0.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.938 . . . . 0.0 110.222 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.55 148.22 30.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.53 164.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.124 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 34' ' ' VAL . 9.8 p -144.59 51.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -96.26 -57.94 2.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -174.19 127.76 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp -86.68 145.49 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.922 ' CB ' HD13 ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' B' ' 44' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.565 HG21 HG21 ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.663 ' CB ' HD11 ' A' ' 62' ' ' ILE . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.458 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.901 HD12 ' ND2' ' A' ' 111' ' ' ASN . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.877 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.037 HG23 HD12 ' A' ' 72' ' ' LEU . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 66' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 79' ' ' THR . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 78' ' ' ILE . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 55.5 m80 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.877 HD11 ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.74 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.728 HD11 ' CD2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.866 ' HB ' HD22 ' A' ' 125' ' ' LEU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.728 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.825 HG11 ' HA3' ' A' ' 64' ' ' GLY . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HD3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 97' ' ' LYS . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.901 ' ND2' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 120' ' ' SER . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 119' ' ' ILE . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.604 ' CB ' HG11 ' A' ' 105' ' ' VAL . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' A' ' 133' ' ' HIS . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.843 ' CE1' HG21 ' A' ' 131' ' ' VAL . 11.5 m-70 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.1 HG13 HG22 ' B' ' 135' ' ' VAL . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.777 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -80.68 159.53 68.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.16 171.37 4.04 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.288 1.152 . . . . 0.0 110.491 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -143.02 71.8 18.54 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.58 123.52 12.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.285 1.15 . . . . 0.0 110.496 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 49.73 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.81 152.89 32.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.239 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.94 28.87 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -114.4 56.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.08 -67.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.179 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.15 71.78 10.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.141 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -95.36 -39.8 9.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -104.15 110.47 22.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER -72.91 150.21 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.446 ' O ' HD23 ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.922 HD13 ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.927 ' CB ' HD13 ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 44' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.438 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.716 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.57 HG21 HG21 ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.678 ' CB ' HD11 ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 110' ' ' MET . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.469 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.678 HD11 ' CB ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 1.038 HG23 HD12 ' B' ' 72' ' ' LEU . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.713 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 1.038 HD12 HG23 ' B' ' 66' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.838 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 79' ' ' THR . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 78' ' ' ILE . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 53.2 m80 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.752 HG11 ' HB1' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.952 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' THR . . . . . 1.022 HG21 HD11 ' B' ' 107' ' ' LEU . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' B' ' 64' ' ' GLY . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.444 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.67 HD21 HD12 ' B' ' 99' ' ' LEU . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 1.022 HD11 HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.6 HD11 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.776 ' HG3' HG23 ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' B' ' 60' ' ' SER . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.432 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 25.1 t-20 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.6 ' N ' HD11 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.464 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.421 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 118' ' ' THR . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.416 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.64 ' HB2' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.843 HG21 ' CE1' ' B' ' 133' ' ' HIS . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.765 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.843 ' CE1' HG21 ' B' ' 131' ' ' VAL . 11.7 m-70 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.44 ' H ' HG12 ' B' ' 134' ' ' VAL . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 135' ' ' VAL . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 134' ' ' VAL . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.564 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.785 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.163 0.506 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 53.38 78.14 0.41 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.349 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.4 166.13 11.84 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.305 1.161 . . . . 0.0 110.46 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -55.85 -54.42 52.21 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.545 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -61.28 114.17 2.09 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 O-C-N 122.766 0.877 . . . . 0.0 110.513 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.93 98.18 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.27 110.01 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 108.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -163.72 46.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.8 117.96 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.33 166.92 20.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.34 -148.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtp85 -141.48 -174.76 4.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.025 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.807 HG23 ' HE2' ' B' ' 53' ' ' PHE . 43.7 mm -86.46 103.89 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -0.815 . . . . 0.0 109.924 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.803 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.627 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD11 ' B' ' 73' ' ' ILE . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.72 HD12 HD22 ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.534 ' N ' HG22 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.819 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.819 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.676 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HB3' HD13 ' A' ' 73' ' ' ILE . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' N ' ' HE3' ' A' ' 55' ' ' LYS . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.435 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.992 HG23 HD12 ' A' ' 72' ' ' LEU . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.992 HD12 HG23 ' A' ' 66' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 79' ' ' THR . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 78' ' ' ILE . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.866 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.454 ' HE1' HD12 ' A' ' 101' ' ' LEU . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' A' ' 64' ' ' GLY . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.863 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.862 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 87' ' ' ILE . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.862 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' A' ' 101' ' ' LEU . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 100' ' ' GLN . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 105' ' ' VAL . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 ' N ' ' A' ' 122' ' ' GLU . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 95' ' ' THR . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 23.5 t-20 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.517 ' CA ' HD11 ' A' ' 108' ' ' ILE . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 117' ' ' ILE . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 105' ' ' VAL . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 125' ' ' LEU . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.745 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.701 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 124' ' ' THR . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.866 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.225 0.536 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 53.46 65.42 5.68 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.54 80.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.304 1.16 . . . . 0.0 110.635 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p -117.77 154.32 51.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.019 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.48 -69.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.284 1.15 . . . . 0.0 110.45 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.34 -156.6 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.58 71.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.31 -1.77 32.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.694 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.57 -11.31 9.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.014 -1.053 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.77 -67.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -73.68 173.37 9.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.55 -62.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -155.84 -164.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.613 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.9 tt -174.23 71.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.962 . . . . 0.0 110.368 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.807 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.807 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 73' ' ' ILE . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.537 ' N ' HG22 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.822 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.664 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.807 ' HE2' HG23 ' A' ' 38' ' ' ILE . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.451 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.591 ' HB2' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.442 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.974 HG23 HD12 ' B' ' 72' ' ' LEU . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.978 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.978 ' N ' HD23 ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.664 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.757 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.477 HG22 ' N ' ' B' ' 79' ' ' THR . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.477 ' N ' HG22 ' B' ' 78' ' ' ILE . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 65.4 m80 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.47 ' O ' HG22 ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' B' ' 64' ' ' GLY . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.845 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.845 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.452 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.586 ' HD2' HG23 ' B' ' 108' ' ' ILE . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.632 HD21 HG21 ' B' ' 95' ' ' THR . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.495 ' CA ' HD11 ' B' ' 108' ' ' ILE . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.508 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.508 ' N ' HG22 ' B' ' 119' ' ' ILE . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.603 ' N ' HG11 ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.702 ' O ' HD22 ' B' ' 125' ' ' LEU . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.702 HD22 ' O ' ' B' ' 124' ' ' THR . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.877 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.831 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.466 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.595 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -77.18 162.42 69.55 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 143.56 98.92 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.282 1.148 . . . . 0.0 110.461 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER 54.47 176.25 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.63 -40.91 43.02 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.201 1.106 . . . . 0.0 110.499 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.56 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.168 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.14 149.54 26.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.147 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.69 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.2 p-10 -158.24 105.78 1.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 0.0 110.172 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 52.97 35.2 18.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.902 . . . . 0.0 110.235 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.3 p -173.73 123.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.49 23.35 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.938 . . . . 0.0 110.202 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 51.6 tt0 -152.71 169.43 22.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 36' ' ' GLN . 2.3 ttp180 -124.38 115.19 20.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -142.03 43.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 109.902 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.061 HD11 HD11 ' B' ' 45' ' ' ILE . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.443 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' B' ' 44' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.043 HD11 HD11 ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.704 HG21 HG21 ' A' ' 45' ' ' ILE . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CZ ' HD22 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 72' ' ' LEU . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.472 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.875 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.793 HD12 ' CG ' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.671 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 73' ' ' ILE . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.884 ' N ' HD23 ' A' ' 72' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.75 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.661 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 84' ' ' ASP . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 124' ' ' THR . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 95' ' ' THR . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.875 HG21 ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.715 HD22 ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.911 HD12 ' N ' ' A' ' 102' ' ' ARG . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.911 ' N ' HD12 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.912 ' O ' HD12 ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 106' ' ' GLN . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.793 ' CG ' HD12 ' A' ' 62' ' ' ILE . 24.0 t30 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 118' ' ' THR . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.724 ' O ' HG11 ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.575 ' O ' HG21 ' A' ' 105' ' ' VAL . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 124' ' ' THR . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' CG2' HD22 ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HB3' HG23 ' A' ' 87' ' ' ILE . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 131' ' ' VAL . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.772 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.437 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.9 m170 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 136' ' ' LYS . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.875 HG22 HG13 ' B' ' 135' ' ' VAL . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' O ' HG12 ' B' ' 134' ' ' VAL . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.19 0.519 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.536 ' N ' ' CD1' ' B' ' 26' ' ' PHE . 14.7 p90 -158.69 77.85 3.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.216 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 102.3 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.146 1.077 . . . . 0.0 110.504 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 85.5 p -150.47 81.31 6.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.46 -44.83 20.57 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.321 1.169 . . . . 0.0 110.527 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.98 84.88 2.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.134 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.09 116.82 11.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB3' HG12 ' B' ' 34' ' ' VAL . 0.3 OUTLIER -148.99 157.34 43.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 21.26 15.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' B' ' 32' ' ' ASP . 7.5 p -111.94 148.32 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -151.53 79.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -138.98 -146.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.903 . . . . 0.0 109.942 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.26 -157.86 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.586 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.6 tt -150.69 71.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.043 HD11 HD11 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.447 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' A' ' 44' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.719 HG21 HG21 ' B' ' 45' ' ' ILE . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.536 ' CE1' HD22 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' B' ' 72' ' ' LEU . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.483 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.799 ' HG2' HG21 ' B' ' 96' ' ' VAL . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' B' ' 111' ' ' ASN . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.596 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.669 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.858 HD23 ' N ' ' B' ' 73' ' ' ILE . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.858 ' N ' HD23 ' B' ' 72' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.605 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.676 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.527 HG22 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.527 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.637 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 31.6 m170 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 86' ' ' VAL . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.686 HG23 ' O ' ' B' ' 85' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 84' ' ' ASP . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.633 ' O ' HG23 ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.918 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 88' ' ' ALA . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.918 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.799 HG21 ' HG2' ' B' ' 61' ' ' MET . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.502 ' N ' HG12 ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' B' ' 88' ' ' ALA . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.693 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.71 HD21 HD12 ' B' ' 99' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.637 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.488 HG22 ' N ' ' B' ' 105' ' ' VAL . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.766 HG11 ' O ' ' B' ' 120' ' ' SER . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.831 ' O ' HD12 ' B' ' 107' ' ' LEU . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 1.037 HD13 HD12 ' B' ' 119' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.689 ' O ' HG23 ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' B' ' 62' ' ' ILE . 6.7 t-20 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.528 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.556 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.575 ' O ' HG23 ' B' ' 118' ' ' THR . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 1.037 HD12 HD13 ' B' ' 107' ' ' LEU . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.766 ' O ' HG11 ' B' ' 105' ' ' VAL . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.524 ' O ' HD22 ' B' ' 125' ' ' LEU . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.676 HD12 HD21 ' B' ' 107' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' B' ' 87' ' ' ILE . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.475 HG13 ' N ' ' B' ' 131' ' ' VAL . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.778 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.778 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.631 ' CE1' HG21 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' LYS . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.875 HG13 HG22 ' A' ' 135' ' ' VAL . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.501 ' O ' HG12 ' A' ' 134' ' ' VAL . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.621 ' HB3' HG23 ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.24 0.543 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 12.2 p90 -146.92 64.97 9.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.38 174.08 2.26 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.327 1.172 . . . . 0.0 110.56 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.97 75.12 9.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 94.11 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.236 1.124 . . . . 0.0 110.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.48 11.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.26 126.31 44.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.31 126.64 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' C ' HG13 ' A' ' 34' ' ' VAL . 14.1 m-85 -86.54 -170.02 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG13 ' C ' ' A' ' 33' ' ' TYR . 28.3 m -151.07 43.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.179 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.91 90.63 2.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -154.26 -46.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.353 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 55.12 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 109.779 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 38' ' ' ILE . 7.6 tt -76.39 57.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 110.672 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.991 ' CD1' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' B' ' 44' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.91 HD11 HD11 ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.733 ' H ' HD11 ' A' ' 66' ' ' ILE . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.733 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD11 HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 66' ' ' ILE . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.972 HD11 HD11 ' B' ' 44' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.788 ' HB2' HG12 ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.817 HG22 ' OXT' ' B' ' 139' ' ' ARG . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 80' ' ' ALA . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.68 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.814 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.814 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HA3' ' A' ' 64' ' ' GLY . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.852 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 100' ' ' GLN . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 118' ' ' THR . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 HG12 ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' HD22 ' A' ' 125' ' ' LEU . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.656 HD21 HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 87' ' ' ILE . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.765 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.833 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG22 HG13 ' B' ' 135' ' ' VAL . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.84 ' OXT' HG22 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.2 0.524 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -148.32 83.25 7.21 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -69.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.324 1.171 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 8.3 p -171.53 160.76 5.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.88 -28.45 81.28 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.236 1.124 . . . . 0.0 110.489 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.13 102.12 13.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 48.13 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -73.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -135.98 19.65 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 110.439 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 34' ' ' VAL . 10.9 p -101.38 58.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.299 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.47 -75.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.183 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -58.27 8.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.105 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.536 ' C ' HG22 ' B' ' 38' ' ' ILE . 3.0 ttt-85 53.13 53.62 11.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.302 -0.874 . . . . 0.0 110.454 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.536 HG22 ' C ' ' B' ' 37' ' ' ARG . 0.7 OUTLIER 36.36 60.8 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.976 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' A' ' 44' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.905 HD11 HD11 ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.71 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.644 HG21 HG21 ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.686 ' O ' HG12 ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' B' ' 73' ' ' ILE . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.742 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.704 HD12 ' ND2' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.742 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.673 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.955 HD11 HD11 ' A' ' 44' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.686 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.797 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.406 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.406 ' N ' HG22 ' B' ' 78' ' ' ILE . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.854 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.84 HG22 ' OXT' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.854 HG11 ' HB1' ' B' ' 80' ' ' ALA . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.684 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.665 HG21 HD21 ' B' ' 125' ' ' LEU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.608 ' HB3' HD11 ' B' ' 87' ' ' ILE . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.638 HG21 HD12 ' B' ' 107' ' ' LEU . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' B' ' 64' ' ' GLY . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HE2' HD12 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.435 ' N ' HD23 ' B' ' 99' ' ' LEU . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.717 ' O ' HD23 ' B' ' 101' ' ' LEU . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.717 HD23 ' O ' ' B' ' 100' ' ' GLN . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.642 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.638 HD12 HG21 ' B' ' 95' ' ' THR . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.642 ' C ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.505 ' HG3' ' CE2' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.533 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.704 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.407 ' H ' HG22 ' B' ' 118' ' ' THR . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.565 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.593 ' O ' HD22 ' B' ' 125' ' ' LEU . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.665 HD21 HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 87' ' ' ILE . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.841 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.841 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 135' ' ' VAL . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.817 ' OXT' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 23.5 p90 -139.19 61.33 20.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.51 -157.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.171 1.09 . . . . 0.0 110.459 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.428 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 11.8 m -144.92 61.72 8.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.37 81.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.289 1.152 . . . . 0.0 110.526 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB1' ' HD2' ' A' ' 33' ' ' TYR . . . -117.99 101.97 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 -44.04 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.46 34.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.542 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -71.55 66.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.63 135.29 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 110.14 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -120.65 169.64 10.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.943 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -174.51 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 113.7 2.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.62 HG12 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -59.35 148.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.759 HD13 HG13 ' B' ' 45' ' ' ILE . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG13 HD13 ' B' ' 40' ' ' LEU . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.653 HG21 HG23 ' A' ' 45' ' ' ILE . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' HD11 ' A' ' 62' ' ' ILE . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' MET . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.743 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD12 ' OD1' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.743 HD11 ' H ' ' A' ' 61' ' ' MET . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD12 HD11 ' B' ' 44' ' ' LEU . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 73' ' ' ILE . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.646 HG13 HD21 ' B' ' 44' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.777 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 36.7 m170 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 86' ' ' VAL . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 64' ' ' GLY . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 84' ' ' ASP . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.709 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.605 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.709 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 108' ' ' ILE . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 125' ' ' LEU . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.799 HG11 ' H ' ' A' ' 122' ' ' GLU . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.657 ' HB2' HD11 ' A' ' 119' ' ' ILE . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.68 ' OD1' HD12 ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 107' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.799 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.723 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' B' ' 135' ' ' VAL . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.584 ' HE ' HG22 ' B' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.1 OUTLIER -52.77 -52.16 67.16 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.904 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.1 Cg_exo -62.62 178.01 1.1 Allowed 'Trans proline' 0 N--CA 1.484 0.948 0 O-C-N 122.833 0.912 . . . . 0.0 110.586 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m 53.77 72.72 1.06 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.153 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.42 121.43 9.58 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.374 1.197 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.56 ' HB1' HG11 ' B' ' 34' ' ' VAL . . . -89.16 47.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -172.4 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.53 91.95 8.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.56 HG11 ' HB1' ' B' ' 30' ' ' ALA . 7.1 p -172.24 155.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.19 -64.46 0.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.266 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.24 -151.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 71.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.725 ' H ' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -146.81 138.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.764 HD13 HG13 ' A' ' 45' ' ' ILE . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.57 ' N ' HD12 ' B' ' 40' ' ' LEU . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 40' ' ' LEU . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.877 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.626 HG21 HG23 ' B' ' 45' ' ' ILE . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 54' ' ' VAL . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.531 ' HB2' HD11 ' B' ' 62' ' ' ILE . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.802 ' HG2' HG21 ' B' ' 96' ' ' VAL . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.929 HD12 ' CG ' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.724 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.739 HD11 ' H ' ' B' ' 61' ' ' MET . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.813 HD12 HD11 ' A' ' 44' ' ' LEU . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.523 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.632 HG13 HD21 ' A' ' 44' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.796 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.877 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.491 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' HD11 ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.736 ' O ' HG22 ' B' ' 86' ' ' VAL . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.724 HD11 ' O ' ' B' ' 64' ' ' GLY . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 84' ' ' ASP . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.578 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.621 ' HB ' HD22 ' B' ' 125' ' ' LEU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' THR . . . . . 1.023 HG21 HD23 ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' B' ' 61' ' ' MET . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.605 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' B' ' 85' ' ' ILE . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' B' ' 106' ' ' GLN . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.757 HD23 ' HB3' ' B' ' 125' ' ' LEU . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.677 ' N ' HD12 ' B' ' 101' ' ' LEU . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.76 HG11 ' O ' ' B' ' 120' ' ' SER . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' B' ' 100' ' ' GLN . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 1.023 HD23 HG21 ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.673 ' O ' HG23 ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' B' ' 113' ' ' ALA . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.929 ' CG ' HD12 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.509 ' HB3' ' SD ' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.601 ' O ' HG21 ' B' ' 105' ' ' VAL . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.76 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.57 ' O ' HG23 ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.757 ' HB3' HD23 ' B' ' 101' ' ' LEU . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.669 ' CG2' HD22 ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.796 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.716 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.531 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' A' ' 135' ' ' VAL . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.53 ' HE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.228 0.537 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -127.02 87.44 56.67 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.228 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.65 -28.71 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.356 1.187 . . . . 0.0 110.597 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.7 90.51 7.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.37 107.6 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.239 1.126 . . . . 0.0 110.536 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.52 159.16 18.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.201 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.34 141.58 58.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 110.45 2.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.15 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 52.77 -167.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.66 176.97 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -61.01 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.04 -64.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 0.0 110.279 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 54.38 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.079 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 38' ' ' ILE . 11.9 tt -64.58 85.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.883 . . . . 0.0 110.281 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 43' ' ' LEU . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.545 ' HB2' HD12 ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 41' ' ' ASN . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' ILE . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.463 ' H ' HG22 ' A' ' 45' ' ' ILE . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 45' ' ' ILE . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.634 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.581 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 59' ' ' ASP . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.807 HD12 HD11 ' B' ' 44' ' ' LEU . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.893 ' N ' HD13 ' A' ' 72' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.886 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.492 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 60.5 m80 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.647 ' C ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.886 HG11 ' CB ' ' A' ' 80' ' ' ALA . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.606 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 122' ' ' GLU . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD23 ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 97' ' ' LYS . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD3' HD23 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' HB2' HD11 ' A' ' 108' ' ' ILE . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.505 ' C ' HD13 ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 117' ' ' ILE . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.716 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.74 ' HA ' HG21 ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.698 ' O ' HD22 ' A' ' 125' ' ' LEU . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 124' ' ' THR . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.751 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CE1' HG21 ' A' ' 131' ' ' VAL . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' B' ' 135' ' ' VAL . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' B' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.302 0.572 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.7 168.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.05 161.39 22.63 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.319 1.168 . . . . 0.0 110.653 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.422 ' O ' ' N ' ' B' ' 30' ' ' ALA . 23.3 p -118.39 95.5 48.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 80.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.179 1.094 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 28' ' ' SER . . . -175.88 86.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.113 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.99 -61.5 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -174.98 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.92 60.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.269 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.528 ' O ' HG13 ' B' ' 34' ' ' VAL . 9.5 p -101.62 60.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.039 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.07 117.97 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -52.91 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.935 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.23 110.66 3.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.886 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt -122.63 150.49 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.706 ' HA ' HD11 ' B' ' 43' ' ' LEU . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.542 ' HB2' HD12 ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' B' ' 41' ' ' ASN . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.48 ' H ' HG22 ' B' ' 45' ' ' ILE . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.471 ' H ' HG22 ' B' ' 45' ' ' ILE . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.504 HG21 HG23 ' B' ' 45' ' ' ILE . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.615 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.419 ' O ' HG13 ' B' ' 54' ' ' VAL . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.479 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.586 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.645 HD11 ' CB ' ' B' ' 59' ' ' ASP . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.505 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.608 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 44' ' ' LEU . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 1.054 HD11 HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.907 ' N ' HD13 ' B' ' 72' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.431 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.892 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.402 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.653 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.892 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.605 HD11 HG23 ' B' ' 127' ' ' VAL . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.799 ' O ' HD23 ' B' ' 101' ' ' LEU . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.799 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.682 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' B' ' 99' ' ' LEU . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.464 HG23 ' HG2' ' B' ' 97' ' ' LYS . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.501 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.463 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 118' ' ' THR . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.526 HG21 HD23 ' B' ' 125' ' ' LEU . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.713 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.713 HD22 ' O ' ' B' ' 124' ' ' THR . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.605 HG23 HD11 ' B' ' 99' ' ' LEU . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.585 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.77 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 1.054 HG23 HD11 ' B' ' 72' ' ' LEU . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.53 ' CE1' HG21 ' B' ' 131' ' ' VAL . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 135' ' ' VAL . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.452 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.297 0.57 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -128.61 68.19 77.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 132.22 39.68 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.257 1.135 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 m -142.74 64.32 15.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.931 . . . . 0.0 110.46 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.38 -72.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.302 1.159 . . . . 0.0 110.497 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' B' ' 72' ' ' LEU . . . -167.73 154.84 8.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.882 . . . . 0.0 110.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' B' ' 96' ' ' VAL . . . -114.91 -142.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 0.0 110.515 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -175.53 54.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.995 -1.066 . . . . 0.0 109.991 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' CD2' HG13 ' A' ' 34' ' ' VAL . 5.6 t80 -57.64 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.0 110.491 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.645 HG13 ' CD2' ' A' ' 33' ' ' TYR . 34.7 m -103.44 -170.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.15 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -170.79 79.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 110.166 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 -166.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' CZ ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER 62.71 131.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 0.0 109.8 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.35 12.07 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 110.657 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.096 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.816 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.02 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD22 HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.009 HD11 HD13 ' B' ' 40' ' ' LEU . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' N ' HG22 ' A' ' 45' ' ' ILE . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.723 HG21 HG23 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.629 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.943 ' HB3' HD13 ' A' ' 73' ' ' ILE . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.607 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 ' CG ' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 96' ' ' VAL . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.646 HD23 ' HG2' ' A' ' 55' ' ' LYS . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.7 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 79' ' ' THR . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 78' ' ' ILE . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 86' ' ' VAL . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 127' ' ' VAL . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 124' ' ' THR . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.804 ' H ' HD12 ' A' ' 108' ' ' ILE . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 100' ' ' GLN . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.567 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 120' ' ' SER . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.033 HD13 HD11 ' A' ' 119' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.804 HD12 ' H ' ' A' ' 96' ' ' VAL . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.766 ' CG ' HD12 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 110' ' ' MET . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 117' ' ' ILE . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 118' ' ' THR . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.033 HD11 HD13 ' A' ' 107' ' ' LEU . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.815 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.62 ' H ' HG11 ' A' ' 105' ' ' VAL . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 86' ' ' VAL . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 130' ' ' VAL . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.873 ' C ' HD12 ' A' ' 132' ' ' ILE . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.559 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' B' ' 135' ' ' VAL . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' B' ' 134' ' ' VAL . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.27 0.557 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.507 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -74.01 -52.62 4.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.783 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.1 99.83 0.2 Allowed 'Trans proline' 0 N--CA 1.483 0.892 0 O-C-N 122.809 0.9 . . . . 0.0 110.518 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.6 m -127.19 81.7 69.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.53 -70.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.309 1.162 . . . . 0.0 110.533 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.84 84.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.16 171.24 14.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 110.314 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' B' ' 34' ' ' VAL . 2.0 t70 -103.99 -177.71 3.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.11 29.49 7.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.741 HG23 ' HG3' ' B' ' 35' ' ' GLU . 34.9 m -116.17 -21.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.741 ' HG3' HG23 ' B' ' 34' ' ' VAL . 4.2 mt-10 -106.43 -166.77 1.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.167 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.94 -148.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 21.97 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.244 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -125.03 96.08 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.083 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.009 HD13 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.81 ' HA ' HD22 ' A' ' 40' ' ' LEU . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.992 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.992 HD22 ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 1.096 HD11 HD13 ' A' ' 40' ' ' LEU . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.491 ' N ' HG22 ' B' ' 45' ' ' ILE . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.713 HG21 HG23 ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.638 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.96 ' HB3' HD13 ' B' ' 73' ' ' ILE . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.498 HG23 ' CG2' ' A' ' 34' ' ' VAL . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.626 ' HG2' HD23 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.612 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.843 HD12 ' OD1' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.665 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' ALA . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.822 HG23 ' HB3' ' A' ' 31' ' ' ALA . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.431 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.642 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.812 ' HB3' ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.96 HD13 ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.638 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.425 HG22 ' N ' ' B' ' 79' ' ' THR . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.425 ' N ' HG22 ' B' ' 78' ' ' ILE . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.414 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 70.0 m80 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.459 ' O ' HG22 ' B' ' 86' ' ' VAL . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.731 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 127' ' ' VAL . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.56 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.984 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 124' ' ' THR . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.984 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 31' ' ' ALA . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' CB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.437 ' O ' ' CG ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.496 ' N ' HD23 ' B' ' 99' ' ' LEU . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.868 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.868 HD23 ' O ' ' B' ' 100' ' ' GLN . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.561 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 105' ' ' VAL . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.837 HG11 ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' B' ' 100' ' ' GLN . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 1.008 HD13 HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.665 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.515 ' C ' HD13 ' B' ' 108' ' ' ILE . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.843 ' OD1' HD12 ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.408 ' OG1' HG23 ' B' ' 105' ' ' VAL . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 1.008 HD11 HD13 ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.837 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.722 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.66 ' HB3' HD11 ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 86' ' ' VAL . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 130' ' ' VAL . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.874 ' C ' HD12 ' B' ' 132' ' ' ILE . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.874 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.557 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 136' ' ' LYS . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 135' ' ' VAL . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 44.4 p90 -161.34 135.82 5.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.92 -159.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.484 0.95 0 O-C-N 123.042 1.022 . . . . 0.0 110.5 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.59 68.26 3.23 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 94.5 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.348 1.183 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.67 84.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.309 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -161.4 42.1 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -113.59 -24.99 8.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.087 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -129.92 149.52 51.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.31 169.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.26 118.88 37.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -135.34 -63.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -138.19 96.25 3.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt -162.37 43.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.907 . . . . 0.0 110.276 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.633 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.675 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.672 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 59' ' ' ASP . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.869 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' A' ' 61' ' ' MET . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.926 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.926 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 131' ' ' VAL . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.857 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.875 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.832 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.878 ' HB ' HD22 ' A' ' 125' ' ' LEU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.832 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.869 HG11 ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.794 HD12 HD21 ' A' ' 101' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' HD23 ' A' ' 101' ' ' LEU . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 99' ' ' LEU . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 119' ' ' ILE . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.482 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.609 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' ILE . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 117' ' ' ILE . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' LEU . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.488 ' H ' HG11 ' A' ' 105' ' ' VAL . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.878 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' A' ' 75' ' ' ASP . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.656 ' NE2' HG21 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 64' ' ' GLY . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HG22 ' B' ' 135' ' ' VAL . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.504 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -71.19 -52.9 8.7 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.81 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_exo -61.72 99.18 0.17 Allowed 'Trans proline' 0 N--CA 1.483 0.886 0 O-C-N 122.803 0.897 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -143.31 164.66 29.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.38 -60.95 0.19 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.323 1.17 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.89 126.52 10.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 110.066 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.04 37.41 2.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.317 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.37 -70.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.39 64.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.061 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.443 HG12 ' H ' ' B' ' 36' ' ' GLN . 48.0 t -85.34 155.71 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.298 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.43 19.35 6.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.438 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.443 ' H ' HG12 ' B' ' 34' ' ' VAL . 3.6 tt0 -174.45 -148.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.014 . . . . 0.0 110.085 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.34 -49.04 1.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 1.025 HD12 HD23 ' B' ' 40' ' ' LEU . 1.2 pt -114.98 126.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.463 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.025 HD23 HD12 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.673 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.421 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.674 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' B' ' 73' ' ' ILE . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' B' ' 62' ' ' ILE . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' B' ' 59' ' ' ASP . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.823 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.669 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.932 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.932 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.674 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.889 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.454 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.819 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.885 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.672 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.883 HG23 ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.823 HG11 ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.784 HD12 HD21 ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.761 ' O ' HD23 ' B' ' 101' ' ' LEU . 4.1 mm-40 -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.81 HD13 ' O ' ' B' ' 125' ' ' LEU . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 108' ' ' ILE . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.883 ' HB3' HG23 ' B' ' 95' ' ' THR . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.626 ' CG ' HD12 ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 117' ' ' ILE . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.426 ' H ' HG22 ' B' ' 118' ' ' THR . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.728 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 105' ' ' VAL . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.819 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.889 HG12 ' HB2' ' B' ' 75' ' ' ASP . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.885 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.518 HG21 ' O ' ' B' ' 64' ' ' GLY . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 135' ' ' VAL . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.747 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.303 0.573 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 1.1 m-85 -69.76 -52.68 13.27 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.94 92.44 0.12 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 O-C-N 122.805 0.897 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.52 171.72 7.56 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.369 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.35 81.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.391 1.206 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.81 -58.27 3.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.26 137.0 36.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.52 122.92 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -101.01 110.4 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.98 156.31 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -85.66 103.59 14.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.46 -159.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 109.971 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -146.11 28.18 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 38' ' ' ILE . 12.1 tt -71.07 96.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 110.331 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.988 HD13 HD12 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.662 ' CB ' HD21 ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.009 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.039 HD12 HD13 ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 45' ' ' ILE . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.809 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 70' ' ' ASP . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.725 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' CG ' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.725 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.95 ' N ' HD23 ' A' ' 72' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.755 ' HB3' HG12 ' A' ' 131' ' ' VAL . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.694 HD13 HG11 ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 78' ' ' ILE . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' B' ' 138' ' ' MET . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 80' ' ' ALA . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.966 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.966 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.797 ' H ' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' H ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 127' ' ' VAL . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.771 ' O ' HD23 ' A' ' 101' ' ' LEU . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 105' ' ' VAL . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' VAL . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.787 ' HB2' HD11 ' A' ' 119' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.797 HD12 ' H ' ' A' ' 96' ' ' VAL . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.844 ' CG ' HD12 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.532 ' OG1' HG23 ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' ' 107' ' ' LEU . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.63 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 125' ' ' LEU . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 99' ' ' LEU . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.694 HG11 HD13 ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.83 ' HB3' HD13 ' B' ' 85' ' ' ILE . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.262 0.553 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -158.34 85.39 2.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.76 132.03 38.13 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.285 1.15 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 41.6 p -69.59 156.85 90.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.145 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.74 81.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.273 1.144 . . . . 0.0 110.597 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.41 33.06 5.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.96 -30.22 10.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 110.165 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 177.54 3.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.43 122.97 40.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.93 -44.57 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -113.94 92.4 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.57 -50.67 4.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 110.256 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.21 139.83 21.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.25 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt -174.23 144.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.764 ' O ' HD12 ' B' ' 43' ' ' LEU . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.039 HD13 HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.675 ' CB ' HD21 ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 1.014 HD13 ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.014 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.988 HD12 HD13 ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.52 ' N ' HG22 ' B' ' 45' ' ' ILE . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.642 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.804 ' HB3' HD13 ' B' ' 73' ' ' ILE . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.432 ' O ' HG13 ' B' ' 54' ' ' VAL . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 70' ' ' ASP . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.718 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.883 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.718 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 56' ' ' ALA . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.66 ' C ' HD13 ' B' ' 71' ' ' LEU . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.953 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.642 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.733 ' HB3' HG12 ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.683 HD13 HG11 ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.428 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.46 ' O ' HG22 ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 138' ' ' MET . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' B' ' 80' ' ' ALA . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.461 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.887 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.887 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.467 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.429 ' HD3' ' HE3' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.795 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.795 HD23 ' O ' ' B' ' 100' ' ' GLN . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 105' ' ' VAL . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.686 HD13 HD11 ' B' ' 119' ' ' ILE . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.883 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.875 ' CG ' HD12 ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.434 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.518 ' OG1' HG23 ' B' ' 105' ' ' VAL . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.688 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.5 ' O ' HD22 ' B' ' 125' ' ' LEU . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.739 HG22 HD21 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.683 HG11 HD13 ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.733 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.481 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 135' ' ' VAL . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.845 ' HB3' HD13 ' A' ' 85' ' ' ILE . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.471 ' HB3' HG23 ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.196 0.522 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.2 155.95 36.02 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.114 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 -66.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.318 1.167 . . . . 0.0 110.446 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -130.96 71.58 82.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.32 130.73 33.22 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 O-C-N 123.33 1.174 . . . . 0.0 110.439 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.68 -178.07 5.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -158.68 97.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.158 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.17 171.77 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 53.17 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 32.8 m -144.24 56.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.18 139.18 38.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.89 -62.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.285 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.2 68.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 38' ' ' ILE . 1.8 tp -159.34 54.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD11 ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.433 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' GLN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' B' ' 44' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.879 HD11 HD11 ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 45' ' ' ILE . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.804 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.706 HD12 ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.804 HD11 ' N ' ' A' ' 61' ' ' MET . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.904 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 79' ' ' THR . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.791 ' O ' HD13 ' A' ' 132' ' ' ILE . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 64' ' ' GLY . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.868 ' HD2' HD12 ' A' ' 107' ' ' LEU . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.734 ' O ' HD23 ' A' ' 101' ' ' LEU . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.645 ' C ' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.489 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.706 ' OD1' HD12 ' A' ' 62' ' ' ILE . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 107' ' ' LEU . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 105' ' ' VAL . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.843 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.791 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.691 ' NE2' HG21 ' A' ' 131' ' ' VAL . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG13 HG22 ' B' ' 135' ' ' VAL . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.508 ' CG ' HD13 ' B' ' 85' ' ' ILE . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HB3' HG23 ' B' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.179 0.514 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.505 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.6 m-85 -62.4 -53.18 60.25 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 110.669 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 2.9 Cg_endo -62.03 153.79 66.49 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 122.825 0.908 . . . . 0.0 110.442 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' B' ' 29' ' ' PRO . 98.7 p -149.34 60.46 4.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.367 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' B' ' 28' ' ' SER . 2.9 Cg_endo -61.86 111.06 1.1 Allowed 'Trans proline' 0 C--N 1.32 -0.955 0 O-C-N 123.262 1.138 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.41 163.27 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 -56.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -92.06 160.73 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 110.051 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -120.59 142.13 49.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.11 153.98 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.136 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.04 -77.69 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.53 -151.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -127.44 74.18 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt -160.97 52.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 45' ' ' ILE . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.48 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' B' ' 46' ' ' GLN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.9 HD11 HD11 ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.461 ' OG1' HG21 ' B' ' 45' ' ' ILE . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.602 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.808 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.832 HD12 ' OD1' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.808 HD11 ' N ' ' B' ' 61' ' ' MET . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.634 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.896 ' N ' HD23 ' B' ' 72' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.442 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.81 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.404 HG22 ' N ' ' B' ' 79' ' ' THR . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.404 ' N ' HG22 ' B' ' 78' ' ' ILE . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.721 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.409 ' HE1' HD12 ' B' ' 101' ' ' LEU . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.793 ' O ' HD13 ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.963 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.963 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.628 HG12 ' H ' ' B' ' 97' ' ' LYS . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.628 ' H ' HG12 ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.778 ' HB2' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.67 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.722 HD21 HD12 ' B' ' 99' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.624 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 105' ' ' VAL . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.708 ' O ' HG13 ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.686 HD13 ' N ' ' B' ' 110' ' ' MET . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HG2' ' HG2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.686 ' N ' HD13 ' B' ' 108' ' ' ILE . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.832 ' OD1' HD12 ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.618 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.525 ' O ' HG23 ' B' ' 118' ' ' THR . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.889 HD13 ' HG ' ' B' ' 125' ' ' LEU . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' B' ' 120' ' ' SER . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.677 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.889 ' HG ' HD13 ' B' ' 119' ' ' ILE . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 130' ' ' VAL . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.823 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.793 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.702 ' NE2' HG21 ' B' ' 131' ' ' VAL . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 135' ' ' VAL . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.553 ' CG ' HD13 ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.23 65.8 69.57 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 110.058 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.96 130.92 32.69 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.271 1.143 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 p -163.15 156.16 16.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.46 -27.11 76.82 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.319 1.168 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.17 135.94 8.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.068 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.6 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -91.92 -175.6 4.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.425 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 39.4 p90 -156.19 25.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -0.84 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 34' ' ' VAL . 33.3 m -105.48 -22.71 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.305 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -89.96 57.27 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -155.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -115.2 -176.3 2.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -169.83 62.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.192 -0.943 . . . . 0.0 110.15 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.907 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 90.8 m-70 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.91 HG21 HG23 ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HD11 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.782 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' A' ' 67' ' ' SER . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 61' ' ' MET . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.847 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.782 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' A' ' 62' ' ' ILE . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 132' ' ' ILE . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.742 HD11 HD13 ' B' ' 43' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 131' ' ' VAL . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.791 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' HD2' ' A' ' 102' ' ' ARG . 53.7 m80 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.791 HG11 ' HB1' ' A' ' 80' ' ' ALA . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 124' ' ' THR . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 88' ' ' ALA . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.847 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' O ' HD23 ' A' ' 101' ' ' LEU . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 100' ' ' GLN . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 105' ' ' VAL . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 99' ' ' LEU . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' SER . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.647 ' N ' HD11 ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 118' ' ' THR . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.624 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 124' ' ' THR . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 87' ' ' ILE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.716 HG23 HD21 ' A' ' 72' ' ' LEU . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.42 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' HA3' ' A' ' 65' ' ' GLY . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.646 HG22 HG13 ' B' ' 135' ' ' VAL . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -53.82 153.48 8.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 110.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.32 144.05 94.71 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.262 1.138 . . . . 0.0 110.675 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 88.6 p -143.03 92.18 6.92 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.112 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.04 124.74 15.9 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 O-C-N 123.155 1.082 . . . . 0.0 110.61 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.93 119.37 19.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.97 68.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -89.74 47.32 1.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 102.24 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.52 -177.86 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.105 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -143.41 68.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 110.224 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' B' ' 38' ' ' ILE . 1.0 OUTLIER -100.28 -54.86 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.23 -71.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.395 -0.816 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.606 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.5 OUTLIER -160.98 72.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.059 -1.026 . . . . 0.0 110.561 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.902 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.902 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.792 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.923 HG23 HG21 ' B' ' 51' ' ' THR . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.492 ' H ' HG22 ' B' ' 45' ' ' ILE . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.923 HG21 HG23 ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.585 ' CB ' HD11 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.561 ' CA ' HD11 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' B' ' 67' ' ' SER . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' B' ' 61' ' ' MET . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.908 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' B' ' 62' ' ' ILE . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.735 HD21 HG23 ' B' ' 132' ' ' ILE . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 44' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.828 ' HB2' HG12 ' B' ' 131' ' ' VAL . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.723 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.79 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.587 ' CE1' ' HD2' ' B' ' 102' ' ' ARG . 55.1 m80 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.79 HG11 ' HB1' ' B' ' 80' ' ' ALA . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.688 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 124' ' ' THR . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.908 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.736 ' HG2' HG23 ' B' ' 108' ' ' ILE . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.714 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' B' ' 101' ' ' LEU . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.587 ' HD2' ' CE1' ' B' ' 82' ' ' HIS . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.679 HG11 ' H ' ' B' ' 122' ' ' GLU . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.633 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' B' ' 97' ' ' LYS . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.533 ' CB ' HD12 ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.589 HD13 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.589 ' N ' HD13 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.518 HG22 ' N ' ' B' ' 120' ' ' SER . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.679 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' B' ' 124' ' ' THR . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 87' ' ' ILE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.554 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.828 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.735 HG23 HD21 ' B' ' 72' ' ' LEU . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.409 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.644 HG22 ' HA3' ' B' ' 65' ' ' GLY . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.646 HG13 HG22 ' A' ' 135' ' ' VAL . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.206 0.527 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.35 155.2 48.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.78 161.23 25.89 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.211 1.111 . . . . 0.0 110.501 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 31' ' ' ALA . 7.0 t -141.51 73.19 24.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.301 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.63 -39.42 54.29 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.29 1.152 . . . . 0.0 110.572 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 107.02 9.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' OG ' ' A' ' 28' ' ' SER . . . -136.53 41.26 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.54 111.55 2.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.856 . . . . 0.0 110.267 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 52.5 67.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' CG2' ' HB1' ' A' ' 31' ' ' ALA . 48.5 t -66.76 -27.73 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.83 124.08 48.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.164 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -96.48 -160.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.186 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 -59.01 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -84.31 57.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.941 HD11 HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.71 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.653 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.94 HD12 HD11 ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 45' ' ' ILE . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.701 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.727 ' HB2' HD11 ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.935 HG23 ' OG ' ' A' ' 67' ' ' SER . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.621 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.935 ' OG ' HG23 ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.837 ' HB2' HG12 ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 79' ' ' THR . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 78' ' ' ILE . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.725 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.499 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 86' ' ' VAL . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.74 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.725 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 124' ' ' THR . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG11 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 108' ' ' ILE . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.832 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 100' ' ' GLN . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 105' ' ' VAL . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' N ' ' A' ' 122' ' ' GLU . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.806 ' CG ' HD12 ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 108' ' ' ILE . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.852 ' HG1' HG23 ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 125' ' ' LEU . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.852 ' N ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 124' ' ' THR . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.773 HG23 HD21 ' A' ' 72' ' ' LEU . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 HG13 ' B' ' 135' ' ' VAL . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 86.18 51.63 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.67 -164.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.326 1.172 . . . . 0.0 110.551 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -162.47 78.48 1.92 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.18 -54.3 1.9 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.252 1.133 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.95 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.343 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.2 -69.11 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.77 106.87 18.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.13 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.83 118.62 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -178.62 5.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.02 -149.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 154.47 29.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt -141.53 49.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.946 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.94 HD11 HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.725 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.941 HD12 HD11 ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.507 ' N ' HG22 ' B' ' 45' ' ' ILE . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.562 HG21 HD13 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.7 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.798 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.743 ' HB2' HD11 ' B' ' 62' ' ' ILE . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.919 HG23 ' OG ' ' B' ' 67' ' ' SER . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.74 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.488 ' O ' HD11 ' B' ' 85' ' ' ILE . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.592 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.62 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.919 ' OG ' HG23 ' B' ' 62' ' ' ILE . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.941 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.941 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.7 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.851 ' HB2' HG12 ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.709 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.507 HG22 ' N ' ' B' ' 79' ' ' THR . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.507 ' N ' HG22 ' B' ' 78' ' ' ILE . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.72 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.742 ' O ' HD13 ' B' ' 132' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.72 HG11 ' HB1' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.658 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.875 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 124' ' ' THR . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.875 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.808 ' H ' HD12 ' B' ' 108' ' ' ILE . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.588 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HG2' ' HD3' ' B' ' 97' ' ' LYS . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.693 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.858 ' O ' HD23 ' B' ' 101' ' ' LEU . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.858 HD23 ' O ' ' B' ' 100' ' ' GLN . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.554 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 105' ' ' VAL . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.808 HD12 ' H ' ' B' ' 96' ' ' VAL . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.436 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.566 ' CG ' HD12 ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.438 ' CE2' ' SD ' ' B' ' 110' ' ' MET . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.629 ' OG1' HG23 ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.642 HG21 HD23 ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' B' ' 119' ' ' ILE . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.663 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.699 ' O ' HD22 ' B' ' 125' ' ' LEU . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.699 HD22 ' O ' ' B' ' 124' ' ' THR . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.469 HG11 ' HB ' ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.604 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.851 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.781 HG23 HD21 ' B' ' 72' ' ' LEU . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.472 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 135' ' ' VAL . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.532 ' HB2' HG23 ' A' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.185 0.516 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 19.0 p90 -53.97 154.29 7.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.76 103.21 0.27 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.274 1.144 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.498 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -54.2 -52.81 65.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.78 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -62.43 119.86 7.14 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 122.886 0.94 . . . . 0.0 110.558 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.2 -162.93 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.272 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.04 -160.79 1.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.91 -47.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -93.7 47.62 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.6 t -54.79 -40.97 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 110.284 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.17 37.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.28 -55.45 2.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.319 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -49.11 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.93 95.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.5 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' OD1' ' ND2' ' A' ' 41' ' ' ASN . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.834 HD21 HG13 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HA ' HD13 ' B' ' 40' ' ' LEU . 2.7 p-10 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.961 HD13 HG21 ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.961 HG21 HD13 ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.648 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' CB ' HD11 ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.607 HD11 ' CB ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.804 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.419 ' CG ' ' HB3' ' A' ' 56' ' ' ALA . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 73' ' ' ILE . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.986 ' N ' HD13 ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.623 ' HB2' HG12 ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 79' ' ' THR . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' HG22 ' A' ' 78' ' ' ILE . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.749 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.453 ' NE2' ' HD2' ' A' ' 102' ' ' ARG . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 64' ' ' GLY . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.749 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 124' ' ' THR . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.747 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.703 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.657 HD21 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.518 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.838 HG11 ' H ' ' A' ' 122' ' ' GLU . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.492 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.489 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.684 HG21 HD23 ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.838 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.717 ' O ' HD22 ' A' ' 125' ' ' LEU . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 132' ' ' ILE . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.548 HG22 ' HA3' ' A' ' 65' ' ' GLY . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.566 HG13 HG22 ' B' ' 135' ' ' VAL . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.1 m-85 -64.29 -52.36 54.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.73 -155.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.942 0 O-C-N 122.785 0.887 . . . . 0.0 110.606 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ALA . 0.4 OUTLIER -147.54 155.34 45.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 75.18 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.313 1.165 . . . . 0.0 110.635 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 28' ' ' SER . . . 51.28 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.3 114.66 14.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.02 -51.04 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.08 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.72 63.45 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.24 77.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.287 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.41 145.36 20.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.83 -150.15 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 110.053 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -52.74 3.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.655 ' O ' HG23 ' B' ' 38' ' ' ILE . 6.3 tp -155.21 85.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 110.391 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.699 ' HA ' HD13 ' A' ' 40' ' ' LEU . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.983 HD13 HG21 ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.457 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' B' ' 50' ' ' ALA . 0.0 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.983 HG21 HD13 ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.642 ' HB3' HG13 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.414 ' O ' HG13 ' B' ' 54' ' ' VAL . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.61 ' CB ' HD11 ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.61 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.794 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.558 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.427 ' CG ' ' HB3' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.741 HD11 HD11 ' B' ' 73' ' ' ILE . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.961 HD13 ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.961 ' N ' HD13 ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.636 ' HB2' HG12 ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.498 HG22 ' N ' ' B' ' 79' ' ' THR . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 64' ' ' GLY . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.714 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.57 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.893 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 124' ' ' THR . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.893 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.725 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.688 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.751 HG11 ' H ' ' B' ' 122' ' ' GLU . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.75 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.551 HD11 ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.412 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.551 ' N ' HD11 ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.419 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.66 HG21 HD23 ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.751 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' B' ' 125' ' ' LEU . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 124' ' ' THR . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.643 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.725 ' C ' HD12 ' B' ' 132' ' ' ILE . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.846 HG23 HD11 ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.532 HG22 ' HA3' ' B' ' 65' ' ' GLY . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 135' ' ' VAL . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.298 0.57 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -144.32 107.92 4.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.855 . . . . 0.0 110.091 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.11 -26.42 75.64 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 O-C-N 122.946 0.972 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m 52.56 69.07 2.57 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.432 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.09 -46.88 14.0 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.314 1.166 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -67.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.49 83.86 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -144.44 123.06 12.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.297 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 52.64 58.57 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.885 . . . . 0.0 110.342 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.46 72.89 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.69 93.46 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 53.42 -149.25 0.41 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.58 146.51 49.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 110.192 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt -163.28 50.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.941 ' HA ' HD22 ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' B' ' 44' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.897 HD11 HD13 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 45' ' ' ILE . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.844 HG21 HG23 ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.65 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HE2' HG23 ' B' ' 38' ' ' ILE . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 72' ' ' LEU . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.609 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.698 ' HB2' HD22 ' A' ' 111' ' ' ASN . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' OD1' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 72' ' ' LEU . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.709 HD11 HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.962 HD11 HD11 ' B' ' 44' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.836 ' HB2' HG12 ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 45.7 m80 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 132' ' ' ILE . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 124' ' ' THR . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.791 HG11 ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.796 HD12 HD21 ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 101' ' ' LEU . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD21 HD12 ' A' ' 99' ' ' LEU . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.521 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.844 ' OD1' HD12 ' A' ' 62' ' ' ILE . 15.9 t30 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 125' ' ' LEU . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.558 ' O ' HG21 ' A' ' 105' ' ' VAL . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' CA ' HG11 ' A' ' 105' ' ' VAL . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 90' ' ' VAL . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 87' ' ' ILE . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.836 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 20.7 m170 -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.863 HG13 HG22 ' B' ' 135' ' ' VAL . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.412 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HG23 ' B' ' 131' ' ' VAL . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.293 0.568 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -125.26 170.71 8.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 -48.84 9.28 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.232 1.122 . . . . 0.0 110.414 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.69 173.64 7.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 113.34 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.349 1.183 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.99 155.51 4.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.18 44.74 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.28 -41.53 89.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -154.93 86.43 1.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.048 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 53.2 t -86.29 80.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.269 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -170.06 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.206 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.33 -60.45 1.92 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.49 80.36 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.689 HG23 ' HE2' ' A' ' 53' ' ' PHE . 4.5 mt -81.78 84.77 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.926 ' HA ' HD22 ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' A' ' 44' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.528 ' H ' HG22 ' B' ' 45' ' ' ILE . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.786 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.857 HG21 HG23 ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.654 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' B' ' 73' ' ' ILE . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.502 HG12 HD22 ' B' ' 72' ' ' LEU . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.611 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.664 ' HB2' HD22 ' B' ' 111' ' ' ASN . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.75 ' SD ' HG22 ' B' ' 95' ' ' THR . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.833 HD12 ' OD1' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.831 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.771 ' CG2' HD12 ' B' ' 72' ' ' LEU . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.771 HD12 ' CG2' ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.969 HD11 HD11 ' A' ' 44' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.654 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.799 ' HB2' HG12 ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.786 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.641 ' CE1' ' HD3' ' B' ' 102' ' ' ARG . 45.7 m80 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.859 ' O ' HD13 ' B' ' 132' ' ' ILE . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.768 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.523 ' O ' HG23 ' B' ' 87' ' ' ILE . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 124' ' ' THR . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.75 HG22 ' SD ' ' B' ' 61' ' ' MET . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.757 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' B' ' 109' ' ' PRO . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.721 HD12 HD21 ' B' ' 101' ' ' LEU . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 125' ' ' LEU . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.641 ' HD3' ' CE1' ' B' ' 82' ' ' HIS . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' B' ' 119' ' ' ILE . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.536 ' CA ' HD12 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.423 ' HB2' HD11 ' B' ' 119' ' ' ILE . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.679 ' C ' HD13 ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.507 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.538 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.833 ' OD1' HD12 ' B' ' 62' ' ' ILE . 24.0 t30 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 118' ' ' THR . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.788 ' HB ' HG22 ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.527 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.616 ' O ' HG23 ' B' ' 90' ' ' VAL . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.736 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 87' ' ' ILE . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.799 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.799 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.859 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.643 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 20.6 m170 -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.863 HG22 HG13 ' A' ' 135' ' ' VAL . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.444 ' HG3' HG21 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 131' ' ' VAL . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -157.88 82.77 2.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.34 177.12 0.88 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.306 1.161 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -162.78 84.14 1.5 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.43 109.98 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.28 1.147 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.41 59.25 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.282 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.77 -153.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -135.88 162.27 33.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.11 -0.993 . . . . 0.0 110.208 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 74.4 m-85 -101.54 132.19 47.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.179 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 34' ' ' VAL . 27.0 m -59.67 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.98 178.93 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.19 -64.97 1.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.15 108.05 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.406 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -157.3 39.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.14 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.027 HD11 HD11 ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG3' ' HG2' ' A' ' 46' ' ' GLN . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' B' ' 44' ' ' LEU . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.999 HD11 HD11 ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 45' ' ' ILE . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.736 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' ' HE1' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.619 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.688 ' O ' HD12 ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 62' ' ' ILE . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 72' ' ' LEU . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 71' ' ' LEU . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.795 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 79' ' ' THR . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' H ' ' A' ' 101' ' ' LEU . 64.3 m80 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 95' ' ' THR . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' PRO . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.88 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.857 HG11 ' H ' ' A' ' 122' ' ' GLU . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.739 ' HB3' HG23 ' A' ' 95' ' ' THR . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.497 ' HE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.8 t30 -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 108' ' ' ILE . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.857 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.624 ' O ' HD22 ' A' ' 125' ' ' LEU . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 134' ' ' VAL . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.734 HG22 HG13 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.459 ' HB3' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.499 ' O ' HD13 ' B' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 52.68 77.43 0.45 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.881 . . . . 0.0 110.337 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 -65.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.367 1.193 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.7 m -69.11 154.9 94.54 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.73 82.2 0.11 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.262 1.138 . . . . 0.0 110.52 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 150.53 43.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.27 84.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.52 98.1 10.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 110.3 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.62 58.67 5.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 110.114 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.97 152.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.77 131.86 44.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -67.94 -67.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.18 0.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 0.0 110.112 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER -154.61 33.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.123 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.999 HD11 HD11 ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 46' ' ' GLN . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' B' ' 45' ' ' ILE . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.682 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.72 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.439 ' HG2' HD11 ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.72 HD11 ' CB ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.798 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.657 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.709 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.799 HD13 ' N ' ' B' ' 72' ' ' LEU . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.799 ' N ' HD13 ' B' ' 71' ' ' LEU . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.794 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.806 ' N ' HG12 ' B' ' 131' ' ' VAL . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' B' ' 77' ' ' ALA . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.454 HG22 ' N ' ' B' ' 79' ' ' THR . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' HG22 ' B' ' 78' ' ' ILE . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.869 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' B' ' 101' ' ' LEU . 64.6 m80 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.666 HG23 ' O ' ' B' ' 85' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.869 HG11 ' HB1' ' B' ' 80' ' ' ALA . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.46 HG21 HG21 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.98 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' B' ' 128' ' ' PHE . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.98 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.798 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.554 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.762 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.686 ' O ' HD23 ' B' ' 101' ' ' LEU . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 105' ' ' VAL . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.675 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' B' ' 88' ' ' ALA . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.591 ' O ' HG23 ' B' ' 108' ' ' ILE . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 97' ' ' LYS . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.645 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.839 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.489 HG22 HD21 ' B' ' 99' ' ' LEU . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' B' ' 89' ' ' ALA . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.485 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.806 HG12 ' N ' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.691 ' N ' HD12 ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 134' ' ' VAL . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.734 HG13 HG22 ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.443 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.486 ' O ' HD13 ' A' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.22 0.533 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.03 78.87 0.72 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.41 169.8 6.14 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.311 1.164 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 31' ' ' ALA . 30.6 t -149.14 74.69 9.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.48 -29.16 88.07 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 123.3 1.158 . . . . 0.0 110.593 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.65 81.23 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.259 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' OG ' ' A' ' 28' ' ' SER . . . -105.65 107.96 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.336 -0.852 . . . . 0.0 110.165 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -134.58 -62.16 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 t80 53.05 89.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.29 61.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.905 . . . . 0.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.65 78.17 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.83 -53.78 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -174.86 142.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 109.973 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -167.24 60.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.76 ' CG ' HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.704 ' HA ' HD22 ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.907 HD13 HG21 ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.566 ' H ' HG22 ' A' ' 45' ' ' ILE . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.907 HG21 HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HB2' HG13 ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' CA ' HD11 ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.75 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 59' ' ' ASP . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 85' ' ' ILE . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.551 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.75 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.719 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 73' ' ' ILE . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' HB ' ' A' ' 131' ' ' VAL . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.669 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 86' ' ' VAL . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.679 HG21 HD12 ' A' ' 132' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 130' ' ' VAL . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.979 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 124' ' ' THR . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.979 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.551 HG11 ' CA ' ' A' ' 64' ' ' GLY . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' NZ ' HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.928 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.928 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 119' ' ' ILE . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.469 HD13 ' C ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HG3' ' CG2' ' A' ' 95' ' ' THR . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 110' ' ' MET . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.469 ' C ' HD13 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 118' ' ' THR . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.757 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.664 ' O ' HD22 ' A' ' 125' ' ' LEU . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 119' ' ' ILE . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 86' ' ' VAL . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.786 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 135' ' ' VAL . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.797 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.895 ' O ' HG23 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' B' ' 130' ' ' VAL . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.245 0.545 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.83 68.65 6.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.157 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.58 -47.46 11.4 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.339 1.178 . . . . 0.0 110.567 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -142.5 79.7 15.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.203 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -21.98 73.33 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.314 1.165 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 7.37 44.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.61 80.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.957 -1.089 . . . . 0.0 110.318 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.08 24.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.32 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' B' ' 34' ' ' VAL . 16.1 t80 -152.64 -55.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' B' ' 33' ' ' TYR . 97.0 t -128.43 116.7 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.245 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.3 -62.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -112.62 -64.3 1.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.32 -44.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.672 ' O ' HG23 ' B' ' 38' ' ' ILE . 2.0 tt -164.14 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.765 ' CG ' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.926 HD13 HG21 ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.549 ' H ' HG22 ' B' ' 45' ' ' ILE . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.926 HG21 HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.657 ' HB2' HG13 ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.545 ' CA ' HD11 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 61' ' ' MET . . . . . 0.738 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.545 HD11 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.597 ' O ' HD11 ' B' ' 85' ' ' ILE . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.55 ' CA ' HG11 ' B' ' 96' ' ' VAL . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.638 ' C ' HD23 ' B' ' 72' ' ' LEU . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.738 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.734 HD13 ' N ' ' B' ' 73' ' ' ILE . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.734 ' N ' HD13 ' B' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' B' ' 131' ' ' VAL . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.672 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASP . . . . . 0.519 ' O ' HG13 ' B' ' 86' ' ' VAL . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.683 HG21 HD12 ' B' ' 132' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' VAL . . . . . 0.916 HG12 HG13 ' B' ' 130' ' ' VAL . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.833 ' O ' HG13 ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.953 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 124' ' ' THR . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' THR . . . . . 0.953 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' VAL . . . . . 0.55 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.471 ' HD3' ' HB2' ' B' ' 63' ' ' ASP . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' GLN . . . . . 0.865 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.865 HD23 ' O ' ' B' ' 100' ' ' GLN . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.752 HG21 ' O ' ' B' ' 120' ' ' SER . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.608 HD12 ' CB ' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ILE . . . . . 0.537 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.459 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' B' ' 60' ' ' SER . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ASN . . . . . 0.514 ' HB3' HD12 ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.537 ' C ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.473 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.404 HG23 ' O ' ' B' ' 117' ' ' ILE . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' B' ' 125' ' ' LEU . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.752 ' O ' HG21 ' B' ' 105' ' ' VAL . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.634 ' CA ' HG11 ' B' ' 105' ' ' VAL . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.65 ' O ' HD22 ' B' ' 125' ' ' LEU . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.8 ' HB3' HD13 ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.833 HG13 ' O ' ' B' ' 87' ' ' ILE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' GLY . . . . . 0.607 ' O ' HG22 ' B' ' 87' ' ' ILE . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.916 HG13 HG12 ' B' ' 86' ' ' VAL . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' HIS . . . . . 0.797 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 135' ' ' VAL . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' ALA . . . . . 0.786 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 38' ' ' ILE . 12.6 tt . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.212 0.529 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.785 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 45' ' ' ILE . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.737 HD12 ' ND2' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.859 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.869 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.948 ' N ' HD23 ' A' ' 72' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.501 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 79' ' ' THR . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 78' ' ' ILE . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.943 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.476 ' HE1' HD12 ' A' ' 101' ' ' LEU . 32.1 m-70 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.859 HD11 ' HA2' ' A' ' 64' ' ' GLY . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.943 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 96' ' ' VAL . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 87' ' ' ILE . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.857 HD12 HD21 ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 99' ' ' LEU . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 120' ' ' SER . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 107' ' ' LEU . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.737 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' THR . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.709 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.771 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.708 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 134' ' ' VAL . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 135' ' ' VAL . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.631 ' HB3' HG23 ' B' ' 131' ' ' VAL . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.519 HD12 HD23 ' B' ' 40' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.318 0.58 . . . . 0.0 109.866 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.761 HD21 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.449 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.764 HD11 HD21 ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.494 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.798 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.614 ' OG1' HG21 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.647 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.868 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.732 HD12 ' ND2' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.833 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.868 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.629 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.945 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.945 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.776 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.798 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.511 HG22 ' N ' ' B' ' 79' ' ' THR . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.511 ' N ' HG22 ' B' ' 78' ' ' ILE . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 31.0 m-70 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.833 HD11 ' HA2' ' B' ' 64' ' ' GLY . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.557 ' O ' HG23 ' B' ' 95' ' ' THR . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.557 HG23 ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.403 ' O ' ' CG ' ' B' ' 97' ' ' LYS . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.432 ' O ' HD23 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 1.001 HD12 HD21 ' B' ' 101' ' ' LEU . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.434 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 1.001 HD21 HD12 ' B' ' 99' ' ' LEU . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.787 HG11 ' O ' ' B' ' 120' ' ' SER . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.755 HD13 ' O ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.497 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.732 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.476 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.413 ' H ' HG22 ' B' ' 118' ' ' THR . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 107' ' ' LEU . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.787 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 90' ' ' VAL . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.654 HD21 HG21 ' B' ' 119' ' ' ILE . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 86' ' ' VAL . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.754 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.76 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.716 ' NE2' HG21 ' B' ' 131' ' ' VAL . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 134' ' ' VAL . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 135' ' ' VAL . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.679 ' HB3' HG23 ' A' ' 131' ' ' VAL . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.3 tp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.212 0.53 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.023 HD12 HD13 ' B' ' 45' ' ' ILE . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.934 ' HB3' HD21 ' B' ' 40' ' ' LEU . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.723 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.072 HD13 HD12 ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' ILE . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.72 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CA ' HD11 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' MET . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.64 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.614 HD11 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.668 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.64 HD11 ' H ' ' A' ' 61' ' ' MET . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 62' ' ' ILE . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 72' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG12 ' A' ' 131' ' ' VAL . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' THR . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.3 m-70 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 127' ' ' VAL . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.019 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 1.019 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.668 HG11 ' HA3' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.796 ' O ' HD23 ' A' ' 101' ' ' LEU . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.742 HD13 ' N ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' C ' HD13 ' A' ' 108' ' ' ILE . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.742 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 118' ' ' THR . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.879 HD13 ' HG ' ' A' ' 125' ' ' LEU . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 125' ' ' LEU . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.879 ' HG ' HD13 ' A' ' 119' ' ' ILE . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 86' ' ' VAL . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 130' ' ' VAL . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD11 ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 1.048 ' CD2' HG12 ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 1.05 HG12 ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.768 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' B' ' 85' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.233 0.539 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.072 HD12 HD13 ' A' ' 45' ' ' ILE . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.912 ' HB3' HD21 ' A' ' 40' ' ' LEU . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HB3' ' CG ' ' B' ' 39' ' ' ASP . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 40' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.517 ' N ' HG22 ' B' ' 45' ' ' ILE . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.722 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.514 ' HB3' HD11 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.597 ' CA ' HD11 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 110' ' ' MET . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.656 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.644 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.656 HD11 ' H ' ' B' ' 61' ' ' MET . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.571 ' OG ' HG23 ' B' ' 62' ' ' ILE . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.723 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.588 ' N ' HD13 ' B' ' 72' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.722 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.714 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.412 HG22 ' N ' ' B' ' 79' ' ' THR . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.412 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 94.4 m-70 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.669 HG23 ' O ' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 127' ' ' VAL . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.684 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.628 HG11 ' HA3' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.472 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.649 HD23 ' O ' ' B' ' 100' ' ' GLN . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.79 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.597 HD13 ' N ' ' B' ' 116' ' ' PRO . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.569 ' C ' HD13 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.597 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.712 HD13 ' HG ' ' B' ' 125' ' ' LEU . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.633 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.634 ' N ' HG11 ' B' ' 105' ' ' VAL . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.619 ' O ' HD22 ' B' ' 125' ' ' LEU . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' B' ' 119' ' ' ILE . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 86' ' ' VAL . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 130' ' ' VAL . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.755 HG23 HD11 ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 1.05 ' CD2' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 1.048 HG12 ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.758 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.38 0.61 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.978 HD21 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.911 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.666 HG23 HG21 ' A' ' 51' ' ' THR . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 45' ' ' ILE . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.655 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.68 HG12 ' HG ' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.777 ' CA ' HD11 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 110' ' ' MET . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.939 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' HG23 ' A' ' 62' ' ' ILE . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.976 HD11 HD21 ' B' ' 43' ' ' LEU . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 72' ' ' LEU . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.835 ' HB3' HG12 ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.551 ' HB ' HG11 ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.9 m-70 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.915 HG11 ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.803 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.803 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.939 HG11 ' O ' ' A' ' 64' ' ' GLY . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CD ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.792 ' O ' HD23 ' A' ' 101' ' ' LEU . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 119' ' ' ILE . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' A' ' 95' ' ' THR . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.482 HG23 ' CD ' ' A' ' 97' ' ' LYS . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HG3' HG21 ' A' ' 95' ' ' THR . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.44 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 118' ' ' THR . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 119' ' ' ILE . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.629 ' O ' HD22 ' A' ' 125' ' ' LEU . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 124' ' ' THR . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 130' ' ' VAL . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 72' ' ' LEU . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 134' ' ' VAL . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.322 0.582 . . . . 0.0 110.203 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.88 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.88 ' N ' HD12 ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.917 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.665 HG23 HG21 ' B' ' 51' ' ' THR . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.488 ' H ' HG22 ' B' ' 45' ' ' ILE . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.665 HG21 HG23 ' B' ' 45' ' ' ILE . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.707 HG12 ' HG ' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.779 ' CA ' HD11 ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.779 HD11 ' CA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.87 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 96' ' ' VAL . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.559 ' CB ' HG23 ' B' ' 62' ' ' ILE . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.978 HD11 HD21 ' A' ' 43' ' ' LEU . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 73' ' ' ILE . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.929 ' N ' HD12 ' B' ' 72' ' ' LEU . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.861 ' HB3' HG12 ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.8 m-70 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' B' ' 80' ' ' ALA . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.87 HG11 ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.698 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.698 HD23 ' O ' ' B' ' 100' ' ' GLN . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.58 HG12 HD13 ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.534 HD13 ' C ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' B' ' 118' ' ' THR . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.58 HD13 HG12 ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' B' ' 119' ' ' ILE . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.502 ' CA ' HG21 ' B' ' 105' ' ' VAL . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' OG ' ' B' ' 120' ' ' SER . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.682 ' O ' HD13 ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.537 HG21 HG21 ' B' ' 86' ' ' VAL . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.656 HG22 ' O ' ' B' ' 130' ' ' VAL . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.766 HG23 HD13 ' B' ' 72' ' ' LEU . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.605 ' O ' HG23 ' B' ' 134' ' ' VAL . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.539 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HB3' HG23 ' A' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.9 tp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.259 0.552 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.07 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.874 ' HA ' HD22 ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.718 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.75 ' CD1' HD12 ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.042 HD11 HD13 ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' HD11 ' B' ' 38' ' ' ILE . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.794 ' OG1' HG21 ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.739 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.709 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.502 ' CB ' HD11 ' A' ' 66' ' ' ILE . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.67 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.033 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.748 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 66' ' ' ILE . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.708 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG11 ' A' ' 130' ' ' VAL . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 78' ' ' ILE . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.829 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.949 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.849 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.869 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.455 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 101' ' ' LEU . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.669 ' O ' HD23 ' A' ' 101' ' ' LEU . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 99' ' ' LEU . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.598 HD11 ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.418 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.511 ' C ' HD11 ' A' ' 108' ' ' ILE . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.598 ' N ' HD11 ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 120' ' ' SER . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 80' ' ' ALA . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.829 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.762 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 65' ' ' GLY . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' B' ' 135' ' ' VAL . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.711 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 49' ' ' SER . 6.5 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.356 0.598 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.864 ' HA ' HD22 ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.748 ' CD1' HD12 ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.455 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.793 ' OG1' HG21 ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.718 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.712 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.483 ' CB ' HD11 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.712 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 1.035 HG23 HD12 ' B' ' 72' ' ' LEU . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 1.035 HD12 HG23 ' B' ' 66' ' ' ILE . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.724 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.677 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.531 ' HB ' HG11 ' B' ' 130' ' ' VAL . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.929 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.473 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.846 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.929 HG11 ' HB1' ' B' ' 80' ' ' ALA . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.75 HG21 HD21 ' B' ' 107' ' ' LEU . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.841 HD12 HD21 ' B' ' 101' ' ' LEU . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.673 ' O ' HD23 ' B' ' 101' ' ' LEU . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.841 HD21 HD12 ' B' ' 99' ' ' LEU . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.547 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.75 HD21 HG21 ' B' ' 95' ' ' THR . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.4 t30 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.459 ' C ' HD13 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.425 ' H ' HG22 ' B' ' 118' ' ' THR . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.513 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.513 ' N ' HG22 ' B' ' 119' ' ' ILE . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.663 ' O ' HG23 ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' B' ' 80' ' ' ALA . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.854 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' B' ' 132' ' ' ILE . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.846 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.441 HG22 ' HA3' ' B' ' 65' ' ' GLY . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 135' ' ' VAL . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.466 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.718 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.177 0.513 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.922 ' CB ' HD13 ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' B' ' 44' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.565 HG21 HG21 ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.663 ' CB ' HD11 ' A' ' 62' ' ' ILE . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.458 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' OD1' ' A' ' 111' ' ' ASN . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.877 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.037 HG23 HD12 ' A' ' 72' ' ' LEU . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 66' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 79' ' ' THR . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 78' ' ' ILE . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.7 m-70 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.877 HD11 ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.74 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.728 HD11 ' CD2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.866 ' HB ' HD22 ' A' ' 125' ' ' LEU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.728 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.825 HG11 ' HA3' ' A' ' 64' ' ' GLY . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HD3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 97' ' ' LYS . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.751 ' OD1' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 120' ' ' SER . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 119' ' ' ILE . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.604 ' CB ' HG11 ' A' ' 105' ' ' VAL . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.817 HG12 ' HB2' ' A' ' 75' ' ' ASP . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.676 ' CD2' ' HB1' ' B' ' 137' ' ' ALA . 44.5 m170 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 1.1 HG13 HG22 ' B' ' 135' ' ' VAL . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' ' CD2' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.777 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.531 . . . . 0.0 110.13 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.446 ' O ' HD23 ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.922 HD13 ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.927 ' CB ' HD13 ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 44' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.438 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.716 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.57 HG21 HG21 ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.678 ' CB ' HD11 ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 110' ' ' MET . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.469 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.678 HD11 ' CB ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 1.038 HG23 HD12 ' B' ' 72' ' ' LEU . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.713 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 1.038 HD12 HG23 ' B' ' 66' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.838 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 79' ' ' THR . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 78' ' ' ILE . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.7 m-70 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.752 HG11 ' HB1' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.952 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 1.022 HG21 HD11 ' B' ' 107' ' ' LEU . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' B' ' 64' ' ' GLY . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.444 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.67 HD21 HD12 ' B' ' 99' ' ' LEU . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 1.022 HD11 HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.6 HD11 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.776 ' HG3' HG23 ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' B' ' 60' ' ' SER . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.432 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 7.5 t30 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.6 ' N ' HD11 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.464 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.421 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 118' ' ' THR . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.416 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.64 ' HB2' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.838 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.765 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.655 ' CD2' ' HB1' ' A' ' 137' ' ' ALA . 44.0 m170 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.44 HG12 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 135' ' ' VAL . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 134' ' ' VAL . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.676 ' HB1' ' CD2' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.785 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.807 HG23 ' HE2' ' B' ' 53' ' ' PHE . 43.7 mm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.084 0.469 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.803 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.627 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD11 ' B' ' 73' ' ' ILE . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.72 HD12 HD22 ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.534 ' N ' HG22 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.819 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.819 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.676 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HB3' HD13 ' A' ' 73' ' ' ILE . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' N ' ' HE3' ' A' ' 55' ' ' LYS . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.435 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.992 HG23 HD12 ' A' ' 72' ' ' LEU . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.992 HD12 HG23 ' A' ' 66' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 79' ' ' THR . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 78' ' ' ILE . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.866 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.454 ' HE1' HD12 ' A' ' 101' ' ' LEU . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' A' ' 64' ' ' GLY . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.863 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.862 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 87' ' ' ILE . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.862 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' A' ' 101' ' ' LEU . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 100' ' ' GLN . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 105' ' ' VAL . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 ' N ' ' A' ' 122' ' ' GLU . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 95' ' ' THR . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 6.1 t30 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.517 ' CA ' HD11 ' A' ' 108' ' ' ILE . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.6 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 117' ' ' ILE . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 105' ' ' VAL . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 125' ' ' LEU . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.745 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.701 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 124' ' ' THR . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.866 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.466 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.613 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.9 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.247 0.546 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.807 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.807 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 73' ' ' ILE . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.537 ' N ' HG22 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.822 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.664 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.807 ' HE2' HG23 ' A' ' 38' ' ' ILE . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.451 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.591 ' HB2' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.442 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.974 HG23 HD12 ' B' ' 72' ' ' LEU . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.978 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.978 ' N ' HD23 ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.664 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.757 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.477 HG22 ' N ' ' B' ' 79' ' ' THR . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.477 ' N ' HG22 ' B' ' 78' ' ' ILE . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.428 ' HE1' HD12 ' B' ' 101' ' ' LEU . 93.3 m-70 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.47 ' O ' HG22 ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' B' ' 64' ' ' GLY . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.845 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.845 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.452 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.586 ' HD2' HG23 ' B' ' 108' ' ' ILE . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.632 HD21 HG21 ' B' ' 95' ' ' THR . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.495 ' CA ' HD11 ' B' ' 108' ' ' ILE . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.508 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.508 ' N ' HG22 ' B' ' 119' ' ' ILE . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.603 ' N ' HG11 ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.702 ' O ' HD22 ' B' ' 125' ' ' LEU . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.702 HD22 ' O ' ' B' ' 124' ' ' THR . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.877 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.831 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.466 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.595 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.269 0.557 . . . . 0.0 109.902 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.061 HD11 HD11 ' B' ' 45' ' ' ILE . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.443 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' B' ' 44' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.043 HD11 HD11 ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.704 HG21 HG21 ' A' ' 45' ' ' ILE . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CZ ' HD22 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 72' ' ' LEU . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.472 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.875 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.793 HD12 ' CG ' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.671 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 73' ' ' ILE . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.884 ' N ' HD23 ' A' ' 72' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.75 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 85' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 84' ' ' ASP . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 124' ' ' THR . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 95' ' ' THR . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.875 HG21 ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.715 HD22 ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.911 HD12 ' N ' ' A' ' 102' ' ' ARG . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.911 ' N ' HD12 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.912 ' O ' HD12 ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 106' ' ' GLN . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.793 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.5 t-20 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 118' ' ' THR . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.724 ' O ' HG11 ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.575 ' O ' HG21 ' A' ' 105' ' ' VAL . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 124' ' ' THR . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' CG2' HD22 ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HB3' HG23 ' A' ' 87' ' ' ILE . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 131' ' ' VAL . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.772 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.637 ' CE1' HG21 ' A' ' 131' ' ' VAL . 15.5 m-70 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 136' ' ' LYS . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.875 HG22 HG13 ' B' ' 135' ' ' VAL . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' O ' HG12 ' B' ' 134' ' ' VAL . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.586 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.6 tt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.199 0.523 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.043 HD11 HD11 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.447 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' A' ' 44' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.719 HG21 HG21 ' B' ' 45' ' ' ILE . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.536 ' CE1' HD22 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' B' ' 72' ' ' LEU . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.483 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.799 ' HG2' HG21 ' B' ' 96' ' ' VAL . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' B' ' 111' ' ' ASN . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.596 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.669 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.858 HD23 ' N ' ' B' ' 73' ' ' ILE . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.858 ' N ' HD23 ' B' ' 72' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.605 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.676 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.527 HG22 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.527 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.468 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 39.2 m-70 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 86' ' ' VAL . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.686 HG23 ' O ' ' B' ' 85' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 84' ' ' ASP . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.633 ' O ' HG23 ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.918 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 88' ' ' ALA . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.918 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.799 HG21 ' HG2' ' B' ' 61' ' ' MET . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.502 ' N ' HG12 ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' B' ' 88' ' ' ALA . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.693 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.71 HD21 HD12 ' B' ' 99' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.488 HG22 ' N ' ' B' ' 105' ' ' VAL . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.766 HG11 ' O ' ' B' ' 120' ' ' SER . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.831 ' O ' HD12 ' B' ' 107' ' ' LEU . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 1.037 HD13 HD12 ' B' ' 119' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.689 ' O ' HG23 ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' B' ' 62' ' ' ILE . 25.7 t30 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.528 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.556 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.575 ' O ' HG23 ' B' ' 118' ' ' THR . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 1.037 HD12 HD13 ' B' ' 107' ' ' LEU . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.766 ' O ' HG11 ' B' ' 105' ' ' VAL . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.524 ' O ' HD22 ' B' ' 125' ' ' LEU . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.676 HD12 HD21 ' B' ' 107' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' B' ' 87' ' ' ILE . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.475 HG13 ' N ' ' B' ' 131' ' ' VAL . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.778 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.778 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.631 ' CE1' HG21 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' LYS . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.875 HG13 HG22 ' A' ' 135' ' ' VAL . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . 0.501 ' O ' HG12 ' A' ' 134' ' ' VAL . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.621 ' HB3' HG23 ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.6 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.991 ' CD1' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' B' ' 44' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.91 HD11 HD11 ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.733 ' H ' HD11 ' A' ' 66' ' ' ILE . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.733 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD11 HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 66' ' ' ILE . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.972 HD11 HD11 ' B' ' 44' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.788 ' HB2' HG12 ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.45 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 96.6 m-70 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.817 HG22 ' OXT' ' B' ' 139' ' ' ARG . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 80' ' ' ALA . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.68 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.814 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.814 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HA3' ' A' ' 64' ' ' GLY . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.852 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 100' ' ' GLN . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 118' ' ' THR . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 HG12 ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' HD22 ' A' ' 125' ' ' LEU . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.656 HD21 HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 87' ' ' ILE . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.765 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.833 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.798 HG22 HG13 ' B' ' 135' ' ' VAL . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.84 ' OXT' HG22 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.406 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.976 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' A' ' 44' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.905 HD11 HD11 ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.71 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.644 HG21 HG21 ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.686 ' O ' HG12 ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' B' ' 73' ' ' ILE . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.742 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.704 HD12 ' ND2' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.742 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.673 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.955 HD11 HD11 ' A' ' 44' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.686 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.797 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.406 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.406 ' N ' HG22 ' B' ' 78' ' ' ILE . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.854 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.418 ' HE1' HD12 ' B' ' 101' ' ' LEU . 97.1 m-70 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.84 HG22 ' OXT' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.854 HG11 ' HB1' ' B' ' 80' ' ' ALA . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.684 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.665 HG21 HD21 ' B' ' 125' ' ' LEU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.608 ' HB3' HD11 ' B' ' 87' ' ' ILE . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.638 HG21 HD12 ' B' ' 107' ' ' LEU . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' B' ' 64' ' ' GLY . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HE2' HD12 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.435 HD23 ' N ' ' B' ' 99' ' ' LEU . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.717 ' O ' HD23 ' B' ' 101' ' ' LEU . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.717 HD23 ' O ' ' B' ' 100' ' ' GLN . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.642 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.638 HD12 HG21 ' B' ' 95' ' ' THR . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.642 HD13 ' C ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.505 ' HG3' ' CE2' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.533 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.704 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.407 ' H ' HG22 ' B' ' 118' ' ' THR . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.565 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.593 ' O ' HD22 ' B' ' 125' ' ' LEU . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.665 HD21 HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 87' ' ' ILE . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.841 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.841 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 135' ' ' VAL . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.817 ' OXT' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.62 HG12 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.215 0.531 . . . . 0.0 110.269 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.759 HD13 HG13 ' B' ' 45' ' ' ILE . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG13 HD13 ' B' ' 40' ' ' LEU . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.653 HG21 HG23 ' A' ' 45' ' ' ILE . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' HD11 ' A' ' 62' ' ' ILE . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' MET . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.743 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.68 HD12 ' OD1' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.743 HD11 ' H ' ' A' ' 61' ' ' MET . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.806 HD12 HD11 ' B' ' 44' ' ' LEU . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 73' ' ' ILE . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.646 HG13 HD21 ' B' ' 44' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.777 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 17.3 m-70 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 86' ' ' VAL . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 64' ' ' GLY . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 84' ' ' ASP . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.709 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.605 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.709 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 108' ' ' ILE . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 125' ' ' LEU . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.799 HG11 ' H ' ' A' ' 122' ' ' GLU . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.657 ' HB2' HD11 ' A' ' 119' ' ' ILE . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.68 ' OD1' HD12 ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 107' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.799 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.723 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' B' ' 135' ' ' VAL . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.584 ' HE ' HG22 ' B' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.557 ' N ' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.37 0.605 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.764 HD13 HG13 ' A' ' 45' ' ' ILE . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.57 ' N ' HD12 ' B' ' 40' ' ' LEU . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 40' ' ' LEU . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.877 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.626 HG21 HG23 ' B' ' 45' ' ' ILE . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.429 HG13 ' O ' ' B' ' 54' ' ' VAL . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.531 ' HB2' HD11 ' B' ' 62' ' ' ILE . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.802 ' HG2' HG21 ' B' ' 96' ' ' VAL . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.929 HD12 ' CG ' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.724 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.739 HD11 ' H ' ' B' ' 61' ' ' MET . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.813 HD12 HD11 ' A' ' 44' ' ' LEU . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.523 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.632 HG13 HD21 ' A' ' 44' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.796 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.877 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.491 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' HD11 ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.736 ' O ' HG22 ' B' ' 86' ' ' VAL . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.724 HD11 ' O ' ' B' ' 64' ' ' GLY . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 84' ' ' ASP . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.578 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.621 ' HB ' HD22 ' B' ' 125' ' ' LEU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 1.023 HG21 HD23 ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' B' ' 61' ' ' MET . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.605 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' B' ' 85' ' ' ILE . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' B' ' 106' ' ' GLN . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.757 HD23 ' HB3' ' B' ' 125' ' ' LEU . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.677 ' N ' HD12 ' B' ' 101' ' ' LEU . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.76 HG11 ' O ' ' B' ' 120' ' ' SER . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' B' ' 100' ' ' GLN . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 1.023 HD23 HG21 ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.673 ' O ' HG23 ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' B' ' 113' ' ' ALA . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.929 ' CG ' HD12 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.509 ' HB3' ' SD ' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.601 ' O ' HG21 ' B' ' 105' ' ' VAL . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.76 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.57 ' O ' HG23 ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.757 ' HB3' HD23 ' B' ' 101' ' ' LEU . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.669 ' CG2' HD22 ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.796 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.716 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.531 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' A' ' 135' ' ' VAL . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.53 ' HE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' ILE . 11.9 tt . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.318 0.58 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 43' ' ' LEU . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.545 ' HB2' HD12 ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 41' ' ' ASN . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' ILE . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.463 ' H ' HG22 ' A' ' 45' ' ' ILE . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 45' ' ' ILE . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.634 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.581 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 59' ' ' ASP . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.807 HD12 HD11 ' B' ' 44' ' ' LEU . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.893 ' N ' HD13 ' A' ' 72' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.886 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 96.3 m-70 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.647 HD13 ' C ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.886 HG11 ' CB ' ' A' ' 80' ' ' ALA . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 99' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.606 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 122' ' ' GLU . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD23 ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 97' ' ' LYS . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD3' HD23 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' HB2' HD11 ' A' ' 108' ' ' ILE . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.505 ' C ' HD13 ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.716 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.74 ' HA ' HG21 ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.698 ' O ' HD22 ' A' ' 125' ' ' LEU . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 124' ' ' THR . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.751 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CE1' HG21 ' A' ' 131' ' ' VAL . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' B' ' 135' ' ' VAL . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' B' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.325 0.583 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.706 ' HA ' HD11 ' B' ' 43' ' ' LEU . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.542 ' HB2' HD12 ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' B' ' 41' ' ' ASN . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.48 ' H ' HG22 ' B' ' 45' ' ' ILE . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.471 ' H ' HG22 ' B' ' 45' ' ' ILE . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.504 HG21 HG23 ' B' ' 45' ' ' ILE . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.615 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' B' ' 54' ' ' VAL . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.479 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.586 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.645 HD11 ' CB ' ' B' ' 59' ' ' ASP . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.505 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.608 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 44' ' ' LEU . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 1.054 HD11 HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.907 ' N ' HD13 ' B' ' 72' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.431 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.892 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.402 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.653 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.892 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.605 HD11 HG23 ' B' ' 127' ' ' VAL . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.799 ' O ' HD23 ' B' ' 101' ' ' LEU . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.799 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.682 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' B' ' 99' ' ' LEU . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.464 HG23 ' HG2' ' B' ' 97' ' ' LYS . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.501 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.463 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 118' ' ' THR . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.526 HG21 HD23 ' B' ' 125' ' ' LEU . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.713 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.713 HD22 ' O ' ' B' ' 124' ' ' THR . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.605 HG23 HD11 ' B' ' 99' ' ' LEU . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.585 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.77 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 1.054 HG23 HD11 ' B' ' 72' ' ' LEU . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.53 ' CE1' HG21 ' B' ' 131' ' ' VAL . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 135' ' ' VAL . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.452 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.093 0.473 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.096 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.816 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.02 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD22 HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.009 HD11 HD13 ' B' ' 40' ' ' LEU . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' N ' HG22 ' A' ' 45' ' ' ILE . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.723 HG21 HG23 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.629 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.943 ' HB3' HD13 ' A' ' 73' ' ' ILE . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.607 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 ' CG ' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 96' ' ' VAL . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.646 HD23 ' HG2' ' A' ' 55' ' ' LYS . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.7 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 79' ' ' THR . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 78' ' ' ILE . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 86' ' ' VAL . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 127' ' ' VAL . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 124' ' ' THR . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.804 ' H ' HD12 ' A' ' 108' ' ' ILE . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 100' ' ' GLN . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.567 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 120' ' ' SER . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.033 HD13 HD11 ' A' ' 119' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.804 HD12 ' H ' ' A' ' 96' ' ' VAL . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.766 ' CG ' HD12 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 110' ' ' MET . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 117' ' ' ILE . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' THR . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.033 HD11 HD13 ' A' ' 107' ' ' LEU . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.815 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.62 ' H ' HG11 ' A' ' 105' ' ' VAL . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 86' ' ' VAL . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 130' ' ' VAL . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.873 ' C ' HD12 ' A' ' 132' ' ' ILE . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.559 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' B' ' 135' ' ' VAL . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' B' ' 134' ' ' VAL . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.174 0.512 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.009 HD13 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.81 ' HA ' HD22 ' A' ' 40' ' ' LEU . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.992 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.992 HD22 ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 1.096 HD11 HD13 ' A' ' 40' ' ' LEU . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.491 ' N ' HG22 ' B' ' 45' ' ' ILE . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.713 HG21 HG23 ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.638 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.96 ' HB3' HD13 ' B' ' 73' ' ' ILE . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.482 HG12 ' HG ' ' B' ' 72' ' ' LEU . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.626 ' HG2' HD23 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.612 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.843 HD12 ' OD1' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.665 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.636 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.431 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.642 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.672 HD23 ' N ' ' B' ' 72' ' ' LEU . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.96 HD13 ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.638 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.425 HG22 ' N ' ' B' ' 79' ' ' THR . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.425 ' N ' HG22 ' B' ' 78' ' ' ILE . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.459 ' O ' HG22 ' B' ' 86' ' ' VAL . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.731 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 127' ' ' VAL . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.56 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.984 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 124' ' ' THR . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.984 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' B' ' 61' ' ' MET . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' CB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 99' ' ' LEU . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.868 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.868 HD23 ' O ' ' B' ' 100' ' ' GLN . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.561 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 105' ' ' VAL . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.837 HG11 ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' B' ' 100' ' ' GLN . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 1.008 HD13 HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.665 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.515 ' C ' HD13 ' B' ' 108' ' ' ILE . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.843 ' OD1' HD12 ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.408 ' OG1' HG23 ' B' ' 105' ' ' VAL . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 1.008 HD11 HD13 ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.837 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.722 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.66 ' HB3' HD11 ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 86' ' ' VAL . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 130' ' ' VAL . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.874 ' C ' HD12 ' B' ' 132' ' ' ILE . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.874 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.557 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 136' ' ' LYS . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 135' ' ' VAL . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.633 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.675 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.672 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 59' ' ' ASP . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.869 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' A' ' 61' ' ' MET . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.926 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.926 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 131' ' ' VAL . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.857 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.875 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.832 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.878 ' HB ' HD22 ' A' ' 125' ' ' LEU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.832 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.869 HG11 ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.794 HD12 HD21 ' A' ' 101' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' HD23 ' A' ' 101' ' ' LEU . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 99' ' ' LEU . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 119' ' ' ILE . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.482 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.609 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' ILE . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' LEU . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.488 ' H ' HG11 ' A' ' 105' ' ' VAL . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.878 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' A' ' 75' ' ' ASP . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.656 ' NE2' HG21 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 64' ' ' GLY . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HG22 ' B' ' 135' ' ' VAL . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 1.025 HD12 HD23 ' B' ' 40' ' ' LEU . 1.2 pt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.421 0.629 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.025 HD23 HD12 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.673 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.421 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.674 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' B' ' 73' ' ' ILE . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' B' ' 62' ' ' ILE . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' B' ' 59' ' ' ASP . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.823 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.669 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.932 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.932 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.674 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.889 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.454 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.819 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.885 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.672 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.883 HG23 ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.823 HG11 ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.784 HD12 HD21 ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.761 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.81 HD13 ' O ' ' B' ' 125' ' ' LEU . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 108' ' ' ILE . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.883 ' HB3' HG23 ' B' ' 95' ' ' THR . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.626 ' CG ' HD12 ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 117' ' ' ILE . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.426 ' H ' HG22 ' B' ' 118' ' ' THR . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.728 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 105' ' ' VAL . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.819 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.889 HG12 ' HB2' ' B' ' 75' ' ' ASP . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.885 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.518 HG21 ' O ' ' B' ' 64' ' ' GLY . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 135' ' ' VAL . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.747 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 38' ' ' ILE . 12.1 tt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.988 HD13 HD12 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.662 ' CB ' HD21 ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.009 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.039 HD12 HD13 ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 45' ' ' ILE . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.809 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 70' ' ' ASP . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.725 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' CG ' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.725 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.95 ' N ' HD23 ' A' ' 72' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.755 ' HB3' HG12 ' A' ' 131' ' ' VAL . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.694 HD13 HG11 ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 78' ' ' ILE . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' B' ' 138' ' ' MET . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 80' ' ' ALA . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.966 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.966 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.797 ' H ' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' H ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 127' ' ' VAL . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.771 ' O ' HD23 ' A' ' 101' ' ' LEU . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 105' ' ' VAL . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' VAL . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.787 ' HB2' HD11 ' A' ' 119' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.797 HD12 ' H ' ' A' ' 96' ' ' VAL . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.844 ' CG ' HD12 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.532 ' OG1' HG23 ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' ' 107' ' ' LEU . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.63 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 125' ' ' LEU . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 99' ' ' LEU . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.694 HG11 HD13 ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.83 ' HB3' HD13 ' B' ' 85' ' ' ILE . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.308 0.575 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.764 ' O ' HD12 ' B' ' 43' ' ' LEU . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.039 HD13 HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.675 ' CB ' HD21 ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 1.014 HD13 ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.014 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.988 HD12 HD13 ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.52 ' N ' HG22 ' B' ' 45' ' ' ILE . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.642 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.804 ' HB3' HD13 ' B' ' 73' ' ' ILE . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 54' ' ' VAL . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 70' ' ' ASP . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.718 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.883 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.718 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 56' ' ' ALA . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.66 ' C ' HD13 ' B' ' 71' ' ' LEU . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.953 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.642 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.733 ' HB3' HG12 ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.683 HD13 HG11 ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.428 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.46 ' O ' HG22 ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 138' ' ' MET . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' B' ' 80' ' ' ALA . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.461 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.887 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.887 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.467 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.429 ' HD3' ' HE3' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.795 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.795 HD23 ' O ' ' B' ' 100' ' ' GLN . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 105' ' ' VAL . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.686 HD13 HD11 ' B' ' 119' ' ' ILE . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.883 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.875 ' CG ' HD12 ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.434 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.518 ' OG1' HG23 ' B' ' 105' ' ' VAL . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.688 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.5 ' O ' HD22 ' B' ' 125' ' ' LEU . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.739 HG22 HD21 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.683 HG11 HD13 ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.733 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.481 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 135' ' ' VAL . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . 0.845 ' HB3' HD13 ' A' ' 85' ' ' ILE . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.471 ' HB3' HG23 ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.8 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.309 0.576 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD11 ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.433 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' GLN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' B' ' 44' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.879 HD11 HD11 ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 45' ' ' ILE . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.804 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.706 HD12 ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.804 HD11 ' N ' ' A' ' 61' ' ' MET . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.904 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 79' ' ' THR . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.791 ' O ' HD13 ' A' ' 132' ' ' ILE . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 64' ' ' GLY . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.868 ' HD2' HD12 ' A' ' 107' ' ' LEU . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 99' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.734 ' O ' HD23 ' A' ' 101' ' ' LEU . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.489 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.706 ' OD1' HD12 ' A' ' 62' ' ' ILE . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 107' ' ' LEU . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 105' ' ' VAL . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.843 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.791 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.691 ' NE2' HG21 ' A' ' 131' ' ' VAL . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG13 HG22 ' B' ' 135' ' ' VAL . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.508 ' CG ' HD13 ' B' ' 85' ' ' ILE . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HB3' HG23 ' B' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.327 0.584 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 45' ' ' ILE . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.48 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' B' ' 46' ' ' GLN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.9 HD11 HD11 ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.461 ' OG1' HG21 ' B' ' 45' ' ' ILE . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.602 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.808 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.832 HD12 ' OD1' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.808 HD11 ' N ' ' B' ' 61' ' ' MET . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.634 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.896 ' N ' HD23 ' B' ' 72' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.442 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.81 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.404 HG22 ' N ' ' B' ' 79' ' ' THR . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.404 ' N ' HG22 ' B' ' 78' ' ' ILE . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.721 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.409 ' HE1' HD12 ' B' ' 101' ' ' LEU . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.793 ' O ' HD13 ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.963 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.963 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.628 HG12 ' H ' ' B' ' 97' ' ' LYS . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.628 ' H ' HG12 ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.778 ' HB2' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.67 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.722 HD21 HD12 ' B' ' 99' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.624 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 105' ' ' VAL . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.708 HG13 ' O ' ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.686 HD13 ' N ' ' B' ' 110' ' ' MET . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HG2' ' HG2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.686 ' N ' HD13 ' B' ' 108' ' ' ILE . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.832 ' OD1' HD12 ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.618 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.525 ' O ' HG23 ' B' ' 118' ' ' THR . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.889 HD13 ' HG ' ' B' ' 125' ' ' LEU . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' B' ' 120' ' ' SER . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.677 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.889 ' HG ' HD13 ' B' ' 119' ' ' ILE . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 130' ' ' VAL . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.823 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.793 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.702 ' NE2' HG21 ' B' ' 131' ' ' VAL . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 135' ' ' VAL . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . 0.553 ' CG ' HD13 ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.282 0.563 . . . . 0.0 110.15 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.907 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 48.0 m80 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.91 HG21 HG23 ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HD11 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.782 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' A' ' 67' ' ' SER . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 61' ' ' MET . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.847 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.782 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' A' ' 62' ' ' ILE . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 132' ' ' ILE . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.742 HD11 HD13 ' B' ' 43' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 131' ' ' VAL . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.791 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 95.6 m-70 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.791 HG11 ' HB1' ' A' ' 80' ' ' ALA . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 124' ' ' THR . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 88' ' ' ALA . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.847 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.721 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' O ' HD23 ' A' ' 101' ' ' LEU . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 100' ' ' GLN . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 105' ' ' VAL . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 99' ' ' LEU . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' SER . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.647 ' N ' HD11 ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 118' ' ' THR . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.624 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 124' ' ' THR . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 87' ' ' ILE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.716 HG23 HD21 ' A' ' 72' ' ' LEU . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.42 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' HA3' ' A' ' 65' ' ' GLY . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.646 HG22 HG13 ' B' ' 135' ' ' VAL . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.606 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.561 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.902 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.902 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.792 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.923 HG23 HG21 ' B' ' 51' ' ' THR . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.492 ' H ' HG22 ' B' ' 45' ' ' ILE . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.923 HG21 HG23 ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.585 ' CB ' HD11 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.561 ' CA ' HD11 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' B' ' 67' ' ' SER . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' B' ' 61' ' ' MET . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.908 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' B' ' 62' ' ' ILE . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.735 HD21 HG23 ' B' ' 132' ' ' ILE . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 44' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.828 ' HB2' HG12 ' B' ' 131' ' ' VAL . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.723 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.79 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 95.7 m-70 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.79 HG11 ' HB1' ' B' ' 80' ' ' ALA . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.688 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 124' ' ' THR . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.908 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.736 ' HG2' HG23 ' B' ' 108' ' ' ILE . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.714 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' B' ' 101' ' ' LEU . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.679 HG11 ' H ' ' B' ' 122' ' ' GLU . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.633 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' B' ' 97' ' ' LYS . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.533 ' CB ' HD12 ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.589 HD13 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.589 ' N ' HD13 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.518 HG22 ' N ' ' B' ' 120' ' ' SER . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.679 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' B' ' 124' ' ' THR . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 87' ' ' ILE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.554 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.828 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.735 HG23 HD21 ' B' ' 72' ' ' LEU . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.409 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.644 HG22 ' HA3' ' B' ' 65' ' ' GLY . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.646 HG13 HG22 ' A' ' 135' ' ' VAL . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.941 HD11 HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.71 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.653 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.94 HD12 HD11 ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 45' ' ' ILE . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.701 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.727 ' HB2' HD11 ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.935 HG23 ' OG ' ' A' ' 67' ' ' SER . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.935 ' OG ' HG23 ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.837 ' HB2' HG12 ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 79' ' ' THR . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 78' ' ' ILE . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.725 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.499 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 86' ' ' VAL . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.74 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.725 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 124' ' ' THR . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG11 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 108' ' ' ILE . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.832 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 100' ' ' GLN . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 105' ' ' VAL . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.852 HG23 ' HG1' ' A' ' 118' ' ' THR . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.806 ' CG ' HD12 ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 108' ' ' ILE . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.852 ' HG1' HG23 ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 125' ' ' LEU . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.852 ' N ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 124' ' ' THR . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.773 HG23 HD21 ' A' ' 72' ' ' LEU . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 HG13 ' B' ' 135' ' ' VAL . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.94 HD11 HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.725 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.941 HD12 HD11 ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.507 ' N ' HG22 ' B' ' 45' ' ' ILE . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.562 HG21 HD13 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.7 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.798 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.743 ' HB2' HD11 ' B' ' 62' ' ' ILE . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.919 HG23 ' OG ' ' B' ' 67' ' ' SER . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.74 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.488 ' O ' HD11 ' B' ' 85' ' ' ILE . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.592 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.62 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.919 ' OG ' HG23 ' B' ' 62' ' ' ILE . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.941 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.941 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.7 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.851 ' HB2' HG12 ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.709 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.507 HG22 ' N ' ' B' ' 79' ' ' THR . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.507 ' N ' HG22 ' B' ' 78' ' ' ILE . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.72 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' B' ' 101' ' ' LEU . 92.1 m-70 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.742 ' O ' HD13 ' B' ' 132' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.72 HG11 ' HB1' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.658 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.875 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 124' ' ' THR . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.875 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.808 ' H ' HD12 ' B' ' 108' ' ' ILE . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.588 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HG2' ' HD3' ' B' ' 97' ' ' LYS . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.693 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.858 ' O ' HD23 ' B' ' 101' ' ' LEU . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.858 HD23 ' O ' ' B' ' 100' ' ' GLN . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.554 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 105' ' ' VAL . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.808 HD12 ' H ' ' B' ' 96' ' ' VAL . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.436 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.566 ' CG ' HD12 ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.438 ' CE2' ' SD ' ' B' ' 110' ' ' MET . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.629 ' OG1' HG23 ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.642 HG21 HD23 ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' B' ' 119' ' ' ILE . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.663 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.699 ' O ' HD22 ' B' ' 125' ' ' LEU . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.699 HD22 ' O ' ' B' ' 124' ' ' THR . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.469 HG11 ' HB ' ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.604 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.851 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.781 HG23 HD21 ' B' ' 72' ' ' LEU . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.472 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 135' ' ' VAL . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.532 ' HB2' HG23 ' A' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.252 0.549 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.834 HD21 HG13 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HA ' HD13 ' B' ' 40' ' ' LEU . 9.6 p30 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.961 HD13 HG21 ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.535 ' N ' ' CD2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.961 HG21 HD13 ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.648 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' CB ' HD11 ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.607 HD11 ' CB ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.804 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.419 ' CG ' ' HB3' ' A' ' 56' ' ' ALA . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 73' ' ' ILE . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.986 ' N ' HD13 ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.623 ' HB2' HG12 ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.444 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 79' ' ' THR . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' HG22 ' A' ' 78' ' ' ILE . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.749 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.453 ' NE2' ' HD2' ' A' ' 102' ' ' ARG . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 64' ' ' GLY . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.749 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 124' ' ' THR . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.747 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.657 HD21 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.518 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.838 HG11 ' H ' ' A' ' 122' ' ' GLU . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.492 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.684 HG21 HD23 ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.838 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.717 ' O ' HD22 ' A' ' 125' ' ' LEU . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 132' ' ' ILE . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.548 HG22 ' HA3' ' A' ' 65' ' ' GLY . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.566 HG13 HG22 ' B' ' 135' ' ' VAL . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.655 ' O ' HG23 ' B' ' 38' ' ' ILE . 6.3 tp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.267 0.556 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.699 ' HA ' HD13 ' A' ' 40' ' ' LEU . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.983 HD13 HG21 ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.457 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' B' ' 50' ' ' ALA . 0.3 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.983 HG21 HD13 ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.642 ' HB3' HG13 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.414 ' O ' HG13 ' B' ' 54' ' ' VAL . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.61 ' CB ' HD11 ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.61 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.794 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.558 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.427 ' CG ' ' HB3' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.741 HD11 HD11 ' B' ' 73' ' ' ILE . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.961 HD13 ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.961 ' N ' HD13 ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.636 ' HB2' HG12 ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.498 HG22 ' N ' ' B' ' 79' ' ' THR . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 64' ' ' GLY . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.714 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.57 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.893 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 124' ' ' THR . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.893 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.725 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.688 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.751 HG11 ' H ' ' B' ' 122' ' ' GLU . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.75 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.551 HD11 ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.412 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.551 ' N ' HD11 ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.419 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.66 HG21 HD23 ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.751 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' B' ' 125' ' ' LEU . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 124' ' ' THR . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.643 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.725 ' C ' HD12 ' B' ' 132' ' ' ILE . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.846 HG23 HD11 ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.532 HG22 ' HA3' ' B' ' 65' ' ' GLY . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 135' ' ' VAL . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.941 ' HA ' HD22 ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' B' ' 44' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.897 HD11 HD13 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 45' ' ' ILE . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.844 HG21 HG23 ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.65 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HE2' HG23 ' B' ' 38' ' ' ILE . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 72' ' ' LEU . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.609 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HA ' HG13 ' A' ' 62' ' ' ILE . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.981 HD12 ' ND2' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 72' ' ' LEU . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.709 HD11 HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.962 HD11 HD11 ' B' ' 44' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.836 ' HB2' HG12 ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.7 m-70 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 132' ' ' ILE . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 124' ' ' THR . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.791 HG11 ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.796 HD12 HD21 ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 101' ' ' LEU . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.796 HD21 HD12 ' A' ' 99' ' ' LEU . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.521 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.981 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.5 t-20 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 125' ' ' LEU . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.558 ' O ' HG21 ' A' ' 105' ' ' VAL . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' CA ' HG11 ' A' ' 105' ' ' VAL . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 90' ' ' VAL . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 87' ' ' ILE . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.836 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.689 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.863 HG13 HG22 ' B' ' 135' ' ' VAL . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.412 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HG23 ' B' ' 131' ' ' VAL . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.689 HG23 ' HE2' ' A' ' 53' ' ' PHE . 4.5 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.255 0.55 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.926 ' HA ' HD22 ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' A' ' 44' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.528 ' H ' HG22 ' B' ' 45' ' ' ILE . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.786 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.857 HG21 HG23 ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.654 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' B' ' 73' ' ' ILE . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.502 HG12 HD22 ' B' ' 72' ' ' LEU . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.611 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' B' ' 62' ' ' ILE . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.75 ' SD ' HG22 ' B' ' 95' ' ' THR . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.983 HD12 ' ND2' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.831 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.771 ' CG2' HD12 ' B' ' 72' ' ' LEU . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.771 HD12 ' CG2' ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.969 HD11 HD11 ' A' ' 44' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.654 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.799 ' HB2' HG12 ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.786 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.4 m-70 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.859 ' O ' HD13 ' B' ' 132' ' ' ILE . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.768 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.523 ' O ' HG23 ' B' ' 87' ' ' ILE . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 124' ' ' THR . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.75 HG22 ' SD ' ' B' ' 61' ' ' MET . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.757 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' B' ' 109' ' ' PRO . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.721 HD12 HD21 ' B' ' 101' ' ' LEU . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 125' ' ' LEU . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' B' ' 119' ' ' ILE . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.536 ' CA ' HD12 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.423 ' HB2' HD11 ' B' ' 119' ' ' ILE . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.679 HD13 ' C ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.507 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.538 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.983 ' ND2' HD12 ' B' ' 62' ' ' ILE . 2.2 t-20 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 118' ' ' THR . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.788 ' HB ' HG22 ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.527 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.616 ' O ' HG23 ' B' ' 90' ' ' VAL . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.736 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 87' ' ' ILE . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.799 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.799 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.859 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.668 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.863 HG22 HG13 ' A' ' 135' ' ' VAL . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.689 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . 0.444 ' HG3' HG21 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 131' ' ' VAL . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.14 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.027 HD11 HD11 ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG3' ' HG2' ' A' ' 46' ' ' GLN . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' B' ' 44' ' ' LEU . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.999 HD11 HD11 ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 45' ' ' ILE . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.736 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' ' HE1' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.619 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 62' ' ' ILE . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 72' ' ' LEU . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 71' ' ' LEU . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.795 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 79' ' ' THR . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.455 ' HE1' HD12 ' A' ' 101' ' ' LEU . 89.2 m-70 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 95' ' ' THR . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' PRO . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.88 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.857 HG11 ' H ' ' A' ' 122' ' ' GLU . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.739 ' HB3' HG23 ' A' ' 95' ' ' THR . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.497 ' HE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 108' ' ' ILE . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.857 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.624 ' O ' HD22 ' A' ' 125' ' ' LEU . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 134' ' ' VAL . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.734 HG22 HG13 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.459 ' HB3' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.499 ' O ' HD13 ' B' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.335 0.588 . . . . 0.0 110.123 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.999 HD11 HD11 ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 46' ' ' GLN . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' B' ' 45' ' ' ILE . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.682 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.72 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.439 ' HG2' HD11 ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.72 HD11 ' CB ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.798 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.657 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.709 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.799 HD13 ' N ' ' B' ' 72' ' ' LEU . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.799 ' N ' HD13 ' B' ' 71' ' ' LEU . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.794 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.806 ' N ' HG12 ' B' ' 131' ' ' VAL . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' B' ' 77' ' ' ALA . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.454 HG22 ' N ' ' B' ' 79' ' ' THR . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' HG22 ' B' ' 78' ' ' ILE . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.869 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.418 ' HE1' HD12 ' B' ' 101' ' ' LEU . 89.1 m-70 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.666 HG23 ' O ' ' B' ' 85' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.869 HG11 ' HB1' ' B' ' 80' ' ' ALA . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.46 HG21 HG21 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.98 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' B' ' 128' ' ' PHE . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.98 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.798 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.554 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.762 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.686 ' O ' HD23 ' B' ' 101' ' ' LEU . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 105' ' ' VAL . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.675 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' B' ' 88' ' ' ALA . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.591 ' O ' HG23 ' B' ' 108' ' ' ILE . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 97' ' ' LYS . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.645 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.839 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.489 HG22 HD21 ' B' ' 99' ' ' LEU . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' B' ' 89' ' ' ALA . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.485 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.806 HG12 ' N ' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.691 ' N ' HD12 ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 134' ' ' VAL . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.734 HG13 HG22 ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . 0.443 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.486 ' O ' HD13 ' A' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.162 0.506 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.76 ' CG ' HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.704 ' HA ' HD22 ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.907 HD13 HG21 ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.566 ' H ' HG22 ' A' ' 45' ' ' ILE . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.907 HG21 HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HB2' HG13 ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.518 ' CA ' HD11 ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.75 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 59' ' ' ASP . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 85' ' ' ILE . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.551 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.75 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.719 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 73' ' ' ILE . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' HB ' ' A' ' 131' ' ' VAL . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.669 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 86' ' ' VAL . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.679 HG21 HD12 ' A' ' 132' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 130' ' ' VAL . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.979 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 124' ' ' THR . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.979 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.551 HG11 ' CA ' ' A' ' 64' ' ' GLY . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' NZ ' HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.928 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.928 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 119' ' ' ILE . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.469 HD13 ' C ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HG3' ' CG2' ' A' ' 95' ' ' THR . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 110' ' ' MET . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.469 ' C ' HD13 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 118' ' ' THR . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.757 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.664 ' O ' HD22 ' A' ' 125' ' ' LEU . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 119' ' ' ILE . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 86' ' ' VAL . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.786 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 135' ' ' VAL . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.797 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.895 ' O ' HG23 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' B' ' 130' ' ' VAL . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.672 ' O ' HG23 ' B' ' 38' ' ' ILE . 2.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.187 0.518 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.765 ' CG ' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.926 HD13 HG21 ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLN . . . . . 0.549 ' H ' HG22 ' B' ' 45' ' ' ILE . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.926 HG21 HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.657 ' HB2' HG13 ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.545 ' CA ' HD11 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' MET . . . . . 0.738 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.545 HD11 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.597 ' O ' HD11 ' B' ' 85' ' ' ILE . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.55 ' CA ' HG11 ' B' ' 96' ' ' VAL . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.638 ' C ' HD23 ' B' ' 72' ' ' LEU . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.738 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.734 HD13 ' N ' ' B' ' 73' ' ' ILE . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.734 ' N ' HD13 ' B' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' B' ' 131' ' ' VAL . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.672 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ASP . . . . . 0.519 ' O ' HG13 ' B' ' 86' ' ' VAL . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.683 HG21 HD12 ' B' ' 132' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . 0.916 HG12 HG13 ' B' ' 130' ' ' VAL . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.833 ' O ' HG13 ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.953 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 124' ' ' THR . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' THR . . . . . 0.953 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' VAL . . . . . 0.55 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.471 ' HD3' ' HB2' ' B' ' 63' ' ' ASP . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' GLN . . . . . 0.865 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.865 HD23 ' O ' ' B' ' 100' ' ' GLN . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' VAL . . . . . 0.752 HG21 ' O ' ' B' ' 120' ' ' SER . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' LEU . . . . . 0.608 HD12 ' CB ' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . 0.537 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.459 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' B' ' 60' ' ' SER . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ASN . . . . . 0.514 ' HB3' HD12 ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' TYR . . . . . 0.48 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.537 ' C ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' PRO . . . . . 0.473 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.404 HG23 ' O ' ' B' ' 117' ' ' ILE . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' B' ' 125' ' ' LEU . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.752 ' O ' HG21 ' B' ' 105' ' ' VAL . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.634 ' CA ' HG11 ' B' ' 105' ' ' VAL . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.65 ' O ' HD22 ' B' ' 125' ' ' LEU . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.8 ' HB3' HD13 ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.833 HG13 ' O ' ' B' ' 87' ' ' ILE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' GLY . . . . . 0.607 ' O ' HG22 ' B' ' 87' ' ' ILE . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.916 HG13 HG12 ' B' ' 86' ' ' VAL . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' HIS . . . . . 0.797 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 135' ' ' VAL . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . 0.786 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' MET . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.71 82.62 17.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 110.231 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.86 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.418 1.22 . . . . 0.0 110.605 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -115.93 152.56 47.7 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 110.142 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.9 -63.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.218 1.115 . . . . 0.0 110.555 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.8 -80.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 110.171 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.99 67.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.321 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.82 120.31 6.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -123.79 30.93 6.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.23 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.97 148.15 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.06 88.09 1.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -27.26 51.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -81.45 134.38 35.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 38' ' ' ILE . 12.6 tt -103.74 78.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 110.356 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 43' ' ' LEU . 7.6 t0 -85.29 65.54 9.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.946 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -52.8 -48.14 67.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 110.514 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.424 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.2 p30 -50.22 -40.47 47.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.178 -0.951 . . . . 0.0 110.185 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -90.02 -18.77 25.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.345 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.34 -66.11 0.59 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.535 -0.728 . . . . 0.0 110.4 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.77 -28.89 30.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 40' ' ' LEU . 1.8 mt -116.74 -151.93 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.051 -1.031 . . . . 0.0 109.558 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -175.49 33.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.098 -1.002 . . . . 0.0 109.97 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -129.66 156.72 78.34 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.887 . . . . 0.0 110.03 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.21 -42.18 30.5 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.269 1.142 . . . . 0.0 110.149 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.96 73.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.879 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.785 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -147.8 38.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.409 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.616 ' OG1' HG21 ' A' ' 45' ' ' ILE . 54.6 m -132.28 143.6 50.01 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 110.939 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -119.27 152.67 36.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.434 -0.791 . . . . 0.0 110.579 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.2 p90 -143.28 164.25 30.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.304 -0.873 . . . . 0.0 109.768 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.7 p -155.42 138.63 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.066 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.62 133.85 44.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.015 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -90.76 102.71 15.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 110.273 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.7 t -134.77 58.23 1.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.31 -130.27 1.43 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -173.68 55.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.164 -1.198 . . . . 0.0 110.159 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.88 -16.42 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.471 -0.768 . . . . 0.0 110.096 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.0 mpp? -138.99 30.87 2.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.737 HD12 ' ND2' ' A' ' 111' ' ' ASN . 15.3 mt -50.87 -26.55 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 110' ' ' MET . 2.8 p30 -49.14 -34.59 14.53 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.914 0.864 . . . . 0.0 109.245 177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.859 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -81.78 -33.68 26.7 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.92 -10.74 3.11 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.31 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.869 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -74.63 98.82 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.913 -1.345 . . . . 0.0 110.51 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 73.3 p -119.35 66.05 0.79 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t0 41.41 56.1 3.27 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.705 -0.622 . . . . 0.0 111.825 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.15 57.81 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.25 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -174.4 -174.15 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -1.198 . . . . 0.0 110.257 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -134.32 113.68 12.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.871 . . . . 0.0 110.117 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.2 tt -78.44 144.74 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.451 -0.781 . . . . 0.0 110.741 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.948 ' N ' HD23 ' A' ' 72' ' ' LEU . 12.3 mm -133.22 98.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.221 -0.925 . . . . 0.0 109.314 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -102.75 154.35 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.796 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.4 m-20 -109.4 98.13 7.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.404 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.501 ' HB2' ' CD2' ' A' ' 128' ' ' PHE . 69.2 p -81.73 101.42 10.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.83 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.25 -49.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 79' ' ' THR . 23.6 mt -98.69 168.66 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 110.434 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.51 ' N ' HG22 ' A' ' 78' ' ' ILE . 5.2 m -102.52 110.37 22.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.943 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.15 -153.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.495 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.47 150.75 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.311 -0.868 . . . . 0.0 109.553 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.476 ' HE1' HD12 ' A' ' 101' ' ' LEU . 32.1 m-70 -54.68 146.75 16.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 110.5 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.53 35.49 22.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.5 147.91 30.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.376 -1.073 . . . . 0.0 109.545 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.859 HD11 ' HA2' ' A' ' 64' ' ' GLY . 9.2 tt -71.65 86.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.951 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.943 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.7 m -125.9 166.88 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.553 HD12 HG22 ' A' ' 96' ' ' VAL . 1.2 tp -91.58 124.96 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.26 153.32 21.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.35 22.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 110.716 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.6 p -152.83 126.55 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 109.694 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 53.03 22.16 2.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.25 33.27 6.96 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.1 mt-10 -103.58 160.77 14.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.099 -1.236 . . . . 0.0 110.387 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.47 107.6 4.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.16 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 1.7 p -139.15 144.91 38.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 87' ' ' ILE . 18.9 t -109.24 123.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -0.942 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 176.26 153.72 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.402 -0.811 . . . . 0.0 110.116 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -76.23 105.62 7.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 108.856 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.857 HD12 HD21 ' A' ' 101' ' ' LEU . 1.4 pt? -119.22 154.24 33.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.008 -1.057 . . . . 0.0 111.495 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.4 mt-30 -116.01 131.69 56.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 99' ' ' LEU . 36.4 mt -125.41 -13.62 6.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 111.068 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -72.98 -58.1 2.71 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.891 -1.13 . . . . 0.0 110.347 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.77 -56.93 0.5 Allowed 'Trans proline' 0 C--N 1.321 -0.872 0 N-CA-C 108.596 -1.348 . . . . 0.0 108.596 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 m -151.88 159.39 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.709 HG21 ' O ' ' A' ' 120' ' ' SER . 33.3 m -80.28 100.61 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.033 -1.042 . . . . 0.0 109.67 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -134.87 133.84 40.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.109 -0.994 . . . . 0.0 111.113 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 107' ' ' LEU . 11.7 tp -115.29 156.12 26.02 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.679 HD13 ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -149.25 101.86 3.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.063 . . . . 0.0 110.972 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 2.9 Cg_endo -64.35 137.56 56.35 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -118.42 -12.59 9.84 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.852 -1.155 . . . . 0.0 110.837 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.737 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -47.54 -47.49 27.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.049 -1.032 . . . . 0.0 110.79 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 p -176.19 -35.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.445 -0.784 . . . . 0.0 109.813 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.16 66.34 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.835 . . . . 0.0 109.732 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.5 p90 -61.76 127.68 32.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.423 -0.798 . . . . 0.0 110.428 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -158.12 90.67 2.23 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.417 -0.802 . . . . 0.0 110.02 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 108.09 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.31 1.163 . . . . 0.0 110.541 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.4 tt -140.02 148.53 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.267 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 118' ' ' THR . 6.4 t -73.5 161.16 30.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.681 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 mt -97.98 -82.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.963 . . . . 0.0 110.322 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.709 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -134.49 -159.19 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.96 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.21 64.18 1.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 53.45 41.47 32.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.907 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.2 -77.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.285 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 90' ' ' VAL . 12.0 m -147.68 83.81 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.681 HD21 HG21 ' A' ' 119' ' ' ILE . 0.3 OUTLIER -124.49 102.61 7.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -145.96 149.01 33.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.024 . . . . 0.0 110.557 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 86' ' ' VAL . 89.4 t -71.26 153.24 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 76' ' ' SER . 9.7 t80 -97.36 -39.04 9.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.477 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -115.22 -148.62 9.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 14.3 p -150.04 16.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 0.0 111.108 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.771 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.9 p -170.56 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.879 -1.138 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.5 mp -152.44 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.429 -0.795 . . . . 0.0 108.928 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.708 ' NE2' HG21 ' A' ' 131' ' ' VAL . 27.4 m170 -71.93 120.19 17.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.88 . . . . 0.0 110.35 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 134' ' ' VAL . 21.7 m -88.32 122.29 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 110.553 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG22 HG13 ' B' ' 135' ' ' VAL . 41.0 t -99.66 97.45 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.099 -1.0 . . . . 0.0 109.503 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -82.92 105.43 13.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.497 -0.752 . . . . 0.0 110.336 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.506 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -62.41 105.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.119 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mtp -113.35 107.34 15.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.631 ' HB3' HG23 ' B' ' 131' ' ' VAL . 25.3 ptt180 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.183 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.235 0.54 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.48 157.6 45.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.451 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 -26.5 82.23 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.339 1.178 . . . . 0.0 110.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.71 73.55 0.31 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.158 -0.964 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.85 126.65 19.39 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.202 1.106 . . . . 0.0 110.444 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.15 -23.83 11.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.166 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -155.96 144.62 20.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -0.873 . . . . 0.0 110.174 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.89 83.21 1.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -103.19 86.97 2.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.315 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 90.3 t -120.41 -31.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.16 6.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 110.212 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -153.55 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.947 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.439 ' C ' HG23 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -152.61 164.07 38.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.143 -0.973 . . . . 0.0 110.295 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.519 HD12 HD23 ' B' ' 40' ' ' LEU . 1.0 OUTLIER -149.69 109.31 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.866 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.407 ' OD2' ' CB ' ' B' ' 42' ' ' GLN . 7.4 t0 -90.21 72.47 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.36 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.761 HD21 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 110.151 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.449 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 12.1 p30 -50.43 -40.86 51.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.407 ' CB ' ' OD2' ' B' ' 39' ' ' ASP . 1.9 tp60 -89.96 -18.81 25.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -0.85 . . . . 0.0 109.316 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.615 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -62.13 -66.3 0.56 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.531 -0.731 . . . . 0.0 110.31 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.01 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.56 -28.83 30.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.764 HD11 HD21 ' A' ' 40' ' ' LEU . 1.8 mt -116.93 -152.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.494 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -175.34 33.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.996 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -129.57 156.76 78.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.853 . . . . 0.0 110.107 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.21 -42.2 30.42 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.272 1.143 . . . . 0.0 110.243 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -175.93 72.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.798 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -147.54 38.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.442 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.614 ' OG1' HG21 ' B' ' 45' ' ' ILE . 53.3 m -132.27 143.65 50.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 110.884 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -119.28 152.88 35.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.473 -0.767 . . . . 0.0 110.557 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.647 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -143.35 164.38 30.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.277 -0.889 . . . . 0.0 109.742 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.7 p -155.42 138.7 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.966 . . . . 0.0 110.138 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.403 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 133.84 44.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.958 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -90.78 102.98 15.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 110.323 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -135.08 58.19 1.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.19 -130.08 1.4 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.412 ' O ' ' ND2' ' B' ' 111' ' ' ASN . 4.4 p30 -174.1 54.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.175 -1.191 . . . . 0.0 110.093 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.6 p -116.68 -15.46 10.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 110.083 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.868 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.1 mpp? -139.93 31.08 2.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.995 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.732 HD12 ' ND2' ' B' ' 111' ' ' ASN . 15.1 mt -51.11 -26.13 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.1 -34.86 14.84 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.939 0.876 . . . . 0.0 109.297 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.833 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -81.53 -33.85 26.98 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.76 -10.61 3.14 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.216 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.868 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -74.54 98.81 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.978 -1.307 . . . . 0.0 110.438 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -119.32 66.14 0.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 110.207 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 13.3 t0 41.26 56.01 3.2 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 0.0 111.839 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.41 57.47 0.01 OUTLIER Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.358 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.7 p-10 -174.18 -174.09 0.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.275 -1.132 . . . . 0.0 110.322 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.629 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -134.24 113.78 12.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 110.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.945 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.2 tt -78.67 144.87 34.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.388 -0.82 . . . . 0.0 110.751 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.945 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.4 mm -133.25 98.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.279 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.9 p -102.88 154.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.846 . . . . 0.0 109.803 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.776 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.4 m-20 -109.26 98.06 7.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.967 -1.083 . . . . 0.0 110.371 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' B' ' 128' ' ' PHE . 70.4 p -81.74 101.39 10.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 109.857 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.798 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.19 -49.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.511 HG22 ' N ' ' B' ' 79' ' ' THR . 23.9 mt -98.71 168.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.511 ' N ' HG22 ' B' ' 78' ' ' ILE . 5.4 m -102.83 110.22 22.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.341 -0.85 . . . . 0.0 109.84 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.89 -153.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.514 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.59 150.37 36.26 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 109.6 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 31.0 m-70 -54.26 146.77 14.59 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.164 -0.96 . . . . 0.0 110.422 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 35.69 22.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -147.71 148.2 30.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.402 -1.057 . . . . 0.0 109.518 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.833 HD11 ' HA2' ' B' ' 64' ' ' GLY . 9.3 tt -71.86 86.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.871 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' B' ' 80' ' ' ALA . 32.5 m -125.95 166.67 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.233 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -91.27 124.94 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.32 152.43 21.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.7 129.2 24.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.9 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.565 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.1 p -152.9 127.09 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.537 -0.727 . . . . 0.0 109.731 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 53.57 21.8 2.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.169 -0.957 . . . . 0.0 110.596 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.19 32.81 6.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' B' ' 94' ' ' PHE . 8.0 mm-40 -105.96 164.51 11.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -1.222 . . . . 0.0 109.97 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.557 ' O ' HG23 ' B' ' 95' ' ' THR . 29.0 m-85 -156.61 117.73 3.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.99 . . . . 0.0 110.404 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.557 HG23 ' O ' ' B' ' 94' ' ' PHE . 13.9 p -155.17 126.1 7.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.0 110.643 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.403 ' O ' ' CG ' ' B' ' 97' ' ' LYS . 17.1 t -75.92 124.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.293 -0.879 . . . . 0.0 109.71 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.432 ' O ' HD23 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -175.48 141.96 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.262 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' B' ' 108' ' ' ILE . 7.5 mttt -76.49 102.79 6.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 1.001 HD12 HD21 ' B' ' 101' ' ' LEU . 1.2 pt? -120.83 154.7 35.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.042 -1.036 . . . . 0.0 111.908 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.434 ' O ' HD23 ' B' ' 101' ' ' LEU . 3.7 mt-30 -113.98 130.53 56.53 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 1.001 HD21 HD12 ' B' ' 99' ' ' LEU . 38.7 mt -123.24 -13.56 7.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.901 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.515 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -72.42 -57.9 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.941 -1.099 . . . . 0.0 110.224 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.37 -55.51 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.906 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -151.7 162.11 41.55 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.787 HG11 ' O ' ' B' ' 120' ' ' SER . 7.3 p -84.77 100.38 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.038 -1.039 . . . . 0.0 109.699 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -143.19 139.28 30.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 0.0 111.249 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -118.93 154.42 33.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.576 -0.703 . . . . 0.0 109.491 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.755 HD13 ' O ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -138.12 101.9 8.38 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 110.508 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.84 144.22 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.497 ' HB2' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -124.04 -15.63 6.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.863 -1.148 . . . . 0.0 110.857 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.732 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.8 OUTLIER -48.51 -41.34 29.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.083 -1.01 . . . . 0.0 110.509 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 83.2 p -176.25 -33.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.492 -0.755 . . . . 0.0 110.295 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 63.86 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 110.235 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.476 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 48.7 p90 -62.3 121.78 14.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 110.249 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.44 96.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.022 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.87 115.39 2.52 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.105 1.055 . . . . 0.0 110.633 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.86 150.62 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.152 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.413 ' H ' HG22 ' B' ' 118' ' ' THR . 7.2 t -77.52 156.19 31.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.894 . . . . 0.0 110.197 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 107' ' ' LEU . 6.1 mt -100.82 -74.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.141 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.787 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -137.85 -161.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 110.509 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.87 64.57 2.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 0.0 110.151 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 53.44 41.16 32.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 0.0 110.21 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.94 -77.23 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.305 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 90' ' ' VAL . 12.1 m -148.14 83.48 1.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.455 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.654 HD21 HG21 ' B' ' 119' ' ' ILE . 0.3 OUTLIER -124.2 102.76 7.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -146.1 149.06 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 86' ' ' VAL . 91.3 t -71.33 153.22 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.375 -0.828 . . . . 0.0 110.238 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' B' ' 76' ' ' SER . 9.6 t80 -97.34 -39.03 9.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.504 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -115.2 -148.86 9.52 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.754 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 14.7 p -149.91 16.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -1.217 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.9 p -170.68 170.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.925 -1.109 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.76 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.5 mp -152.44 82.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.47 -0.769 . . . . 0.0 108.93 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.716 ' NE2' HG21 ' B' ' 131' ' ' VAL . 27.6 m170 -72.01 120.07 17.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -0.854 . . . . 0.0 110.333 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 134' ' ' VAL . 21.5 m -88.2 122.24 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.531 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 135' ' ' VAL . 40.5 t -99.68 97.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -82.86 105.62 14.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.429 -0.795 . . . . 0.0 110.251 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.7 104.81 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 7.3 mtp -112.93 107.3 15.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 110.196 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.679 ' HB3' HG23 ' A' ' 131' ' ' VAL . 25.2 ptt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.226 0.536 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.15 165.22 14.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.24 178.34 0.6 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.322 1.17 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 67.19 3.97 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.64 117.32 4.13 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.263 1.139 . . . . 0.0 110.515 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.51 59.89 1.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.27 151.44 51.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -39.67 3.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 33' ' ' TYR . 34.6 p90 -90.66 144.39 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 0.0 110.169 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.14 -41.38 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.902 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.94 -155.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.69 -159.19 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.75 51.89 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 110.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.3 tp -57.88 126.2 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ASN . 1.4 t70 -55.92 -66.86 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.023 HD12 HD13 ' B' ' 45' ' ' ILE . 1.1 tp 30.2 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.21 0.529 . . . . 0.0 112.116 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.934 ' HB3' HD21 ' B' ' 40' ' ' LEU . 15.2 p30 -51.7 -37.59 51.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.247 -0.908 . . . . 0.0 108.74 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 2.4 tp60 -79.81 -30.75 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.723 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -52.55 -65.72 0.51 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.431 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -95.06 -36.42 11.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.001 -1.062 . . . . 0.0 110.471 -179.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.072 HD13 HD12 ' B' ' 40' ' ' LEU . 4.7 mt -105.92 173.87 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.26 -0.9 . . . . 0.0 109.99 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' ILE . 75.4 mt-30 -130.86 -44.87 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.008 -1.058 . . . . 0.0 110.375 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.0 m80 -67.71 149.37 98.31 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.242 -0.911 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.32 -50.44 3.56 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 123.162 1.085 . . . . 0.0 110.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.75 1.03 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.411 -0.806 . . . . 0.0 109.738 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -131.58 38.12 3.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.385 -0.822 . . . . 0.0 109.978 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 61.2 m -130.35 133.71 46.62 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.043 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.72 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -110.57 150.34 29.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.481 -0.762 . . . . 0.0 110.067 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' B' ' 43' ' ' LEU . 9.6 p90 -143.2 157.73 44.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.376 -0.828 . . . . 0.0 110.082 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 9.3 p -155.45 139.36 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.74 132.14 43.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 110.196 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -91.19 112.03 23.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -136.24 66.99 1.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -0.926 . . . . 0.0 110.298 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.56 -133.31 1.77 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CA ' HD11 ' A' ' 62' ' ' ILE . 3.2 p30 -176.68 34.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -1.117 . . . . 0.0 109.812 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 110' ' ' MET . 58.7 p -107.85 -39.23 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.092 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.64 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -103.37 28.7 6.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -0.916 . . . . 0.0 109.661 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.614 HD11 ' CA ' ' A' ' 59' ' ' ASP . 33.6 mt -55.26 -27.28 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 2.9 p30 -53.77 -27.49 29.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.371 -0.831 . . . . 0.0 108.974 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.668 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -84.63 -37.44 10.57 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.28 -14.55 2.08 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.248 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.64 HD11 ' H ' ' A' ' 61' ' ' MET . 1.7 pp -76.31 105.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.932 -1.334 . . . . 0.0 110.543 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.56 ' OG ' HG23 ' A' ' 62' ' ' ILE . 1.8 m -131.27 66.38 1.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 110.455 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.2 t0 40.39 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.749 -0.594 . . . . 0.0 112.13 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.34 55.67 0.67 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.299 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' O ' ' CE ' ' A' ' 55' ' ' LYS . 4.4 p30 -175.56 170.35 2.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 0.0 110.036 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -118.14 130.45 56.12 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 110.626 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HG23 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -95.96 123.03 39.39 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.447 -0.783 . . . . 0.0 109.151 179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 72' ' ' LEU . 33.4 mm -119.51 105.62 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 110.461 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -103.22 151.82 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 110.074 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.694 ' HB2' HG12 ' A' ' 131' ' ' VAL . 2.9 m-20 -112.07 97.98 7.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 84.3 p -76.79 101.67 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.847 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.68 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' THR . 2.5 mp -108.51 163.32 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.347 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 25.5 m -95.88 120.39 36.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.86 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.68 -151.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.338 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -142.78 150.25 39.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.3 m-70 -55.37 144.0 26.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 110.266 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.97 40.62 16.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -145.7 143.58 29.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -1.119 . . . . 0.0 109.775 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 85' ' ' ILE . 6.3 tt -73.21 101.25 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 127' ' ' VAL . 28.2 m -145.93 -178.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.893 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -99.55 125.69 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.148 -0.97 . . . . 0.0 110.468 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.019 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -91.54 168.7 11.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.014 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 133.21 13.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 110.455 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 5.4 p -152.67 126.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 110.081 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 53.88 21.96 3.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.261 -0.899 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.16 32.73 6.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.2 mm-40 -105.53 161.13 14.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.216 -1.167 . . . . 0.0 110.062 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -138.25 89.59 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 0.0 110.527 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.019 ' CG2' ' HB3' ' A' ' 88' ' ' ALA . 9.8 t -111.33 -177.97 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.441 -0.787 . . . . 0.0 109.895 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.668 HG11 ' HA3' ' A' ' 64' ' ' GLY . 0.8 OUTLIER -136.43 -147.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.29 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 65.55 179.45 0.2 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.502 -0.749 . . . . 0.0 110.93 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -87.66 136.56 32.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.443 -0.785 . . . . 0.0 110.358 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 99' ' ' LEU . 2.2 pt? -123.04 152.53 40.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 110.33 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.796 ' O ' HD23 ' A' ' 101' ' ' LEU . 46.5 mt-30 -124.32 126.82 46.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.7 mt -131.87 -12.05 3.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.148 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.64 -57.93 1.19 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.793 -1.192 . . . . 0.0 110.21 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.48 -51.16 3.55 Favored 'Trans proline' 0 C--N 1.322 -0.859 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.6 m -151.01 162.63 40.48 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.827 HG12 ' HB ' ' A' ' 119' ' ' ILE . 21.9 t -90.29 100.7 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.924 -1.11 . . . . 0.0 109.922 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.68 150.91 32.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.232 -0.918 . . . . 0.0 110.466 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.585 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -145.28 137.73 25.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.742 HD13 ' N ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -141.27 77.92 19.49 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.255 -0.903 . . . . 0.0 110.517 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -71.81 -153.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.114 1.06 . . . . 0.0 110.172 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 70.48 147.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.471 -0.768 . . . . 0.0 110.97 178.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 3.4 t-20 -101.75 -70.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -83.6 -35.92 24.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.861 . . . . 0.0 109.517 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.99 56.51 3.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.483 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.6 p90 -62.52 124.51 21.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.813 . . . . 0.0 110.612 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' C ' HD13 ' A' ' 108' ' ' ILE . 3.7 m -134.05 84.54 42.52 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.391 -0.818 . . . . 0.0 109.536 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.742 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.2 Cg_exo -58.42 128.41 28.33 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.291 1.153 . . . . 0.0 110.88 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.1 tp -139.65 136.35 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 0.0 110.166 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 118' ' ' THR . 7.4 t -85.82 160.81 19.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 0.0 110.222 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.879 HD13 ' HG ' ' A' ' 125' ' ' LEU . 13.9 mt -119.38 169.41 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -59.86 -159.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.237 -0.914 . . . . 0.0 110.453 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.63 66.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' N ' HG21 ' A' ' 105' ' ' VAL . 11.1 tt0 52.78 60.78 3.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -75.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.89 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 125' ' ' LEU . 22.8 m -148.03 81.4 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.136 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.879 ' HG ' HD13 ' A' ' 119' ' ' ILE . 2.7 mm? -124.37 102.91 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.26 152.64 38.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.0 110.618 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 86' ' ' VAL . 94.8 t -72.27 153.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -38.29 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 110.332 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -120.24 -142.03 6.48 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 130' ' ' VAL . 13.3 p -152.87 19.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.0 110.825 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.694 HG12 ' HB2' ' A' ' 75' ' ' ASP . 7.2 p -167.69 161.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.976 -1.078 . . . . 0.0 111.062 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD11 ' A' ' 72' ' ' LEU . 46.7 mm -141.16 70.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 1.048 ' CD2' HG12 ' B' ' 135' ' ' VAL . 0.1 OUTLIER -66.37 141.5 57.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.907 . . . . 0.0 110.478 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.7 t -114.3 128.0 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -0.787 . . . . 0.0 109.924 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.05 HG12 ' CD2' ' B' ' 133' ' ' HIS . 6.1 t -101.33 97.33 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.946 . . . . 0.0 109.124 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' CD2' ' B' ' 133' ' ' HIS . 0.0 OUTLIER -89.74 104.33 16.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.768 ' HB2' ' CE1' ' B' ' 133' ' ' HIS . . . -61.53 109.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.61 102.37 10.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.901 . . . . 0.0 110.334 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.41 ' HA ' HG23 ' B' ' 85' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.121 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.192 0.52 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.36 156.52 91.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.39 -72.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.317 1.167 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 7.1 t -118.42 90.51 39.04 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.885 . . . . 0.0 110.283 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.07 108.4 0.49 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.355 1.187 . . . . 0.0 110.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.5 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 110.225 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 147.29 45.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.296 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' B' ' 34' ' ' VAL . 31.2 t0 -97.01 75.43 2.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.86 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.413 -0.804 . . . . 0.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' B' ' 32' ' ' ASP . 57.7 t -112.39 138.36 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.049 -1.032 . . . . 0.0 110.261 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.33 166.72 17.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.328 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -63.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -127.25 108.46 10.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 110.16 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 15.8 tt -60.99 144.76 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' B' ' 41' ' ' ASN . 1.4 t70 -58.45 -67.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 109.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.072 HD12 HD13 ' A' ' 45' ' ' ILE . 1.1 tp 30.19 -86.47 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.265 0.555 . . . . 0.0 112.068 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.912 ' HB3' HD21 ' A' ' 40' ' ' LEU . 15.3 p30 -51.68 -37.29 50.03 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 108.813 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HB3' ' CG ' ' B' ' 39' ' ' ASP . 2.4 tp60 -80.08 -30.61 39.29 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -52.68 -65.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.359 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.82 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.89 -36.54 11.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.07 . . . . 0.0 110.502 -179.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 40' ' ' LEU . 4.7 mt -106.02 173.86 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -0.907 . . . . 0.0 109.98 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.517 ' N ' HG22 ' B' ' 45' ' ' ILE . 75.2 mt-30 -130.78 -44.9 1.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.896 -1.127 . . . . 0.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.0 m80 -67.67 149.31 98.35 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.12 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.18 -50.5 3.61 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.1 1.052 . . . . 0.0 110.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.77 1.03 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.626 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -131.69 38.24 3.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.952 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -130.36 133.76 46.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 111.012 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.722 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -110.63 150.28 29.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.757 . . . . 0.0 110.076 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.514 ' HB3' HD11 ' A' ' 43' ' ' LEU . 9.6 p90 -143.18 157.7 44.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.505 -0.747 . . . . 0.0 110.166 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 9.3 p -155.4 139.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.882 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.69 132.23 43.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 0.0 110.147 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -91.31 112.08 23.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 110.246 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 46.8 t -136.32 67.13 1.47 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -176.61 -133.34 1.78 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.597 ' CA ' HD11 ' B' ' 62' ' ' ILE . 3.2 p30 -176.47 34.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -1.099 . . . . 0.0 109.807 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' B' ' 110' ' ' MET . 59.8 p -107.52 -40.11 5.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.656 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -102.47 28.96 5.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.822 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' B' ' 59' ' ' ASP . 33.3 mt -55.51 -26.37 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.19 -0.943 . . . . 0.0 109.179 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 97' ' ' LYS . 2.8 p30 -54.41 -27.41 36.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.418 -0.801 . . . . 0.0 108.855 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.644 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -84.85 -37.69 10.06 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.53 -14.7 2.03 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.254 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.656 HD11 ' H ' ' B' ' 61' ' ' MET . 1.7 pp -76.08 105.15 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.024 -1.28 . . . . 0.0 110.667 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.571 ' OG ' HG23 ' B' ' 62' ' ' ILE . 1.8 m -131.3 66.39 1.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 0.0 110.48 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 40.37 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.751 -0.593 . . . . 0.0 112.153 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.26 55.73 0.67 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.321 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.3 p30 -175.56 170.43 2.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 109.945 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.723 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -118.33 130.41 56.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 0.0 110.549 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.755 HD11 HG23 ' B' ' 132' ' ' ILE . 0.8 OUTLIER -95.9 123.0 39.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.324 -0.86 . . . . 0.0 109.069 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.588 ' N ' HD13 ' B' ' 72' ' ' LEU . 33.6 mm -119.51 105.76 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.117 . . . . 0.0 110.416 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.722 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -103.16 151.77 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 110.134 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.714 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -112.06 97.91 6.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.349 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 84.3 p -76.76 101.68 5.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.843 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.66 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.412 HG22 ' N ' ' B' ' 79' ' ' THR . 2.5 mp -108.37 163.49 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.386 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.412 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.9 m -96.12 120.43 36.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.757 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.67 -151.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.34 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.79 150.13 39.58 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.21 -0.931 . . . . 0.0 109.581 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 94.4 m-70 -55.29 144.02 26.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.17 -0.957 . . . . 0.0 110.327 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.78 16.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -145.85 143.43 29.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 109.717 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.669 HG23 ' O ' ' B' ' 85' ' ' ILE . 6.6 tt -72.85 101.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 110.452 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 127' ' ' VAL . 26.7 m -145.93 -178.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.531 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.8 OUTLIER -99.94 124.88 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.576 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.684 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.43 168.45 11.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 132.48 12.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.46 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 5.3 p -152.71 126.14 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 110.156 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.9 24.77 3.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.312 -0.868 . . . . 0.0 110.656 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.72 33.18 8.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.7 mt-10 -105.2 164.2 12.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.286 -1.126 . . . . 0.0 110.233 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -136.49 91.35 2.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.935 . . . . 0.0 110.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.684 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.3 p -111.52 169.7 8.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 109.712 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.628 HG11 ' HA3' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -129.21 -147.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.394 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.472 ' CB ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tttm 63.54 178.85 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.394 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 134.58 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.79 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.9 pt? -122.65 153.41 39.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.313 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -121.56 128.99 52.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.652 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.649 HD23 ' O ' ' B' ' 100' ' ' GLN . 22.3 mt -127.63 -9.9 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.887 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.512 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -75.12 -52.89 3.01 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.836 -1.165 . . . . 0.0 110.079 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -66.59 -54.61 0.43 Allowed 'Trans proline' 0 C--N 1.32 -0.95 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.1 m -151.63 156.86 41.27 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.8 m -77.71 100.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.002 -1.061 . . . . 0.0 109.801 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -147.27 138.84 24.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 110.664 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.79 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.3 tp -136.46 144.15 44.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.597 HD13 ' N ' ' B' ' 116' ' ' PRO . 1.4 tp -148.88 77.21 9.39 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.988 -1.07 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -69.44 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.117 1.061 . . . . 0.0 109.368 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 68.04 151.67 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.191 -0.943 . . . . 0.0 110.974 178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -107.53 -80.0 0.57 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -0.76 . . . . 0.0 109.637 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.8 p -72.99 -36.07 66.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 109.811 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.98 55.81 3.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.5 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.479 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.2 p90 -62.79 125.27 23.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.432 -0.792 . . . . 0.0 110.873 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.569 ' C ' HD13 ' B' ' 108' ' ' ILE . 6.6 m -138.19 89.31 14.46 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 0.0 109.295 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.597 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -58.61 130.68 38.35 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.288 1.152 . . . . 0.0 111.111 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.6 tp -133.96 133.21 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.439 -0.788 . . . . 0.0 109.964 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 8.7 t -85.0 156.99 20.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.367 -0.833 . . . . 0.0 110.224 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.712 HD13 ' HG ' ' B' ' 125' ' ' LEU . 8.6 mt -116.98 167.42 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.079 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.633 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.2 OUTLIER -61.02 -157.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 110.001 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.03 66.13 1.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 110.158 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.634 ' N ' HG11 ' B' ' 105' ' ' VAL . 11.4 tt0 53.06 60.7 3.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.313 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.71 -75.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.229 -0.919 . . . . 0.0 110.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.619 ' O ' HD22 ' B' ' 125' ' ' LEU . 22.2 m -148.01 81.45 1.49 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.266 -0.896 . . . . 0.0 110.19 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' B' ' 119' ' ' ILE . 2.7 mm? -124.48 102.49 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -146.97 152.49 38.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.01 -1.057 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.559 HG21 HG21 ' B' ' 86' ' ' VAL . 93.2 t -72.2 153.19 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 110.238 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -38.28 14.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.361 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.19 -141.98 6.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.631 HG22 ' O ' ' B' ' 130' ' ' VAL . 13.6 p -152.86 18.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -1.183 . . . . 0.0 110.864 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' B' ' 75' ' ' ASP . 7.2 p -167.61 161.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.998 -1.064 . . . . 0.0 111.147 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.755 HG23 HD11 ' B' ' 72' ' ' LEU . 46.5 mm -141.26 70.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 1.05 ' CD2' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -66.41 141.56 57.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 110.486 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 64.2 t -114.32 128.17 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.908 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 1.048 HG12 ' CD2' ' A' ' 133' ' ' HIS . 6.0 t -101.47 97.4 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.18 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.416 ' C ' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -89.76 104.37 16.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.72 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.758 ' HB2' ' CE1' ' A' ' 133' ' ' HIS . . . -61.72 109.97 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.58 102.25 10.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.43 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.178 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.207 0.527 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -106.85 173.0 3.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.346 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.87 170.45 5.96 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.325 1.171 . . . . 0.0 110.678 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 52.63 61.82 11.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.447 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.16 127.67 21.81 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.266 1.14 . . . . 0.0 110.431 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.83 99.57 7.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.287 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.1 96.25 5.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -70.05 95.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.149 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.74 89.03 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.58 -31.24 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -95.69 130.69 42.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.52 -54.36 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mtp-105 -77.06 -18.89 57.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.379 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -144.09 85.48 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.139 -0.976 . . . . 0.0 110.171 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -90.46 53.17 2.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.2 pp -45.78 -39.46 8.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.499 -0.751 . . . . 0.0 111.007 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 40' ' ' LEU . 19.6 p30 -60.94 -31.5 71.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 109.464 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -91.82 -12.34 34.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.669 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.978 HD21 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -92.76 -33.46 14.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.498 -0.751 . . . . 0.0 110.185 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.911 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.64 -38.62 4.25 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.808 -1.182 . . . . 0.0 110.131 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.666 HG23 HG21 ' A' ' 51' ' ' THR . 28.3 mm -96.96 175.18 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.976 -1.078 . . . . 0.0 109.468 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.497 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.6 mt-30 -143.79 14.88 1.75 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.957 -1.09 . . . . 0.0 111.137 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 40.3 m80 -148.89 151.82 35.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 110.262 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.22 -50.02 3.17 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 O-C-N 123.192 1.101 . . . . 0.0 110.353 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.96 37.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 110.171 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.44 31.91 5.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.292 -0.88 . . . . 0.0 109.986 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 45' ' ' ILE . 38.8 m -132.36 127.41 35.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 110.757 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.655 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -108.09 152.57 24.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.913 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 9.8 p90 -142.19 163.62 32.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.369 -0.832 . . . . 0.0 110.06 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.68 HG12 ' HG ' ' A' ' 72' ' ' LEU . 7.3 p -155.49 139.06 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 110.34 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 133.66 41.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.978 -1.077 . . . . 0.0 109.684 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -97.88 106.79 19.15 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.187 -0.945 . . . . 0.0 110.38 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.32 42.14 3.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.153 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.94 -142.99 4.08 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.777 ' CA ' HD11 ' A' ' 62' ' ' ILE . 34.0 p30 -174.24 38.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.23 -1.159 . . . . 0.0 110.176 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -103.26 -42.66 5.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.4 mtm -116.59 38.3 3.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 110.067 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' CA ' ' A' ' 59' ' ' ASP . 6.0 mt -56.37 -17.64 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 110' ' ' MET . 2.8 p30 -42.72 -29.46 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.486 -0.759 . . . . 0.0 111.036 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.939 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 174.79 31.48 0.03 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.689 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.18 -72.74 0.14 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.7 pp -129.69 132.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.373 -1.075 . . . . 0.0 110.606 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' HG23 ' A' ' 62' ' ' ILE . 1.1 m -131.14 64.82 1.57 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.02 -1.05 . . . . 0.0 110.779 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 67' ' ' SER . 6.2 p-10 26.58 101.95 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.73 58.44 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -175.34 154.04 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -1.126 . . . . 0.0 109.814 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.976 HD11 HD21 ' B' ' 43' ' ' LEU . 3.5 tm? -109.42 117.01 32.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 110.483 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.56 142.4 27.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 72' ' ' LEU . 23.9 mm -128.85 112.08 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.2 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -105.16 158.71 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.762 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.835 ' HB3' HG12 ' A' ' 131' ' ' VAL . 22.9 t70 -118.77 98.15 6.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.024 . . . . 0.0 110.607 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.455 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 13.9 p -81.06 99.92 8.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.18 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.647 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.551 ' HB ' HG11 ' A' ' 130' ' ' VAL . 2.4 mp -97.04 162.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 110.538 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.8 127.46 39.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -73.11 -158.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.882 . . . . 0.0 110.356 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.25 148.66 33.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.813 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 94.9 m-70 -56.6 144.26 32.61 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.218 -0.927 . . . . 0.0 110.369 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.42 32.56 11.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -147.71 157.79 43.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.285 -1.126 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.686 HD11 ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -80.06 88.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.08 -1.012 . . . . 0.0 109.241 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.915 HG11 ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -119.42 165.14 15.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.05 122.8 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.085 -1.01 . . . . 0.0 109.554 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.803 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -88.9 153.15 21.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.63 128.53 20.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.327 -0.858 . . . . 0.0 110.695 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.52 120.17 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.61 -0.682 . . . . 0.0 109.455 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 54.59 25.9 6.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 110.733 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.12 33.69 7.15 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.229 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt-10 -108.02 164.38 12.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.263 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -146.77 116.6 7.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.817 . . . . 0.0 110.185 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.803 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 71.4 p -136.49 153.06 51.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.186 -0.947 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.939 HG11 ' O ' ' A' ' 64' ' ' GLY . 7.3 t -123.25 119.36 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.029 -1.045 . . . . 0.0 110.635 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CD ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 171.35 167.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.275 -0.891 . . . . 0.0 109.797 179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 88.89 3.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.124 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.9 pt? -86.65 154.17 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 110.818 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.792 ' O ' HD23 ' A' ' 101' ' ' LEU . 9.4 pt20 -128.83 132.09 47.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.257 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.792 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.1 mt -127.56 -9.98 5.66 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.932 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -79.6 -58.97 0.61 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 120.872 -1.142 . . . . 0.0 110.086 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.6 -53.66 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.824 0 N-CA-C 108.56 -1.362 . . . . 0.0 108.56 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.28 152.03 32.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 119' ' ' ILE . 21.2 t -83.89 101.85 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.23 142.84 33.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.896 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.593 HD21 ' OG1' ' A' ' 95' ' ' THR . 20.1 tp -132.25 156.37 46.62 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.598 -0.689 . . . . 0.0 109.756 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.482 HG23 ' CD ' ' A' ' 97' ' ' LYS . 2.8 tp -142.39 68.82 21.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.996 -1.065 . . . . 0.0 111.073 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HG3' HG21 ' A' ' 95' ' ' THR . 2.7 Cg_endo -71.12 113.84 3.72 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 120.9 1.067 . . . . 0.0 109.968 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.44 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER 174.93 177.86 0.15 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.859 -1.15 . . . . 0.0 111.366 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 62' ' ' ILE . 2.8 t-20 -126.89 -80.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.4 p -96.13 -27.85 14.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.038 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.98 68.69 6.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.629 -0.669 . . . . 0.0 109.213 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 51.6 p90 -61.82 123.64 18.56 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.467 -0.771 . . . . 0.0 111.171 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -140.32 86.89 12.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.76 132.34 44.82 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 O-C-N 123.335 1.176 . . . . 0.0 110.664 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -123.18 130.74 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 110.227 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 118' ' ' THR . 7.4 t -84.13 144.46 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 109.952 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 105' ' ' VAL . 3.5 mt -106.09 168.12 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 119' ' ' ILE . 60.7 p -62.75 -161.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.71 66.32 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 52.35 57.13 6.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.537 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.08 -75.94 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.966 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.629 ' O ' HD22 ' A' ' 125' ' ' LEU . 98.4 m -148.15 81.39 1.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.116 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 124' ' ' THR . 1.7 mm? -125.8 100.41 6.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -146.31 151.58 37.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.519 HG21 HG21 ' A' ' 86' ' ' VAL . 48.1 t -72.47 153.31 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.835 . . . . 0.0 110.408 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.64 -38.59 10.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -117.51 -142.27 7.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 130' ' ' VAL . 7.8 p -150.42 16.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.119 -1.224 . . . . 0.0 111.188 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.7 p -167.54 165.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.752 -1.218 . . . . 0.0 111.467 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.756 HG23 HD13 ' A' ' 72' ' ' LEU . 1.7 mp -152.66 77.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.539 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.42 113.77 8.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.628 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 134' ' ' VAL . 31.3 m -86.84 118.72 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 110.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' B' ' 135' ' ' VAL . 94.9 t -100.17 102.29 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.342 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -84.29 105.15 14.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.92 108.7 1.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 110.291 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.78 102.69 9.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.209 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.265 0.555 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -75.49 154.15 85.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 110.117 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.36 127.07 20.85 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.286 1.151 . . . . 0.0 110.491 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.8 155.55 88.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 107.44 0.52 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 123.26 1.137 . . . . 0.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.91 31.73 6.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 110.031 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.15 67.96 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.361 -0.837 . . . . 0.0 110.364 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.19 114.83 8.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.95 . . . . 0.0 110.131 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 52.66 95.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.924 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.665 HG13 ' O ' ' B' ' 34' ' ' VAL . 9.3 p -139.95 111.57 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 110.344 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -135.63 87.22 2.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.081 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -149.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.939 . . . . 0.0 109.906 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -42.91 11.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.107 -0.996 . . . . 0.0 110.303 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -68.69 70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -90.81 50.84 1.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.119 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.88 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.3 pp -45.99 -39.23 8.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.399 -0.813 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.88 ' N ' HD12 ' B' ' 40' ' ' LEU . 19.9 p30 -61.24 -31.54 71.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.403 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -91.74 -12.72 33.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.59 -33.31 14.47 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 110.153 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.917 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.69 -38.87 4.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.665 HG23 HG21 ' B' ' 51' ' ' THR . 28.2 mm -96.83 175.29 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.987 -1.07 . . . . 0.0 109.368 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.488 ' H ' HG22 ' B' ' 45' ' ' ILE . 10.4 mt-30 -143.98 15.13 1.72 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.945 -1.097 . . . . 0.0 111.054 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 40.1 m80 -148.95 151.75 35.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.955 -1.091 . . . . 0.0 110.186 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.06 -50.41 2.97 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.197 1.104 . . . . 0.0 110.316 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.71 37.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.366 -0.834 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.728 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.58 32.03 5.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.938 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.665 HG21 HG23 ' B' ' 45' ' ' ILE . 40.3 m -132.42 127.44 35.38 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.243 -0.911 . . . . 0.0 110.777 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.5 OUTLIER -108.03 152.61 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.48 -0.763 . . . . 0.0 109.769 179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.473 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 9.9 p90 -142.29 163.4 32.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.707 HG12 ' HG ' ' B' ' 72' ' ' LEU . 7.2 p -155.34 139.28 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 110.428 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -75.59 133.66 40.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.014 -1.054 . . . . 0.0 109.695 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -97.88 107.07 19.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.77 42.24 3.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.141 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.45 -141.98 3.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.779 ' CA ' HD11 ' B' ' 62' ' ' ILE . 33.9 p30 -175.32 37.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.092 -1.24 . . . . 0.0 110.003 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 110' ' ' MET . 1.5 m -102.55 -43.16 5.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 110.262 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 59.8 mtm -116.12 40.74 2.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.779 HD11 ' CA ' ' B' ' 59' ' ' ASP . 5.7 mt -59.32 -16.13 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.564 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -43.99 -30.03 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.402 -0.811 . . . . 0.0 110.598 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.87 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 175.74 30.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.852 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 96' ' ' VAL . . . -128.86 -72.33 0.15 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.755 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.7 pp -129.61 132.73 66.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.299 -1.118 . . . . 0.0 110.591 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.559 ' CB ' HG23 ' B' ' 62' ' ' ILE . 1.1 m -131.24 64.87 1.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.073 -1.017 . . . . 0.0 110.803 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' B' ' 67' ' ' SER . 6.1 p-10 26.5 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.78 58.57 1.41 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -175.52 153.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.725 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.978 HD11 HD21 ' A' ' 43' ' ' LEU . 3.5 tm? -109.42 117.31 33.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 110.369 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.929 HD12 ' N ' ' B' ' 73' ' ' ILE . 0.1 OUTLIER -88.72 142.46 27.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.84 . . . . 0.0 109.297 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.929 ' N ' HD12 ' B' ' 72' ' ' LEU . 23.5 mm -129.02 112.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.934 . . . . 0.0 110.278 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.6 p -105.19 158.71 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.349 -0.844 . . . . 0.0 109.804 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.861 ' HB3' HG12 ' B' ' 131' ' ' VAL . 22.6 t70 -118.71 98.19 6.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.144 -0.972 . . . . 0.0 110.647 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 13.5 p -81.09 99.97 8.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.489 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.728 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.24 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.555 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' B' ' 130' ' ' VAL . 2.4 mp -97.19 161.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.317 -0.865 . . . . 0.0 110.582 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -93.17 127.75 38.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 110.061 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.885 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.48 -158.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.247 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.17 148.82 33.99 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.958 . . . . 0.0 109.797 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 93.8 m-70 -56.96 144.14 35.06 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.277 -0.889 . . . . 0.0 110.452 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.28 11.5 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -147.36 158.28 43.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.183 -1.187 . . . . 0.0 109.647 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.64 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -80.78 88.43 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.131 -0.981 . . . . 0.0 109.245 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.885 HG11 ' HB1' ' B' ' 80' ' ' ALA . 34.7 m -119.2 165.15 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.895 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.1 122.46 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.15 -0.969 . . . . 0.0 109.598 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -88.7 153.09 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 128.59 21.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.847 . . . . 0.0 110.787 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.6 p -152.89 121.84 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.629 -0.669 . . . . 0.0 109.641 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.68 20.18 3.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.915 . . . . 0.0 110.754 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.1 33.36 5.77 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.3 mt-10 -107.31 164.57 12.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -1.216 . . . . 0.0 110.322 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -151.19 96.51 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.096 -1.003 . . . . 0.0 110.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.8 OUTLIER -111.26 170.34 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.87 HG11 ' O ' ' B' ' 64' ' ' GLY . 2.1 t -135.55 114.75 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.142 -0.974 . . . . 0.0 110.119 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 2.3 mmtt 171.26 170.96 0.08 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.222 -0.924 . . . . 0.0 110.224 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -79.73 108.07 13.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.6 pt? -112.18 150.2 31.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -0.967 . . . . 0.0 110.939 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.698 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.1 OUTLIER -118.7 132.32 56.16 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.405 -0.809 . . . . 0.0 109.039 179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.698 HD23 ' O ' ' B' ' 100' ' ' GLN . 21.3 mt -127.97 -8.46 5.46 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.987 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -80.98 -59.71 0.46 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.841 -1.162 . . . . 0.0 110.104 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.64 -52.0 2.12 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 N-CA-C 108.642 -1.33 . . . . 0.0 108.642 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.38 155.46 38.7 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.58 HG12 HD13 ' B' ' 119' ' ' ILE . 21.3 t -88.37 100.29 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.007 -1.058 . . . . 0.0 109.963 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -140.45 146.3 38.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.517 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.5 tp -144.49 148.29 34.34 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.331 -0.856 . . . . 0.0 110.161 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.534 HD13 ' C ' ' B' ' 115' ' ' SER . 0.5 OUTLIER -149.39 72.25 9.96 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.132 -0.98 . . . . 0.0 110.975 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.585 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.8 Cg_endo -68.54 -145.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' B' ' 109' ' ' PRO . 19.5 mmt 74.24 157.72 0.19 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 121.671 0.748 . . . . 0.0 111.296 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -102.97 -82.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.657 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.6 p -86.47 -32.32 20.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.058 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.71 61.44 6.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.6 p90 -62.11 127.56 31.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.466 -0.771 . . . . 0.0 110.56 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.534 ' C ' HD13 ' B' ' 108' ' ' ILE . 28.9 m -129.69 93.25 35.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.92 119.4 6.63 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.096 1.051 . . . . 0.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.28 138.67 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 110.728 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' B' ' 118' ' ' THR . 7.7 t -99.32 154.86 17.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.466 -0.771 . . . . 0.0 109.981 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.58 HD13 HG12 ' B' ' 105' ' ' VAL . 2.8 mp -110.15 168.64 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.328 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' B' ' 119' ' ' ILE . 61.2 p -59.62 -161.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.299 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 65.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.358 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.502 ' CA ' HG21 ' B' ' 105' ' ' VAL . 29.1 tt0 52.76 57.07 6.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 110.49 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' OG ' ' B' ' 120' ' ' SER . 16.3 t70 -63.84 -75.97 0.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 98.5 m -148.08 81.37 1.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.682 ' O ' HD13 ' B' ' 101' ' ' LEU . 1.7 mm? -125.63 100.24 6.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.932 . . . . 0.0 110.14 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -146.12 151.45 37.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.075 -1.015 . . . . 0.0 110.487 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.537 HG21 HG21 ' B' ' 86' ' ' VAL . 48.4 t -72.6 153.3 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 110.396 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -95.44 -38.9 10.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 110.298 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -117.22 -142.08 7.14 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.656 HG22 ' O ' ' B' ' 130' ' ' VAL . 7.8 p -150.52 16.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -1.22 . . . . 0.0 111.185 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.861 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.7 p -167.46 166.08 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.758 -1.214 . . . . 0.0 111.472 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.766 HG23 HD13 ' B' ' 72' ' ' LEU . 1.7 mp -152.79 77.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -71.41 113.38 8.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.625 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.605 ' O ' HG23 ' B' ' 134' ' ' VAL . 31.7 m -86.41 118.69 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 0.0 110.049 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.993 HG22 HG22 ' A' ' 135' ' ' VAL . 95.1 t -100.14 102.31 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -84.27 105.05 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 110.011 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.539 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.92 108.93 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 102.82 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.056 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HB3' HG23 ' A' ' 131' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.235 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.78 161.94 61.93 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.33 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.52 175.34 1.66 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.29 1.153 . . . . 0.0 110.508 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.25 169.29 8.2 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 106.02 0.38 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.313 1.165 . . . . 0.0 110.508 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.35 170.87 8.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.21 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.31 52.15 14.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.316 -0.865 . . . . 0.0 110.394 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -143.11 116.78 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.174 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 53.25 46.03 27.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 32' ' ' ASP . 34.7 m -123.77 21.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 110.311 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.66 176.18 7.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.015 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -160.21 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.122 -0.986 . . . . 0.0 110.023 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.9 -46.49 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 110.043 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.9 tp -163.65 66.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' CB ' ' A' ' 42' ' ' GLN . 5.5 t70 -86.59 81.31 8.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.156 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.07 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -67.96 -39.6 83.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.21 -0.931 . . . . 0.0 110.003 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.874 ' HA ' HD22 ' B' ' 40' ' ' LEU . 11.8 p30 -51.04 -34.84 31.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 109.721 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' CB ' ' OD2' ' A' ' 39' ' ' ASP . 0.6 OUTLIER -89.96 -23.65 21.49 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.718 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.99 -67.43 0.41 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.76 -0.587 . . . . 0.0 110.29 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.75 ' CD1' HD12 ' B' ' 71' ' ' LEU . 1.7 mm? -74.15 -30.16 62.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.032 -1.042 . . . . 0.0 109.923 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.042 HD11 HD13 ' B' ' 40' ' ' LEU . 1.7 mt -110.4 -149.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.119 -0.988 . . . . 0.0 109.607 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -168.66 30.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.894 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -134.73 159.58 71.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 110.027 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 -48.02 7.18 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.263 1.138 . . . . 0.0 110.45 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HA ' HD11 ' B' ' 38' ' ' ILE . 82.8 p -168.47 75.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -151.09 41.09 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.794 ' OG1' HG21 ' A' ' 45' ' ' ILE . 42.6 m -132.77 149.65 52.25 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.705 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.695 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -124.31 153.98 40.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.48 -0.762 . . . . 0.0 110.782 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.739 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.5 p90 -143.84 166.04 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.33 -0.856 . . . . 0.0 110.063 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.81 138.87 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.72 132.83 44.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.058 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.58 108.01 18.86 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 110.234 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 t -133.95 49.9 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.26 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -171.88 43.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.709 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -129.27 21.59 5.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.249 -1.148 . . . . 0.0 110.029 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.3 p -93.06 6.7 47.02 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.239 -0.913 . . . . 0.0 110.488 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.502 ' CB ' HD11 ' A' ' 66' ' ' ILE . 6.0 mtt -151.99 21.13 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.917 -1.114 . . . . 0.0 110.345 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 ' CB ' ' A' ' 59' ' ' ASP . 15.8 mt -56.67 -24.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.012 -1.055 . . . . 0.0 108.723 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.2 p30 -50.32 -27.04 5.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.437 -0.79 . . . . 0.0 109.26 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.67 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -90.76 -39.07 5.94 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 150.64 -19.86 1.02 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.257 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.033 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 pp -69.85 107.97 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.26 . . . . 0.0 110.495 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.0 t -131.33 66.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.032 -1.043 . . . . 0.0 110.333 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.9 t0 40.76 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.734 -0.604 . . . . 0.0 111.848 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.86 55.79 0.51 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.419 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -174.47 174.73 2.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -1.188 . . . . 0.0 110.025 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.748 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.5 tm? -127.43 121.19 30.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.138 -0.976 . . . . 0.0 110.209 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 66' ' ' ILE . 6.4 tt -85.7 144.67 27.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.481 -0.762 . . . . 0.0 110.616 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.7 mm -134.48 98.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 110.171 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 52' ' ' TYR . 13.8 p -100.87 155.93 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 109.62 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.708 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.0 m-20 -115.13 99.63 7.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.928 -1.107 . . . . 0.0 110.876 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.1 p -82.06 101.3 10.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 109.685 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.65 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.154 -0.966 . . . . 0.0 110.419 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.533 ' HB ' HG11 ' A' ' 130' ' ' VAL . 3.1 mp -94.84 170.29 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 78' ' ' ILE . 98.4 m -99.02 123.47 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -74.14 -152.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 110.363 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.36 149.18 34.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.908 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.4 m-70 -57.91 144.09 40.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 37.99 10.95 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.4 m-20 -149.95 144.91 26.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -1.03 . . . . 0.0 109.478 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.829 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.2 tt -65.96 79.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.248 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.949 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.8 m -120.29 162.85 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.809 . . . . 0.0 109.821 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.7 OUTLIER -91.11 127.37 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 110.362 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -91.06 167.54 12.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 132.1 13.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.849 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.9 p -152.55 123.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.26 23.52 5.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -0.916 . . . . 0.0 110.461 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.86 33.43 7.39 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 94' ' ' PHE . 1.9 mt-10 -105.94 162.36 13.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -1.173 . . . . 0.0 110.556 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 34.4 m-85 -139.95 110.67 6.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.368 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.869 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 59.2 p -114.14 164.2 14.18 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.131 -0.98 . . . . 0.0 109.949 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.455 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.8 t -132.21 95.28 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.216 -0.927 . . . . 0.0 110.169 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER 175.96 176.97 0.23 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.911 -1.118 . . . . 0.0 110.342 179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.95 113.73 24.8 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.405 -0.809 . . . . 0.0 109.126 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 101' ' ' LEU . 1.3 pt? -115.43 152.53 32.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.012 . . . . 0.0 111.041 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.669 ' O ' HD23 ' A' ' 101' ' ' LEU . 40.5 mt-30 -116.21 130.74 56.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 99' ' ' LEU . 25.5 mt -125.01 -10.41 7.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 110.87 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.529 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 2.9 mpp_? -81.9 -59.98 0.41 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.959 -1.088 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.529 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.72 -52.41 2.38 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.84 157.46 42.94 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 105' ' ' VAL . 33.7 m -88.37 101.4 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.009 . . . . 0.0 110.384 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -143.06 143.12 31.75 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.129 -0.982 . . . . 0.0 110.665 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.786 HD12 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -145.22 149.07 34.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.458 -0.776 . . . . 0.0 109.905 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.598 HD11 ' N ' ' A' ' 115' ' ' SER . 1.7 tp -152.51 84.49 4.69 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.09 -1.006 . . . . 0.0 111.146 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -70.59 -157.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.113 1.059 . . . . 0.0 109.714 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 68.04 152.13 0.08 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.356 -0.84 . . . . 0.0 111.079 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.418 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 25.0 t-20 -96.9 -80.32 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.84 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.3 p -78.22 -39.26 41.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.142 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.83 59.05 5.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.86 . . . . 0.0 109.732 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.511 ' C ' HD11 ' A' ' 108' ' ' ILE . 44.3 p90 -69.41 120.4 15.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 110.823 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.598 ' N ' HD11 ' A' ' 108' ' ' ILE . 1.8 m -112.96 93.44 24.86 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.305 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.3 Cg_exo -58.52 124.38 15.68 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 O-C-N 123.158 1.083 . . . . 0.0 110.735 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.5 tp -138.39 131.13 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.353 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.441 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -89.04 149.4 23.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 110.078 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 120' ' ' SER . 3.4 mt -98.04 166.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' A' ' 119' ' ' ILE . 12.4 t -55.85 -173.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.957 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.4 t -67.18 74.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.16 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER 52.81 53.33 12.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.318 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -69.7 -80.64 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.227 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.655 ' O ' HG23 ' A' ' 90' ' ' VAL . 16.1 m -148.18 81.42 1.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.962 . . . . 0.0 110.338 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -127.92 109.42 11.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.17 151.38 37.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.029 . . . . 0.0 110.633 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 80' ' ' ALA . 66.2 t -71.09 152.91 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.812 . . . . 0.0 110.243 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.56 -62.73 1.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -94.37 -143.94 15.0 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.829 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.4 p -152.19 17.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -1.184 . . . . 0.0 110.98 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.762 ' C ' HD12 ' A' ' 132' ' ' ILE . 13.4 p -173.73 168.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.914 -1.116 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.7 mp -151.25 80.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.483 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -66.92 133.1 49.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.718 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 65' ' ' GLY . 89.1 t -102.08 120.48 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.479 -0.763 . . . . 0.0 109.795 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' B' ' 135' ' ' VAL . 39.8 t -99.54 98.25 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.997 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.42 11.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.454 -0.778 . . . . 0.0 110.047 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.9 105.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.51 102.94 9.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.12 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.711 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.179 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.185 0.516 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -125.81 71.57 67.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.26 -160.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.308 1.162 . . . . 0.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.2 m -155.4 81.55 4.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.66 105.58 0.37 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 O-C-N 123.278 1.147 . . . . 0.0 110.527 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.77 149.55 26.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.225 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 167.42 22.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.283 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.4 -30.66 23.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.902 . . . . 0.0 110.233 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -77.29 75.82 3.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 110.279 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 34' ' ' VAL . 34.1 m -72.64 154.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -119.59 151.34 38.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 110.379 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -104.88 -141.93 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.704 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -174.24 -179.98 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.795 -1.191 . . . . 0.0 110.392 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 49' ' ' SER . 6.5 tt -121.03 31.59 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.084 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.18 92.51 3.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -75.43 -40.29 57.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 0.0 110.349 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.864 ' HA ' HD22 ' A' ' 40' ' ' LEU . 11.8 p30 -50.93 -34.78 30.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.012 . . . . 0.0 109.801 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -23.73 21.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 108.824 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.97 -67.52 0.41 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.807 -0.558 . . . . 0.0 110.297 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.748 ' CD1' HD12 ' A' ' 71' ' ' LEU . 1.7 mm? -73.97 -30.31 62.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.107 -0.996 . . . . 0.0 110.002 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 40' ' ' LEU . 1.7 mt -110.34 -149.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.455 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.72 30.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.853 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -134.89 159.54 71.76 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.265 -0.897 . . . . 0.0 110.026 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.96 -48.12 7.23 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.323 1.17 . . . . 0.0 110.484 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 83.2 p -168.49 75.55 0.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.902 . . . . 0.0 110.066 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.677 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.67 41.21 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.793 ' OG1' HG21 ' B' ' 45' ' ' ILE . 42.8 m -132.79 149.72 52.24 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.704 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -124.33 154.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 110.682 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.718 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.4 p90 -143.93 166.11 25.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 0.0 110.042 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.2 p -155.84 138.66 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.942 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.439 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.61 132.79 44.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 110.031 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -87.75 108.35 19.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -134.12 49.99 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -171.75 43.2 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.712 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -129.48 21.91 5.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -1.146 . . . . 0.0 110.028 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 82.9 p -93.27 6.46 48.01 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.902 . . . . 0.0 110.504 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.483 ' CB ' HD11 ' B' ' 66' ' ' ILE . 5.9 mtt -151.83 20.99 0.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.712 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.8 mt -56.57 -24.61 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.906 -1.121 . . . . 0.0 108.822 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.2 p30 -50.42 -26.91 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.28 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.661 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -90.74 -39.04 5.96 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 150.63 -19.99 1.02 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 1.035 HG23 HD12 ' B' ' 72' ' ' LEU . 1.8 pp -69.79 108.07 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 12.5 t -131.29 66.71 1.53 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.068 -1.02 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 29.7 t0 40.71 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.746 -0.597 . . . . 0.0 111.907 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.78 55.59 0.51 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.76 -1.21 . . . . 0.0 110.51 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.418 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.0 p30 -174.3 175.01 2.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -1.187 . . . . 0.0 110.067 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.5 tm? -127.79 121.29 29.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.187 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 1.035 HD12 HG23 ' B' ' 66' ' ' ILE . 6.4 tt -85.95 144.66 27.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.472 -0.768 . . . . 0.0 110.591 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.845 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -134.48 98.96 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.939 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 13.6 p -100.86 155.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.29 -0.882 . . . . 0.0 109.642 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.724 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.7 m-20 -114.89 99.58 7.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.944 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.435 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 58.5 p -82.0 101.1 10.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.789 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.677 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.61 -54.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 110.51 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.531 ' HB ' HG11 ' B' ' 130' ' ' VAL . 3.1 mp -94.93 170.26 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.25 -0.906 . . . . 0.0 110.462 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 98.3 m -99.11 123.31 43.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.428 -0.795 . . . . 0.0 110.153 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.929 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -73.87 -152.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 110.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -145.42 149.03 33.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -57.73 144.14 39.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.84 38.07 10.9 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.473 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.4 m-20 -150.02 144.85 26.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.846 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.0 tt -65.84 79.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 110.33 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.929 HG11 ' HB1' ' B' ' 80' ' ' ALA . 31.8 m -120.39 163.11 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -91.27 126.99 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.455 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.722 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.74 167.04 12.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 109.954 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.57 132.12 13.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.55 124.92 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.543 -0.723 . . . . 0.0 109.939 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.3 24.99 5.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.955 . . . . 0.0 110.593 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.42 32.97 7.84 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 3.3 mm-40 -107.44 164.81 11.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -1.136 . . . . 0.0 110.236 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.437 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 37.4 m-85 -148.94 104.71 3.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.197 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.75 HG21 HD21 ' B' ' 107' ' ' LEU . 20.6 p -109.42 169.23 8.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.195 -0.94 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.1 t -130.95 100.55 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.115 -0.99 . . . . 0.0 110.401 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 2.5 mmtt 173.51 173.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.993 -1.067 . . . . 0.0 110.386 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.14 117.16 24.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.376 -0.827 . . . . 0.0 109.044 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.841 HD12 HD21 ' B' ' 101' ' ' LEU . 1.4 pt? -119.25 153.43 35.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.036 -1.04 . . . . 0.0 111.147 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.673 ' O ' HD23 ' B' ' 101' ' ' LEU . 22.5 mt-30 -116.07 131.92 56.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.841 HD21 HD12 ' B' ' 99' ' ' LEU . 29.7 mt -126.04 -10.74 6.53 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.929 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.547 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -82.36 -59.6 0.41 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.948 -1.095 . . . . 0.0 110.312 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.4 -53.54 1.39 Allowed 'Trans proline' 0 C--N 1.323 -0.781 0 N-CA-C 109.028 -1.182 . . . . 0.0 109.028 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.04 152.43 33.45 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.662 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -83.27 100.74 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.161 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.45 141.15 39.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.75 HD21 HG21 ' B' ' 95' ' ' THR . 1.9 tp -142.26 148.31 37.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.398 -0.814 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.459 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -154.71 78.82 4.91 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.045 -1.034 . . . . 0.0 111.145 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' B' ' 97' ' ' LYS . 2.5 Cg_endo -69.17 -156.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.047 1.025 . . . . 0.0 109.864 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.409 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 68.37 152.8 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.392 -0.817 . . . . 0.0 110.904 178.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.4 t30 -98.77 -82.31 0.43 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.422 -0.799 . . . . 0.0 109.858 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 85.1 p -77.58 -40.49 42.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 110.117 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.23 57.13 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' B' ' 114' ' ' TYR . 46.8 p90 -74.61 131.05 40.6 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.774 0.797 . . . . 0.0 111.079 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.459 ' C ' HD13 ' B' ' 108' ' ' ILE . 5.8 m -131.1 93.13 31.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.17 132.22 47.88 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 O-C-N 123.124 1.065 . . . . 0.0 111.225 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.29 141.28 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.782 . . . . 0.0 109.948 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.425 ' H ' HG22 ' B' ' 118' ' ' THR . 8.2 t -93.43 148.81 21.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.513 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -99.15 169.43 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.094 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.513 ' N ' HG22 ' B' ' 119' ' ' ILE . 10.1 t -57.25 -174.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.2 t -66.96 73.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' B' ' 120' ' ' SER . 0.7 OUTLIER 53.35 53.37 11.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -80.52 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.663 ' O ' HG23 ' B' ' 90' ' ' VAL . 14.9 m -148.27 81.42 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -127.93 109.3 11.45 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.893 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -146.11 151.42 37.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 110.636 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' B' ' 80' ' ' ALA . 64.4 t -71.25 152.93 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 110.27 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.49 -62.8 1.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 110.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -94.36 -144.02 15.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.854 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 11.3 p -152.15 17.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -1.193 . . . . 0.0 110.988 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' B' ' 132' ' ' ILE . 13.5 p -173.61 168.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.907 -1.121 . . . . 0.0 111.175 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.846 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.7 mp -151.18 80.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -66.88 133.14 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 110.69 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.441 HG22 ' HA3' ' B' ' 65' ' ' GLY . 88.0 t -102.02 120.43 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 135' ' ' VAL . 39.5 t -99.52 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.76 106.4 11.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 0.0 109.995 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.466 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.92 105.37 0.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.53 102.87 9.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.718 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.178 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -56.66 148.86 44.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.149 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.78 119.25 6.24 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 O-C-N 123.109 1.057 . . . . 0.0 110.394 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.499 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -63.62 -53.83 47.89 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 110.474 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 28' ' ' SER . 2.9 Cg_endo -62.49 104.07 0.35 Allowed 'Trans proline' 0 N--CA 1.484 0.914 0 O-C-N 122.939 0.968 . . . . 0.0 110.541 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.23 -80.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.03 73.31 0.83 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.938 . . . . 0.0 110.222 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.55 148.22 30.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.53 164.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.124 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 34' ' ' VAL . 9.8 p -144.59 51.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 93.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -96.26 -57.94 2.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -174.19 127.76 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 110.368 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tp -86.68 145.49 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.0 110.075 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.1 t70 -91.44 19.84 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.333 -0.854 . . . . 0.0 109.801 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD13 ' CB ' ' B' ' 41' ' ' ASN . 0.3 OUTLIER -51.14 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.995 -1.065 . . . . 0.0 110.423 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.922 ' CB ' HD13 ' B' ' 40' ' ' LEU . 5.8 p-10 -64.01 -20.8 66.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.006 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.11 -15.38 53.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.648 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -118.91 -28.35 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 0.0 110.65 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' B' ' 44' ' ' LEU . 1.6 mp -89.18 -26.64 21.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 0.0 109.643 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' B' ' 40' ' ' LEU . 8.5 mt -145.33 -133.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.314 -0.866 . . . . 0.0 108.879 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -176.16 -57.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.386 -1.446 . . . . 0.0 110.592 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 32.1 m80 -52.75 138.95 42.09 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 0.0 110.173 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.65 -39.65 33.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 122.96 0.979 . . . . 0.0 110.271 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.3 t -157.95 43.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.383 -0.823 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -127.87 36.26 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.565 HG21 HG21 ' A' ' 45' ' ' ILE . 35.5 m -133.14 131.06 40.02 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.728 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -103.68 151.58 22.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 109.912 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.1 p90 -142.76 164.47 30.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.862 . . . . 0.0 109.934 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 8.3 p -155.3 139.49 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.63 130.15 39.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.125 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -87.79 102.88 15.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.405 -0.809 . . . . 0.0 110.235 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.5 t -134.96 58.66 1.76 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 110.214 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.95 -137.36 3.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.663 ' CB ' HD11 ' A' ' 62' ' ' ILE . 10.7 p-10 -166.99 29.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -1.088 . . . . 0.0 109.77 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.3 p -93.63 -1.51 55.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.458 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -155.69 32.33 0.36 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.008 -1.058 . . . . 0.0 109.854 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.751 HD12 ' OD1' ' A' ' 111' ' ' ASN . 6.7 mt -53.21 -24.53 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.1 p30 -48.09 -32.33 6.66 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.579 0.704 . . . . 0.0 109.732 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.877 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -86.13 -30.87 21.61 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.8 -19.24 3.14 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.576 -1.297 . . . . 0.0 109.87 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.037 HG23 HD12 ' A' ' 72' ' ' LEU . 1.7 pp -68.34 101.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.188 -1.183 . . . . 0.0 110.281 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -128.6 66.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.0 -1.063 . . . . 0.0 110.329 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 39.75 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.762 -0.586 . . . . 0.0 111.836 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.61 48.68 0.25 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.267 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -173.72 177.5 2.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.103 -1.234 . . . . 0.0 110.363 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -129.1 123.78 33.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 66' ' ' ILE . 6.8 tt -88.91 150.28 22.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.748 . . . . 0.0 110.418 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 72' ' ' LEU . 17.6 mm -138.85 98.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -98.5 148.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.2 m-20 -105.14 98.22 7.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.074 . . . . 0.0 110.758 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 73.6 p -83.8 101.49 11.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.719 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.94 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.91 . . . . 0.0 110.19 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 79' ' ' THR . 3.2 mt -112.66 163.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.3 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 78' ' ' ILE . 21.3 m -92.1 122.1 34.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.883 . . . . 0.0 110.118 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.74 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -69.15 -149.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.254 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.32 149.23 34.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.864 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.486 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.7 m-70 -61.11 143.25 55.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.02 36.14 7.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -158.09 155.21 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.567 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.877 HD11 ' HA2' ' A' ' 64' ' ' GLY . 10.0 tt -72.47 89.43 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.997 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.74 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.0 m -120.04 163.01 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.782 . . . . 0.0 110.017 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.728 HD11 ' CD2' ' A' ' 94' ' ' PHE . 0.8 OUTLIER -89.76 115.34 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.099 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.17 156.5 18.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.922 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.41 135.52 22.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.238 -0.914 . . . . 0.0 110.545 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.866 ' HB ' HD22 ' A' ' 125' ' ' LEU . 3.7 p -152.8 122.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.682 -0.637 . . . . 0.0 109.747 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 53.87 21.19 2.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.9 33.37 5.55 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.163 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.9 mt-10 -105.98 163.31 12.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.728 ' CD2' HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -143.86 105.94 4.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 109.992 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 41.8 p -126.87 155.39 43.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 110.502 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.825 HG11 ' HA3' ' A' ' 64' ' ' GLY . 26.1 t -125.97 108.67 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HD3' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.14 164.77 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 110.19 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -76.75 89.82 3.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.228 -0.92 . . . . 0.0 109.113 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.4 pt? -94.31 149.87 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 111.121 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.733 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.1 mt-30 -120.96 130.95 54.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.4 -0.813 . . . . 0.0 108.869 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 100' ' ' GLN . 21.3 mt -126.22 -10.03 6.43 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.949 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.77 -58.58 0.72 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.861 -1.149 . . . . 0.0 109.961 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.17 -54.3 1.15 Allowed 'Trans proline' 0 C--N 1.323 -0.787 0 N-CA-C 108.659 -1.323 . . . . 0.0 108.659 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.3 m -151.32 151.45 31.81 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -82.14 103.49 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.125 -0.984 . . . . 0.0 110.083 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -150.86 144.73 25.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.455 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HD3' ' A' ' 97' ' ' LYS . 3.2 tp -117.77 156.6 28.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -146.27 109.89 4.27 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.877 -1.139 . . . . 0.0 111.818 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.92 159.41 38.23 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -132.21 -26.68 1.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.659 -1.275 . . . . 0.0 111.754 -178.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.751 ' OD1' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -46.82 -68.81 0.16 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.914 -1.116 . . . . 0.0 110.335 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.0 p -156.66 -36.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.0 110.47 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.52 59.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.0 109.824 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.9 p90 -62.24 127.53 31.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 0.0 110.331 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.3 m -162.54 92.04 1.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.923 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.89 121.21 9.47 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 O-C-N 123.286 1.15 . . . . 0.0 110.778 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -129.47 150.64 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 110.013 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 7.5 t -99.17 157.47 16.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 120' ' ' SER . 48.2 mm -88.7 170.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.99 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 119' ' ' ILE . 4.8 t -72.82 76.53 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.09 -1.007 . . . . 0.0 110.274 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.8 t 53.47 51.93 14.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.604 ' CB ' HG11 ' A' ' 105' ' ' VAL . 2.5 tt0 51.67 42.7 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.591 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -76.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 0.0 109.965 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 90' ' ' VAL . 83.1 m -148.02 81.73 1.49 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.033 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.866 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -125.3 104.62 8.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -146.37 149.78 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.56 149.98 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.156 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.91 -29.14 12.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.389 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.96 -149.4 8.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 8.9 p -147.02 13.04 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.151 -1.205 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.817 HG12 ' HB2' ' A' ' 75' ' ' ASP . 13.3 p -172.69 168.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.143 . . . . 0.0 111.382 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.8 mp -147.85 84.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.676 ' CD2' ' HB1' ' B' ' 137' ' ' ALA . 44.5 m170 -80.2 112.58 17.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.942 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.1 p -84.52 146.54 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.913 . . . . 0.0 109.411 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.1 HG13 HG22 ' B' ' 135' ' ' VAL . 39.9 t -123.66 104.56 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.021 -1.05 . . . . 0.0 110.398 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -87.05 106.65 18.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.106 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' HB1' ' CD2' ' B' ' 133' ' ' HIS . . . -79.89 112.9 17.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.74 114.89 23.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.777 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.165 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -80.68 159.53 68.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.16 171.37 4.04 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.288 1.152 . . . . 0.0 110.491 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -143.02 71.8 18.54 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.248 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.58 123.52 12.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.285 1.15 . . . . 0.0 110.496 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.48 49.73 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.925 . . . . 0.0 110.283 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -152.81 152.89 32.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.91 . . . . 0.0 110.239 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.94 28.87 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.252 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -114.4 56.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.08 -67.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.179 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.15 71.78 10.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.141 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -95.36 -39.8 9.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -104.15 110.47 22.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.193 -0.942 . . . . 0.0 110.283 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 39' ' ' ASP . 0.6 OUTLIER -72.91 150.21 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.446 ' O ' HD23 ' B' ' 43' ' ' LEU . 3.1 t70 -91.23 20.2 5.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.201 -0.937 . . . . 0.0 109.903 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.922 HD13 ' CB ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -50.97 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.954 -1.091 . . . . 0.0 110.54 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.927 ' CB ' HD13 ' A' ' 40' ' ' LEU . 6.0 p-10 -63.51 -21.25 66.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.94 -1.1 . . . . 0.0 110.159 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.79 -15.73 53.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 110.942 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.652 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -118.63 -28.0 5.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 44' ' ' LEU . 1.6 mp -89.48 -26.49 20.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.15 -0.969 . . . . 0.0 109.78 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.713 HD12 ' CG ' ' A' ' 40' ' ' LEU . 8.4 mt -145.54 -133.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.259 -0.901 . . . . 0.0 108.906 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.438 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -176.27 -57.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.433 -1.417 . . . . 0.0 110.658 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.716 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 32.0 m80 -52.92 138.93 43.89 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -39.96 33.06 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 O-C-N 123.001 1.0 . . . . 0.0 110.216 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.4 t -157.71 43.89 0.33 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -127.85 36.05 4.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.57 HG21 HG21 ' B' ' 45' ' ' ILE . 37.3 m -132.93 130.79 40.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.758 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.668 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -103.36 151.49 22.69 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.493 -0.755 . . . . 0.0 110.01 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.721 ' HB3' HD13 ' B' ' 73' ' ' ILE . 6.2 p90 -142.84 164.39 30.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 109.967 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 8.3 p -155.21 139.62 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 109.957 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.72 130.49 40.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -88.03 102.96 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.371 -0.831 . . . . 0.0 110.221 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 4.3 t -134.93 58.56 1.76 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.265 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.95 -138.69 3.49 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.678 ' CB ' HD11 ' B' ' 62' ' ' ILE . 10.5 p-10 -165.57 28.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.714 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 110' ' ' MET . 32.4 p -93.1 -1.73 56.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.472 -0.768 . . . . 0.0 110.517 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.469 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.2 OUTLIER -154.57 31.02 0.42 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.046 -1.034 . . . . 0.0 110.203 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.678 HD11 ' CB ' ' B' ' 59' ' ' ASP . 6.6 mt -53.42 -24.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.926 -1.109 . . . . 0.0 108.432 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 1.6 p30 -48.61 -32.67 8.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.515 -0.741 . . . . 0.0 109.265 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.847 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -85.02 -31.52 23.06 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.73 3.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 1.038 HG23 HD12 ' B' ' 72' ' ' LEU . 1.7 pp -68.06 101.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.178 -1.189 . . . . 0.0 110.349 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.5 t -128.72 66.27 1.41 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 110.383 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 1.6 t70 39.57 86.34 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.818 -0.551 . . . . 0.0 111.897 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 48.99 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.281 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -173.88 177.44 2.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.134 -1.215 . . . . 0.0 110.173 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.713 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.0 OUTLIER -128.95 123.94 33.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.143 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 1.038 HD12 HG23 ' B' ' 66' ' ' ILE . 6.9 tt -89.06 150.22 22.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.385 -0.822 . . . . 0.0 110.353 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 17.4 mm -138.83 98.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.007 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.668 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -98.44 148.51 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.523 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.838 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.2 m-20 -105.16 98.18 7.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.028 . . . . 0.0 110.762 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 74.0 p -83.76 101.53 11.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.422 -0.799 . . . . 0.0 109.694 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.726 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.9 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.31 -0.869 . . . . 0.0 110.199 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 79' ' ' THR . 3.2 mt -112.9 164.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 78' ' ' ILE . 21.1 m -92.09 122.12 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 110.195 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.752 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -69.34 -149.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.218 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.3 148.88 33.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.7 m-70 -60.92 143.15 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 110.153 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.444 ' HA2' ' CG ' ' B' ' 98' ' ' LYS . . . 91.0 35.25 7.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -157.93 157.04 32.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -1.129 . . . . 0.0 109.7 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.847 HD11 ' HA2' ' B' ' 64' ' ' GLY . 10.0 tt -73.95 89.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.121 -0.987 . . . . 0.0 109.949 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.752 HG11 ' HB1' ' B' ' 80' ' ' ALA . 30.0 m -120.04 162.84 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.8 . . . . 0.0 110.032 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.64 115.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.038 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.952 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.41 155.1 19.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.984 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.6 135.97 25.4 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' B' ' 125' ' ' LEU . 3.6 p -152.76 123.15 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.61 -0.681 . . . . 0.0 109.74 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 55.06 20.22 3.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.62 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.01 33.46 5.49 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.321 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 22.2 mm-40 -106.12 159.11 16.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.051 -1.264 . . . . 0.0 110.707 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -129.9 91.95 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 1.022 HG21 HD11 ' B' ' 107' ' ' LEU . 29.0 m -95.13 154.58 17.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.363 -0.836 . . . . 0.0 110.715 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' B' ' 64' ' ' GLY . 10.9 t -136.21 98.55 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.828 . . . . 0.0 109.622 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' B' ' 109' ' ' PRO . 0.1 OUTLIER 174.2 173.7 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.787 -1.196 . . . . 0.0 110.454 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.444 ' CG ' ' HA2' ' B' ' 83' ' ' GLY . 0.1 OUTLIER -82.56 112.12 19.17 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.726 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -120.8 153.47 37.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.134 -0.979 . . . . 0.0 111.057 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.649 ' O ' HD23 ' B' ' 101' ' ' LEU . 44.5 mt-30 -120.73 130.31 54.0 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.451 -0.78 . . . . 0.0 109.003 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.67 HD21 HD12 ' B' ' 99' ' ' LEU . 22.0 mt -125.43 -12.83 6.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 110.836 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.17 -58.93 0.94 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.943 -1.098 . . . . 0.0 110.081 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.47 -52.17 2.74 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 4.2 m -150.84 160.21 44.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.0 m -88.94 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.046 -1.034 . . . . 0.0 110.296 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -141.98 137.23 31.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.62 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 1.022 HD11 HG21 ' B' ' 95' ' ' THR . 1.4 tp -139.25 148.61 43.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.635 -0.666 . . . . 0.0 109.715 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.6 HD11 ' N ' ' B' ' 115' ' ' SER . 2.1 tp -154.8 80.37 4.51 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.115 -0.99 . . . . 0.0 111.394 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.776 ' HG3' HG23 ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.84 -153.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.096 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' B' ' 60' ' ' SER . 2.2 mmt 71.58 156.38 0.16 Allowed 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.766 0.794 . . . . 0.0 111.523 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.432 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 7.5 t30 -104.98 -71.56 0.74 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.434 0.635 . . . . 0.0 109.448 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -90.54 -30.74 17.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.378 -0.826 . . . . 0.0 109.805 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.92 57.73 3.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.7 p90 -62.85 120.19 10.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -0.821 . . . . 0.0 110.999 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.6 ' N ' HD11 ' B' ' 108' ' ' ILE . 49.6 m -122.25 90.67 49.15 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.41 -0.806 . . . . 0.0 109.416 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.464 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.3 Cg_exo -57.77 123.16 13.07 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 123.265 1.139 . . . . 0.0 110.861 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.421 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.5 OUTLIER -140.49 132.91 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 118' ' ' THR . 7.6 t -86.2 160.71 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.848 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.416 ' CD1' ' HG ' ' B' ' 125' ' ' LEU . 28.4 mm -88.33 165.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.233 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 5.5 t -74.53 77.14 1.96 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t 53.94 51.43 14.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.855 . . . . 0.0 110.162 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.64 ' HB2' HG11 ' B' ' 105' ' ' VAL . 2.4 tt0 51.96 42.86 30.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 110.525 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.47 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' B' ' 90' ' ' VAL . 81.9 m -148.16 81.83 1.48 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.893 . . . . 0.0 110.058 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -125.41 104.54 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 110.248 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -146.23 149.83 34.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.72 149.92 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.365 -0.834 . . . . 0.0 110.149 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -101.96 -28.95 12.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.16 -149.56 8.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 8.8 p -146.96 13.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -1.224 . . . . 0.0 111.188 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.838 HG12 ' HB2' ' B' ' 75' ' ' ASP . 13.1 p -172.67 169.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.974 -1.078 . . . . 0.0 111.304 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.765 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.8 mp -148.03 84.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.655 ' CD2' ' HB1' ' A' ' 137' ' ' ALA . 44.0 m170 -80.15 112.63 17.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.966 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.44 HG12 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -84.71 146.46 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.328 -0.858 . . . . 0.0 109.357 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 135' ' ' VAL . 39.8 t -123.58 104.51 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 110.377 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.425 ' O ' HG12 ' A' ' 134' ' ' VAL . 5.6 ttmt -86.97 106.76 18.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 110.085 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.676 ' HB1' ' CD2' ' A' ' 133' ' ' HIS . . . -80.04 112.91 17.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.73 114.82 23.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.867 . . . . 0.0 110.181 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.785 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.163 0.506 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 53.38 78.14 0.41 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.349 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.4 166.13 11.84 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.305 1.161 . . . . 0.0 110.46 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -55.85 -54.42 52.21 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.545 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -61.28 114.17 2.09 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 O-C-N 122.766 0.877 . . . . 0.0 110.513 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.93 98.18 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.144 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.27 110.01 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.77 108.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.293 -0.88 . . . . 0.0 110.184 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -163.72 46.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.213 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.8 117.96 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -80.33 166.92 20.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.34 -148.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 mtp85 -141.48 -174.76 4.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.025 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.807 HG23 ' HE2' ' B' ' 53' ' ' PHE . 43.7 mm -86.46 103.89 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.396 -0.815 . . . . 0.0 109.924 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -92.28 42.77 1.11 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.083 -1.011 . . . . 0.0 109.666 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.1 pp -45.63 -40.78 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.548 -0.72 . . . . 0.0 110.821 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.803 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.7 p-10 -58.8 -32.85 69.72 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.15 -31.36 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 111.025 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.627 HD11 ' CD1' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.44 -35.44 27.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 110.866 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 HD11 ' B' ' 73' ' ' ILE . 2.5 mp -92.58 -32.82 14.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.997 -1.065 . . . . 0.0 109.949 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.72 HD12 HD22 ' B' ' 40' ' ' LEU . 96.7 mt -121.07 170.43 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 109.787 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.534 ' N ' HG22 ' A' ' 45' ' ' ILE . 28.7 mm-40 -124.93 -34.63 2.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.933 -1.104 . . . . 0.0 110.755 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.819 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 35.6 m80 -91.3 143.95 29.05 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.18 -36.57 46.27 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.074 1.039 . . . . 0.0 110.102 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -155.61 42.51 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 109.776 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.819 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -130.09 35.26 4.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.388 -0.82 . . . . 0.0 109.99 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 35.8 m -133.9 123.97 25.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.676 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.67 151.66 19.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.298 -0.876 . . . . 0.0 109.874 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HB3' HD13 ' A' ' 73' ' ' ILE . 5.8 p90 -143.18 161.6 37.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.53 132.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.65 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.57 134.77 45.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.023 . . . . 0.0 110.251 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' N ' ' HE3' ' A' ' 55' ' ' LYS . . . -88.86 110.14 20.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.16 51.06 2.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.89 -150.58 9.32 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.603 ' HB2' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -149.03 25.35 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -1.146 . . . . 0.0 109.87 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.13 -2.35 46.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.0 110.703 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.435 ' H ' HD11 ' A' ' 66' ' ' ILE . 3.8 mtt -142.97 25.31 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.952 -1.092 . . . . 0.0 110.33 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 59' ' ' ASP . 19.6 mt -57.13 -23.6 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.898 -1.126 . . . . 0.0 108.963 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 29.7 p30 -52.22 -24.9 7.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.73 -38.26 5.57 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.2 -19.64 1.2 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.318 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.992 HG23 HD12 ' A' ' 72' ' ' LEU . 2.0 pp -70.87 111.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.248 . . . . 0.0 110.576 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -131.4 66.11 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.056 -1.028 . . . . 0.0 110.338 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.36 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.844 -0.535 . . . . 0.0 112.042 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.03 49.47 0.25 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.236 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.2 p30 -174.13 171.98 3.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.234 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.1 tm? -124.3 125.48 44.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.992 HD12 HG23 ' A' ' 66' ' ' ILE . 6.5 tt -90.91 149.9 21.72 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.305 -0.872 . . . . 0.0 110.921 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 72' ' ' LEU . 18.9 mm -140.71 100.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.016 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.6 p -99.66 146.74 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 5.6 m-20 -102.73 98.93 8.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.992 -1.068 . . . . 0.0 110.831 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.423 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 53.9 p -83.96 101.66 11.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.81 -40.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 79' ' ' THR . 4.0 mt -114.28 167.61 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.452 -0.78 . . . . 0.0 110.217 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.478 ' N ' HG22 ' A' ' 78' ' ' ILE . 90.2 m -100.52 113.78 26.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.034 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.866 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -62.19 -149.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.33 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.4 149.74 44.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.454 ' HE1' HD12 ' A' ' 101' ' ' LEU . 93.4 m-70 -54.9 141.82 31.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 110.186 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.4 37.57 9.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 23.9 m-20 -148.16 142.04 25.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -1.054 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' A' ' 64' ' ' GLY . 8.8 tt -64.43 82.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 110.052 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.863 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.3 m -123.9 166.78 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.583 -0.698 . . . . 0.0 109.833 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -95.95 125.23 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.468 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.862 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.83 167.76 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.141 -0.974 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.21 134.53 15.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 111.086 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.6 p -152.69 120.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.704 -0.622 . . . . 0.0 109.654 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.98 30.46 11.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.898 . . . . 0.0 110.973 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 33.27 8.57 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 15.7 mt-10 -110.2 164.92 12.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -1.218 . . . . 0.0 110.123 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 87' ' ' ILE . 44.6 m-85 -150.33 105.51 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.067 -1.021 . . . . 0.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.862 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.4 p -104.71 168.91 8.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.711 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -133.88 94.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.15 -0.969 . . . . 0.0 110.575 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.1 OUTLIER 178.94 176.5 0.55 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.899 -1.126 . . . . 0.0 110.702 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 96.06 9.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 109.201 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.715 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -95.59 147.18 23.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 0.0 111.258 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' A' ' 101' ' ' LEU . 6.3 mt-30 -119.68 134.47 55.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.506 -0.746 . . . . 0.0 109.032 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 100' ' ' GLN . 19.5 mt -130.3 -9.03 4.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 111.004 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.546 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -80.58 -59.55 0.5 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.837 -1.164 . . . . 0.0 110.208 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -62.85 -53.44 1.65 Allowed 'Trans proline' 0 C--N 1.323 -0.815 0 N-CA-C 109.069 -1.166 . . . . 0.0 109.069 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 105' ' ' VAL . 32.3 m -150.98 166.39 30.83 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG11 ' N ' ' A' ' 122' ' ' GLU . 34.4 m -91.04 99.96 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 0.0 110.053 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.98 141.34 34.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.156 -0.965 . . . . 0.0 110.851 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 95' ' ' THR . 0.5 OUTLIER -144.37 142.93 30.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.443 -0.786 . . . . 0.0 109.416 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.701 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.8 OUTLIER -151.04 78.66 7.19 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.935 -1.103 . . . . 0.0 111.65 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -71.09 -155.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.054 1.028 . . . . 0.0 109.561 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.1 150.96 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.205 -0.934 . . . . 0.0 110.888 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 6.1 t30 -98.86 -72.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.469 -0.769 . . . . 0.0 109.713 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 87.8 p -83.5 -33.77 25.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.86 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.07 55.6 3.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.517 ' CA ' HD11 ' A' ' 108' ' ' ILE . 49.5 p90 -68.56 121.7 16.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.42 -0.8 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 108' ' ' ILE . 3.1 m -128.25 82.25 68.89 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.443 -0.786 . . . . 0.0 109.257 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.63 128.55 26.17 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.405 1.213 . . . . 0.0 111.438 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 117' ' ' ILE . 6.4 tt -140.67 136.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.489 -0.757 . . . . 0.0 109.943 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 105' ' ' VAL . 8.9 t -83.35 147.93 27.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.221 -0.925 . . . . 0.0 110.038 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.57 HG21 HD23 ' A' ' 125' ' ' LEU . 3.2 mt -85.89 168.8 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.169 -0.957 . . . . 0.0 110.274 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 15.1 m -73.37 84.86 1.46 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 110.526 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.68 47.68 24.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 110.614 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.745 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER 51.56 50.42 18.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 110.463 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.94 -74.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 110.086 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.701 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.8 m -148.02 81.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.074 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 124' ' ' THR . 3.0 mm? -125.37 113.63 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.154 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -146.34 159.09 43.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.424 HG11 ' HB ' ' A' ' 86' ' ' VAL . 33.2 t -80.56 147.08 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -0.858 . . . . 0.0 110.361 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -32.91 13.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.99 -152.96 9.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.866 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -146.84 14.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -1.224 . . . . 0.0 111.009 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.758 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -173.44 169.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -148.98 85.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 23.1 m80 -66.79 110.4 3.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.498 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.11 119.76 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.993 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 135' ' ' VAL . 48.8 t -102.04 97.95 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -0.883 . . . . 0.0 110.054 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.13 105.14 16.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.384 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -61.86 107.15 0.79 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -114.12 108.36 16.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.344 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.225 0.536 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 53.46 65.42 5.68 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.109 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.54 80.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.304 1.16 . . . . 0.0 110.635 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 24.2 p -117.77 154.32 51.03 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.019 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.48 -69.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.284 1.15 . . . . 0.0 110.45 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.34 -156.6 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.58 71.35 0.48 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.313 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.31 -1.77 32.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.694 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.57 -11.31 9.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.014 -1.053 . . . . 0.0 110.551 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.77 -67.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -73.68 173.37 9.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.55 -62.39 0.37 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -155.84 -164.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.613 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.9 tt -174.23 71.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.962 . . . . 0.0 110.368 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -91.39 46.82 1.33 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.185 -0.947 . . . . 0.0 109.306 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.807 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.2 pp -45.8 -41.83 11.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.588 -0.695 . . . . 0.0 111.057 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.807 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.9 p-10 -58.53 -33.37 69.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.968 -1.083 . . . . 0.0 109.672 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.07 -30.61 16.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.133 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -83.05 -35.37 25.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 110.835 -178.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 73' ' ' ILE . 2.5 mp -92.58 -32.77 14.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.878 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 40' ' ' LEU . 96.7 mt -121.25 170.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.91 . . . . 0.0 109.807 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.537 ' N ' HG22 ' B' ' 45' ' ' ILE . 28.7 mm-40 -124.94 -34.82 2.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 110.703 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.822 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 35.8 m80 -91.11 143.89 29.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 110.082 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.15 -36.77 45.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 O-C-N 123.073 1.039 . . . . 0.0 110.076 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.2 t -155.34 42.5 0.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -130.03 35.24 4.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.334 -0.854 . . . . 0.0 110.033 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 34.4 m -133.82 124.1 25.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 110.513 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.664 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.2 OUTLIER -97.81 151.73 19.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.435 -0.79 . . . . 0.0 109.871 179.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.807 ' HE2' HG23 ' A' ' 38' ' ' ILE . 5.8 p90 -143.3 161.72 37.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 110.182 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.3 p -155.57 132.86 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.585 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.58 134.87 45.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.159 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.451 ' N ' ' HE3' ' B' ' 55' ' ' LYS . . . -88.99 110.11 20.85 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.44 -0.787 . . . . 0.0 110.213 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -136.1 51.18 2.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.6 9.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.591 ' HB2' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -149.25 25.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -1.088 . . . . 0.0 109.816 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -96.36 -2.46 45.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.709 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.442 ' H ' HD11 ' B' ' 66' ' ' ILE . 3.7 mtt -142.85 25.14 1.81 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 0.0 110.318 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' B' ' 59' ' ' ASP . 20.5 mt -57.06 -23.62 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.984 -1.072 . . . . 0.0 108.878 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 28.2 p30 -52.24 -24.97 8.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.406 -0.809 . . . . 0.0 109.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.863 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.79 -37.97 5.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.82 -19.43 1.26 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.388 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.974 HG23 HD12 ' B' ' 72' ' ' LEU . 2.0 pp -71.02 111.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -1.227 . . . . 0.0 110.478 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -131.41 66.29 1.54 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.29 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 38.3 86.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.823 -0.548 . . . . 0.0 112.058 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.15 49.12 0.25 Allowed Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.267 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 4.2 p30 -173.98 172.07 3.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -1.211 . . . . 0.0 110.28 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 44' ' ' LEU . 1.2 tm? -124.16 125.26 44.16 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.312 -0.868 . . . . 0.0 110.077 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.978 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.5 tt -90.81 149.77 21.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 110.927 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.978 ' N ' HD23 ' B' ' 72' ' ' LEU . 19.2 mm -140.66 100.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 110.073 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.664 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -99.72 146.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.793 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.757 ' HB2' HG12 ' B' ' 131' ' ' VAL . 5.7 m-20 -102.84 98.96 8.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.992 -1.068 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.418 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 53.9 p -83.98 101.58 11.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.61 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.477 HG22 ' N ' ' B' ' 79' ' ' THR . 4.0 mt -114.27 167.63 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.477 ' N ' HG22 ' B' ' 78' ' ' ILE . 89.3 m -100.52 113.9 27.07 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.883 . . . . 0.0 110.02 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -62.15 -149.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -139.33 149.85 44.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.791 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.428 ' HE1' HD12 ' B' ' 101' ' ' LEU . 93.3 m-70 -54.82 141.9 31.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.141 -0.974 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.1 38.01 9.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.47 ' O ' HG22 ' B' ' 86' ' ' VAL . 23.4 m-20 -148.48 141.7 25.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.097 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.863 HD11 ' O ' ' B' ' 64' ' ' GLY . 8.9 tt -63.86 82.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.186 -0.946 . . . . 0.0 110.103 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.2 m -124.39 166.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 109.68 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -95.89 124.96 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 110.429 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.845 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.87 168.24 12.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.045 -1.034 . . . . 0.0 109.734 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.66 15.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 111.022 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.4 p -152.8 122.36 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.666 -0.647 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 55.32 21.23 4.0 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.255 -0.903 . . . . 0.0 110.71 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.42 33.31 5.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -107.93 164.37 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -144.32 102.55 3.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.467 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.845 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 44.8 p -100.89 164.04 12.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 109.796 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.452 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 7.0 t -131.58 89.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 0.0 110.551 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.586 ' HD2' HG23 ' B' ' 108' ' ' ILE . 0.1 OUTLIER -178.76 178.63 0.78 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.86 -1.15 . . . . 0.0 110.859 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -78.96 89.33 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 0.0 109.632 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.528 HD22 ' CG2' ' B' ' 86' ' ' VAL . 1.9 pt? -74.24 140.74 45.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 111.035 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -126.43 128.18 46.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.832 . . . . 0.0 109.202 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.0 mt -131.43 -10.3 3.64 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.251 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.525 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -79.24 -58.44 0.67 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.859 -1.151 . . . . 0.0 110.409 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.67 -54.34 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 31.3 m -151.58 164.49 36.74 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 105' ' ' VAL . 35.4 m -89.09 100.08 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.007 . . . . 0.0 109.848 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -146.53 146.61 30.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 111.222 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.632 HD21 HG21 ' B' ' 95' ' ' THR . 1.7 tp -145.29 141.39 28.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.608 -0.683 . . . . 0.0 109.431 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' B' ' 97' ' ' LYS . 0.7 OUTLIER -146.13 79.33 10.88 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.971 -1.081 . . . . 0.0 111.367 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -69.49 -156.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 O-C-N 123.109 1.057 . . . . 0.0 109.577 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.73 150.73 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.214 -0.929 . . . . 0.0 110.863 178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 22.7 t-20 -99.18 -75.55 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.614 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 4.9 p -79.41 -34.69 41.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.905 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.93 57.9 4.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.495 ' CA ' HD11 ' B' ' 108' ' ' ILE . 48.6 p90 -62.87 120.2 10.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.778 . . . . 0.0 110.577 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' B' ' 108' ' ' ILE . 10.2 m -117.24 91.45 37.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.357 -0.839 . . . . 0.0 109.716 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.8 119.94 7.39 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 O-C-N 123.292 1.154 . . . . 0.0 110.631 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.545 ' O ' HG23 ' B' ' 117' ' ' ILE . 3.5 tp -140.18 123.72 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 110.267 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -85.39 156.26 20.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.864 . . . . 0.0 109.994 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.508 HG22 ' N ' ' B' ' 120' ' ' SER . 4.2 mt -94.19 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 110.426 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.508 ' N ' HG22 ' B' ' 119' ' ' ILE . 15.2 m -78.4 85.69 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 110.505 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.4 t 51.63 48.05 23.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.567 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.603 ' N ' HG11 ' B' ' 105' ' ' VAL . 0.8 OUTLIER 51.17 50.38 19.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 0.0 110.537 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.87 -74.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.702 ' O ' HD22 ' B' ' 125' ' ' LEU . 60.8 m -147.92 81.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.072 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.702 HD22 ' O ' ' B' ' 124' ' ' THR . 3.0 mm? -125.53 113.48 17.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.132 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -146.36 159.23 43.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.333 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.418 HG11 ' HB ' ' B' ' 86' ' ' VAL . 31.7 t -80.73 146.89 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 110.413 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -33.12 13.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.385 -0.822 . . . . 0.0 109.993 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -119.9 -152.86 9.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.877 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 9.3 p -146.98 14.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 111.038 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.7 p -173.48 169.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.831 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.4 mp -149.08 85.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.466 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 22.8 m80 -66.8 110.44 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.375 -0.828 . . . . 0.0 110.567 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.14 119.76 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.979 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.831 HG22 HG13 ' A' ' 135' ' ' VAL . 49.0 t -102.0 97.79 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.013 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -86.03 104.99 16.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -61.66 106.92 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 3.4 mmt -113.96 108.16 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 110.304 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.595 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.211 0.529 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -77.18 162.42 69.55 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 143.56 98.92 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.282 1.148 . . . . 0.0 110.461 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER 54.47 176.25 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 0.0 110.16 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.63 -40.91 43.02 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.201 1.106 . . . . 0.0 110.499 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.56 -55.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.168 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -106.14 149.54 26.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.147 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.69 ' O ' HG12 ' A' ' 34' ' ' VAL . 7.2 p-10 -158.24 105.78 1.93 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 0.0 110.172 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 52.97 35.2 18.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.902 . . . . 0.0 110.235 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.3 p -173.73 123.68 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.49 23.35 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.938 . . . . 0.0 110.202 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 51.6 tt0 -152.71 169.43 22.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 110.12 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 36' ' ' GLN . 2.3 ttp180 -124.38 115.19 20.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 0.0 110.39 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -142.03 43.31 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.848 . . . . 0.0 109.902 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -91.66 72.69 5.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.262 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.061 HD11 HD11 ' B' ' 45' ' ' ILE . 0.3 OUTLIER -45.58 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.529 -0.732 . . . . 0.0 111.757 -179.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.443 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 12.1 p-10 -47.43 -31.03 3.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 111.582 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -8.67 59.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.079 -1.013 . . . . 0.0 110.593 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -114.63 -26.1 8.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.017 -1.052 . . . . 0.0 110.516 -179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' B' ' 44' ' ' LEU . 2.7 mp -101.01 -12.42 18.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.043 HD11 HD11 ' B' ' 40' ' ' LEU . 8.3 mt -139.99 -133.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.979 -1.076 . . . . 0.0 109.155 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -172.29 -58.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.544 -1.348 . . . . 0.0 110.294 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m170 -54.62 149.31 22.1 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.943 . . . . 0.0 110.159 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.14 -58.98 0.25 Allowed 'Trans proline' 0 C--N 1.32 -0.929 0 O-C-N 123.096 1.05 . . . . 0.0 110.227 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -143.99 51.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -133.27 36.59 3.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.704 HG21 HG21 ' A' ' 45' ' ' ILE . 61.5 m -131.2 117.87 19.64 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 110.834 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.6 m-85 -95.14 150.03 20.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.464 -0.773 . . . . 0.0 109.773 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CZ ' HD22 ' B' ' 43' ' ' LEU . 1.4 p90 -142.6 162.08 36.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.09 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HD22 ' A' ' 72' ' ' LEU . 9.0 p -155.44 131.37 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.845 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 126.4 29.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -77.46 100.6 6.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.389 -0.819 . . . . 0.0 109.985 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 m -131.96 45.22 2.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.256 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.98 -163.78 26.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.472 ' CB ' HD11 ' A' ' 62' ' ' ILE . 6.1 p-10 -134.72 24.69 3.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -1.147 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -94.18 -4.14 49.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.728 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.875 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -143.59 36.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.943 -1.098 . . . . 0.0 110.095 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.793 HD12 ' CG ' ' A' ' 111' ' ' ASN . 78.8 mt -70.61 -24.11 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.039 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 2.9 p30 -53.96 -24.68 17.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.459 -0.776 . . . . 0.0 108.972 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -92.0 -55.55 1.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.362 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.6 pp -128.13 99.04 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.053 -1.263 . . . . 0.0 110.26 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.16 66.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 110.505 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 33.85 61.99 0.46 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.72 39.61 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.21 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 2.9 p30 -174.9 165.25 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.037 -1.272 . . . . 0.0 110.704 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.671 HD22 ' N ' ' A' ' 72' ' ' LEU . 1.4 tm? -113.28 128.25 56.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.443 -0.785 . . . . 0.0 109.356 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.884 HD23 ' N ' ' A' ' 73' ' ' ILE . 8.2 tt -99.78 150.37 22.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.249 -0.907 . . . . 0.0 111.126 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.884 ' N ' HD23 ' A' ' 72' ' ' LEU . 24.6 mt -140.3 98.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 110.144 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.8 p -86.79 152.23 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.622 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.0 m-20 -108.41 98.29 7.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.858 -1.151 . . . . 0.0 110.555 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 9.9 p -85.2 101.44 12.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.732 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -177.47 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 110.251 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 79' ' ' THR . 13.5 mt -86.23 169.05 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 78' ' ' ILE . 11.8 m -114.86 119.85 37.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 110.036 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.32 -149.67 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.22 173.42 11.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 109.794 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.833 ' NE2' HD11 ' A' ' 101' ' ' LEU . 40.1 m-70 -51.01 144.43 8.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.087 -1.008 . . . . 0.0 111.054 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.56 32.21 57.81 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.75 ' O ' HG22 ' A' ' 86' ' ' VAL . 1.2 m-20 -128.13 121.58 29.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.25 . . . . 0.0 109.654 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 85' ' ' ILE . 13.8 tt -54.59 97.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 84' ' ' ASP . 34.0 m -150.05 166.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 109.654 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 87' ' ' ILE . 2.3 tp -89.44 115.19 28.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.12 156.42 18.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.815 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.48 153.77 33.09 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.155 -0.966 . . . . 0.0 110.896 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 124' ' ' THR . 3.2 p -153.86 119.84 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.28 0.562 . . . . 0.0 109.934 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.94 19.6 2.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.291 -0.881 . . . . 0.0 111.277 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.33 33.16 3.23 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.126 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.9 mt-10 -114.64 164.41 14.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -1.166 . . . . 0.0 110.473 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 95' ' ' THR . 18.5 m-85 -133.79 146.94 51.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -156.9 116.79 3.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.875 HG21 ' HG2' ' A' ' 61' ' ' MET . 15.2 t -75.62 174.82 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 CA-C-O 121.521 0.677 . . . . 0.0 109.8 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' H ' HG12 ' A' ' 96' ' ' VAL . 1.3 mmtt 71.46 177.09 0.27 Allowed 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.482 0.658 . . . . 0.0 110.71 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB2' ' N ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.34 142.25 41.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.537 -0.727 . . . . 0.0 110.686 -179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.715 HD22 ' CG2' ' A' ' 127' ' ' VAL . 1.6 pt? -95.74 129.37 42.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.454 -0.779 . . . . 0.0 110.089 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.41 113.92 19.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.911 HD12 ' N ' ' A' ' 102' ' ' ARG . 1.2 pp -129.37 -15.32 4.11 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.321 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.911 ' N ' HD12 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -66.08 -61.23 5.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.822 -1.174 . . . . 0.0 109.977 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.67 -56.15 0.7 Allowed 'Trans proline' 0 N--CA 1.484 0.924 0 N-CA-C 108.783 -1.276 . . . . 0.0 108.783 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 15.8 m -147.25 158.53 43.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 119' ' ' ILE . 10.7 p -90.08 99.9 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 111.792 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.912 ' O ' HD12 ' A' ' 107' ' ' LEU . 14.4 pt20 -143.04 146.16 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.377 -0.827 . . . . 0.0 109.25 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 106' ' ' GLN . 0.9 OUTLIER -144.05 152.7 41.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.931 -1.105 . . . . 0.0 111.79 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 30.48 95.83 0.04 OUTLIER Pre-proline 0 N--CA 1.506 2.334 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.6 Cg_endo -69.46 -13.24 35.1 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 120.568 0.845 . . . . 0.0 110.6 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.501 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.8 ttt 67.54 162.87 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.013 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.793 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.5 t-20 -46.47 -84.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.372 -0.83 . . . . 0.0 110.925 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 p -140.65 13.61 2.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.78 -79.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.045 -1.034 . . . . 0.0 109.803 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' A' ' 115' ' ' SER . 38.2 p90 -143.48 169.56 17.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 110.175 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' A' ' 114' ' ' TYR . 1.6 m -50.7 169.59 0.21 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.243 -0.911 . . . . 0.0 110.286 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.4 Cg_exo -56.96 163.73 7.18 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.074 1.039 . . . . 0.0 110.309 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.1 tp -79.7 117.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.96 . . . . 0.0 110.492 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 118' ' ' THR . 9.5 t -76.21 128.52 35.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.837 . . . . 0.0 109.612 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.724 ' O ' HG11 ' A' ' 105' ' ' VAL . 28.1 mt -114.28 172.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.919 . . . . 0.0 110.198 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.575 ' O ' HG21 ' A' ' 105' ' ' VAL . 2.5 p -47.96 172.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.037 -1.039 . . . . 0.0 110.991 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m -61.74 81.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.261 -0.899 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' SER . 22.7 tt0 47.26 43.57 15.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.286 -0.883 . . . . 0.0 111.017 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.33 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.141 -0.975 . . . . 0.0 109.896 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.525 ' O ' HD22 ' A' ' 125' ' ' LEU . 15.3 m -148.24 80.49 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.036 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 124' ' ' THR . 2.3 mm? -121.44 127.28 50.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -146.39 165.13 30.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.102 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' CG2' HD22 ' A' ' 99' ' ' LEU . 99.3 t -81.78 153.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 110.449 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HB3' HG23 ' A' ' 87' ' ' ILE . 20.3 t80 -106.26 -42.22 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -107.93 -142.84 10.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 131' ' ' VAL . 10.1 p -148.49 -37.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 111.501 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.772 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.8 p -136.52 168.53 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.796 -1.19 . . . . 0.0 111.706 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.7 mp -139.56 84.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.637 ' CE1' HG21 ' A' ' 131' ' ' VAL . 15.5 m-70 -67.6 110.88 3.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.629 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 136' ' ' LYS . 14.5 p -85.04 143.47 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.669 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.875 HG22 HG13 ' B' ' 135' ' ' VAL . 46.2 t -118.39 98.42 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 110.428 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' O ' HG12 ' B' ' 134' ' ' VAL . 12.2 mttp -85.34 110.07 18.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.356 -0.84 . . . . 0.0 110.061 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.83 131.11 48.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.24 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.88 104.72 8.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.613 ' HB3' HG23 ' B' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.163 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.19 0.519 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' B' ' 26' ' ' PHE . 14.7 p90 -158.69 77.85 3.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.216 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 102.3 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.146 1.077 . . . . 0.0 110.504 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 85.5 p -150.47 81.31 6.65 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 110.179 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.46 -44.83 20.57 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.321 1.169 . . . . 0.0 110.527 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.98 84.88 2.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.87 . . . . 0.0 110.134 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.09 116.82 11.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.215 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.498 ' HB3' HG12 ' B' ' 34' ' ' VAL . 0.3 OUTLIER -148.99 157.34 43.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.281 -0.887 . . . . 0.0 110.225 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 21.26 15.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.25 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' B' ' 32' ' ' ASP . 7.5 p -111.94 148.32 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -151.53 79.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -138.98 -146.0 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.903 . . . . 0.0 109.942 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.26 -157.86 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.586 ' O ' HG23 ' B' ' 38' ' ' ILE . 1.6 tt -150.69 71.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -91.11 67.21 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 108.814 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.043 HD11 HD11 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -44.07 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.723 -0.61 . . . . 0.0 111.925 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.447 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 11.8 p-10 -47.36 -30.76 3.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.333 -0.854 . . . . 0.0 111.58 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -8.83 58.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.002 -1.061 . . . . 0.0 110.621 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -114.83 -25.84 8.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.09 -1.007 . . . . 0.0 110.57 -179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.023 HD23 HD23 ' A' ' 44' ' ' LEU . 2.7 mp -101.16 -12.64 18.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.658 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 40' ' ' LEU . 8.2 mt -139.94 -133.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.029 -1.045 . . . . 0.0 109.123 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.5 OUTLIER -172.19 -58.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.548 -1.345 . . . . 0.0 110.341 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.0 m170 -54.66 149.29 22.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.204 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -58.89 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 O-C-N 123.242 1.127 . . . . 0.0 110.225 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -144.12 51.3 1.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.741 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -133.21 36.73 3.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.343 -0.848 . . . . 0.0 110.306 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.719 HG21 HG21 ' B' ' 45' ' ' ILE . 59.5 m -131.33 117.84 19.48 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.6 m-85 -95.02 150.0 20.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.35 -0.843 . . . . 0.0 109.74 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.536 ' CE1' HD22 ' A' ' 43' ' ' LEU . 1.3 p90 -142.62 162.01 36.59 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.054 -1.029 . . . . 0.0 110.099 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' B' ' 72' ' ' LEU . 9.1 p -155.4 131.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.394 -0.816 . . . . 0.0 109.717 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 126.2 29.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.076 -1.015 . . . . 0.0 109.991 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -77.21 100.62 5.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.433 -0.792 . . . . 0.0 110.033 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 13.7 m -132.11 45.46 2.77 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.266 -0.896 . . . . 0.0 110.281 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.05 -163.59 26.2 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.483 ' CB ' HD11 ' B' ' 62' ' ' ILE . 6.1 p-10 -134.88 24.66 3.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -93.93 -5.18 48.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.799 ' HG2' HG21 ' B' ' 96' ' ' VAL . 0.0 OUTLIER -142.51 37.1 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 110.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' B' ' 111' ' ' ASN . 76.1 mt -70.82 -24.09 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.139 -0.975 . . . . 0.0 109.001 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.9 p30 -53.64 -24.63 14.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.377 -0.827 . . . . 0.0 109.019 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CG1' ' B' ' 96' ' ' VAL . . . -92.58 -55.3 1.68 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.55 41.1 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.39 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.596 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.6 pp -128.0 99.07 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.107 -1.231 . . . . 0.0 110.217 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.4 ' O ' ' C ' ' B' ' 68' ' ' ASP . 0.3 OUTLIER -120.22 66.82 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.079 -1.013 . . . . 0.0 110.451 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 5.4 p-10 33.89 62.19 0.45 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.64 39.52 0.02 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.181 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 2.9 p30 -174.81 165.45 3.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.241 . . . . 0.0 110.677 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.669 HD22 ' N ' ' B' ' 72' ' ' LEU . 1.4 tm? -113.55 128.17 56.34 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.427 -0.796 . . . . 0.0 109.366 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.858 HD23 ' N ' ' B' ' 73' ' ' ILE . 8.2 tt -99.66 150.24 22.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.105 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.858 ' N ' HD23 ' B' ' 72' ' ' LEU . 24.4 mt -140.29 98.74 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.246 -0.909 . . . . 0.0 110.115 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.7 p -86.91 152.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.62 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.605 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.0 m-20 -108.3 98.31 7.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.953 -1.092 . . . . 0.0 110.573 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 9.5 p -85.23 101.44 12.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.366 -0.834 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.676 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -177.54 -59.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 110.206 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.527 HG22 ' N ' ' B' ' 79' ' ' THR . 13.7 mt -86.16 168.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.527 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.3 m -114.57 119.76 37.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 110.123 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.39 -149.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.294 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.33 172.75 12.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.468 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 39.2 m-70 -50.98 143.88 9.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.007 . . . . 0.0 110.883 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.09 31.49 55.14 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.717 ' O ' HG22 ' B' ' 86' ' ' VAL . 1.2 m-20 -128.48 123.09 32.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -1.225 . . . . 0.0 109.498 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.686 HG23 ' O ' ' B' ' 85' ' ' ILE . 13.7 tt -56.67 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 84' ' ' ASP . 34.1 m -149.74 166.25 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.755 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.633 ' O ' HG23 ' B' ' 87' ' ' ILE . 2.3 tp -89.43 115.36 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.818 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.918 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.26 156.13 18.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.817 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.15 153.46 32.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 111.138 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 124' ' ' THR . 3.3 p -153.97 120.0 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.367 0.603 . . . . 0.0 110.073 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 54.1 20.06 2.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.208 -0.932 . . . . 0.0 111.422 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.08 33.29 3.03 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.398 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 6.1 mt-10 -116.59 164.89 13.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.121 -1.223 . . . . 0.0 110.078 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' B' ' 88' ' ' ALA . 32.8 m-85 -141.68 138.8 32.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 110.403 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.918 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 3.2 p -146.51 126.15 13.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.892 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.799 HG21 ' HG2' ' B' ' 61' ' ' MET . 23.8 t -80.63 171.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.502 ' N ' HG12 ' B' ' 96' ' ' VAL . 11.0 tptm 70.02 168.7 0.3 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' N ' ' B' ' 84' ' ' ASP . 0.0 OUTLIER -75.52 147.08 40.03 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.574 -0.704 . . . . 0.0 109.7 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' B' ' 88' ' ' ALA . 1.7 pt? -122.69 145.73 48.12 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.693 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.5 tp60 -110.21 127.24 54.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.236 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.71 HD21 HD12 ' B' ' 99' ' ' LEU . 17.2 mt -122.67 -13.56 7.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 110.714 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.8 mpp_? -86.02 -60.29 0.28 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 110.751 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.93 -49.88 4.57 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.488 HG22 ' N ' ' B' ' 105' ' ' VAL . 26.1 m -150.24 173.51 13.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.766 HG11 ' O ' ' B' ' 120' ' ' SER . 2.1 t -105.11 99.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.055 -1.028 . . . . 0.0 110.065 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.831 ' O ' HD12 ' B' ' 107' ' ' LEU . 60.8 mt-30 -141.86 147.43 37.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.415 -0.803 . . . . 0.0 110.155 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 1.037 HD13 HD12 ' B' ' 119' ' ' ILE . 2.4 mp -139.48 154.27 47.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.139 -0.976 . . . . 0.0 111.404 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.689 ' O ' HG23 ' B' ' 108' ' ' ILE . 3.0 tt 19.48 103.76 0.01 OUTLIER Pre-proline 0 N--CA 1.51 2.561 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.76 -15.61 44.58 Favored 'Trans proline' 0 C--N 1.32 -0.941 0 O-C-N 122.62 0.8 . . . . 0.0 110.374 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' OD2' ' B' ' 63' ' ' ASP . 3.7 ttm 65.71 158.4 0.11 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.017 -1.052 . . . . 0.0 109.941 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' B' ' 62' ' ' ILE . 25.7 t30 -44.92 -88.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.481 -0.762 . . . . 0.0 111.219 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.5 p -133.11 6.14 3.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.934 -1.104 . . . . 0.0 110.714 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.05 -78.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' B' ' 115' ' ' SER . 35.0 p90 -143.47 167.03 23.17 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.141 -0.974 . . . . 0.0 109.825 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.528 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.95 -178.21 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.51 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.3 Cg_exo -62.68 156.1 55.04 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 122.756 0.872 . . . . 0.0 110.261 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.556 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.1 tt -79.58 124.33 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.575 ' O ' HG23 ' B' ' 118' ' ' THR . 10.2 t -80.03 122.33 26.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 109.821 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 1.037 HD12 HD13 ' B' ' 107' ' ' LEU . 98.2 mt -106.09 172.02 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.223 -0.923 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.766 ' O ' HG11 ' B' ' 105' ' ' VAL . 2.5 p -47.89 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.235 -0.916 . . . . 0.0 110.517 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -61.97 80.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.943 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 120' ' ' SER . 22.3 tt0 48.2 43.82 19.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.175 -0.953 . . . . 0.0 110.884 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.46 -81.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.524 ' O ' HD22 ' B' ' 125' ' ' LEU . 15.4 m -148.28 80.73 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.676 HD12 HD21 ' B' ' 107' ' ' LEU . 2.3 mm? -121.26 128.65 52.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.313 -0.867 . . . . 0.0 109.525 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -147.39 165.06 31.33 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.873 -1.142 . . . . 0.0 110.847 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' B' ' 86' ' ' VAL . 97.5 t -81.87 153.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 110.367 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' B' ' 87' ' ' ILE . 20.6 t80 -106.11 -42.03 5.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.175 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.0 -142.98 10.45 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.475 HG13 ' N ' ' B' ' 131' ' ' VAL . 10.3 p -148.39 -37.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -1.231 . . . . 0.0 111.478 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.778 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.9 p -136.48 168.48 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.833 -1.167 . . . . 0.0 111.638 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.778 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.7 mp -139.61 84.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.631 ' CE1' HG21 ' B' ' 131' ' ' VAL . 15.5 m-70 -67.36 110.79 3.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.681 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' LYS . 14.5 p -84.95 143.45 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.875 HG13 HG22 ' A' ' 135' ' ' VAL . 46.5 t -118.42 98.09 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.098 -1.001 . . . . 0.0 110.447 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.501 ' O ' HG12 ' A' ' 134' ' ' VAL . 12.2 mttp -85.04 110.13 18.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.306 -0.871 . . . . 0.0 110.054 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.81 130.88 47.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 104.58 8.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 110.268 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.621 ' HB3' HG23 ' A' ' 131' ' ' VAL . 9.3 ptp180 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.183 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.24 0.543 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 12.2 p90 -146.92 64.97 9.47 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.174 -0.954 . . . . 0.0 110.318 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.38 174.08 2.26 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.327 1.172 . . . . 0.0 110.56 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.97 75.12 9.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 94.11 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.979 0 O-C-N 123.236 1.124 . . . . 0.0 110.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.48 11.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.26 126.31 44.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.299 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.31 126.64 2.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' C ' HG13 ' A' ' 34' ' ' VAL . 14.1 m-85 -86.54 -170.02 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG13 ' C ' ' A' ' 33' ' ' TYR . 28.3 m -151.07 43.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.179 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.91 90.63 2.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 110.318 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -154.26 -46.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.353 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 55.12 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 109.779 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 38' ' ' ILE . 7.6 tt -76.39 57.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 110.672 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -91.16 69.76 6.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 108.961 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.991 ' CD1' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -44.93 -71.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.621 -0.674 . . . . 0.0 111.595 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 5.6 p-10 -46.82 -33.7 4.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.399 -0.813 . . . . 0.0 111.397 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -85.49 -8.82 58.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.076 -1.015 . . . . 0.0 110.826 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.15 -27.3 8.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.927 -1.108 . . . . 0.0 110.527 -179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' B' ' 44' ' ' LEU . 2.3 mp -100.56 -11.08 20.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.91 HD11 HD11 ' B' ' 40' ' ' LEU . 9.4 mt -141.78 -129.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.937 -1.102 . . . . 0.0 109.551 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -174.04 -52.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.539 -1.351 . . . . 0.0 110.584 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 31.0 m80 -68.31 147.08 98.23 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.164 -0.96 . . . . 0.0 110.247 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.66 -53.01 1.5 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.077 1.041 . . . . 0.0 110.05 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m -144.49 43.94 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.394 -0.817 . . . . 0.0 109.831 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -125.67 35.46 4.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.847 . . . . 0.0 109.884 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.648 HG21 HG21 ' A' ' 45' ' ' ILE . 55.3 m -131.76 137.84 48.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' O ' HG12 ' A' ' 74' ' ' VAL . 2.1 m-85 -113.4 150.36 32.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.368 -0.833 . . . . 0.0 110.046 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.0 p90 -142.88 161.92 36.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.4 p -155.21 131.45 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.88 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.43 127.04 31.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -80.52 100.98 8.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.416 -0.803 . . . . 0.0 110.301 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 26.1 t -136.11 63.46 1.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.426 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.73 -133.18 1.93 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 36.1 p-10 -169.04 42.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -1.154 . . . . 0.0 109.65 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.3 m -104.26 -10.98 17.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.47 -0.769 . . . . 0.0 110.426 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.733 ' H ' HD11 ' A' ' 66' ' ' ILE . 1.6 mtt -149.64 31.14 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.01 -1.056 . . . . 0.0 110.384 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 111' ' ' ASN . 83.0 mt -52.86 -25.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.772 -1.205 . . . . 0.0 108.682 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.6 p30 -50.49 -29.21 9.92 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 109.009 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.684 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -86.75 -34.18 11.8 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.32 -11.46 2.51 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.551 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.733 HD11 ' H ' ' A' ' 61' ' ' MET . 1.5 pp -76.77 101.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.976 -1.308 . . . . 0.0 110.617 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 t -131.17 67.16 1.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.632 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 25.8 t0 41.3 58.87 2.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.641 -0.662 . . . . 0.0 111.822 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.15 49.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.533 -1.317 . . . . 0.0 110.095 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 4.0 p30 -173.9 162.22 3.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.068 -1.254 . . . . 0.0 110.282 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD11 HD11 ' B' ' 44' ' ' LEU . 1.5 tm? -116.71 122.83 45.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.877 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 66' ' ' ILE . 6.1 tt -89.71 148.83 23.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.342 -0.849 . . . . 0.0 110.892 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.972 HD11 HD11 ' B' ' 44' ' ' LEU . 17.7 mm -140.33 99.09 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.999 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.2 p -98.85 146.37 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.799 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.788 ' HB2' HG12 ' A' ' 131' ' ' VAL . 4.3 m-20 -103.51 98.37 8.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.607 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 65.9 p -82.21 101.1 10.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.273 -0.892 . . . . 0.0 109.693 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.76 -60.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.28 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -90.65 163.64 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.339 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.9 m -94.32 120.22 34.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.92 . . . . 0.0 110.137 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.858 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -67.53 -154.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -0.93 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.22 149.38 34.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.785 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.45 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 96.6 m-70 -54.63 143.51 24.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.86 31.51 17.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 146.8 45.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -1.143 . . . . 0.0 109.77 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.817 HG22 ' OXT' ' B' ' 139' ' ' ARG . 0.1 OUTLIER -74.77 64.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 122.487 1.137 . . . . 0.0 109.056 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.858 HG11 ' HB1' ' A' ' 80' ' ' ALA . 35.6 m -103.3 171.42 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.053 -1.029 . . . . 0.0 109.734 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.68 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -89.45 132.97 32.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.118 -0.989 . . . . 0.0 110.152 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.814 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 151.66 21.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.945 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.8 122.14 21.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.393 -0.817 . . . . 0.0 110.543 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 125' ' ' LEU . 3.8 p -152.17 122.74 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 109.676 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 55.45 26.8 9.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.952 . . . . 0.0 110.207 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 33.52 10.82 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.4 mm-40 -104.17 160.59 14.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.091 -1.241 . . . . 0.0 110.771 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -145.04 98.2 3.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.483 -0.761 . . . . 0.0 109.377 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.814 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.8 p -110.96 178.53 4.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.2 -0.937 . . . . 0.0 110.906 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HA3' ' A' ' 64' ' ' GLY . 4.0 t -135.97 102.11 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.276 -0.89 . . . . 0.0 110.636 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER 179.53 170.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.965 -1.085 . . . . 0.0 110.35 179.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.94 89.35 3.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.841 . . . . 0.0 109.647 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.467 ' CB ' ' CD1' ' A' ' 107' ' ' LEU . 1.6 pt? -75.78 142.98 42.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.894 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.852 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.52 130.35 49.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 109.104 179.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 100' ' ' GLN . 17.1 mt -130.13 -8.18 4.33 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.148 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -76.56 -58.94 1.08 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 120.792 -1.192 . . . . 0.0 110.001 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.29 -54.98 0.84 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 m -151.39 153.31 34.46 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 119' ' ' ILE . 14.4 t -85.02 100.2 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.933 -1.104 . . . . 0.0 109.672 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -147.78 151.58 36.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.758 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.467 ' CD1' ' CB ' ' A' ' 99' ' ' LEU . 6.6 tp -145.54 152.49 39.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.737 . . . . 0.0 109.955 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -147.02 76.42 11.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.062 -1.024 . . . . 0.0 111.119 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 2.7 Cg_endo -72.24 -153.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.201 1.106 . . . . 0.0 109.7 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mmt 72.66 157.11 0.18 Allowed 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.758 0.789 . . . . 0.0 111.604 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 15.0 t-20 -102.17 -82.57 0.48 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.74 -0.6 . . . . 0.0 109.626 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.7 p -86.19 -29.11 23.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.808 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.47 62.81 6.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.425 -0.797 . . . . 0.0 109.292 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 46.2 p90 -61.83 135.33 57.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.464 -0.773 . . . . 0.0 110.705 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.0 m -150.67 89.17 4.45 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 128.05 26.63 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.369 1.194 . . . . 0.0 110.736 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.6 142.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.315 -0.866 . . . . 0.0 110.275 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 118' ' ' THR . 5.5 t -109.17 161.29 15.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.942 . . . . 0.0 110.226 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 HG12 ' A' ' 105' ' ' VAL . 2.7 mp -122.45 169.37 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -55.71 -173.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.661 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.8 p -71.2 77.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.315 -0.866 . . . . 0.0 110.392 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.51 59.95 4.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.409 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -76.0 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.921 . . . . 0.0 110.058 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' HD22 ' A' ' 125' ' ' LEU . 4.0 m -147.88 81.86 1.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.656 HD21 HG21 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -131.02 109.1 10.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -147.12 156.89 43.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 110.327 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 87' ' ' ILE . 48.9 t -70.83 150.26 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.789 . . . . 0.0 110.035 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.86 -42.8 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 110.347 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -119.3 -142.58 6.82 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.765 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 11.9 p -144.32 11.04 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 111.157 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.833 ' C ' HD12 ' A' ' 132' ' ' ILE . 14.1 p -172.77 169.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.76 -1.213 . . . . 0.0 111.221 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.833 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.2 mp -146.0 84.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.492 ' CD2' ' CB ' ' B' ' 137' ' ' ALA . 28.7 m80 -68.83 110.0 4.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.755 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.21 124.99 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.816 . . . . 0.0 109.68 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.798 HG22 HG13 ' B' ' 135' ' ' VAL . 21.6 t -100.04 100.47 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.079 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -85.81 104.23 15.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.359 -0.838 . . . . 0.0 110.133 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.83 114.59 3.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 103.76 11.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.84 ' OXT' HG22 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.274 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.2 0.524 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -148.32 83.25 7.21 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -69.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.324 1.171 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 8.3 p -171.53 160.76 5.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.244 -0.91 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.88 -28.45 81.28 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.236 1.124 . . . . 0.0 110.489 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.13 102.12 13.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 48.13 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.17 -73.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 110.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -135.98 19.65 3.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 110.439 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 34' ' ' VAL . 10.9 p -101.38 58.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.299 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -118.47 -75.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.183 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -58.27 8.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 110.105 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.536 ' C ' HG22 ' B' ' 38' ' ' ILE . 3.0 ttt-85 53.13 53.62 11.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.302 -0.874 . . . . 0.0 110.454 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.536 HG22 ' C ' ' B' ' 37' ' ' ARG . 0.7 OUTLIER 36.36 60.8 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.349 0.595 . . . . 0.0 111.746 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -91.26 71.93 6.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 109.563 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.976 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -45.94 -70.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 111.369 -179.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.402 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 5.6 p-10 -47.28 -33.62 5.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.387 -0.821 . . . . 0.0 111.457 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -85.54 -8.71 58.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.002 -1.061 . . . . 0.0 110.882 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -111.13 -27.03 8.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.98 -1.075 . . . . 0.0 110.466 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.995 HD23 HD23 ' A' ' 44' ' ' LEU . 2.3 mp -100.84 -11.06 20.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.684 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.905 HD11 HD11 ' A' ' 40' ' ' LEU . 9.5 mt -141.77 -129.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.9 -1.125 . . . . 0.0 109.462 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -174.01 -52.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.491 -1.381 . . . . 0.0 110.56 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.71 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.9 m80 -68.4 147.11 98.16 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.29 -0.881 . . . . 0.0 110.128 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.59 -53.03 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.915 0 O-C-N 123.064 1.033 . . . . 0.0 110.088 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.6 m -144.39 43.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' B' ' 47' ' ' HIS . . . -125.76 35.75 4.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.454 -0.779 . . . . 0.0 109.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.644 HG21 HG21 ' B' ' 45' ' ' ILE . 55.2 m -131.95 137.94 48.13 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 110.618 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.686 ' O ' HG12 ' B' ' 74' ' ' VAL . 2.1 m-85 -113.53 150.34 33.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.473 -0.767 . . . . 0.0 109.986 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.686 ' HB3' HD13 ' B' ' 73' ' ' ILE . 8.9 p90 -142.95 161.91 36.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.26 131.59 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.97 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.412 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.47 127.03 31.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 110.038 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -80.62 100.92 8.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 110.327 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 24.7 t -136.2 63.69 1.58 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.485 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.74 -133.35 2.01 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -169.35 47.14 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -1.078 . . . . 0.0 109.724 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -107.53 -11.36 15.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.432 -0.793 . . . . 0.0 110.304 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.742 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.0 mtt -150.09 33.11 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.146 -0.971 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.704 HD12 ' ND2' ' B' ' 111' ' ' ASN . 72.7 mt -53.66 -26.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.886 -1.134 . . . . 0.0 108.175 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.533 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 2.8 p30 -49.22 -29.89 6.3 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 109.18 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -86.33 -34.3 12.52 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.88 -11.27 2.62 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.48 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.742 HD11 ' H ' ' B' ' 61' ' ' MET . 1.5 pp -76.9 101.43 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.953 -1.322 . . . . 0.0 110.586 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 t -131.33 67.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 110.572 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 25.6 t0 41.31 58.66 2.57 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.584 -0.697 . . . . 0.0 111.844 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.39 49.71 0.01 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.148 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' O ' ' CE ' ' B' ' 55' ' ' LYS . 4.0 p30 -173.88 161.97 3.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.25 . . . . 0.0 110.323 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 44' ' ' LEU . 1.5 tm? -116.53 122.77 45.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -0.891 . . . . 0.0 109.894 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.673 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.1 tt -89.56 148.88 23.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 0.0 110.944 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.955 HD11 HD11 ' A' ' 44' ' ' LEU . 17.6 mm -140.39 99.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 109.998 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.686 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.08 146.56 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.797 ' HB2' HG12 ' B' ' 131' ' ' VAL . 4.2 m-20 -103.62 98.36 8.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 68.4 p -82.19 101.03 10.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.0 109.699 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.78 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.406 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -90.66 163.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.401 -0.812 . . . . 0.0 110.389 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.406 ' N ' HG22 ' B' ' 78' ' ' ILE . 18.4 m -94.38 120.18 34.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.853 . . . . 0.0 110.08 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.854 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -67.43 -154.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.941 . . . . 0.0 110.265 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.0 m -145.23 149.14 34.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -0.886 . . . . 0.0 109.822 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.418 ' HE1' HD12 ' B' ' 101' ' ' LEU . 97.1 m-70 -54.24 143.69 22.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 110.552 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.49 31.79 17.96 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.45 145.07 42.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -1.184 . . . . 0.0 109.879 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.84 HG22 ' OXT' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -72.98 64.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 122.401 1.096 . . . . 0.0 109.228 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.854 HG11 ' HB1' ' B' ' 80' ' ' ALA . 35.5 m -103.46 171.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 109.668 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.684 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -89.5 133.13 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.13 -0.982 . . . . 0.0 110.025 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.28 152.59 21.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.986 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.87 121.22 19.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.665 HG21 HD21 ' B' ' 125' ' ' LEU . 4.0 p -152.48 121.0 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.57 -0.706 . . . . 0.0 109.578 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 54.57 20.76 3.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -0.815 . . . . 0.0 110.772 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.77 33.5 6.37 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.497 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.7 OUTLIER -106.65 164.42 12.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.608 ' HB3' HD11 ' B' ' 87' ' ' ILE . 51.3 m-85 -143.03 86.53 1.92 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.794 . . . . 0.0 110.286 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.638 HG21 HD12 ' B' ' 107' ' ' LEU . 2.0 m -87.34 168.94 12.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.123 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' B' ' 64' ' ' GLY . 24.9 t -136.55 96.17 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HE2' HD12 ' B' ' 108' ' ' ILE . 0.2 OUTLIER 170.99 -178.93 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.12 -0.987 . . . . 0.0 109.774 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -76.03 88.36 2.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.175 -0.953 . . . . 0.0 109.98 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.435 HD23 ' N ' ' B' ' 99' ' ' LEU . 2.1 pt? -71.22 134.53 46.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.843 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.717 ' O ' HD23 ' B' ' 101' ' ' LEU . 52.1 mt-30 -116.87 126.43 52.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 110.004 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.717 HD23 ' O ' ' B' ' 100' ' ' GLN . 10.5 mt -126.51 -8.07 6.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.444 -0.785 . . . . 0.0 110.466 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.642 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 15.6 mmm180 -79.27 -64.03 0.36 Allowed Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.014 -1.054 . . . . 0.0 109.91 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -60.92 -55.64 1.26 Allowed 'Trans proline' 0 N--CA 1.482 0.844 0 N-CA-C 108.708 -1.304 . . . . 0.0 108.708 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.45 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.8 m -81.8 105.08 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.202 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -155.39 150.98 27.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.002 -1.061 . . . . 0.0 111.532 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.638 HD12 HG21 ' B' ' 95' ' ' THR . 2.7 mm? -115.81 150.63 36.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.642 HD13 ' C ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -128.4 94.05 36.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.057 -1.027 . . . . 0.0 112.047 -178.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.505 ' HG3' ' CE2' ' B' ' 114' ' ' TYR . 2.6 Cg_endo -70.74 152.62 64.38 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 N-CA-C 108.144 -1.522 . . . . 0.0 108.144 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.533 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -130.05 -51.0 1.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.454 -1.404 . . . . 0.0 112.0 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.704 ' ND2' HD12 ' B' ' 62' ' ' ILE . 0.7 OUTLIER -47.95 -83.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.991 -1.068 . . . . 0.0 111.315 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.4 p -174.39 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.592 -1.317 . . . . 0.0 111.18 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.1 -74.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.029 -1.044 . . . . 0.0 109.57 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' B' ' 109' ' ' PRO . 21.4 p90 -143.34 172.89 12.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.638 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -75.85 168.04 31.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.022 . . . . 0.0 110.487 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.07 153.03 54.71 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.265 1.139 . . . . 0.0 110.34 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.4 155.14 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 0.0 110.985 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.407 ' H ' HG22 ' B' ' 118' ' ' THR . 6.5 t -110.72 161.14 16.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.616 HD13 ' HG ' ' B' ' 125' ' ' LEU . 2.9 mp -116.83 167.97 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.565 ' O ' HG21 ' B' ' 105' ' ' VAL . 0.4 OUTLIER -55.41 -171.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.236 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 76.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 52.72 60.31 3.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.25 -75.77 0.27 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.064 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.593 ' O ' HD22 ' B' ' 125' ' ' LEU . 4.0 m -148.02 81.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.665 HD21 HG21 ' B' ' 90' ' ' VAL . 0.5 OUTLIER -131.14 109.02 10.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.24 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -147.18 157.04 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.123 -0.985 . . . . 0.0 110.454 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.684 HG13 ' O ' ' B' ' 87' ' ' ILE . 48.6 t -70.96 150.19 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.474 -0.766 . . . . 0.0 110.129 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.7 -42.65 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.373 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -119.6 -142.76 6.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.755 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.0 p -144.22 11.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.162 -1.199 . . . . 0.0 111.193 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.841 ' C ' HD12 ' B' ' 132' ' ' ILE . 14.0 p -172.82 169.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.96 -1.087 . . . . 0.0 111.217 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.841 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.2 mp -146.39 84.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.494 ' CD2' ' CB ' ' A' ' 137' ' ' ALA . 28.2 m80 -68.86 110.04 4.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.712 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.19 124.97 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.675 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 135' ' ' VAL . 21.6 t -100.0 100.35 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.195 -0.94 . . . . 0.0 110.11 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -85.75 104.17 15.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.801 . . . . 0.0 110.166 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 133' ' ' HIS . . . -61.64 114.55 3.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.92 103.56 11.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.817 ' OXT' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.267 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.173 0.511 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 23.5 p90 -139.19 61.33 20.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.306 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.51 -157.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.171 1.09 . . . . 0.0 110.459 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.428 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 11.8 m -144.92 61.72 8.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.221 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_exo -61.37 81.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.289 1.152 . . . . 0.0 110.526 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB1' ' HD2' ' A' ' 33' ' ' TYR . . . -117.99 101.97 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 -44.04 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.46 34.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.542 ' HD2' ' HB1' ' A' ' 30' ' ' ALA . 0.9 OUTLIER -71.55 66.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.222 -0.924 . . . . 0.0 110.356 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -124.63 135.29 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 110.14 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -120.65 169.64 10.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.943 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -174.51 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.6 113.7 2.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -0.872 . . . . 0.0 110.211 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.62 HG12 HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -59.35 148.02 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.44 16.76 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.348 -0.845 . . . . 0.0 111.006 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.759 HD13 HG13 ' B' ' 45' ' ' ILE . 1.9 pp -74.47 -36.87 63.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.898 -1.127 . . . . 0.0 108.763 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.56 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 p-10 -80.24 -2.95 47.23 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 109.035 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.79 -58.97 2.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.95 -1.093 . . . . 0.0 109.917 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -75.13 -13.64 60.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.312 -0.867 . . . . 0.0 112.234 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 43' ' ' LEU . 1.2 mp -112.39 -21.7 11.24 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.664 -1.272 . . . . 0.0 110.148 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG13 HD13 ' B' ' 40' ' ' LEU . 22.7 mm -129.85 169.7 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.993 . . . . 0.0 109.249 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 62.9 mt-30 -139.17 4.78 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.074 -1.016 . . . . 0.0 111.434 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 31.2 m80 -148.96 152.15 36.12 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.748 -1.22 . . . . 0.0 110.418 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.93 -49.63 3.8 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.338 1.178 . . . . 0.0 110.334 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -139.17 29.31 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 110.028 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -117.06 30.01 7.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.206 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.653 HG21 HG23 ' A' ' 45' ' ' ILE . 49.4 m -129.63 130.08 45.16 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.653 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.07 151.22 26.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.313 -0.867 . . . . 0.0 110.288 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.42 157.95 44.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.855 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.0 p -155.42 134.58 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.214 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 135.6 45.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.812 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.95 107.03 18.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.3 54.11 1.94 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.32 -177.58 47.81 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.515 ' HB2' HD11 ' A' ' 62' ' ' ILE . 10.3 p-10 -131.0 36.04 3.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -1.098 . . . . 0.0 109.972 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' MET . 3.8 t -102.49 -22.53 14.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 110.226 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.743 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.1 mtt -126.54 40.94 3.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.315 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.68 HD12 ' OD1' ' A' ' 111' ' ' ASN . 47.4 mt -67.45 -25.01 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 108.752 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.9 p30 -52.05 -24.47 6.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.386 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.718 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -92.58 -51.68 2.29 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.05 40.4 0.02 OUTLIER Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.444 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.743 HD11 ' H ' ' A' ' 61' ' ' MET . 1.8 pp -128.58 106.92 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.011 -1.288 . . . . 0.0 110.385 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.11 66.88 1.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.969 -1.082 . . . . 0.0 110.661 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.48 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 121.256 0.551 . . . . 0.0 112.481 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.75 53.55 0.55 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -175.23 149.91 1.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -1.119 . . . . 0.0 109.919 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.806 HD12 HD11 ' B' ' 44' ' ' LEU . 3.4 tm? -107.39 125.74 51.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.263 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 73' ' ' ILE . 6.2 tt -92.65 143.54 26.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.503 -0.748 . . . . 0.0 110.502 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.646 HG13 HD21 ' B' ' 44' ' ' LEU . 19.4 mm -132.94 98.85 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.754 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -99.02 158.97 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 109.927 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.777 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.3 m-20 -117.8 98.35 6.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.95 -1.093 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 60.6 p -84.97 101.41 12.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.87 -45.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.363 -0.835 . . . . 0.0 110.315 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.493 HG22 ' N ' ' A' ' 79' ' ' THR . 3.3 mp -104.14 169.07 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.357 -0.839 . . . . 0.0 110.348 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 78' ' ' ILE . 24.6 m -106.15 109.92 22.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -63.18 -149.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.839 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.62 24.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.159 -0.963 . . . . 0.0 109.784 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 17.3 m-70 -52.44 144.75 12.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.101 -0.999 . . . . 0.0 110.535 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 98' ' ' LYS . . . 74.23 36.9 49.6 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 86' ' ' VAL . 83.6 m-20 -134.59 120.93 20.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -1.178 . . . . 0.0 109.948 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.718 HD11 ' O ' ' A' ' 64' ' ' GLY . 11.9 tt -54.81 96.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 110.015 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 84' ' ' ASP . 33.1 m -149.35 170.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.65 121.88 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.274 -0.891 . . . . 0.0 110.0 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.709 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.47 163.26 15.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.901 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.16 138.7 17.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.761 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.605 ' HB ' HD22 ' A' ' 125' ' ' LEU . 4.2 p -152.78 124.16 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.535 -0.728 . . . . 0.0 109.943 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 54.77 20.63 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.319 -0.863 . . . . 0.0 110.705 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.08 5.65 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 20.5 mm-40 -108.36 164.42 12.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 0.0 110.36 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -144.22 124.75 13.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.992 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.709 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.6 p -134.08 169.33 17.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.354 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 3.9 t -129.3 91.01 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.342 -0.848 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.572 ' HG2' HG23 ' A' ' 108' ' ' ILE . 15.6 tptt -177.13 166.84 2.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.987 -1.071 . . . . 0.0 110.197 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 15.5 mtpt -76.51 88.88 3.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 108.904 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 107' ' ' LEU . 1.7 pt? -64.54 131.64 47.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.0 111.205 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.3 mm-40 -121.04 118.84 30.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.099 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 125' ' ' LEU . 25.3 mt -120.17 -13.99 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -0.931 . . . . 0.0 110.853 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.43 -58.3 7.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.611 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.94 -58.62 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 N-CA-C 108.601 -1.346 . . . . 0.0 108.601 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 m -152.26 155.13 37.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.799 HG11 ' H ' ' A' ' 122' ' ' GLU . 35.4 m -76.06 100.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.006 -1.059 . . . . 0.0 109.646 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -145.34 147.67 32.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.968 -1.082 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.657 ' HB2' HD11 ' A' ' 119' ' ' ILE . 5.8 tp -145.21 155.32 43.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -157.53 78.77 3.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 111.821 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -72.29 -153.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 N-CA-C 109.282 -1.084 . . . . 0.0 109.282 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 60' ' ' SER . 0.0 OUTLIER 65.42 152.71 0.06 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.267 -0.895 . . . . 0.0 111.232 177.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.68 ' OD1' HD12 ' A' ' 62' ' ' ILE . 12.6 t-20 -101.13 -84.49 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.556 -0.715 . . . . 0.0 109.801 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -71.52 -32.31 68.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.094 -1.004 . . . . 0.0 109.892 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.1 54.32 3.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.448 -0.782 . . . . 0.0 109.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 42.8 p90 -62.75 115.69 4.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 0.0 110.4 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 m -127.27 83.25 66.52 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.39 122.11 11.13 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.35 1.184 . . . . 0.0 110.637 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 117' ' ' ILE . 1.4 tt -136.66 134.15 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 110.096 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.3 t -83.57 146.46 28.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.18 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 107' ' ' LEU . 4.2 mt -94.69 175.37 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 109.226 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -51.99 -179.76 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 66.0 p -65.03 75.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.01 . . . . 0.0 110.647 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.799 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER 48.72 42.57 19.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.274 -0.891 . . . . 0.0 110.769 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -82.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 90' ' ' VAL . 87.0 m -148.34 81.47 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 101' ' ' LEU . 1.0 OUTLIER -117.48 117.13 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.917 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -146.07 159.76 42.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' CG2' HG21 ' A' ' 86' ' ' VAL . 99.0 t -81.14 153.23 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.779 . . . . 0.0 110.613 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.3 -48.07 5.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 109.839 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -106.01 -147.09 14.67 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.4 p -154.66 16.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.062 -1.257 . . . . 0.0 111.811 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.777 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.4 p -173.7 168.67 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.649 -1.282 . . . . 0.0 111.592 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.723 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.3 mp -155.7 81.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -71.47 111.0 6.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.668 -179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.03 118.26 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.665 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' B' ' 135' ' ' VAL . 85.9 t -101.62 98.06 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.85 106.11 13.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -0.841 . . . . 0.0 109.739 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.51 104.87 0.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.98 102.77 11.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.341 -0.849 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.584 ' HE ' HG22 ' B' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.233 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.184 0.516 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.49 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.1 OUTLIER -52.77 -52.16 67.16 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 110.904 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.1 Cg_exo -62.62 178.01 1.1 Allowed 'Trans proline' 0 N--CA 1.484 0.948 0 O-C-N 122.833 0.912 . . . . 0.0 110.586 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m 53.77 72.72 1.06 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.153 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.42 121.43 9.58 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.374 1.197 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.56 ' HB1' HG11 ' B' ' 34' ' ' VAL . . . -89.16 47.38 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.07 -22.42 66.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 110.215 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -172.4 -37.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 110.204 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.53 91.95 8.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.56 HG11 ' HB1' ' B' ' 30' ' ' ALA . 7.1 p -172.24 155.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -55.19 -64.46 0.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.266 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.24 -151.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.96 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 71.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 110.142 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.725 ' H ' HD13 ' B' ' 38' ' ' ILE . 0.1 OUTLIER -146.81 138.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.89 24.95 2.56 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.764 HD13 HG13 ' A' ' 45' ' ' ILE . 2.1 pp -73.88 -36.7 64.82 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.008 -1.058 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.57 ' N ' HD12 ' B' ' 40' ' ' LEU . 9.4 p-10 -80.27 -2.92 47.2 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.107 -0.995 . . . . 0.0 109.058 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -89.94 -58.82 2.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.965 -1.084 . . . . 0.0 109.943 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -75.25 -13.57 60.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 0.0 112.247 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.999 HD13 HD13 ' B' ' 43' ' ' LEU . 1.2 mp -112.48 -21.76 11.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.603 -1.311 . . . . 0.0 110.128 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.759 HG13 HD13 ' A' ' 40' ' ' LEU . 23.6 mm -129.94 169.27 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 109.345 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' B' ' 47' ' ' HIS . 63.5 mt-30 -138.98 4.84 2.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 111.371 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.807 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . 32.8 m80 -148.86 151.97 36.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.828 -1.17 . . . . 0.0 110.322 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.79 -49.76 3.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 O-C-N 123.333 1.175 . . . . 0.0 110.287 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 16.5 m -139.14 29.37 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.355 -0.841 . . . . 0.0 110.103 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.877 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -117.1 30.13 7.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.626 HG21 HG23 ' B' ' 45' ' ' ILE . 49.2 m -129.76 130.16 45.03 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 110.546 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -108.13 151.0 26.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 110.291 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -142.25 157.99 44.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.429 HG13 ' O ' ' B' ' 54' ' ' VAL . 9.1 p -155.43 134.49 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 110.295 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.57 45.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.932 . . . . 0.0 109.787 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.89 107.08 18.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.354 -0.841 . . . . 0.0 110.269 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -131.43 54.15 1.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.46 -177.7 47.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.531 ' HB2' HD11 ' B' ' 62' ' ' ILE . 10.3 p-10 -130.78 36.58 3.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -1.131 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -102.8 -23.16 13.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.802 ' HG2' HG21 ' B' ' 96' ' ' VAL . 2.1 mtt -126.0 45.16 2.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.902 . . . . 0.0 110.0 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.929 HD12 ' CG ' ' B' ' 111' ' ' ASN . 55.1 mt -71.82 -25.84 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.101 -0.999 . . . . 0.0 108.546 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' CG ' ' B' ' 97' ' ' LYS . 2.9 p30 -51.53 -24.71 5.54 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.508 -0.745 . . . . 0.0 109.27 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.724 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -92.0 -52.61 2.21 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.61 40.13 0.02 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.739 HD11 ' H ' ' B' ' 61' ' ' MET . 1.8 pp -128.57 107.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.033 -1.274 . . . . 0.0 110.352 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.23 66.9 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.994 -1.066 . . . . 0.0 110.659 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 34.44 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.03 53.22 0.55 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.91 149.95 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -1.151 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.813 HD12 HD11 ' A' ' 44' ' ' LEU . 3.4 tm? -107.51 125.87 51.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 110.171 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.523 HD23 ' N ' ' B' ' 73' ' ' ILE . 6.2 tt -92.7 143.44 26.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.632 HG13 HD21 ' A' ' 44' ' ' LEU . 19.4 mm -132.86 98.93 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.4 p -99.21 158.94 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.95 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.796 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.3 m-20 -117.81 98.31 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.948 -1.095 . . . . 0.0 110.591 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 60.7 p -84.88 101.36 12.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.548 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.877 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.95 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 79' ' ' THR . 3.3 mp -103.9 169.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 110.314 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.491 ' N ' HG22 ' B' ' 78' ' ' ILE . 25.1 m -106.17 109.9 21.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.119 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -63.14 -149.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.27 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -145.26 166.64 24.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 109.732 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.65 ' CE1' HD11 ' B' ' 101' ' ' LEU . 18.5 m-70 -51.91 144.65 11.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.988 -1.07 . . . . 0.0 110.86 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.98 57.12 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.736 ' O ' HG22 ' B' ' 86' ' ' VAL . 82.1 m-20 -133.13 118.64 18.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.239 . . . . 0.0 110.016 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.724 HD11 ' O ' ' B' ' 64' ' ' GLY . 12.7 tt -51.85 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.327 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 84' ' ' ASP . 33.2 m -149.68 170.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.561 -0.712 . . . . 0.0 110.048 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.578 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.73 121.22 39.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.24 163.31 15.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.57 17.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 110.818 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.621 ' HB ' HD22 ' B' ' 125' ' ' LEU . 4.3 p -152.6 122.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.16 22.05 3.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.236 -0.915 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.31 33.7 5.59 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.471 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.7 mm-40 -109.73 164.57 12.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -1.214 . . . . 0.0 110.697 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -136.82 128.21 28.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.24 -0.912 . . . . 0.0 110.147 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 1.023 HG21 HD23 ' B' ' 107' ' ' LEU . 1.1 p -142.36 129.43 20.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.306 -0.871 . . . . 0.0 110.242 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' B' ' 61' ' ' MET . 2.9 t -84.41 178.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-O 121.566 0.698 . . . . 0.0 110.015 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.605 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.8 OUTLIER 71.69 -179.44 0.22 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.598 0.713 . . . . 0.0 111.194 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' B' ' 85' ' ' ILE . 0.2 OUTLIER -75.59 132.5 40.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.629 -0.669 . . . . 0.0 110.993 -178.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' B' ' 127' ' ' VAL . 1.6 pt? -90.22 128.09 36.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.793 . . . . 0.0 109.418 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' B' ' 106' ' ' GLN . 1.9 mt-30 -121.45 113.27 19.61 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.757 HD23 ' HB3' ' B' ' 125' ' ' LEU . 2.3 pp -133.83 -5.22 2.81 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.162 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.677 ' N ' HD12 ' B' ' 101' ' ' LEU . 15.3 mtt180 -72.64 -58.97 2.6 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.766 -1.208 . . . . 0.0 109.426 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.81 -56.19 0.54 Allowed 'Trans proline' 0 C--N 1.324 -0.72 0 N-CA-C 108.536 -1.371 . . . . 0.0 108.536 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 25.3 m -151.17 164.52 36.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.76 HG11 ' O ' ' B' ' 120' ' ' SER . 32.8 m -80.25 107.65 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -0.976 . . . . 0.0 111.209 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' B' ' 100' ' ' GLN . 6.9 pt20 -142.99 145.58 33.08 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.429 -0.794 . . . . 0.0 109.223 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 1.023 HD23 HG21 ' B' ' 95' ' ' THR . 4.9 tp -144.34 156.86 44.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.852 -1.155 . . . . 0.0 113.21 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.673 ' O ' HG23 ' B' ' 108' ' ' ILE . 4.8 tt 15.84 116.08 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.604 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.3 Cg_endo -73.96 -37.98 2.51 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 120.833 1.022 . . . . 0.0 110.477 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' B' ' 113' ' ' ALA . 1.8 ttt 72.68 127.24 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.929 ' CG ' HD12 ' B' ' 62' ' ' ILE . 17.9 t-20 -48.37 -90.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.45 -0.781 . . . . 0.0 111.253 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.5 p -64.52 -37.72 88.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.95 -1.094 . . . . 0.0 110.826 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.509 ' HB3' ' SD ' ' B' ' 110' ' ' MET . . . -81.91 54.09 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.074 -1.016 . . . . 0.0 110.302 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 40.0 p90 -61.9 111.02 1.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.0 109.826 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -172.66 95.18 0.37 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.927 . . . . 0.0 110.0 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.83 108.46 0.38 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.077 1.04 . . . . 0.0 109.983 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 4.1 tt -79.7 130.52 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.965 . . . . 0.0 110.244 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 8.6 t -83.89 136.56 34.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.601 ' O ' HG21 ' B' ' 105' ' ' VAL . 3.4 mt -104.24 170.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.76 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.1 OUTLIER -56.54 -177.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.269 -0.895 . . . . 0.0 111.013 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 62.8 p -66.29 76.72 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.769 . . . . 0.0 110.346 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.43 41.72 17.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.263 -0.898 . . . . 0.0 110.778 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 -82.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.171 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.57 ' O ' HG23 ' B' ' 90' ' ' VAL . 86.6 m -148.35 81.45 1.47 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.757 ' HB3' HD23 ' B' ' 101' ' ' LEU . 1.0 OUTLIER -117.7 116.45 27.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.935 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -145.34 160.06 42.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.467 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.669 ' CG2' HD22 ' B' ' 99' ' ' LEU . 99.2 t -81.3 153.27 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.664 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.27 -48.09 5.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.888 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -105.88 -147.03 14.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' B' ' 130' ' ' VAL . 11.4 p -154.68 15.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.029 -1.277 . . . . 0.0 111.712 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.796 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.2 p -173.45 168.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.723 -1.236 . . . . 0.0 111.574 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.716 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.3 mp -155.67 81.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.531 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.5 OUTLIER -71.56 110.65 6.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.765 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.8 118.42 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.683 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 1.054 HG22 HG22 ' A' ' 135' ' ' VAL . 85.2 t -101.8 98.01 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 110.333 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -81.86 106.12 13.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.735 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.47 104.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 110.202 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.01 102.76 11.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.53 ' HE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.228 0.537 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -127.02 87.44 56.67 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.228 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.65 -28.71 82.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.356 1.187 . . . . 0.0 110.597 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.7 90.51 7.74 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.199 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.37 107.6 0.44 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.239 1.126 . . . . 0.0 110.536 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.52 159.16 18.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.201 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.34 141.58 58.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.8 110.45 2.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.15 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 52.77 -167.65 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.66 176.97 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -61.01 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -78.04 -64.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.875 . . . . 0.0 110.279 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 54.38 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 110.079 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 38' ' ' ILE . 11.9 tt -64.58 85.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -0.883 . . . . 0.0 110.281 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.47 -8.81 49.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.24 -0.913 . . . . 0.0 110.423 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.708 ' HA ' HD11 ' A' ' 43' ' ' LEU . 1.3 tm? -60.08 -45.0 94.37 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.079 -1.013 . . . . 0.0 109.115 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.545 ' HB2' HD12 ' A' ' 45' ' ' ILE . 53.0 p-10 -75.23 -11.61 60.11 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.148 -0.97 . . . . 0.0 109.114 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.402 ' N ' ' OD1' ' A' ' 41' ' ' ASN . 0.7 OUTLIER -85.08 -63.62 1.3 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.943 -1.098 . . . . 0.0 110.967 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -65.85 -14.8 62.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.086 -1.009 . . . . 0.0 112.481 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.021 HD13 HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -105.51 -17.03 14.55 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.472 -1.393 . . . . 0.0 110.564 -179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 41' ' ' ASN . 13.1 mt -112.95 173.64 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.983 -1.073 . . . . 0.0 109.684 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' ILE . 38.1 mm-40 -128.91 -3.67 5.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.764 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.463 ' H ' HG22 ' A' ' 45' ' ' ILE . 44.3 m80 -149.25 153.78 38.09 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.0 110.018 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -43.39 25.25 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 O-C-N 123.217 1.114 . . . . 0.0 110.131 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.37 74.52 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.441 -0.787 . . . . 0.0 109.653 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -173.53 43.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.0 110.041 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 45' ' ' ILE . 50.7 m -132.13 134.95 46.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.149 -0.969 . . . . 0.0 110.804 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.634 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -111.3 152.9 26.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 110.108 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' B' ' 43' ' ' LEU . 6.2 p90 -142.46 159.25 42.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.919 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.1 p -155.54 133.64 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 138.04 46.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.001 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -99.78 104.71 16.43 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.339 -0.851 . . . . 0.0 110.239 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 1.4 m -133.2 60.74 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.32 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.69 -144.23 5.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.6 p30 -158.57 26.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -1.137 . . . . 0.0 110.026 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -95.97 -10.27 29.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 110.589 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.581 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.5 mtt -137.88 28.06 2.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 110.591 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' CB ' ' A' ' 59' ' ' ASP . 11.8 mt -57.58 -24.47 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.955 -1.09 . . . . 0.0 108.634 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 2.1 p30 -50.45 -26.74 5.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.485 -0.76 . . . . 0.0 109.376 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -92.27 -37.54 5.9 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.9 -21.14 1.27 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.166 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.9 pp -68.01 109.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.253 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.1 t -131.45 66.88 1.53 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.006 -1.059 . . . . 0.0 110.748 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 38.96 96.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.845 -0.535 . . . . 0.0 112.288 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.75 51.66 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.447 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 9.6 p-10 -175.52 157.93 2.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.241 . . . . 0.0 110.142 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.807 HD12 HD11 ' B' ' 44' ' ' LEU . 3.5 tm? -111.43 123.05 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.142 -0.974 . . . . 0.0 110.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.031 HD11 HG23 ' A' ' 132' ' ' ILE . 1.6 tm? -91.49 141.45 28.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.054 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.893 ' N ' HD13 ' A' ' 72' ' ' LEU . 21.7 mm -130.74 109.99 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.056 -1.028 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -107.35 159.52 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.452 -0.78 . . . . 0.0 110.14 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' HB2' HG12 ' A' ' 131' ' ' VAL . 15.0 m-20 -118.34 98.54 6.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.045 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 10.7 p -81.27 101.55 9.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.667 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -174.31 -47.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 110.211 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.61 161.51 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.319 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -94.55 124.66 38.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.886 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -69.04 -149.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.7 m -141.87 151.02 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CD2' ' HG2' ' A' ' 102' ' ' ARG . 96.3 m-70 -50.84 142.2 11.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.974 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.51 35.45 19.85 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 86' ' ' VAL . 2.1 m-20 -142.52 138.74 31.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.129 -1.218 . . . . 0.0 109.992 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.647 HD13 ' C ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.16 90.5 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.959 -1.088 . . . . 0.0 109.432 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.886 HG11 ' CB ' ' A' ' 80' ' ' ALA . 35.8 m -131.69 168.46 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.831 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.0 OUTLIER -89.75 118.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 0.0 110.201 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.53 165.15 14.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.128 -0.983 . . . . 0.0 110.02 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.39 21.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.115 -0.99 . . . . 0.0 110.913 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.7 p -152.61 122.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.722 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.39 21.05 3.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.01 33.47 4.95 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.117 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -110.8 164.91 12.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.128 -1.219 . . . . 0.0 110.503 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -142.57 112.08 6.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 58.2 p -118.22 152.29 35.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.332 -0.855 . . . . 0.0 110.379 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 11.9 t -115.5 101.24 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 110.407 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.725 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.8 179.23 0.08 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.862 -1.149 . . . . 0.0 110.167 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -87.45 88.77 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.035 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 99' ' ' LEU . 2.2 pt? -65.09 137.44 57.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 0.0 110.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.3 mt-30 -123.48 124.93 43.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.819 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.0 mt -128.51 -9.56 5.13 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.548 -0.72 . . . . 0.0 110.802 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.606 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mmt-85 -71.89 -65.4 0.85 Allowed Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.858 -1.151 . . . . 0.0 110.155 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -60.4 -52.97 3.28 Favored 'Trans proline' 0 N--CA 1.484 0.946 0 N-CA-C 108.745 -1.29 . . . . 0.0 108.745 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 18.5 m -148.78 164.51 34.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 122' ' ' GLU . 14.5 p -96.49 101.36 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.011 -1.056 . . . . 0.0 110.574 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -149.67 159.59 44.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.006 -1.059 . . . . 0.0 110.829 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD23 ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -145.08 152.25 39.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 109.796 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 97' ' ' LYS . 1.3 tp -155.46 81.3 4.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.964 -1.085 . . . . 0.0 111.23 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD3' HD23 ' A' ' 107' ' ' LEU . 2.4 Cg_endo -70.73 -156.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.15 1.079 . . . . 0.0 109.491 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.02 156.08 0.11 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.138 -0.976 . . . . 0.0 111.314 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 13.4 t30 -100.09 -80.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.668 . . . . 0.0 109.541 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 p -79.83 -38.06 33.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.861 . . . . 0.0 109.664 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' HB2' HD11 ' A' ' 108' ' ' ILE . 43.5 p90 -68.55 124.4 23.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.656 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.505 ' C ' HD13 ' A' ' 108' ' ' ILE . 64.0 m -118.53 95.29 48.65 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.537 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.47 121.05 9.15 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 123.096 1.051 . . . . 0.0 110.667 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.4 tt -133.58 129.16 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.883 . . . . 0.0 110.261 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 118' ' ' THR . 7.3 t -86.04 160.51 19.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 110.076 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.716 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.6 mt -107.9 169.68 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.258 -0.901 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.512 ' N ' HG22 ' A' ' 119' ' ' ILE . 8.6 m -82.87 90.16 6.92 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.114 -0.991 . . . . 0.0 111.116 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.8 m 48.99 49.01 20.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 111.014 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.74 ' HA ' HG21 ' A' ' 105' ' ' VAL . 9.4 tt0 51.05 55.46 9.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.163 -0.961 . . . . 0.0 110.778 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -74.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.698 ' O ' HD22 ' A' ' 125' ' ' LEU . 96.0 m -148.27 81.04 1.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.95 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.698 HD22 ' O ' ' A' ' 124' ' ' THR . 4.0 mm? -123.67 108.02 12.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.214 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -146.36 157.25 43.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.505 HG21 HG21 ' A' ' 86' ' ' VAL . 65.8 t -72.64 153.04 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.395 -0.816 . . . . 0.0 110.749 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.51 -42.53 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.837 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -110.89 -154.28 13.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.8 p -140.71 9.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.281 . . . . 0.0 111.138 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.751 HG12 ' HB2' ' A' ' 75' ' ' ASP . 14.1 p -173.38 169.16 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.833 -1.167 . . . . 0.0 111.248 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 1.031 HG23 HD11 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -151.65 83.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.533 ' CE1' HG21 ' A' ' 131' ' ' VAL . 1.2 m-70 -68.06 114.18 6.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.858 . . . . 0.0 110.685 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.2 119.77 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 109.727 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' B' ' 135' ' ' VAL . 98.6 t -99.75 98.16 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.146 -0.971 . . . . 0.0 110.29 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 108.25 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.432 -0.793 . . . . 0.0 109.698 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HA ' ' ND1' ' B' ' 133' ' ' HIS . . . -61.15 104.61 0.4 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.48 102.78 10.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 110.116 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' B' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.302 0.572 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.7 168.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.05 161.39 22.63 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.319 1.168 . . . . 0.0 110.653 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.422 ' O ' ' N ' ' B' ' 30' ' ' ALA . 23.3 p -118.39 95.5 48.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.361 -0.837 . . . . 0.0 110.157 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 80.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.179 1.094 . . . . 0.0 110.642 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 28' ' ' SER . . . -175.88 86.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.113 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.99 -61.5 2.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -174.98 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.181 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.92 60.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.269 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.528 HG13 ' O ' ' B' ' 34' ' ' VAL . 9.5 p -101.62 60.37 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 110.039 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.07 117.97 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -52.91 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.935 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.23 110.66 3.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.886 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.6 pt -122.63 150.49 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.507 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.43 -7.59 52.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.354 -0.841 . . . . 0.0 110.29 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.706 ' HA ' HD11 ' B' ' 43' ' ' LEU . 1.4 tm? -60.06 -44.56 94.64 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.095 -1.003 . . . . 0.0 109.045 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.542 ' HB2' HD12 ' B' ' 45' ' ' ILE . 52.2 p-10 -75.49 -11.69 60.08 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.148 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.03 -63.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.027 . . . . 0.0 110.931 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -66.35 -14.59 62.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.072 -1.018 . . . . 0.0 112.454 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.009 HD13 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -105.57 -16.99 14.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.426 -1.421 . . . . 0.0 110.482 -179.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' B' ' 41' ' ' ASN . 13.2 mt -112.97 173.58 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.924 -1.11 . . . . 0.0 109.663 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.48 ' H ' HG22 ' B' ' 45' ' ' ILE . 37.9 mm-40 -128.9 -3.62 5.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.933 . . . . 0.0 110.726 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.471 ' H ' HG22 ' B' ' 45' ' ' ILE . 44.6 m80 -149.23 153.85 38.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.918 -1.113 . . . . 0.0 110.019 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.05 -43.36 24.93 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.186 1.098 . . . . 0.0 110.119 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 2.0 m -148.43 74.48 1.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.666 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -173.5 43.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.111 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.504 HG21 HG23 ' B' ' 45' ' ' ILE . 49.9 m -132.18 135.04 46.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 110.808 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.615 ' O ' HG12 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -111.43 152.77 27.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.475 -0.766 . . . . 0.0 110.162 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.447 ' HB2' ' CD2' ' A' ' 43' ' ' LEU . 6.3 p90 -142.36 159.06 42.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 109.865 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' B' ' 54' ' ' VAL . 7.3 p -155.46 133.56 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 138.05 45.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 110.047 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.479 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -99.73 104.75 16.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 1.4 m -133.18 60.83 1.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.24 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.98 -144.62 6.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.6 p30 -157.96 27.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 110.068 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' B' ' 110' ' ' MET . 23.4 t -96.25 -9.26 30.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 110.669 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.586 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.2 mtt -138.28 26.5 2.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.925 -1.11 . . . . 0.0 110.478 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.645 HD11 ' CB ' ' B' ' 59' ' ' ASP . 12.1 mt -56.32 -24.88 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.871 -1.143 . . . . 0.0 108.819 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.1 p30 -50.59 -26.72 5.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.418 -0.801 . . . . 0.0 109.408 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.505 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -91.68 -38.15 5.91 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.22 -21.05 1.22 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.472 -1.346 . . . . 0.0 110.165 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.608 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.9 pp -68.07 109.31 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.106 -1.232 . . . . 0.0 110.246 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.3 t -131.46 66.79 1.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.979 -1.076 . . . . 0.0 110.803 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 0.6 OUTLIER 39.12 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.799 -0.563 . . . . 0.0 112.337 178.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.57 51.78 0.65 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.827 -1.177 . . . . 0.0 110.412 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 9.6 p-10 -175.49 157.84 2.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.249 . . . . 0.0 110.117 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 44' ' ' LEU . 3.5 tm? -111.38 122.95 49.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 1.054 HD11 HG23 ' B' ' 132' ' ' ILE . 1.6 tm? -91.47 141.37 28.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 110.147 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.907 ' N ' HD13 ' B' ' 72' ' ' LEU . 21.4 mm -130.64 109.94 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.615 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -107.23 159.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 110.225 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.77 ' HB2' HG12 ' B' ' 131' ' ' VAL . 14.8 m-20 -118.55 98.39 6.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.034 -1.042 . . . . 0.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.431 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 10.4 p -81.21 101.6 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -174.4 -47.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.69 161.55 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 0.0 110.283 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -94.58 124.67 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.892 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -69.0 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 150.93 42.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 109.778 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.3 m-70 -51.11 141.94 13.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 110.823 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.14 35.31 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.402 ' O ' HG22 ' B' ' 86' ' ' VAL . 2.2 m-20 -142.69 139.8 31.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -1.182 . . . . 0.0 109.864 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.653 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -68.33 90.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.999 -1.063 . . . . 0.0 109.408 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.892 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.6 m -131.68 168.61 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.958 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.0 OUTLIER -89.87 118.53 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.141 -0.975 . . . . 0.0 110.264 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.75 165.03 14.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.882 . . . . 0.0 109.846 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.53 142.31 21.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 3.8 p -152.8 123.69 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.593 -0.692 . . . . 0.0 109.826 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.61 21.88 2.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.14 33.31 5.51 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.121 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 21.5 mm-40 -110.1 164.64 12.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -1.165 . . . . 0.0 110.417 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -143.87 117.22 9.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.4 p -128.69 162.21 27.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.473 ' CG1' ' HA3' ' B' ' 64' ' ' GLY . 3.2 t -123.77 99.31 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 44.2 tptt -175.88 167.28 3.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.136 -0.978 . . . . 0.0 110.703 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -76.14 88.59 3.04 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.489 -0.884 . . . . 0.0 108.853 178.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.605 HD11 HG23 ' B' ' 127' ' ' VAL . 1.8 pt? -66.71 132.5 48.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 111.138 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.799 ' O ' HD23 ' B' ' 101' ' ' LEU . 65.1 mt-30 -121.63 124.12 43.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.071 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.799 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -128.39 -9.34 5.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 111.009 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.89 -59.7 0.9 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 109.821 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.25 -54.55 1.35 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 N-CA-C 108.287 -1.467 . . . . 0.0 108.287 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.6 m -151.68 163.42 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.682 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.3 m -91.62 100.78 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.134 -0.979 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -152.28 152.54 32.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 111.436 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' B' ' 99' ' ' LEU . 6.5 tp -145.08 154.95 43.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.639 -0.663 . . . . 0.0 109.345 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.464 HG23 ' HG2' ' B' ' 97' ' ' LYS . 0.3 OUTLIER -154.92 77.75 5.02 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 120.916 -1.115 . . . . 0.0 111.464 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -68.48 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 122.973 0.986 . . . . 0.0 109.677 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' B' ' 60' ' ' SER . 0.0 OUTLIER 65.31 145.34 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.322 -0.862 . . . . 0.0 110.562 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 62' ' ' ILE . 23.6 t-20 -97.5 -69.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.377 -0.827 . . . . 0.0 109.377 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 25.0 p -82.9 -34.86 26.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.675 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 61.22 4.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.82 . . . . 0.0 109.495 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.501 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 48.8 p90 -62.18 119.21 8.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 110.649 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -125.93 81.71 65.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.463 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.0 Cg_endo -60.38 136.29 67.02 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.301 1.158 . . . . 0.0 110.883 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.473 ' O ' HG23 ' B' ' 117' ' ' ILE . 0.7 OUTLIER -139.72 130.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 110.004 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.429 ' H ' HG22 ' B' ' 118' ' ' THR . 8.9 t -84.98 156.32 21.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.526 HG21 HD23 ' B' ' 125' ' ' LEU . 38.8 mm -103.22 156.66 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -75.02 88.32 2.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 110.187 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.7 m 51.43 48.92 22.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.322 -0.862 . . . . 0.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' B' ' 105' ' ' VAL . 10.1 tt0 50.92 55.61 9.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.153 -0.967 . . . . 0.0 110.716 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.88 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.056 -1.027 . . . . 0.0 109.807 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.713 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.9 m -148.03 81.04 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.975 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.713 HD22 ' O ' ' B' ' 124' ' ' THR . 4.0 mm? -123.62 108.54 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.14 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -146.56 157.31 43.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 110.319 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.605 HG23 HD11 ' B' ' 99' ' ' LEU . 67.8 t -72.81 152.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 0.0 110.587 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 -42.68 7.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 109.783 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -110.68 -154.17 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.585 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -140.84 9.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.093 -1.239 . . . . 0.0 111.106 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.77 HG12 ' HB2' ' B' ' 75' ' ' ASP . 14.1 p -173.53 169.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.941 -1.099 . . . . 0.0 111.249 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 1.054 HG23 HD11 ' B' ' 72' ' ' LEU . 1.0 OUTLIER -151.55 83.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.53 ' CE1' HG21 ' B' ' 131' ' ' VAL . 1.2 m-70 -68.02 114.14 6.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 110.653 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.6 t -84.37 119.71 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 135' ' ' VAL . 99.4 t -99.68 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 110.242 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 108.18 13.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.676 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.452 ' HA ' ' ND1' ' A' ' 133' ' ' HIS . . . -61.17 104.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 86.5 mmm -113.61 102.73 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.43 -0.794 . . . . 0.0 110.062 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 131' ' ' VAL . 10.6 ptm180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.343 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.297 0.57 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -128.61 68.19 77.83 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 132.22 39.68 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.257 1.135 . . . . 0.0 110.288 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 m -142.74 64.32 15.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.931 . . . . 0.0 110.46 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.38 -72.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.302 1.159 . . . . 0.0 110.497 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' B' ' 72' ' ' LEU . . . -167.73 154.84 8.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.882 . . . . 0.0 110.133 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' B' ' 96' ' ' VAL . . . -114.91 -142.47 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 0.0 110.515 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -175.53 54.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.995 -1.066 . . . . 0.0 109.991 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.645 ' CD2' HG13 ' A' ' 34' ' ' VAL . 5.6 t80 -57.64 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 0.0 110.491 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.645 HG13 ' CD2' ' A' ' 33' ' ' TYR . 34.7 m -103.44 -170.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -0.981 . . . . 0.0 110.15 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -170.79 79.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 110.166 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.83 -166.28 1.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' O ' ' CZ ' ' B' ' 53' ' ' PHE . 0.0 OUTLIER 62.71 131.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 0.0 109.8 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.35 12.07 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 110.657 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.52 81.73 5.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.096 HD13 HD11 ' B' ' 45' ' ' ILE . 0.4 OUTLIER -65.27 -42.34 93.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 110.656 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.816 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.5 p-10 -53.33 -35.07 59.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.42 -8.52 47.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.227 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.02 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.97 -32.63 12.5 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -178.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD22 HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -100.76 -20.46 15.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.793 -1.192 . . . . 0.0 110.137 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.009 HD11 HD13 ' B' ' 40' ' ' LEU . 31.5 mt -103.82 172.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.029 -1.044 . . . . 0.0 110.218 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' N ' HG22 ' A' ' 45' ' ' ILE . 65.7 mt-30 -120.48 -29.03 4.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -96.42 161.05 28.2 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.164 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.32 -63.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.256 1.135 . . . . 0.0 110.409 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.59 59.98 1.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.359 -0.838 . . . . 0.0 109.846 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.7 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -145.82 44.67 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.255 -0.903 . . . . 0.0 110.044 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.723 HG21 HG23 ' A' ' 45' ' ' ILE . 35.0 m -133.44 136.78 45.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.136 -0.978 . . . . 0.0 111.193 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.629 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -122.05 161.65 22.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.658 -0.651 . . . . 0.0 109.532 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.943 ' HB3' HD13 ' A' ' 73' ' ' ILE . 4.2 p90 -142.92 170.69 15.22 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 0.0 110.318 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG12 ' HG ' ' A' ' 72' ' ' LEU . 9.0 p -151.38 138.34 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 110.056 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HG2' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -94.56 135.98 35.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -81.48 107.48 14.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -136.55 45.27 2.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.77 -127.99 1.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 18.7 p-10 -174.83 38.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -1.111 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.8 p -105.06 31.56 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.319 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.607 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -179.96 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.966 0.889 . . . . 0.0 109.292 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 ' CG ' ' A' ' 111' ' ' ASN . 33.7 mt -65.33 -22.66 31.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.714 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.3 p30 -50.46 -26.8 5.5 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.818 0.818 . . . . 0.0 109.037 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 96' ' ' VAL . . . -93.39 -41.05 4.61 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 147.92 -13.19 1.3 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.847 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.5 pp -67.33 98.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.857 -1.378 . . . . 0.0 110.16 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -122.73 66.75 0.96 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.147 -0.97 . . . . 0.0 109.979 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.21 58.67 3.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.658 -0.651 . . . . 0.0 111.703 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 61.69 0.01 OUTLIER Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.568 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' OD2' ' HA ' ' A' ' 66' ' ' ILE . 3.8 p30 -176.1 132.9 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.156 -1.202 . . . . 0.0 110.263 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.646 HD23 ' HG2' ' A' ' 55' ' ' LYS . 3.4 tm? -108.31 131.01 55.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.32 149.62 39.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.19 -0.944 . . . . 0.0 110.305 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 ' HB3' ' A' ' 53' ' ' PHE . 8.1 mm -117.95 97.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.1 p -89.05 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.281 -0.887 . . . . 0.0 110.378 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.2 m-20 -116.47 98.59 6.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.568 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -84.35 101.51 12.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.656 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.7 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.32 -52.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 110.266 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 79' ' ' THR . 2.8 mp -106.24 164.53 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 0.0 110.404 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 78' ' ' ILE . 27.5 m -92.65 149.55 21.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -96.37 -150.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.191 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.64 155.37 42.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -49.52 143.05 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.973 . . . . 0.0 110.96 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.54 33.75 37.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 86' ' ' VAL . 49.7 m-20 -133.54 132.95 41.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -1.224 . . . . 0.0 109.889 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -65.61 86.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 122.266 1.031 . . . . 0.0 109.743 -179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 127' ' ' VAL . 29.5 m -139.4 172.52 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.8 -1.187 . . . . 0.0 110.329 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -89.53 123.99 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 110.272 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.945 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.92 162.3 15.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.208 -0.932 . . . . 0.0 109.822 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.41 139.88 18.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 110.793 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 124' ' ' THR . 4.6 p -153.06 124.69 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 109.856 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 53.77 21.19 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.34 32.23 5.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -107.86 164.42 12.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -1.176 . . . . 0.0 110.123 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -144.61 120.37 10.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.749 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.945 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 22.1 p -124.04 167.48 14.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.746 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.804 ' H ' HD12 ' A' ' 108' ' ' ILE . 40.8 t -127.78 78.51 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.11 -0.994 . . . . 0.0 110.795 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.21 169.64 3.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.878 -1.139 . . . . 0.0 110.179 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 89.14 3.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.271 -0.893 . . . . 0.0 109.343 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 99' ' ' LEU . 2.2 pt? -60.91 143.21 55.45 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.891 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.9 tt0 -126.53 129.36 48.46 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.58 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 100' ' ' GLN . 16.3 mt -129.92 -7.51 4.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.353 -0.842 . . . . 0.0 110.963 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.567 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -81.16 -64.65 0.27 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.863 -1.148 . . . . 0.0 110.293 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.3 Cg_endo -63.87 -54.57 0.88 Allowed 'Trans proline' 0 N--CA 1.483 0.857 0 N-CA-C 108.505 -1.383 . . . . 0.0 108.505 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.8 m -151.13 173.23 14.62 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.815 HG11 ' O ' ' A' ' 120' ' ' SER . 36.0 m -101.46 100.61 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.006 -1.059 . . . . 0.0 110.556 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -123.39 153.7 40.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.033 HD13 HD11 ' A' ' 119' ' ' ILE . 4.9 tp -139.19 157.99 44.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.308 -0.87 . . . . 0.0 111.813 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.804 HD12 ' H ' ' A' ' 96' ' ' VAL . 2.9 tt -21.15 123.05 0.11 Allowed Pre-proline 0 N--CA 1.508 2.46 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -71.69 -26.97 18.88 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 120.908 1.072 . . . . 0.0 110.568 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.47 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 1.8 ttt 79.49 158.56 0.17 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.772 -0.58 . . . . 0.0 110.567 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.766 ' CG ' HD12 ' A' ' 62' ' ' ILE . 30.0 t30 -48.0 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.643 -0.661 . . . . 0.0 111.631 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' MET . 78.4 p 37.62 29.88 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.992 -0.443 . . . . 0.0 112.183 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 110' ' ' MET . . . -80.63 -68.03 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.811 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 114' ' ' TYR . 27.3 p90 -143.72 156.05 44.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.808 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -50.75 172.74 0.12 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.15 -0.969 . . . . 0.0 109.748 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 115' ' ' SER . 3.6 Cg_exo -58.08 133.17 53.8 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.864 0.928 . . . . 0.0 110.075 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 117' ' ' ILE . 15.9 tt -86.42 132.32 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 110.623 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 118' ' ' THR . 9.5 t -79.87 127.11 31.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.328 -0.857 . . . . 0.0 110.245 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.033 HD11 HD13 ' A' ' 107' ' ' LEU . 3.4 mt -72.57 -82.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.815 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -166.03 -166.43 0.92 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 110.119 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.05 63.97 1.3 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.62 ' H ' HG11 ' A' ' 105' ' ' VAL . 1.9 mt-10 55.3 65.32 1.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.835 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.7 -83.75 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 m -148.91 81.68 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.725 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -124.94 121.06 33.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.82 162.77 37.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.604 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.64 HG21 HG21 ' A' ' 86' ' ' VAL . 61.5 t -92.59 153.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.612 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -95.33 -60.93 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.52 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -79.5 -164.66 28.94 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 130' ' ' VAL . 14.1 p -138.54 1.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.162 -1.199 . . . . 0.0 111.734 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.873 ' C ' HD12 ' A' ' 132' ' ' ILE . 11.6 p -171.79 149.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.67 -1.269 . . . . 0.0 111.687 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.873 HD12 ' C ' ' A' ' 131' ' ' VAL . 1.8 mp -135.14 88.08 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.559 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.2 OUTLIER -66.83 110.05 3.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.354 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 136' ' ' LYS . 7.2 p -76.34 148.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' B' ' 135' ' ' VAL . 93.9 t -126.59 101.07 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.956 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' B' ' 134' ' ' VAL . 0.0 OUTLIER -88.41 113.98 24.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.37 104.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.151 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.58 106.45 16.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.154 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.27 0.557 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.507 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -74.01 -52.62 4.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.783 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.1 99.83 0.2 Allowed 'Trans proline' 0 N--CA 1.483 0.892 0 O-C-N 122.809 0.9 . . . . 0.0 110.518 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 1.6 m -127.19 81.7 69.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.148 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.53 -70.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 O-C-N 123.309 1.162 . . . . 0.0 110.533 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.84 84.24 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.16 171.24 14.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 110.314 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' B' ' 34' ' ' VAL . 2.0 t70 -103.99 -177.71 3.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.11 29.49 7.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.229 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.741 HG23 ' HG3' ' B' ' 35' ' ' GLU . 34.9 m -116.17 -21.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.741 ' HG3' HG23 ' B' ' 34' ' ' VAL . 4.2 mt-10 -106.43 -166.77 1.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.167 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.94 -148.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 21.97 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.092 -1.005 . . . . 0.0 110.244 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -125.03 96.08 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.083 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -90.6 55.6 3.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.009 HD13 HD11 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -53.52 -40.59 65.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.877 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.81 ' HA ' HD22 ' A' ' 40' ' ' LEU . 13.5 p-10 -55.09 -34.91 64.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.639 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -91.36 -8.69 47.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.861 . . . . 0.0 110.188 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.992 ' CD1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -96.13 -32.63 12.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -178.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.992 HD22 ' CD1' ' B' ' 43' ' ' LEU . 0.0 OUTLIER -100.63 -20.37 15.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.819 -1.176 . . . . 0.0 110.104 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 1.096 HD11 HD13 ' A' ' 40' ' ' LEU . 29.7 mt -103.74 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.014 -1.054 . . . . 0.0 110.277 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.491 ' N ' HG22 ' B' ' 45' ' ' ILE . 65.0 mt-30 -120.65 -29.11 4.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 110.226 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -96.4 160.96 28.48 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.44 -63.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.319 1.168 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 59.78 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -145.58 44.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.713 HG21 HG23 ' B' ' 45' ' ' ILE . 37.5 m -133.54 136.77 45.21 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.188 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.638 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -122.11 161.55 22.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.672 -0.642 . . . . 0.0 109.524 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.96 ' HB3' HD13 ' B' ' 73' ' ' ILE . 4.2 p90 -142.96 170.72 15.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.379 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.498 HG23 ' CG2' ' A' ' 34' ' ' VAL . 9.1 p -151.38 138.88 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 110.095 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.626 ' HG2' HD23 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -95.03 135.71 36.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 110.087 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.417 ' CB ' ' OD2' ' B' ' 70' ' ' ASP . . . -81.29 107.13 13.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.26 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -136.15 45.55 2.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.867 . . . . 0.0 110.015 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.06 -127.78 1.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 18.8 p-10 -175.26 38.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -1.106 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 p -104.08 27.77 7.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.387 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.612 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -176.43 38.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.915 0.864 . . . . 0.0 109.571 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.843 HD12 ' OD1' ' B' ' 111' ' ' ASN . 29.8 mt -66.0 -21.63 29.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 108.699 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.665 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.29 -25.97 6.62 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 30' ' ' ALA . . . -93.9 -41.51 4.35 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.75 -13.4 1.16 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.975 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.822 HG23 ' HB3' ' A' ' 31' ' ' ALA . 1.5 pp -67.55 98.73 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.886 -1.361 . . . . 0.0 110.139 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 28.2 t -122.92 66.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.943 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 t0 43.24 58.66 3.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 111.705 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.95 61.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.629 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.431 ' OD2' ' HA ' ' B' ' 66' ' ' ILE . 3.8 p30 -175.85 133.09 0.26 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -1.216 . . . . 0.0 110.276 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.642 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.4 tm? -108.67 131.41 54.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.899 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.812 ' HB3' ' HB1' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -117.05 150.14 39.14 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.253 -0.905 . . . . 0.0 110.334 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.96 HD13 ' HB3' ' B' ' 53' ' ' PHE . 8.3 mm -118.24 97.59 5.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.638 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.1 p -89.01 152.97 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.177 -0.952 . . . . 0.0 110.29 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.1 m-20 -116.44 98.6 6.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 110.585 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 88.1 p -84.27 101.44 11.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.29 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 110.301 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.425 HG22 ' N ' ' B' ' 79' ' ' THR . 2.8 mp -106.18 164.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.319 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.425 ' N ' HG22 ' B' ' 78' ' ' ILE . 27.7 m -92.77 149.32 21.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -96.0 -150.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -145.57 155.4 43.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.159 -0.963 . . . . 0.0 109.87 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -49.86 143.04 8.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.962 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.48 37.1 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.459 ' O ' HG22 ' B' ' 86' ' ' VAL . 49.2 m-20 -133.39 133.4 42.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -1.188 . . . . 0.0 109.881 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.731 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.15 87.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.096 -1.003 . . . . 0.0 109.742 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 127' ' ' VAL . 30.8 m -139.71 172.48 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.768 -1.208 . . . . 0.0 110.358 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.56 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.7 OUTLIER -89.58 123.62 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.984 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.73 162.15 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 93' ' ' GLU . . . -153.17 140.54 19.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 110.945 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 124' ' ' THR . 5.0 p -153.16 124.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.632 -0.668 . . . . 0.0 109.943 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.82 20.68 3.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.15 -0.969 . . . . 0.0 110.794 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.13 32.2 5.65 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.43 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 4.3 mm-40 -109.33 164.87 12.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -1.22 . . . . 0.0 109.992 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -145.42 105.35 4.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.462 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.984 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 1.2 p -105.91 174.08 6.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 109.811 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 31' ' ' ALA . 64.7 t -136.27 82.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.088 -1.007 . . . . 0.0 111.835 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.462 ' HB2' ' CB ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -178.11 169.9 1.87 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.22 -0.925 . . . . 0.0 109.647 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -75.42 88.33 2.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.078 -1.013 . . . . 0.0 108.896 179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 99' ' ' LEU . 2.1 pt? -63.3 143.53 57.72 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.839 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.868 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -127.85 129.08 46.35 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.868 HD23 ' O ' ' B' ' 100' ' ' GLN . 17.5 mt -129.95 -8.5 4.41 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.159 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.561 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -81.29 -61.99 0.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.81 -1.181 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -63.93 -54.66 0.84 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 105' ' ' VAL . 5.6 m -151.27 173.25 14.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.837 HG11 ' O ' ' B' ' 120' ' ' SER . 29.6 m -100.57 100.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.003 -1.06 . . . . 0.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.415 ' HG2' ' HB3' ' B' ' 100' ' ' GLN . 0.0 OUTLIER -122.33 150.4 42.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 1.008 HD13 HD11 ' B' ' 119' ' ' ILE . 5.1 tp -135.71 157.16 47.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 111.398 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.665 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -32.58 133.13 0.3 Allowed Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.515 ' C ' HD13 ' B' ' 108' ' ' ILE . 2.1 Cg_endo -71.6 -81.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 N-CA-C 109.186 -1.121 . . . . 0.0 109.186 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 153.28 -178.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.843 ' OD1' HD12 ' B' ' 62' ' ' ILE . 9.5 t30 -71.35 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -73.97 -30.6 62.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.922 -1.111 . . . . 0.0 110.24 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.69 56.54 2.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.274 -0.891 . . . . 0.0 109.829 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 40.4 p90 -62.44 111.69 2.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.331 -0.856 . . . . 0.0 110.054 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.16 105.78 0.35 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.88 111.42 0.79 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 122.87 0.931 . . . . 0.0 109.823 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' B' ' 107' ' ' LEU . 0.6 OUTLIER -91.15 131.1 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.678 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.408 ' OG1' HG23 ' B' ' 105' ' ' VAL . 8.4 t -85.26 139.92 31.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.115 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 1.008 HD11 HD13 ' B' ' 107' ' ' LEU . 3.8 mt -83.25 -80.53 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.837 ' O ' HG11 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -163.88 -166.16 1.13 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.107 -0.996 . . . . 0.0 109.752 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.56 63.91 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.722 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.9 mt-10 55.29 65.76 1.4 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.82 -83.77 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.861 . . . . 0.0 110.46 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.584 ' O ' HG23 ' B' ' 90' ' ' VAL . 4.2 m -148.97 81.73 1.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.828 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.66 ' HB3' HD11 ' B' ' 101' ' ' LEU . 0.6 OUTLIER -125.04 121.01 33.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 109.928 179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -146.78 162.75 37.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.059 -1.025 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.629 HG21 HG21 ' B' ' 86' ' ' VAL . 59.0 t -92.5 153.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.714 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -95.05 -60.66 1.64 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.526 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -79.86 -164.65 29.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 130' ' ' VAL . 14.3 p -138.67 1.94 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.073 -1.251 . . . . 0.0 111.78 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.874 ' C ' HD12 ' B' ' 132' ' ' ILE . 11.8 p -172.34 149.6 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.715 -1.241 . . . . 0.0 111.605 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.874 HD12 ' C ' ' B' ' 131' ' ' VAL . 1.8 mp -134.91 87.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.557 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -66.73 109.98 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -0.827 . . . . 0.0 110.388 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 136' ' ' LYS . 7.2 p -76.23 148.77 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.272 -0.893 . . . . 0.0 109.971 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.732 HG22 HG22 ' A' ' 135' ' ' VAL . 93.9 t -126.55 101.13 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.887 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -88.38 114.17 24.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.57 104.72 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.7 106.89 16.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -0.851 . . . . 0.0 110.044 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.578 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.245 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 44.4 p90 -161.34 135.82 5.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.92 -159.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.484 0.95 0 O-C-N 123.042 1.022 . . . . 0.0 110.5 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.59 68.26 3.23 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 94.5 0.12 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.348 1.183 . . . . 0.0 110.453 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.67 84.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.309 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -161.4 42.1 0.15 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -113.59 -24.99 8.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.087 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -129.92 149.52 51.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.154 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.31 169.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.26 118.88 37.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -135.34 -63.55 0.67 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.197 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -138.19 96.25 3.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.168 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 tt -162.37 43.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.907 . . . . 0.0 110.276 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.3 t70 -90.07 69.01 7.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.633 HD21 HD11 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -53.79 -44.39 70.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -0.822 . . . . 0.0 110.567 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.3 p30 -53.42 -40.61 65.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -89.8 -17.28 28.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.303 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.675 ' CD1' HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -62.81 -65.93 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -82.3 -25.92 33.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' B' ' 40' ' ' LEU . 2.6 mt -117.81 -144.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.238 -0.913 . . . . 0.0 109.255 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -175.55 -37.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.871 -1.143 . . . . 0.0 110.044 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -59.89 152.54 58.9 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.93 -45.22 13.52 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.223 1.117 . . . . 0.0 110.287 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -165.64 79.51 0.3 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 0.0 110.003 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -158.55 37.79 0.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.219 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 62.4 m -132.17 148.05 52.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.146 -0.971 . . . . 0.0 110.828 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.672 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.57 154.11 42.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 110.647 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB3' HD13 ' A' ' 73' ' ' ILE . 6.8 p90 -143.6 164.55 30.1 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.21 -0.931 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.7 p -155.58 134.48 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 109.85 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 136.23 45.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.098 -1.001 . . . . 0.0 110.001 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.58 106.14 18.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.368 -0.832 . . . . 0.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -127.7 49.67 2.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.185 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.23 -147.13 5.31 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 32.0 p30 -160.7 40.43 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -1.173 . . . . 0.0 110.188 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.06 -7.11 27.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -151.77 39.25 0.62 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.024 -1.048 . . . . 0.0 110.151 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 59' ' ' ASP . 13.2 mt -55.61 -22.04 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.993 -1.067 . . . . 0.0 109.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 3.0 p30 -49.74 -33.88 17.45 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.999 0.904 . . . . 0.0 108.941 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.869 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -83.16 -33.81 22.4 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.84 -12.69 3.39 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.457 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' A' ' 61' ' ' MET . 1.4 pp -71.93 98.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.981 -1.305 . . . . 0.0 110.467 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.71 66.77 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t70 42.16 39.19 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.666 -0.646 . . . . 0.0 111.682 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.39 61.91 0.04 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.371 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.03 174.37 2.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -1.156 . . . . 0.0 110.107 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.663 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.3 tm? -128.16 107.03 9.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.157 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.926 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.1 tt -71.54 142.69 50.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.5 -0.75 . . . . 0.0 110.441 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.926 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.7 mm -134.42 98.88 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.291 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 131' ' ' VAL . 12.3 p -103.12 157.47 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.419 -0.8 . . . . 0.0 110.318 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.857 ' HB2' HG12 ' A' ' 131' ' ' VAL . 3.4 m-20 -110.84 97.31 6.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.802 -1.186 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 85.1 p -81.14 100.97 9.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.95 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 110.376 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.99 155.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.418 -0.801 . . . . 0.0 110.395 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.3 m -91.24 107.91 19.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.926 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.14 -153.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 110.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -144.86 149.87 36.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 92.7 m-70 -56.03 144.94 27.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 110.201 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.02 31.26 12.31 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.3 m-20 -143.1 149.87 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.431 -1.041 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.875 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.0 tt -69.96 69.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 80' ' ' ALA . 34.7 m -103.93 163.4 3.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.445 -0.784 . . . . 0.0 109.588 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -89.47 129.8 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 0.0 109.751 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.832 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.49 151.27 22.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 110.033 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.32 120.93 21.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.878 ' HB ' HD22 ' A' ' 125' ' ' LEU . 5.2 p -152.29 125.43 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.733 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 53.81 23.79 4.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.0 110.275 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.08 33.65 8.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.6 mm-40 -105.35 163.46 12.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.193 . . . . 0.0 110.846 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -146.39 80.54 1.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.506 -0.747 . . . . 0.0 109.507 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.832 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 69.2 p -88.35 170.67 10.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 110.592 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.869 HG11 ' HA3' ' A' ' 64' ' ' GLY . 20.0 t -134.62 106.2 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER 173.04 164.24 0.13 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.53 97.16 4.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.794 HD12 HD21 ' A' ' 101' ' ' LEU . 1.1 pt? -98.72 153.37 18.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.877 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.621 ' O ' HD23 ' A' ' 101' ' ' LEU . 12.4 mp0 -121.14 125.58 47.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.366 -0.833 . . . . 0.0 109.164 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.794 HD21 HD12 ' A' ' 99' ' ' LEU . 19.7 mt -122.79 -12.08 8.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 110.743 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -77.14 -57.7 1.09 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.91 -1.119 . . . . 0.0 110.333 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.32 -53.57 1.41 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 N-CA-C 108.937 -1.216 . . . . 0.0 108.937 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.3 m -151.71 157.05 41.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.9 m -77.72 108.47 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.065 -1.022 . . . . 0.0 109.915 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -147.36 136.74 22.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.041 -1.037 . . . . 0.0 111.13 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 119' ' ' ILE . 9.2 tp -133.79 156.26 48.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.626 -0.671 . . . . 0.0 109.577 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.7 tp -142.66 61.94 11.91 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.913 -1.117 . . . . 0.0 111.387 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.8 Cg_endo -66.06 115.94 3.73 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.482 ' CG ' ' HA ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -176.83 149.75 0.75 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.778 -1.202 . . . . 0.0 112.482 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.609 ' CG ' HD12 ' A' ' 62' ' ' ILE . 2.2 t30 -84.72 -74.96 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.1 p -117.79 -26.28 6.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.447 -0.783 . . . . 0.0 110.055 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.32 74.14 7.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.245 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' HA ' ' CG ' ' A' ' 110' ' ' MET . 52.0 p90 -61.56 131.14 49.12 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.616 0.722 . . . . 0.0 111.461 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 108' ' ' ILE . 49.6 m -131.96 96.0 21.1 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.74 123.01 12.59 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.115 1.06 . . . . 0.0 110.737 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.4 tt -133.38 125.04 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 9.6 t -80.12 136.28 36.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' LEU . 2.9 mt -84.54 170.21 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 110.171 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.6 m -53.46 -177.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 p -68.64 78.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.488 ' H ' HG11 ' A' ' 105' ' ' VAL . 14.9 mt-10 52.33 57.6 6.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.33 -0.856 . . . . 0.0 110.486 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.69 -79.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.635 ' O ' HG23 ' A' ' 90' ' ' VAL . 5.8 m -148.05 81.46 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.878 HD22 ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -131.22 104.56 7.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 0.0 110.059 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -146.3 151.97 38.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 67.9 t -70.49 153.13 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.503 -0.748 . . . . 0.0 110.017 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -99.1 -44.13 6.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.685 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -120.89 -144.28 6.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 12.3 p -142.07 10.98 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 111.129 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.857 HG12 ' HB2' ' A' ' 75' ' ' ASP . 9.8 p -168.56 170.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.884 -1.135 . . . . 0.0 111.005 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -151.84 83.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.656 ' NE2' HG21 ' A' ' 131' ' ' VAL . 28.9 m170 -74.8 125.76 29.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 64' ' ' GLY . 86.5 t -95.2 124.26 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.235 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HG22 ' B' ' 135' ' ' VAL . 40.8 t -99.92 99.07 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.83 107.23 14.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.457 -0.777 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -63.62 109.4 1.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.38 104.33 11.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.166 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.289 0.566 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.504 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 0.2 OUTLIER -71.19 -52.9 8.7 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 110.81 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_exo -61.72 99.18 0.17 Allowed 'Trans proline' 0 N--CA 1.483 0.886 0 O-C-N 122.803 0.897 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -143.31 164.66 29.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 0.0 110.168 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.38 -60.95 0.19 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.323 1.17 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.89 126.52 10.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 110.066 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.04 37.41 2.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.281 -0.887 . . . . 0.0 110.317 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.37 -70.9 0.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.39 64.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.061 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.443 HG12 ' H ' ' B' ' 36' ' ' GLN . 48.0 t -85.34 155.71 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.266 -0.896 . . . . 0.0 110.298 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.43 19.35 6.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.438 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.443 ' H ' HG12 ' B' ' 34' ' ' VAL . 3.6 tt0 -174.45 -148.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.078 -1.014 . . . . 0.0 110.085 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -129.34 -49.04 1.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 1.025 HD12 HD23 ' B' ' 40' ' ' LEU . 1.2 pt -114.98 126.49 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.463 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.405 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.4 t0 -89.96 59.94 4.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.954 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.025 HD23 HD12 ' B' ' 38' ' ' ILE . 0.7 OUTLIER -51.26 -43.18 61.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.0 110.127 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.455 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.3 p30 -54.02 -40.53 67.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.764 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -89.92 -16.95 28.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.299 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.673 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.46 -65.69 0.65 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.507 -0.746 . . . . 0.0 110.319 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.02 HD23 HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -82.51 -25.7 33.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 109.806 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 40' ' ' LEU . 2.7 mt -117.98 -144.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.421 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.6 OUTLIER -175.7 -36.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -59.97 152.62 59.42 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.06 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.07 -45.4 12.67 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.223 1.117 . . . . 0.0 110.269 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -165.35 79.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.84 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -158.61 37.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.245 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 61.2 m -131.73 148.25 52.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 110.909 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.674 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.92 154.08 43.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.618 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.727 ' HB3' HD13 ' B' ' 73' ' ' ILE . 7.0 p90 -143.65 164.58 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.102 -0.999 . . . . 0.0 110.034 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.57 134.38 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 109.877 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 136.37 46.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.074 -1.016 . . . . 0.0 109.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.67 106.16 18.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.262 -0.899 . . . . 0.0 110.439 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 49.2 m -127.72 49.5 2.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.171 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.03 -147.35 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.639 ' HB2' HD11 ' B' ' 62' ' ' ILE . 32.4 p30 -160.59 40.33 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -1.206 . . . . 0.0 110.329 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.68 -7.76 27.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.952 . . . . 0.0 110.673 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.0 OUTLIER -151.2 38.91 0.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.986 -1.071 . . . . 0.0 110.31 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' B' ' 59' ' ' ASP . 13.2 mt -54.91 -22.38 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.946 -1.096 . . . . 0.0 109.16 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.8 p30 -49.57 -33.55 15.31 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.91 0.862 . . . . 0.0 108.955 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.823 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -83.51 -33.54 22.08 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.58 -12.68 3.46 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.517 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.4 pp -72.0 98.91 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.033 -1.275 . . . . 0.0 110.429 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.59 66.85 1.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.043 -1.036 . . . . 0.0 110.361 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t70 42.04 39.16 1.25 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.625 -0.672 . . . . 0.0 111.754 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.44 61.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -175.14 174.29 2.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.202 -1.175 . . . . 0.0 110.092 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.669 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.3 tm? -127.85 107.03 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 110.177 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.932 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.1 tt -71.59 142.8 50.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 110.501 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.932 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.4 mm -134.55 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.16 -0.962 . . . . 0.0 109.262 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.674 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.2 p -103.07 157.37 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.442 -0.786 . . . . 0.0 110.353 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.889 ' HB2' HG12 ' B' ' 131' ' ' VAL . 3.3 m-20 -110.84 97.41 6.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 110.196 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.454 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 85.2 p -81.33 100.92 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.84 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.82 -63.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 110.256 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.84 155.2 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.37 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 25.6 m -91.44 108.18 19.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.869 . . . . 0.0 109.816 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.819 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.33 -153.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.13 149.35 34.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 92.9 m-70 -55.73 144.87 25.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 110.163 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.07 31.41 12.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' B' ' 86' ' ' VAL . 30.8 m-20 -143.3 149.83 38.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -1.042 . . . . 0.0 109.078 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.885 ' O ' HD13 ' B' ' 132' ' ' ILE . 8.1 tt -69.9 69.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 110.353 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.672 HG11 ' CB ' ' B' ' 80' ' ' ALA . 34.8 m -103.96 163.63 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.457 -0.777 . . . . 0.0 109.638 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -89.69 129.91 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.1 -1.0 . . . . 0.0 109.853 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' B' ' 95' ' ' THR . . . -89.39 151.95 21.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.963 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.02 120.12 19.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.501 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' B' ' 125' ' ' LEU . 5.2 p -152.48 124.25 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.55 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 55.03 21.23 3.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.0 110.268 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.06 33.76 7.57 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 20.2 mt-10 -103.33 162.06 13.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.117 -1.225 . . . . 0.0 110.867 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' B' ' 93' ' ' GLU . 25.5 m-85 -138.99 78.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.701 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.883 HG23 ' HB3' ' B' ' 109' ' ' PRO . 22.4 m -83.17 164.73 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.714 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.823 HG11 ' HA3' ' B' ' 64' ' ' GLY . 16.3 t -136.15 101.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.288 -0.882 . . . . 0.0 110.056 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 96' ' ' VAL . 0.0 OUTLIER 172.25 168.03 0.11 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.027 -1.045 . . . . 0.0 110.003 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -76.68 105.21 7.61 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.273 -0.892 . . . . 0.0 108.956 179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.784 HD12 HD21 ' B' ' 101' ' ' LEU . 1.1 pt? -108.75 153.39 23.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.994 . . . . 0.0 111.238 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.761 ' O ' HD23 ' B' ' 101' ' ' LEU . 0.0 OUTLIER -116.94 129.05 55.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.81 HD13 ' O ' ' B' ' 125' ' ' LEU . 21.6 mt -127.1 -14.68 5.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 111.104 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.541 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -79.94 -59.15 0.57 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.0 110.195 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.78 -51.23 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 N-CA-C 108.97 -1.204 . . . . 0.0 108.97 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 3.5 m -150.62 157.48 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 105' ' ' VAL . 33.5 m -87.8 102.22 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.007 -1.058 . . . . 0.0 110.205 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.2 138.46 33.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.0 110.866 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 99' ' ' LEU . 14.7 tp -133.54 156.46 47.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.765 . . . . 0.0 109.908 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' B' ' 108' ' ' ILE . 7.5 tp -138.96 64.49 34.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 111.392 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.883 ' HB3' HG23 ' B' ' 95' ' ' THR . 2.7 Cg_endo -67.23 111.76 2.35 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.005 1.003 . . . . 0.0 109.561 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER -175.85 149.9 0.97 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.808 -1.182 . . . . 0.0 112.458 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.626 ' CG ' HD12 ' B' ' 62' ' ' ILE . 2.0 t30 -85.53 -78.02 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 17.4 p -114.38 -22.5 9.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.42 77.37 6.55 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.472 -0.767 . . . . 0.0 109.066 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.5 p90 -60.93 127.76 33.14 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.502 -0.749 . . . . 0.0 111.042 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.5 m -132.75 92.6 26.23 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.717 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.4 112.17 1.1 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.262 1.138 . . . . 0.0 110.653 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.511 ' O ' HG23 ' B' ' 117' ' ' ILE . 15.4 tt -116.97 125.3 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.426 ' H ' HG22 ' B' ' 118' ' ' THR . 7.4 t -78.57 148.8 33.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.978 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.728 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.0 mt -102.39 168.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 105' ' ' VAL . 8.0 m -57.28 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.35 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 2.5 p -69.14 78.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 52.43 57.69 6.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.308 -0.87 . . . . 0.0 110.447 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.68 -78.89 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.17 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.618 ' O ' HG23 ' B' ' 90' ' ' VAL . 5.7 m -148.2 81.42 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' B' ' 90' ' ' VAL . 0.2 OUTLIER -131.2 104.65 7.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.045 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.28 151.94 38.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 67.2 t -70.5 153.14 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.96 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -99.17 -44.21 6.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -120.72 -144.38 7.03 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.04 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.819 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 12.3 p -142.06 11.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -1.165 . . . . 0.0 111.198 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.889 HG12 ' HB2' ' B' ' 75' ' ' ASP . 9.8 p -168.61 170.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.76 -1.212 . . . . 0.0 110.934 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.885 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.5 mp -151.79 83.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' B' ' 131' ' ' VAL . 28.9 m170 -74.71 125.52 28.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.383 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.518 HG21 ' O ' ' B' ' 64' ' ' GLY . 85.7 t -94.99 124.18 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 135' ' ' VAL . 39.7 t -99.91 99.25 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.521 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -81.97 107.16 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.534 -0.729 . . . . 0.0 110.344 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -63.4 109.69 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 ttt -116.63 104.14 11.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.747 ' HB3' HG23 ' A' ' 131' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.303 0.573 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 1.1 m-85 -69.76 -52.68 13.27 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.965 . . . . 0.0 110.896 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 26' ' ' PHE . 3.1 Cg_exo -61.94 92.44 0.12 Allowed 'Trans proline' 0 N--CA 1.483 0.869 0 O-C-N 122.805 0.897 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.52 171.72 7.56 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 110.369 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.35 81.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.391 1.206 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.81 -58.27 3.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.26 137.0 36.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.164 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.52 122.92 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 110.218 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -101.01 110.4 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.392 -0.818 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.98 156.31 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.149 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -85.66 103.59 14.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.46 -159.26 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 109.971 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -146.11 28.18 1.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 38' ' ' ILE . 12.1 tt -71.07 96.31 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 110.331 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 t70 -90.79 24.41 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.988 HD13 HD12 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -66.04 -60.53 2.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.604 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.662 ' CB ' HD21 ' B' ' 40' ' ' LEU . 22.3 p30 -68.7 -10.8 58.51 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.128 -0.983 . . . . 0.0 110.045 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -90.66 -55.57 3.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 111.179 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -68.71 -14.24 62.89 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 111.657 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.009 ' N ' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -110.9 -25.26 9.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.741 -1.225 . . . . 0.0 109.099 177.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.039 HD12 HD13 ' B' ' 40' ' ' LEU . 35.0 mt -143.3 171.36 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.485 -0.759 . . . . 0.0 109.464 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 45' ' ' ILE . 36.4 mt-30 -151.58 52.58 0.83 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.962 -1.086 . . . . 0.0 110.729 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.464 ' CG ' ' O ' ' A' ' 46' ' ' GLN . 43.3 m80 -154.44 147.55 18.14 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.4 -31.71 72.3 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.159 1.084 . . . . 0.0 110.049 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.8 t -176.0 43.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.445 -0.785 . . . . 0.0 109.826 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -122.82 22.94 9.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 0.0 110.096 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 76.6 m -118.93 132.52 56.09 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.165 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.647 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.39 155.15 34.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 110.015 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.809 ' HB3' HD13 ' A' ' 73' ' ' ILE . 9.7 p90 -142.64 163.57 32.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.6 p -155.35 130.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.713 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -72.44 129.72 39.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.959 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 70' ' ' ASP . . . -81.07 100.98 9.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.163 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.52 44.47 2.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.31 -164.23 15.01 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.55 43.69 1.62 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -1.137 . . . . 0.0 110.175 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -108.67 -27.58 9.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.725 ' H ' HD11 ' A' ' 66' ' ' ILE . 2.4 mpp? -122.74 41.68 3.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.844 HD12 ' CG ' ' A' ' 111' ' ' ASN . 36.1 mt -69.56 -23.0 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' HD11 ' A' ' 108' ' ' ILE . 2.5 p30 -51.36 -26.38 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -89.06 -44.93 4.94 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.56 -15.99 0.96 Allowed Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.835 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.725 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -67.38 101.19 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.311 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.22 67.14 1.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 110.463 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.0 t70 39.69 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.6 . . . . 0.0 111.92 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.14 43.96 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.152 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.7 p-10 -175.23 131.0 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -1.183 . . . . 0.0 110.258 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.4 tm? -91.16 133.38 35.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.3 tt -97.78 144.06 27.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.837 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.95 ' N ' HD23 ' A' ' 72' ' ' LEU . 10.5 mm -126.59 98.86 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.877 . . . . 0.0 108.865 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.4 p -103.23 159.46 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.413 -0.804 . . . . 0.0 110.641 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.755 ' HB3' HG12 ' A' ' 131' ' ' VAL . 32.5 t70 -124.94 98.11 5.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.989 -1.069 . . . . 0.0 110.586 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 36.2 p -80.08 100.03 8.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.708 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -173.25 -49.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.378 -0.826 . . . . 0.0 110.487 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.694 HD13 HG11 ' A' ' 130' ' ' VAL . 2.8 mp -101.75 166.5 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.198 -0.939 . . . . 0.0 110.375 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 78' ' ' ILE . 12.7 m -105.49 109.03 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.38 -0.825 . . . . 0.0 110.046 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -59.74 -157.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.925 . . . . 0.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -135.02 152.51 51.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.826 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -52.91 139.66 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.982 . . . . 0.0 110.466 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.62 35.46 11.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -141.11 129.07 21.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -1.133 . . . . 0.0 109.687 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' B' ' 138' ' ' MET . 8.5 tt -58.62 89.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 110.295 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 80' ' ' ALA . 22.9 m -136.13 175.64 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 110.038 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -92.72 125.42 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.477 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.966 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -90.0 166.14 13.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.04 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.42 134.78 14.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 110.724 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.4 p -153.06 125.21 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.547 -0.721 . . . . 0.0 110.14 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 53.31 24.38 3.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.749 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.43 30.36 8.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 19.7 mt-10 -103.98 164.27 11.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.982 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -139.65 90.36 2.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.134 -0.979 . . . . 0.0 110.83 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.966 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 6.6 p -104.95 166.62 10.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.797 ' H ' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -119.93 -154.91 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.951 -178.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' H ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 56.2 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.531 0.681 . . . . 0.0 110.576 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HD3' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -83.1 141.53 31.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 110.257 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 127' ' ' VAL . 1.7 pt? -122.12 148.19 45.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 0.0 110.099 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.771 ' O ' HD23 ' A' ' 101' ' ' LEU . 60.5 mt-30 -116.8 126.44 53.08 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.183 -0.948 . . . . 0.0 109.608 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.771 HD23 ' O ' ' A' ' 100' ' ' GLN . 14.9 mt -125.12 -13.05 6.86 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.402 -0.811 . . . . 0.0 110.667 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.596 ' HB2' ' HD3' ' A' ' 103' ' ' PRO . 1.0 OUTLIER -86.73 -47.06 0.52 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.856 -1.152 . . . . 0.0 110.365 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 102' ' ' ARG . 2.5 Cg_endo -69.79 -57.24 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.835 0 N-CA-C 108.563 -1.36 . . . . 0.0 108.563 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 105' ' ' VAL . 53.1 m -150.4 170.91 17.92 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' VAL . 30.9 m -87.98 102.13 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 110.56 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -140.43 146.25 38.05 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.787 ' HB2' HD11 ' A' ' 119' ' ' ILE . 17.8 tp -145.41 156.67 43.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.977 -1.077 . . . . 0.0 112.181 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.797 HD12 ' H ' ' A' ' 96' ' ' VAL . 4.0 tt -4.21 123.7 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.608 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' MET . 2.4 Cg_endo -72.55 -26.41 16.69 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.106 1.056 . . . . 0.0 110.191 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.8 OUTLIER 74.77 160.87 0.24 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.551 -0.718 . . . . 0.0 110.643 -179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.844 ' CG ' HD12 ' A' ' 62' ' ' ILE . 44.0 t30 -75.15 -101.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.384 -0.823 . . . . 0.0 111.255 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 p -49.1 -33.86 12.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.696 -1.252 . . . . 0.0 110.349 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.21 50.48 1.86 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.34 -0.85 . . . . 0.0 109.428 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 46.0 p90 -62.16 110.02 1.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.004 0.907 . . . . 0.0 109.94 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.1 m -173.79 114.73 0.34 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.494 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.39 102.59 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 N-CA-C 109.448 -1.02 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 107' ' ' LEU . 2.6 tp -79.51 133.35 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.116 -0.99 . . . . 0.0 110.261 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.532 ' OG1' HG23 ' A' ' 105' ' ' VAL . 9.1 t -97.07 146.68 24.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.787 HD11 ' HB2' ' A' ' 107' ' ' LEU . 5.3 mt -106.18 169.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.63 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.7 m -52.22 172.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.373 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.36 80.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.083 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 120' ' ' SER . 1.4 tp10 52.29 63.79 2.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 110.42 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.4 -80.88 0.36 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.438 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 125' ' ' LEU . 30.0 m -147.49 89.19 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.729 ' HB3' HD13 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -137.62 119.74 15.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.323 -0.861 . . . . 0.0 109.999 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -147.11 157.82 43.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.82 -1.175 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 99' ' ' LEU . 45.5 t -75.75 153.15 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.503 -0.748 . . . . 0.0 110.178 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.6 -64.63 1.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.2 -0.937 . . . . 0.0 110.536 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -96.45 -143.38 14.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.694 HG11 HD13 ' A' ' 78' ' ' ILE . 11.8 p -157.58 21.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -1.194 . . . . 0.0 111.172 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 75' ' ' ASP . 13.3 p -164.55 152.13 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.914 -1.116 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 131' ' ' VAL . 41.8 mm -143.5 68.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.5 OUTLIER -66.73 109.8 3.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.47 117.76 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.067 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' B' ' 135' ' ' VAL . 62.1 t -102.34 97.57 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 110.007 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -84.55 105.71 15.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.371 -0.83 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.62 104.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.83 ' HB3' HD13 ' B' ' 85' ' ' ILE . 4.9 mtt -114.88 102.85 10.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' B' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.262 0.553 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -158.34 85.39 2.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.199 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.76 132.03 38.13 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.285 1.15 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 41.6 p -69.59 156.85 90.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.145 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.74 81.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.043 0 O-C-N 123.273 1.144 . . . . 0.0 110.597 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.41 33.06 5.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.96 -30.22 10.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 110.165 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 177.54 3.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 110.115 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -122.43 122.97 40.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 89.2 t -80.93 -44.57 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -113.94 92.4 3.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -99.57 -50.67 4.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 110.256 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.21 139.83 21.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.25 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 tt -174.23 144.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.764 ' O ' HD12 ' B' ' 43' ' ' LEU . 3.2 t70 -90.76 27.27 1.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.461 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.039 HD13 HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -67.45 -60.92 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.675 ' CB ' HD21 ' A' ' 40' ' ' LEU . 22.4 p30 -68.86 -10.83 59.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.069 -1.019 . . . . 0.0 109.992 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -90.55 -55.66 3.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 111.148 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 1.014 HD13 ' N ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -68.66 -14.13 62.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -178.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.014 ' N ' HD13 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -111.04 -25.21 9.9 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.825 -1.172 . . . . 0.0 109.136 177.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.988 HD12 HD13 ' A' ' 40' ' ' LEU . 35.3 mt -143.38 171.29 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 109.367 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.52 ' N ' HG22 ' B' ' 45' ' ' ILE . 36.5 mt-30 -151.47 52.52 0.83 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.721 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' B' ' 46' ' ' GLN . 43.2 m80 -154.36 147.56 18.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.46 -31.8 71.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 O-C-N 123.032 1.017 . . . . 0.0 109.935 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.2 t -175.9 43.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.858 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -122.87 22.99 9.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.081 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' B' ' 75' ' ' ASP . 76.5 m -118.96 132.76 56.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 111.068 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.642 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -120.54 155.15 34.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 110.032 179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.804 ' HB3' HD13 ' B' ' 73' ' ' ILE . 9.6 p90 -142.67 163.41 32.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 0.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 54' ' ' VAL . 7.6 p -155.2 130.83 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.721 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.446 ' HE2' ' N ' ' B' ' 56' ' ' ALA . 0.0 OUTLIER -72.59 129.31 37.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 70' ' ' ASP . . . -80.62 100.97 8.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.208 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 44.24 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.187 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.06 -164.03 14.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' HB2' ' ND2' ' B' ' 111' ' ' ASN . 6.5 p-10 -142.86 44.04 1.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -1.155 . . . . 0.0 110.268 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -109.2 -27.42 9.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.33 -0.857 . . . . 0.0 110.118 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.718 ' H ' HD11 ' B' ' 66' ' ' ILE . 2.4 mpp? -123.02 42.01 3.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.944 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' B' ' 111' ' ' ASN . 38.6 mt -70.31 -22.24 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.031 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.883 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.3 p30 -51.54 -27.97 12.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 63' ' ' ASP . . . -86.74 -46.05 5.27 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.5 -15.86 0.97 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.296 -1.43 . . . . 0.0 110.855 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.718 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -67.56 100.91 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.034 -1.274 . . . . 0.0 110.332 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.88 67.14 1.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.96 -1.087 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 32.2 t70 39.57 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.795 -0.566 . . . . 0.0 111.942 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.15 43.72 0.43 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 56' ' ' ALA . 5.8 p-10 -175.08 130.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.202 -1.175 . . . . 0.0 110.303 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.66 ' C ' HD13 ' B' ' 71' ' ' LEU . 2.4 tm? -90.89 133.49 35.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.261 -0.899 . . . . 0.0 109.882 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.953 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.3 tt -97.94 144.06 27.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.694 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.953 ' N ' HD23 ' B' ' 72' ' ' LEU . 10.7 mm -126.61 98.83 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 108.846 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.642 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -103.19 159.5 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.344 -0.848 . . . . 0.0 110.682 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.733 ' HB3' HG12 ' B' ' 131' ' ' VAL . 32.6 t70 -124.96 98.16 5.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.09 -1.006 . . . . 0.0 110.601 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.441 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 37.0 p -80.18 99.97 8.05 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.204 -0.935 . . . . 0.0 109.494 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -173.19 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 110.44 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.683 HD13 HG11 ' B' ' 130' ' ' VAL . 2.8 mp -101.36 166.59 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 110.394 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.428 ' N ' HG22 ' B' ' 78' ' ' ILE . 12.9 m -105.52 108.98 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.037 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.55 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -59.63 -157.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.382 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -135.03 152.81 52.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.747 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -53.37 139.47 30.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.514 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.87 35.32 11.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.46 ' O ' HG22 ' B' ' 86' ' ' VAL . 0.9 OUTLIER -140.94 129.05 22.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -1.141 . . . . 0.0 109.631 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.83 HD13 ' HB3' ' A' ' 138' ' ' MET . 8.6 tt -58.66 89.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 110.24 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.55 HG11 ' CB ' ' B' ' 80' ' ' ALA . 22.7 m -135.7 175.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 110.061 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.461 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.6 OUTLIER -93.1 125.93 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.476 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.887 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -90.24 165.75 13.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.47 134.78 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 110.756 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.1 p -152.79 123.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 53.63 21.64 2.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.878 . . . . 0.0 110.9 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.06 33.21 6.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.473 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 0.6 OUTLIER -106.11 164.19 12.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -1.162 . . . . 0.0 110.116 179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.48 101.0 4.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 110.589 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.887 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -112.27 175.88 5.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.445 -0.785 . . . . 0.0 109.518 179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 97' ' ' LYS . 0.9 OUTLIER -136.12 -152.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.388 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.467 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.1 OUTLIER 50.95 179.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.51 -0.744 . . . . 0.0 111.126 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.429 ' HD3' ' HE3' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -80.73 141.11 35.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.3 pt? -122.88 143.63 49.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.916 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.795 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.0 mt-30 -119.39 124.12 45.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 109.632 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.795 HD23 ' O ' ' B' ' 100' ' ' GLN . 12.1 mt -125.97 -19.41 4.82 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.426 -0.796 . . . . 0.0 110.617 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -77.99 -57.07 0.99 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.982 -1.073 . . . . 0.0 110.549 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.7 Cg_endo -62.17 -53.39 2.01 Favored 'Trans proline' 0 C--N 1.322 -0.846 0 N-CA-C 109.482 -1.007 . . . . 0.0 109.482 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 105' ' ' VAL . 16.7 m -150.76 173.24 14.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.619 -0.676 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -89.77 100.26 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -142.13 145.48 34.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 0.0 110.053 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.686 HD13 HD11 ' B' ' 119' ' ' ILE . 8.0 tp -134.36 156.01 49.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.793 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.883 HD11 ' OD2' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -41.54 135.32 2.01 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.962 -0.461 . . . . 0.0 111.326 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' B' ' 110' ' ' MET . 2.5 Cg_endo -68.99 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.822 0 O-C-N 123.062 1.033 . . . . 0.0 110.174 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 158.7 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.875 ' CG ' HD12 ' B' ' 62' ' ' ILE . 9.6 t30 -62.37 -68.12 0.36 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.962 -1.086 . . . . 0.0 109.83 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 84.9 p -154.59 29.98 0.43 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.43 -74.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.896 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 114' ' ' TYR . 29.9 p90 -144.13 172.67 12.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 110.188 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 0.7 OUTLIER -53.71 -178.35 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.374 -0.829 . . . . 0.0 109.562 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -62.71 163.94 20.11 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 O-C-N 122.894 0.944 . . . . 0.0 110.371 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.434 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.1 tp -112.89 132.17 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 0.0 110.595 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.518 ' OG1' HG23 ' B' ' 105' ' ' VAL . 14.8 t -78.26 145.08 35.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.688 HD13 ' HG ' ' B' ' 125' ' ' LEU . 7.8 mt -103.64 169.9 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.6 m -51.77 171.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.223 -0.923 . . . . 0.0 110.095 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.52 79.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 110.194 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 120' ' ' SER . 1.4 tp10 52.48 64.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.53 -81.14 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -0.881 . . . . 0.0 110.421 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.5 ' O ' HD22 ' B' ' 125' ' ' LEU . 29.6 m -147.37 89.06 1.75 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 110.365 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' B' ' 101' ' ' LEU . 0.2 OUTLIER -137.46 119.89 15.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.936 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.16 157.74 43.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.84 -1.162 . . . . 0.0 110.759 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.739 HG22 HD21 ' B' ' 99' ' ' LEU . 45.7 t -75.57 153.26 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.523 -0.735 . . . . 0.0 110.084 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -93.83 -64.49 1.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.49 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -96.5 -143.47 14.9 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.683 HG11 HD13 ' B' ' 78' ' ' ILE . 11.9 p -157.58 21.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -1.201 . . . . 0.0 111.159 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.733 HG12 ' HB3' ' B' ' 75' ' ' ASP . 13.2 p -164.73 152.22 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.973 -1.079 . . . . 0.0 111.156 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 131' ' ' VAL . 41.2 mm -143.69 68.19 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.481 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -66.72 109.93 3.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 110.138 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.52 117.74 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 110.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 135' ' ' VAL . 61.7 t -102.29 97.56 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.224 -0.923 . . . . 0.0 110.007 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -84.64 105.56 15.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -0.868 . . . . 0.0 110.056 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.41 104.76 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.845 ' HB3' HD13 ' A' ' 85' ' ' ILE . 4.9 mtt -114.95 102.86 10.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.471 ' HB3' HG23 ' A' ' 131' ' ' VAL . 14.6 ptm180 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.216 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.196 0.522 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.2 155.95 36.02 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 0.0 110.114 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.37 -66.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.318 1.167 . . . . 0.0 110.446 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -130.96 71.58 82.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.32 130.73 33.22 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 O-C-N 123.33 1.174 . . . . 0.0 110.439 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.68 -178.07 5.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.248 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -158.68 97.13 1.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.92 . . . . 0.0 110.158 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.17 171.77 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.235 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 53.17 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 32.8 m -144.24 56.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 110.126 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.18 139.18 38.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -122.89 -62.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 110.285 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -172.2 68.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 110.345 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 38' ' ' ILE . 1.8 tp -159.34 54.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -90.11 71.55 7.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -0.866 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD11 ' B' ' 45' ' ' ILE . 1.7 mm? -53.91 -34.17 58.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.433 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 9.0 p30 -57.91 -43.5 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.85 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' GLN . 1.4 tt0 -87.65 -19.35 27.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.058 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -61.28 -66.44 0.54 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.747 -0.596 . . . . 0.0 110.499 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' B' ' 44' ' ' LEU . 0.8 OUTLIER -76.87 -31.97 57.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.008 -1.058 . . . . 0.0 109.957 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.879 HD11 HD11 ' B' ' 40' ' ' LEU . 1.4 mp -122.04 -132.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.09 -1.006 . . . . 0.0 109.576 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 45' ' ' ILE . 1.6 mt-30 -174.25 -36.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.343 . . . . 0.0 110.403 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 30.1 m80 -56.22 143.95 62.46 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.184 -0.948 . . . . 0.0 110.084 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.81 -54.96 0.76 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 O-C-N 123.021 1.011 . . . . 0.0 110.117 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.3 p -143.52 50.83 1.37 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.817 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.781 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -134.53 39.69 3.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 45' ' ' ILE . 57.0 m -130.47 146.78 52.08 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 110.891 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -125.71 152.5 45.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.385 -0.822 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' B' ' 43' ' ' LEU . 6.4 p90 -143.15 160.72 39.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.28 -0.887 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.6 p -155.24 133.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.065 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.01 139.68 46.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 109.993 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -101.06 101.07 11.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -125.38 52.97 1.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.86 -136.26 2.18 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.7 p30 -162.36 31.52 0.11 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 110.021 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 61' ' ' MET . 38.6 m -87.51 13.12 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.804 ' N ' HD11 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -174.99 37.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.188 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.706 HD12 ' OD1' ' A' ' 111' ' ' ASN . 20.8 mt -53.99 -23.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.019 -1.05 . . . . 0.0 108.388 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 2.9 p30 -46.98 -28.99 1.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.847 0.832 . . . . 0.0 109.663 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -93.51 -35.15 6.31 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -12.45 2.59 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.414 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.804 HD11 ' N ' ' A' ' 61' ' ' MET . 1.5 pp -67.64 98.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.007 -1.29 . . . . 0.0 110.013 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.71 66.32 1.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 110.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 41.4 66.38 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.652 -0.655 . . . . 0.0 111.883 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.76 55.27 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.26 159.53 3.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.205 -1.173 . . . . 0.0 110.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.5 tm? -117.2 116.48 27.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 110.226 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.6 tt -79.47 141.68 36.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.413 -0.805 . . . . 0.0 110.777 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.904 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mm -128.9 99.18 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.6 p -103.85 158.53 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.439 -0.788 . . . . 0.0 110.181 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.843 ' HB2' HG12 ' A' ' 131' ' ' VAL . 6.0 m-20 -115.94 98.37 6.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.947 -1.096 . . . . 0.0 110.561 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 92.0 p -78.86 101.4 7.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.661 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.781 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -56.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.932 . . . . 0.0 110.515 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 79' ' ' THR . 3.1 mp -99.14 161.68 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.303 -0.873 . . . . 0.0 110.587 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 78' ' ' ILE . 17.3 m -97.39 133.83 41.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.833 . . . . 0.0 109.929 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -84.9 -148.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.56 150.67 37.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.994 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 90.4 m-70 -53.96 142.87 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 110.425 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.03 12.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 86' ' ' VAL . 30.0 m-20 -148.6 143.11 26.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.293 -1.122 . . . . 0.0 109.302 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.791 ' O ' HD13 ' A' ' 132' ' ' ILE . 12.0 tt -63.92 83.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.13 -0.981 . . . . 0.0 109.952 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 80' ' ' ALA . 29.9 m -119.17 161.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.431 -0.793 . . . . 0.0 109.99 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -89.68 124.24 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.96 . . . . 0.0 109.912 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.35 163.07 15.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.109 -0.994 . . . . 0.0 110.123 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.04 133.73 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.631 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 4.6 p -152.67 123.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.601 -0.687 . . . . 0.0 109.803 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 54.07 23.22 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.658 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.14 33.44 6.58 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 3.6 mt-10 -107.84 164.44 12.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.157 -1.202 . . . . 0.0 110.442 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -145.11 117.54 8.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.131 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.616 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.3 p -133.0 162.17 32.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 64' ' ' GLY . 6.8 t -123.71 117.31 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.868 ' HD2' HD12 ' A' ' 107' ' ' LEU . 8.7 ptpt 169.19 155.51 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.569 -0.707 . . . . 0.0 109.892 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.82 88.88 2.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -0.957 . . . . 0.0 108.626 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 99' ' ' LEU . 2.0 pt? -77.83 146.71 35.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 111.422 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.734 ' O ' HD23 ' A' ' 101' ' ' LEU . 34.1 mt-30 -123.87 129.13 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.4 mt -126.95 -9.25 6.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.196 -0.94 . . . . 0.0 110.838 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -75.06 -60.07 1.25 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.932 -1.105 . . . . 0.0 110.031 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -64.12 -57.05 0.37 Allowed 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.414 -1.418 . . . . 0.0 108.414 178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.68 148.44 27.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 105' ' ' VAL . 35.5 m -78.5 100.29 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.964 -1.085 . . . . 0.0 109.846 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.58 148.84 31.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 119' ' ' ILE . 2.4 mm? -109.85 156.89 19.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' C ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -127.22 92.03 44.91 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.839 -1.163 . . . . 0.0 111.525 -178.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.66 148.59 87.22 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 N-CA-C 108.462 -1.399 . . . . 0.0 108.462 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.489 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 2.9 mtt -131.88 -30.05 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.682 -1.261 . . . . 0.0 111.883 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.706 ' OD1' HD12 ' A' ' 62' ' ' ILE . 3.0 t30 -46.69 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.031 -1.043 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.6 p -128.33 -28.46 2.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.34 54.46 2.76 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.144 -0.973 . . . . 0.0 110.338 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 45.5 p90 -62.81 114.08 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 0.0 109.764 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.8 m -171.99 112.65 0.39 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.611 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.1 Cg_exo -59.75 102.63 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 122.781 0.885 . . . . 0.0 110.409 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 107' ' ' LEU . 19.9 tt -91.33 141.14 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -101.54 150.33 23.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.649 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 107' ' ' LEU . 3.9 mt -113.85 174.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.464 -0.773 . . . . 0.0 109.153 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.519 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.8 m -48.65 168.26 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.15 82.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.756 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HG2' ' CG1' ' A' ' 105' ' ' VAL . 80.9 mt-10 52.58 49.54 20.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.375 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.08 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' HD22 ' A' ' 125' ' ' LEU . 5.1 m -148.78 81.21 1.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.228 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.16 112.54 14.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 110.033 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -146.46 160.88 41.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.972 -1.08 . . . . 0.0 110.702 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 39.1 t -73.03 153.54 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.559 -0.713 . . . . 0.0 110.691 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.6 -44.12 6.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.267 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -114.37 -143.79 8.4 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.2 p -147.34 14.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -1.197 . . . . 0.0 111.143 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.843 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -169.88 169.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.791 -1.193 . . . . 0.0 111.131 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.791 HD13 ' O ' ' A' ' 85' ' ' ILE . 2.0 mp -152.43 77.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.529 -0.732 . . . . 0.0 109.07 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.691 ' NE2' HG21 ' A' ' 131' ' ' VAL . 46.6 m170 -71.89 120.12 17.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.363 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.14 125.53 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG13 HG22 ' B' ' 135' ' ' VAL . 44.9 t -99.91 100.56 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 110.401 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.02 103.39 14.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 110.003 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -61.85 120.77 11.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.376 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.508 ' CG ' HD13 ' B' ' 85' ' ' ILE . 4.2 tpp -120.71 103.56 9.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HB3' HG23 ' B' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.179 0.514 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.505 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.6 m-85 -62.4 -53.18 60.25 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.3 -0.875 . . . . 0.0 110.669 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 2.9 Cg_endo -62.03 153.79 66.49 Favored 'Trans proline' 0 N--CA 1.483 0.873 0 O-C-N 122.825 0.908 . . . . 0.0 110.442 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD3' ' B' ' 29' ' ' PRO . 98.7 p -149.34 60.46 4.63 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.367 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' B' ' 28' ' ' SER . 2.9 Cg_endo -61.86 111.06 1.1 Allowed 'Trans proline' 0 C--N 1.32 -0.955 0 O-C-N 123.262 1.138 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.41 163.27 38.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -123.74 -56.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.036 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -92.06 160.73 15.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 110.051 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -120.59 142.13 49.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 110.148 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.11 153.98 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.136 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.04 -77.69 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.53 -151.37 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -127.44 74.18 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 5.7 tt -160.97 52.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 110.021 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -83.57 66.63 9.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.879 HD11 HD11 ' A' ' 45' ' ' ILE . 1.7 mm? -51.33 -33.43 29.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.48 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 9.1 p30 -58.53 -43.28 89.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 109.797 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' B' ' 46' ' ' GLN . 1.3 tt0 -87.86 -19.44 27.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.363 -0.836 . . . . 0.0 109.052 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.599 ' CD1' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.49 -66.61 0.51 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.631 -0.668 . . . . 0.0 110.435 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.928 HD23 HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -76.6 -31.87 57.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.061 -1.025 . . . . 0.0 110.029 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.9 HD11 HD11 ' A' ' 40' ' ' LEU . 1.4 mp -122.18 -132.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.121 -0.987 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' B' ' 45' ' ' ILE . 1.6 mt-30 -174.34 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.456 -1.403 . . . . 0.0 110.358 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 30.4 m80 -56.43 143.75 65.26 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.7 -55.29 0.71 Allowed 'Trans proline' 0 N--CA 1.483 0.878 0 O-C-N 122.993 0.996 . . . . 0.0 110.132 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.7 p -143.16 50.94 1.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -134.53 39.8 3.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 110.059 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.461 ' OG1' HG21 ' B' ' 45' ' ' ILE . 55.3 m -130.74 146.62 52.25 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.868 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.656 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -125.6 152.59 44.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.426 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.464 ' CB ' HD11 ' A' ' 43' ' ' LEU . 6.4 p90 -143.2 160.97 39.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.6 p -155.35 133.98 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.94 139.47 46.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.602 ' HB2' HG22 ' B' ' 66' ' ' ILE . . . -100.9 100.87 11.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 110.254 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' B' ' 68' ' ' ASP . 23.1 t -125.39 53.24 1.55 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 110.137 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.28 -136.93 2.33 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.76 31.36 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -1.115 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 37.9 m -87.01 11.12 14.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.808 ' N ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -172.75 41.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.832 HD12 ' OD1' ' B' ' 111' ' ' ASN . 27.6 mt -59.66 -22.85 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.986 -1.071 . . . . 0.0 108.41 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 2.7 p30 -48.55 -29.03 3.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.914 0.864 . . . . 0.0 109.113 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -91.68 -36.56 6.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.74 -12.78 2.42 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.418 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.808 HD11 ' N ' ' B' ' 61' ' ' MET . 1.5 pp -67.59 98.75 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.007 -1.29 . . . . 0.0 110.117 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.5 t -130.57 66.45 1.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 110.552 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' SER . 34.1 t0 41.36 66.6 0.65 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.612 -0.68 . . . . 0.0 111.734 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.54 55.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.101 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -174.06 159.51 3.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -1.18 . . . . 0.0 110.204 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.634 ' C ' HD13 ' B' ' 71' ' ' LEU . 3.5 tm? -117.02 116.49 27.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.103 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.896 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.6 tt -79.61 141.67 36.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.463 -0.773 . . . . 0.0 110.592 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.896 ' N ' HD23 ' B' ' 72' ' ' LEU . 13.1 mm -128.86 99.36 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.598 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.656 HG12 ' O ' ' B' ' 52' ' ' TYR . 12.6 p -103.74 158.49 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.823 ' HB2' HG12 ' B' ' 131' ' ' VAL . 6.0 m-20 -116.0 98.51 6.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.09 -1.006 . . . . 0.0 110.512 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.442 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.7 p -78.94 101.1 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.81 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.79 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.962 . . . . 0.0 110.503 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.404 HG22 ' N ' ' B' ' 79' ' ' THR . 3.1 mp -98.61 161.51 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 110.702 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.404 ' N ' HG22 ' B' ' 78' ' ' ILE . 17.7 m -97.23 133.94 41.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.913 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.721 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -84.99 -148.84 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -144.47 150.62 37.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.409 ' HE1' HD12 ' B' ' 101' ' ' LEU . 90.1 m-70 -53.79 142.5 23.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.467 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.61 12.4 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' B' ' 86' ' ' VAL . 29.5 m-20 -148.56 140.82 24.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.793 ' O ' HD13 ' B' ' 132' ' ' ILE . 12.4 tt -61.52 84.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.903 . . . . 0.0 110.152 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.721 HG11 ' CB ' ' B' ' 80' ' ' ALA . 30.3 m -119.97 161.25 19.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.472 -0.768 . . . . 0.0 109.916 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 87' ' ' ILE . 0.9 OUTLIER -89.76 124.31 42.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.942 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.963 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.34 164.33 14.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 110.197 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.86 133.41 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 110.648 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.9 p -152.75 125.89 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.744 . . . . 0.0 109.934 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 52.8 22.45 2.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.693 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.13 33.58 6.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.458 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 8.4 mm-40 -106.04 163.5 12.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.128 -1.219 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.412 ' CD2' HD11 ' B' ' 87' ' ' ILE . 0.1 OUTLIER -139.58 110.37 6.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 0.0 110.286 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.963 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 70.4 p -125.36 163.84 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.874 . . . . 0.0 110.163 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.628 HG12 ' H ' ' B' ' 97' ' ' LYS . 3.1 t -117.0 -178.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.628 ' H ' HG12 ' B' ' 96' ' ' VAL . 1.3 tptt 75.28 166.78 0.28 Allowed 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 121.643 0.735 . . . . 0.0 111.335 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 142.34 41.6 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.533 0.683 . . . . 0.0 111.125 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.778 ' HB2' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.59 149.72 43.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.45 -0.781 . . . . 0.0 109.869 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.67 ' O ' HD23 ' B' ' 101' ' ' LEU . 58.7 mt-30 -114.84 125.45 53.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.131 -0.98 . . . . 0.0 109.21 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.722 HD21 HD12 ' B' ' 99' ' ' LEU . 13.2 mt -125.21 -10.25 7.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.627 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.624 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -89.11 -47.64 0.42 Allowed Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.937 -1.102 . . . . 0.0 110.444 179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -71.93 -55.54 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 N-CA-C 108.426 -1.413 . . . . 0.0 108.426 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 105' ' ' VAL . 28.7 m -147.21 173.58 12.4 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.708 HG13 ' O ' ' B' ' 105' ' ' VAL . 11.2 p -99.84 100.13 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.895 -1.128 . . . . 0.0 111.048 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' B' ' 100' ' ' GLN . 11.6 pt20 -138.91 149.01 44.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.088 -1.007 . . . . 0.0 109.609 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.778 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.9 tp -145.53 152.1 39.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.889 -1.132 . . . . 0.0 113.18 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.686 HD13 ' N ' ' B' ' 110' ' ' MET . 0.1 OUTLIER 27.4 109.34 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.471 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HG2' ' HG2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -72.83 -28.93 13.0 Favored 'Trans proline' 0 N--CA 1.483 0.888 0 C-N-CA 120.465 0.777 . . . . 0.0 110.611 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.686 ' N ' HD13 ' B' ' 108' ' ' ILE . 2.9 ttm 73.69 158.94 0.21 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.832 ' OD1' HD12 ' B' ' 62' ' ' ILE . 10.0 t-20 -69.9 -119.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 110.717 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 92.9 p -47.6 -26.23 1.41 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.685 -1.26 . . . . 0.0 110.56 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.52 51.51 2.25 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.3 -0.875 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 43.3 p90 -62.19 112.24 2.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.861 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -172.0 96.45 0.39 Allowed Pre-proline 0 C--N 1.303 -1.456 0 O-C-N 121.177 -0.952 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.91 114.13 1.75 Allowed 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.019 1.01 . . . . 0.0 109.657 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.618 ' O ' HG23 ' B' ' 117' ' ' ILE . 2.9 tp -78.84 115.85 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.415 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.525 ' O ' HG23 ' B' ' 118' ' ' THR . 7.2 t -80.62 124.41 28.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.491 -0.756 . . . . 0.0 109.842 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.889 HD13 ' HG ' ' B' ' 125' ' ' LEU . 4.0 mt -101.91 170.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.917 . . . . 0.0 110.215 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.46 ' N ' ' CG2' ' B' ' 119' ' ' ILE . 2.7 m -45.91 171.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.608 0.718 . . . . 0.0 111.647 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.01 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.416 -0.802 . . . . 0.0 110.451 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 120' ' ' SER . 80.2 mt-10 51.9 48.69 22.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.561 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' B' ' 120' ' ' SER . 22.5 t70 -65.63 -84.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.677 ' O ' HD22 ' B' ' 125' ' ' LEU . 5.6 m -148.62 81.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.09 -1.006 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.889 ' HG ' HD13 ' B' ' 119' ' ' ILE . 1.5 mm? -128.09 113.04 15.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -146.68 160.8 41.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.033 -1.042 . . . . 0.0 110.735 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' B' ' 86' ' ' VAL . 39.3 t -73.04 153.58 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.586 -0.696 . . . . 0.0 110.584 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -99.63 -44.05 6.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 110.321 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -114.34 -143.59 8.35 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.603 HG22 ' O ' ' B' ' 130' ' ' VAL . 12.3 p -147.45 13.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.073 -1.251 . . . . 0.0 111.164 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.823 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -169.79 169.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.785 -1.197 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.793 HD13 ' O ' ' B' ' 85' ' ' ILE . 2.0 mp -152.49 77.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.702 ' NE2' HG21 ' B' ' 131' ' ' VAL . 45.9 m170 -71.76 120.15 16.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 110.41 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.15 125.51 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 135' ' ' VAL . 44.9 t -99.96 100.42 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.902 . . . . 0.0 110.323 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 103.85 14.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -62.02 121.15 12.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.359 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.553 ' CG ' HD13 ' A' ' 85' ' ' ILE . 4.1 tpp -121.04 103.95 9.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.508 ' HB3' HG23 ' A' ' 131' ' ' VAL . 3.9 ptt180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.379 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -134.23 65.8 69.57 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 110.058 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.96 130.92 32.69 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 O-C-N 123.271 1.143 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.0 p -163.15 156.16 16.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.46 -27.11 76.82 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.319 1.168 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.17 135.94 8.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.068 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.6 78.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -91.92 -175.6 4.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 110.425 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 39.4 p90 -156.19 25.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.356 -0.84 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 34' ' ' VAL . 33.3 m -105.48 -22.71 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.305 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -89.96 57.27 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 0.0 110.249 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.31 -155.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -115.2 -176.3 2.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 110.268 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -169.83 62.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.192 -0.943 . . . . 0.0 110.15 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -90.24 54.49 2.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.209 -0.932 . . . . 0.0 110.107 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 41' ' ' ASN . 3.6 pp -44.6 -31.91 1.28 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.683 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.907 ' N ' HD12 ' A' ' 40' ' ' LEU . 5.6 p-10 -64.75 -43.96 91.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.146 -0.971 . . . . 0.0 109.078 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.62 -8.52 58.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -77.09 -67.08 0.75 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.393 -0.817 . . . . 0.0 111.195 -179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' B' ' 44' ' ' LEU . 0.3 OUTLIER -84.59 -27.31 27.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.931 -1.105 . . . . 0.0 110.859 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 51' ' ' THR . 19.6 mm -104.97 173.97 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.928 -1.108 . . . . 0.0 109.821 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 45' ' ' ILE . 10.9 mt-30 -137.95 18.55 2.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.043 -1.036 . . . . 0.0 110.49 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 48.0 m80 -149.48 151.61 33.74 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.138 -0.976 . . . . 0.0 110.181 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.16 -56.37 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.174 1.091 . . . . 0.0 110.278 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.06 54.17 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.349 -0.844 . . . . 0.0 109.998 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -142.37 39.44 1.57 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.357 -0.839 . . . . 0.0 110.09 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.91 HG21 HG23 ' A' ' 45' ' ' ILE . 55.0 m -132.38 142.97 49.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.0 110.749 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.679 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -120.66 153.22 37.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.406 -0.809 . . . . 0.0 110.225 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' B' ' 43' ' ' LEU . 7.7 p90 -142.97 163.97 31.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 109.853 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 6.9 p -155.36 139.67 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.957 . . . . 0.0 110.002 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 130.49 40.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 110.051 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -82.81 105.49 13.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 110.278 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 61.1 1.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 110.283 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.76 -151.33 7.69 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CA ' HD11 ' A' ' 62' ' ' ILE . 7.3 p-10 -169.8 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' MET . 2.2 p -106.53 -41.45 5.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.883 . . . . 0.0 109.875 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.782 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -105.5 32.33 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.858 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' A' ' 67' ' ' SER . 5.9 mt -52.22 -25.36 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.133 -0.979 . . . . 0.0 109.329 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 61' ' ' MET . 9.0 p-10 -52.17 -37.49 54.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.418 -0.802 . . . . 0.0 109.068 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.847 ' HA3' HG11 ' A' ' 96' ' ' VAL . . . -76.43 -38.93 31.98 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 147.88 -17.78 1.41 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.318 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.782 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -72.59 98.18 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.265 . . . . 0.0 110.577 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' A' ' 62' ' ' ILE . 47.5 t -132.42 65.94 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.665 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 67' ' ' SER . 22.4 t0 28.37 97.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.41 50.98 0.59 Allowed Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.184 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 8.1 p-10 -176.54 159.76 1.94 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -1.111 . . . . 0.0 109.959 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' CD1' ' B' ' 44' ' ' LEU . 1.9 tm? -116.45 113.04 22.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 132' ' ' ILE . 3.3 tt -72.51 147.45 45.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 110.71 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.742 HD11 HD13 ' B' ' 43' ' ' LEU . 13.2 mm -132.42 98.39 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.346 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' TYR . 12.2 p -102.83 155.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 131' ' ' VAL . 84.2 m-20 -111.15 98.15 7.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.957 -1.09 . . . . 0.0 110.514 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.427 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 56.7 p -77.77 101.28 6.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.791 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.72 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.81 -59.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.8 158.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 110.314 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.7 m -90.16 121.57 32.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.791 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -60.47 -157.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.192 -0.943 . . . . 0.0 110.252 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.8 149.5 38.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 95.6 m-70 -59.82 142.17 53.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.58 39.47 8.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.65 151.42 27.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -1.098 . . . . 0.0 109.528 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -66.75 93.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.047 -1.033 . . . . 0.0 109.523 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.791 HG11 ' HB1' ' A' ' 80' ' ' ALA . 22.6 m -128.35 151.41 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 110.072 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.698 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.5 OUTLIER -88.94 117.46 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 95' ' ' THR . . . -89.17 165.14 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.47 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.08 135.21 14.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 124' ' ' THR . 5.2 p -152.97 127.61 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.724 -0.61 . . . . 0.0 109.789 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.15 21.48 3.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.2 18.7 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 4.9 mt-10 -93.8 156.81 16.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -1.2 . . . . 0.0 110.381 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.99 95.14 3.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 110.266 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 88' ' ' ALA . 1.9 p -121.07 165.33 15.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.847 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.5 t -132.04 -142.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.521 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER 65.74 162.81 0.15 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.19 -0.943 . . . . 0.0 109.869 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 125.47 29.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.155 -0.966 . . . . 0.0 110.118 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.721 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.8 pt? -122.31 152.88 39.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' O ' HD23 ' A' ' 101' ' ' LEU . 82.8 mt-30 -119.93 128.87 54.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.506 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 100' ' ' GLN . 20.1 mt -126.49 -12.38 6.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.943 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.527 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -77.07 -58.27 1.03 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.477 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.43 -52.63 3.02 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 N-CA-C 109.325 -1.067 . . . . 0.0 109.325 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 105' ' ' VAL . 89.8 m -150.85 168.75 23.53 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 105' ' ' VAL . 34.2 m -89.36 99.99 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.999 -1.063 . . . . 0.0 109.962 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -145.49 139.77 27.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 99' ' ' LEU . 1.2 tp -141.56 142.1 33.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.8 . . . . 0.0 109.605 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.647 HD11 ' N ' ' A' ' 115' ' ' SER . 2.7 tp -141.87 73.76 22.83 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.02 -1.05 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 3.2 Cg_exo -64.57 -145.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 109.213 -1.11 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' SER . 6.5 mmt 69.6 171.94 0.3 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.104 -0.998 . . . . 0.0 110.858 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' SER . 18.8 t-20 -115.65 -85.54 0.62 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.514 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -83.28 -31.9 26.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.983 . . . . 0.0 109.646 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.29 57.93 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.489 -0.757 . . . . 0.0 109.632 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 50.6 p90 -62.85 123.71 19.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.363 -0.836 . . . . 0.0 110.706 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.647 ' N ' HD11 ' A' ' 108' ' ' ILE . 37.0 m -117.18 97.87 51.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.414 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.4 Cg_exo -56.05 116.16 2.98 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 O-C-N 123.129 1.068 . . . . 0.0 110.698 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -136.64 133.43 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.254 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 118' ' ' THR . 9.7 t -93.29 160.06 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' SER . 3.5 mt -91.5 169.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -49.06 -67.39 0.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.256 -0.903 . . . . 0.0 110.373 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.3 t -174.62 69.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.192 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.624 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.4 OUTLIER 52.45 48.97 21.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.32 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.56 -72.39 0.47 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.567 ' O ' HG23 ' A' ' 90' ' ' VAL . 25.7 m -146.86 81.25 1.55 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 110.338 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 124' ' ' THR . 0.9 OUTLIER -126.5 99.52 5.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.336 -0.853 . . . . 0.0 109.758 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -146.26 152.73 39.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.968 -1.083 . . . . 0.0 110.964 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 87' ' ' ILE . 39.2 t -79.21 153.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.771 . . . . 0.0 110.036 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.05 -43.38 10.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.792 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -110.74 -150.02 12.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 130' ' ' VAL . 10.2 p -138.94 5.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -1.219 . . . . 0.0 111.361 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -160.51 169.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.781 -1.2 . . . . 0.0 110.78 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.716 HG23 HD21 ' A' ' 72' ' ' LEU . 2.4 mp -148.47 80.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.425 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.42 ' CE1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.42 14.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 110.394 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.628 HG22 ' HA3' ' A' ' 65' ' ' GLY . 45.6 t -83.51 120.85 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.01 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.646 HG22 HG13 ' B' ' 135' ' ' VAL . 39.5 t -99.88 97.76 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.876 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.77 106.53 11.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.382 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.96 105.61 2.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.86 106.03 12.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HB2' HG23 ' B' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -53.82 153.48 8.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 110.26 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.32 144.05 94.71 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.262 1.138 . . . . 0.0 110.675 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 88.6 p -143.03 92.18 6.92 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.0 110.112 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.04 124.74 15.9 Favored 'Trans proline' 0 C--N 1.32 -0.942 0 O-C-N 123.155 1.082 . . . . 0.0 110.61 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.93 119.37 19.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.893 . . . . 0.0 110.234 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -166.97 68.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -89.74 47.32 1.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 102.24 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -0.918 . . . . 0.0 110.224 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.52 -177.86 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.105 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -143.41 68.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 110.224 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' B' ' 38' ' ' ILE . 1.0 OUTLIER -100.28 -54.86 2.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.23 -71.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.395 -0.816 . . . . 0.0 110.203 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.606 ' O ' HG23 ' B' ' 38' ' ' ILE . 0.5 OUTLIER -160.98 72.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.059 -1.026 . . . . 0.0 110.561 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -90.3 50.68 1.88 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 109.776 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.902 HD12 ' N ' ' B' ' 41' ' ' ASN . 3.6 pp -45.32 -32.5 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.599 -0.688 . . . . 0.0 110.802 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.902 ' N ' HD12 ' B' ' 40' ' ' LEU . 5.7 p-10 -64.83 -43.99 91.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.054 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.52 -8.62 58.86 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.191 -0.943 . . . . 0.0 109.291 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -77.44 -67.03 0.76 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.322 -0.861 . . . . 0.0 111.17 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.792 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -84.54 -27.28 27.44 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.1 . . . . 0.0 110.898 -179.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.923 HG23 HG21 ' B' ' 51' ' ' THR . 19.8 mm -105.15 173.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.934 -1.103 . . . . 0.0 109.899 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.492 ' H ' HG22 ' B' ' 45' ' ' ILE . 11.1 mt-30 -137.81 18.63 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.544 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 47.2 m80 -149.53 151.67 33.72 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.3 -56.19 0.59 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 O-C-N 123.2 1.105 . . . . 0.0 110.3 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.97 54.25 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -0.83 . . . . 0.0 109.973 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -142.45 39.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.923 HG21 HG23 ' B' ' 45' ' ' ILE . 55.3 m -132.31 143.2 49.72 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 110.818 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.692 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -121.01 153.24 37.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.523 -0.735 . . . . 0.0 110.268 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.585 ' CB ' HD11 ' A' ' 43' ' ' LEU . 7.7 p90 -142.95 164.18 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 109.901 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.0 p -155.44 139.62 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.934 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 130.63 40.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.028 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -82.73 105.62 13.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.221 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.24 61.32 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.2 -151.4 7.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.561 ' CA ' HD11 ' B' ' 62' ' ' ILE . 7.4 p-10 -169.61 30.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.416 ' O ' ' N ' ' B' ' 111' ' ' ASN . 2.2 p -106.49 -40.52 5.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.145 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.786 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.1 OUTLIER -106.69 32.17 4.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.925 HG23 ' HB2' ' B' ' 67' ' ' SER . 6.3 mt -51.76 -25.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.314 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' B' ' 61' ' ' MET . 9.1 p-10 -51.56 -37.69 50.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.437 -0.789 . . . . 0.0 109.106 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.908 ' HA3' HG11 ' B' ' 96' ' ' VAL . . . -76.44 -38.7 32.51 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 108.599 -1.801 . . . . 0.0 108.599 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.644 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 147.55 -17.77 1.47 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.514 -1.327 . . . . 0.0 110.416 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.786 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -72.61 98.0 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.256 . . . . 0.0 110.497 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.925 ' HB2' HG23 ' B' ' 62' ' ' ILE . 48.1 t -132.21 65.85 1.57 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.04 -1.037 . . . . 0.0 110.691 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' B' ' 67' ' ' SER . 22.3 t0 28.51 97.15 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.21 51.19 0.6 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.741 -1.218 . . . . 0.0 110.153 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 8.1 p-10 -176.63 159.52 1.87 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 110.044 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 44' ' ' LEU . 1.9 tm? -116.25 112.87 22.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.735 HD21 HG23 ' B' ' 132' ' ' ILE . 3.3 tt -72.29 147.23 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.463 -0.773 . . . . 0.0 110.833 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 44' ' ' LEU . 13.8 mm -132.11 98.28 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.692 HG12 ' O ' ' B' ' 52' ' ' TYR . 11.7 p -102.73 155.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.837 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.828 ' HB2' HG12 ' B' ' 131' ' ' VAL . 83.5 m-20 -111.15 98.2 7.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.108 . . . . 0.0 110.552 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 57.9 p -77.81 101.49 6.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.728 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.723 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.94 -59.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.57 158.43 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.334 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 90.9 m -90.24 121.61 32.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.428 -0.795 . . . . 0.0 110.03 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.79 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -60.32 -157.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.325 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -142.85 149.29 38.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.76 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 95.7 m-70 -59.48 142.55 52.25 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 110.311 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.07 39.23 8.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.54 150.98 27.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -1.115 . . . . 0.0 109.47 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.659 HG23 ' O ' ' B' ' 85' ' ' ILE . 0.0 OUTLIER -66.53 93.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.995 -1.066 . . . . 0.0 109.444 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.79 HG11 ' HB1' ' B' ' 80' ' ' ALA . 22.8 m -128.57 151.63 35.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.965 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.688 ' O ' HG13 ' B' ' 127' ' ' VAL . 0.5 OUTLIER -88.89 118.05 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.389 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.53 165.31 14.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.567 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 135.3 14.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 110.486 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 124' ' ' THR . 5.1 p -153.15 127.59 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.623 -0.673 . . . . 0.0 109.876 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 53.43 22.83 3.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.264 -0.898 . . . . 0.0 110.634 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.4 26.05 14.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.455 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 24.0 mm-40 -96.8 162.33 13.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 110.216 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.4 96.34 3.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 62.9 p -119.06 167.95 11.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.437 -0.79 . . . . 0.0 109.674 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.908 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.5 t -136.07 -141.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.736 ' HG2' HG23 ' B' ' 108' ' ' ILE . 28.1 tptt 60.02 166.1 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 0.0 110.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.89 124.97 28.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.313 -0.867 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.714 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.8 pt? -121.57 148.94 43.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.085 -1.009 . . . . 0.0 110.244 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.724 ' O ' HD23 ' B' ' 101' ' ' LEU . 35.8 mt-30 -116.84 128.72 55.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.724 HD23 ' O ' ' B' ' 100' ' ' GLN . 20.2 mt -124.88 -11.83 7.12 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.368 -0.832 . . . . 0.0 110.799 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -76.98 -59.07 0.96 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.937 -1.102 . . . . 0.0 110.202 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.12 -52.86 2.38 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.062 -1.168 . . . . 0.0 109.062 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.0 m -150.97 164.33 36.65 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.679 HG11 ' H ' ' B' ' 122' ' ' GLU . 34.3 m -88.12 100.27 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.067 -1.02 . . . . 0.0 110.055 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -140.78 136.61 32.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 110.614 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.633 ' CD1' HD13 ' B' ' 99' ' ' LEU . 5.6 tp -130.86 156.09 45.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.753 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.736 HG23 ' HG2' ' B' ' 97' ' ' LYS . 5.2 tp -146.14 66.26 11.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.954 -1.091 . . . . 0.0 111.226 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.8 Cg_endo -69.3 110.15 2.39 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 O-C-N 123.178 1.094 . . . . 0.0 109.572 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' B' ' 114' ' ' TYR . 0.0 OUTLIER 178.68 171.0 0.82 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.946 -1.096 . . . . 0.0 111.36 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.533 ' CB ' HD12 ' B' ' 62' ' ' ILE . 2.3 t-20 -108.03 -79.04 0.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -106.94 -23.08 12.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.619 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.33 74.49 6.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.483 -0.76 . . . . 0.0 109.06 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.475 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 45.0 p90 -61.13 121.71 13.18 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.571 0.701 . . . . 0.0 111.21 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 61.3 m -121.22 93.06 48.81 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.06 109.98 0.61 Allowed 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.165 1.087 . . . . 0.0 110.818 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.589 HD13 ' N ' ' B' ' 118' ' ' THR . 0.1 OUTLIER -121.83 121.15 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.589 ' N ' HD13 ' B' ' 117' ' ' ILE . 9.7 t -86.32 145.93 26.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.116 -0.99 . . . . 0.0 110.058 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.518 HG22 ' N ' ' B' ' 120' ' ' SER . 3.8 mt -84.48 168.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.0 110.181 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.518 ' N ' HG22 ' B' ' 119' ' ' ILE . 0.5 OUTLIER -51.3 -69.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 110.653 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 8.5 t -173.57 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.24 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.679 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.4 OUTLIER 52.01 48.71 22.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.259 -0.901 . . . . 0.0 110.302 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.42 -72.6 0.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.281 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 90' ' ' VAL . 26.3 m -146.69 81.43 1.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.545 HD22 ' O ' ' B' ' 124' ' ' THR . 0.9 OUTLIER -126.65 99.09 5.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.706 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -146.07 152.74 39.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.972 -1.08 . . . . 0.0 110.979 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 87' ' ' ILE . 38.8 t -79.11 153.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.754 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.09 -43.47 10.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -110.65 -149.9 12.14 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.027 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.554 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.3 p -139.09 5.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -1.186 . . . . 0.0 111.43 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.828 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -160.51 168.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.782 -1.199 . . . . 0.0 110.84 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.735 HG23 HD21 ' B' ' 72' ' ' LEU . 2.4 mp -148.27 80.34 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.389 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.409 ' CE1' HG21 ' B' ' 131' ' ' VAL . 0.3 OUTLIER -75.79 114.31 14.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.354 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.644 HG22 ' HA3' ' B' ' 65' ' ' GLY . 45.4 t -83.38 120.95 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.083 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.646 HG13 HG22 ' A' ' 135' ' ' VAL . 39.3 t -99.9 97.71 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.87 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.75 106.45 11.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -0.858 . . . . 0.0 110.432 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.8 105.58 2.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.9 mtt -117.97 106.46 12.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 110.248 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.565 ' HB2' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.17 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.206 0.527 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.35 155.2 48.86 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.78 161.23 25.89 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.211 1.111 . . . . 0.0 110.501 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 31' ' ' ALA . 7.0 t -141.51 73.19 24.96 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.301 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.63 -39.42 54.29 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.29 1.152 . . . . 0.0 110.572 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 107.02 9.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 110.204 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' OG ' ' A' ' 28' ' ' SER . . . -136.53 41.26 2.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.54 111.55 2.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.331 -0.856 . . . . 0.0 110.267 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 52.5 67.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.243 -0.911 . . . . 0.0 110.375 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' CG2' ' HB1' ' A' ' 31' ' ' ALA . 48.5 t -66.76 -27.73 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.83 124.08 48.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.164 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -96.48 -160.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.186 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.22 -59.01 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.472 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -84.31 57.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 110.075 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.31 76.13 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.336 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.941 HD11 HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -52.58 -43.8 65.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.994 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.71 ' HA ' HD22 ' B' ' 40' ' ' LEU . 13.4 p-10 -53.92 -42.57 68.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.487 -0.758 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -87.96 -16.43 33.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.569 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.653 HD13 HD11 ' B' ' 73' ' ' ILE . 0.0 OUTLIER -64.24 -63.93 1.02 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.514 -0.741 . . . . 0.0 110.314 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -89.69 -38.46 13.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 110.29 -179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.94 HD12 HD11 ' B' ' 40' ' ' LEU . 55.3 mt -107.7 173.24 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 109.803 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.516 ' N ' HG22 ' A' ' 45' ' ' ILE . 29.8 mt-30 -130.77 -46.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.977 -1.077 . . . . 0.0 110.687 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 34.1 m80 -52.54 143.64 27.19 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 110.168 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.65 -34.85 61.57 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 O-C-N 123.059 1.031 . . . . 0.0 110.203 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.19 50.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 0.0 109.713 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.702 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -136.07 40.51 2.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 45' ' ' ILE . 28.6 m -134.68 134.3 40.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.137 -0.977 . . . . 0.0 110.849 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.701 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -111.12 153.11 26.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.502 -0.749 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.783 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.0 p90 -143.64 160.28 40.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.313 -0.867 . . . . 0.0 110.303 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.1 p -155.52 132.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.2 -0.938 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.37 140.58 48.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.132 -0.98 . . . . 0.0 110.294 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -102.14 101.96 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.866 . . . . 0.0 110.252 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 m -130.73 65.42 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.89 -134.73 2.28 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.727 ' HB2' HD11 ' A' ' 62' ' ' ILE . 40.0 p-10 -172.79 38.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -1.141 . . . . 0.0 110.181 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -99.36 -28.04 13.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.254 -0.904 . . . . 0.0 110.244 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.1 mtt -124.29 39.42 3.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 110.107 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.935 HG23 ' OG ' ' A' ' 67' ' ' SER . 78.6 mt -66.42 -12.53 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.414 -0.804 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 6.3 p30 -47.43 -24.12 0.75 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . 161.03 39.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -142.67 -63.73 0.03 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.4 pp -128.2 123.94 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -1.211 . . . . 0.0 110.718 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.935 ' OG ' HG23 ' A' ' 62' ' ' ILE . 2.7 m -131.25 65.77 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.938 . . . . 0.0 110.539 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.75 98.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.13 58.64 0.97 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.531 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' OD2' ' CB ' ' A' ' 56' ' ' ALA . 4.6 p-10 -176.91 122.96 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.223 -1.163 . . . . 0.0 110.003 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' B' ' 44' ' ' LEU . 3.4 tm? -86.71 111.31 20.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 73' ' ' ILE . 5.0 tt -72.08 142.03 49.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 72' ' ' LEU . 11.4 mm -132.56 97.95 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 109.02 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.9 p -99.39 149.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.851 . . . . 0.0 110.14 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.837 ' HB2' HG12 ' A' ' 131' ' ' VAL . 8.1 m-20 -105.71 98.71 8.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.661 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 96.3 p -81.08 101.42 9.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 109.657 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -175.83 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 79' ' ' THR . 2.7 mp -102.74 170.75 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.383 -0.823 . . . . 0.0 110.198 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.501 ' N ' HG22 ' A' ' 78' ' ' ILE . 92.6 m -98.56 139.11 34.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.725 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -82.63 -150.84 0.09 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.366 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.26 149.08 34.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.499 ' CD2' ' HD3' ' A' ' 102' ' ' ARG . 92.9 m-70 -56.74 141.83 42.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.283 -0.885 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.74 37.22 8.74 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 86' ' ' VAL . 4.1 m-20 -154.54 141.18 18.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -1.049 . . . . 0.0 109.449 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.74 ' O ' HD13 ' A' ' 132' ' ' ILE . 8.7 tt -60.01 90.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.921 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.725 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.8 m -124.99 157.85 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.5 tp -89.48 109.34 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.32 159.79 17.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.58 145.67 23.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.89 . . . . 0.0 110.477 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 124' ' ' THR . 3.7 p -153.07 125.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.606 -0.684 . . . . 0.0 109.86 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 53.11 22.07 2.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.356 -0.84 . . . . 0.0 110.74 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.52 31.37 6.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 11.1 mt-10 -107.61 164.19 12.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -1.166 . . . . 0.0 110.401 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -141.02 130.88 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 110.253 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.1 p -145.0 145.95 31.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG11 ' CA ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -122.43 97.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.211 -0.931 . . . . 0.0 109.535 -179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 108' ' ' ILE . 2.0 tptt -173.44 163.27 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 110.393 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -76.86 93.79 3.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.886 . . . . 0.0 109.159 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.809 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.6 pt? -99.7 153.71 18.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 111.358 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.832 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.6 mt-30 -125.34 135.4 52.41 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 100' ' ' GLN . 23.5 mt -129.79 -10.8 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 111.092 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.1 OUTLIER -82.82 -62.12 0.31 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.831 -1.168 . . . . 0.0 110.08 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.94 3.51 Favored 'Trans proline' 0 N--CA 1.481 0.768 0 N-CA-C 108.603 -1.345 . . . . 0.0 108.603 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 105' ' ' VAL . 63.2 m -150.66 168.14 25.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.852 HG23 ' HG1' ' A' ' 118' ' ' THR . 31.5 m -101.54 100.34 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.988 -1.07 . . . . 0.0 110.241 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -135.66 141.26 44.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.212 -0.93 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -145.65 141.05 27.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.547 -0.721 . . . . 0.0 109.416 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -147.76 65.47 9.13 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.916 -1.115 . . . . 0.0 112.261 -179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 108' ' ' ILE . 2.5 Cg_endo -70.26 -149.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.451 ' N ' ' OD2' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 68.29 152.47 0.09 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.972 -1.08 . . . . 0.0 111.362 177.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.806 ' CG ' HD12 ' A' ' 62' ' ' ILE . 7.6 t-20 -99.81 -83.57 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.558 -0.714 . . . . 0.0 109.757 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.2 p -76.05 -26.45 56.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.9 42.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.819 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.2 p90 -62.71 119.06 8.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.939 . . . . 0.0 110.434 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.421 ' C ' HD13 ' A' ' 108' ' ' ILE . 14.8 m -131.37 86.22 50.86 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.793 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.8 105.49 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 O-C-N 123.292 1.154 . . . . 0.0 110.028 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.15 155.3 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 110.282 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.852 ' HG1' HG23 ' A' ' 105' ' ' VAL . 5.2 t -100.63 144.15 29.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG21 HD23 ' A' ' 125' ' ' LEU . 4.1 mt -75.28 169.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.968 . . . . 0.0 109.877 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 119' ' ' ILE . 11.9 m -70.58 84.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.101 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 9.4 p 49.59 50.3 18.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 110.621 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.852 ' N ' HG11 ' A' ' 105' ' ' VAL . 1.4 tt0 53.14 51.63 15.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.49 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -53.84 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 110.008 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' A' ' 125' ' ' LEU . 62.3 m -148.55 81.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.185 -0.947 . . . . 0.0 110.122 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 124' ' ' THR . 3.8 mm? -123.47 115.47 21.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -0.926 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -146.32 159.93 42.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 86' ' ' VAL . 43.1 t -87.19 153.21 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.65 -38.18 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 110.189 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -108.39 -150.78 15.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -142.44 9.09 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 111.092 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.5 p -172.28 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.791 -1.193 . . . . 0.0 111.047 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.773 HG23 HD21 ' A' ' 72' ' ' LEU . 2.3 mp -148.74 82.76 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.469 ' NE2' ' CB ' ' B' ' 137' ' ' ALA . 26.8 m80 -67.15 120.11 13.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.47 124.82 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -0.864 . . . . 0.0 109.948 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 HG13 ' B' ' 135' ' ' VAL . 21.5 t -99.69 97.81 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.111 -0.993 . . . . 0.0 109.787 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -84.93 103.25 13.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.472 ' CB ' ' NE2' ' B' ' 133' ' ' HIS . . . -63.05 106.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.136 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.05 102.92 11.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 110.257 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' B' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.238 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.234 0.54 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 86.18 51.63 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.67 -164.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.326 1.172 . . . . 0.0 110.551 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -162.47 78.48 1.92 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.105 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.18 -54.3 1.9 Allowed 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.252 1.133 . . . . 0.0 110.52 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.95 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.343 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.2 -69.11 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.77 106.87 18.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.13 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.83 118.62 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.892 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -178.62 5.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 110.174 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.02 -149.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.926 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 154.47 29.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 110.048 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.3 tt -141.53 49.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.946 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -88.38 81.69 7.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.4 -0.813 . . . . 0.0 110.528 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.94 HD11 HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -53.24 -43.82 67.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.924 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.725 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.5 p-10 -53.59 -42.66 67.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.385 -0.822 . . . . 0.0 109.924 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -87.74 -17.02 32.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.417 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -63.65 -64.3 0.93 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.457 -0.777 . . . . 0.0 110.355 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.978 HD23 HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -89.44 -38.51 14.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.309 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.941 HD12 HD11 ' A' ' 40' ' ' LEU . 55.5 mt -107.57 173.1 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.507 ' N ' HG22 ' B' ' 45' ' ' ILE . 29.8 mt-30 -130.57 -45.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.018 -1.051 . . . . 0.0 110.663 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 34.1 m80 -52.78 143.62 29.13 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 110.198 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.55 -34.76 63.12 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 O-C-N 123.088 1.046 . . . . 0.0 110.211 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -165.28 50.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.814 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -136.4 40.55 2.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.845 . . . . 0.0 110.01 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.562 HG21 HD13 ' B' ' 45' ' ' ILE . 29.0 m -134.63 134.21 40.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.788 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.7 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -110.91 153.19 25.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.803 . . . . 0.0 110.068 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.798 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.0 p90 -143.74 160.11 41.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.4 132.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 140.58 48.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.233 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -102.23 101.85 12.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -0.891 . . . . 0.0 110.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 15.6 m -130.61 65.37 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.81 -134.64 2.25 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.743 ' HB2' HD11 ' B' ' 62' ' ' ILE . 40.0 p-10 -172.8 38.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -1.145 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 30.6 t -99.17 -29.1 13.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.072 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -123.94 48.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 109.427 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.919 HG23 ' OG ' ' B' ' 67' ' ' SER . 86.3 mt -75.69 -10.39 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.0 109.789 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.74 ' OD2' HD11 ' B' ' 108' ' ' ILE . 2.9 p30 -49.54 -23.78 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.488 ' O ' HD11 ' B' ' 85' ' ' ILE . . . 162.3 35.02 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.777 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.592 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -137.89 -63.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.194 0 O-C-N 120.846 -1.385 . . . . 0.0 109.972 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.62 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.4 pp -128.06 124.35 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -1.201 . . . . 0.0 110.841 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.919 ' OG ' HG23 ' B' ' 62' ' ' ILE . 2.5 m -131.45 65.63 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 32.92 98.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.08 58.4 0.98 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.522 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' CB ' ' B' ' 56' ' ' ALA . 4.6 p-10 -176.54 123.27 0.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -1.16 . . . . 0.0 110.126 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 44' ' ' LEU . 3.4 tm? -86.98 110.85 20.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 110.053 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.941 HD23 ' N ' ' B' ' 73' ' ' ILE . 5.0 tt -71.82 142.16 49.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.492 -0.755 . . . . 0.0 110.932 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.941 ' N ' HD23 ' B' ' 72' ' ' LEU . 11.2 mm -132.65 98.04 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.357 -0.839 . . . . 0.0 108.949 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.7 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.9 p -99.5 150.01 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.107 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.851 ' HB2' HG12 ' B' ' 131' ' ' VAL . 8.2 m-20 -105.91 98.81 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 110.664 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 95.4 p -81.2 101.46 9.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.668 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.709 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -175.93 -56.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.222 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.507 HG22 ' N ' ' B' ' 79' ' ' THR . 2.7 mp -102.75 170.73 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.355 -0.841 . . . . 0.0 110.186 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.507 ' N ' HG22 ' B' ' 78' ' ' ILE . 92.4 m -98.48 138.94 34.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.075 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.72 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -82.48 -151.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -145.18 148.89 34.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.927 . . . . 0.0 110.129 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' B' ' 101' ' ' LEU . 92.1 m-70 -56.09 142.45 36.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 37.05 9.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.43 ' O ' HG22 ' B' ' 86' ' ' VAL . 4.0 m-20 -154.43 140.11 18.0 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.25 -1.147 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.742 ' O ' HD13 ' B' ' 132' ' ' ILE . 9.6 tt -58.45 90.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.108 -0.995 . . . . 0.0 110.028 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.72 HG11 ' HB1' ' B' ' 80' ' ' ALA . 36.0 m -125.32 157.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 110.025 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.658 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.5 tp -89.59 109.53 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.91 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.875 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.46 159.68 17.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.6 145.48 23.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 110.636 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 124' ' ' THR . 3.7 p -153.12 122.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.565 -0.709 . . . . 0.0 109.862 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 53.5 20.81 2.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.306 -0.871 . . . . 0.0 111.19 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.27 33.18 4.65 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.194 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.46 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.4 mm-40 -111.1 164.13 13.16 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.186 -1.184 . . . . 0.0 110.376 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -138.06 120.8 16.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.481 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.875 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 26.8 p -137.67 116.05 11.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -0.809 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.808 ' H ' HD12 ' B' ' 108' ' ' ILE . 0.9 OUTLIER -83.78 -171.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.532 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.588 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 72.08 179.63 0.23 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.458 0.647 . . . . 0.0 110.639 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HG2' ' HD3' ' B' ' 97' ' ' LYS . 3.7 pttt -85.03 136.01 33.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.805 . . . . 0.0 111.095 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.693 HD23 ' H ' ' B' ' 99' ' ' LEU . 1.6 pt? -122.6 148.55 45.1 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.491 -0.756 . . . . 0.0 109.354 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.858 ' O ' HD23 ' B' ' 101' ' ' LEU . 24.5 mt-30 -113.76 129.06 56.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 109.802 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.858 HD23 ' O ' ' B' ' 100' ' ' GLN . 14.7 mt -127.64 -13.45 5.35 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.841 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.554 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 2.0 mpt_? -90.46 -62.5 0.2 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 120.815 -1.178 . . . . 0.0 110.468 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -63.27 -48.62 5.84 Favored 'Trans proline' 0 N--CA 1.483 0.861 0 N-CA-C 109.081 -1.161 . . . . 0.0 109.081 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.502 HG22 ' N ' ' B' ' 105' ' ' VAL . 29.7 m -150.05 173.27 14.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' B' ' 105' ' ' VAL . 32.7 m -106.99 102.17 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 111.247 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -133.72 154.9 50.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.225 -0.922 . . . . 0.0 109.53 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' B' ' 99' ' ' LEU . 5.4 tp -139.04 156.4 47.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.961 -1.087 . . . . 0.0 112.443 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.808 HD12 ' H ' ' B' ' 96' ' ' VAL . 3.6 tt -15.08 123.15 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.49 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.436 ' CD ' ' HD2' ' B' ' 97' ' ' LYS . 2.4 Cg_endo -73.95 -25.31 14.3 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 O-C-N 123.082 1.043 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.438 ' SD ' ' CE2' ' B' ' 114' ' ' TYR . 3.6 ttt 70.03 153.69 0.12 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.176 -0.953 . . . . 0.0 110.058 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.566 ' CG ' HD12 ' B' ' 62' ' ' ILE . 7.9 t-20 -46.73 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.398 -0.813 . . . . 0.0 110.964 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.8 p -128.14 13.24 6.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.926 -1.109 . . . . 0.0 110.584 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.22 -78.09 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.998 . . . . 0.0 109.734 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.438 ' CE2' ' SD ' ' B' ' 110' ' ' MET . 36.4 p90 -143.59 146.56 33.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.09 -1.006 . . . . 0.0 110.143 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.6 m -50.53 168.8 0.22 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.93 144.86 54.29 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.095 1.05 . . . . 0.0 110.332 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -107.9 146.79 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.562 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.629 ' OG1' HG23 ' B' ' 105' ' ' VAL . 7.4 t -95.83 145.92 24.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.642 HG21 HD23 ' B' ' 125' ' ' LEU . 3.9 mt -92.33 167.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 110.361 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.475 ' N ' HG22 ' B' ' 119' ' ' ILE . 11.6 m -77.28 89.88 3.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.38 -0.825 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 10.7 p 48.3 50.94 15.79 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.294 -0.878 . . . . 0.0 110.636 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.663 ' H ' HG11 ' B' ' 105' ' ' VAL . 1.4 tt0 52.49 51.79 15.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -54.04 -79.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 110.041 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.699 ' O ' HD22 ' B' ' 125' ' ' LEU . 66.1 m -148.48 81.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.245 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.699 HD22 ' O ' ' B' ' 124' ' ' THR . 3.8 mm? -123.44 116.76 23.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 110.06 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -147.09 160.05 42.87 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 0.0 110.285 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.469 HG11 ' HB ' ' B' ' 86' ' ' VAL . 43.5 t -87.31 153.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.411 -0.806 . . . . 0.0 110.361 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.69 -38.03 10.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.129 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -108.54 -151.0 15.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.604 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.6 p -142.34 9.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -1.195 . . . . 0.0 111.158 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.851 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.5 p -172.4 171.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.863 -1.148 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.781 HG23 HD21 ' B' ' 72' ' ' LEU . 2.3 mp -148.82 82.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.472 ' NE2' ' CB ' ' A' ' 137' ' ' ALA . 27.2 m80 -66.85 120.04 12.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.558 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 47.2 t -93.46 124.8 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.92 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 135' ' ' VAL . 21.4 t -99.67 97.78 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.963 . . . . 0.0 109.821 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -84.82 103.17 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.383 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.469 ' CB ' ' NE2' ' A' ' 133' ' ' HIS . . . -63.16 106.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.086 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -109.96 102.96 11.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.244 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.532 ' HB2' HG23 ' A' ' 131' ' ' VAL . 3.2 ttt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.183 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.185 0.516 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 19.0 p90 -53.97 154.29 7.7 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.278 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.76 103.21 0.27 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.274 1.144 . . . . 0.0 110.518 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.498 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -54.2 -52.81 65.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.78 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 28' ' ' SER . 3.0 Cg_endo -62.43 119.86 7.14 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 O-C-N 122.886 0.94 . . . . 0.0 110.558 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.2 -162.93 1.04 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.272 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -156.04 -160.79 1.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.91 -47.1 1.38 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.881 . . . . 0.0 110.183 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -93.7 47.62 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.6 t -54.79 -40.97 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.175 -0.953 . . . . 0.0 110.284 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' HG3' ' ND2' ' A' ' 41' ' ' ASN . 1.1 tt0 -148.17 37.42 0.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 110.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.28 -55.45 2.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.319 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -49.11 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.23 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.93 95.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.5 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 43' ' ' LEU . 3.6 t0 -82.42 69.75 9.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.834 HD21 HG13 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -49.39 -50.19 41.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 111.042 -179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.705 ' HA ' HD13 ' B' ' 40' ' ' LEU . 9.6 p30 -50.33 -41.66 51.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 0.0 110.257 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 5.2 tt0 -89.86 -16.73 29.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.876 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -65.02 -65.03 0.72 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 110.222 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -90.13 -18.12 26.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.501 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.961 HD13 HG21 ' A' ' 51' ' ' THR . 3.6 mt -143.73 -141.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.102 -0.999 . . . . 0.0 109.263 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.9 mt-30 -167.96 -84.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.706 -1.246 . . . . 0.0 109.781 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.535 ' N ' ' CD2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -47.38 105.13 0.46 Allowed Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.457 -0.777 . . . . 0.0 110.409 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.13 -13.96 42.2 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 122.989 0.994 . . . . 0.0 111.236 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -116.1 31.25 6.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.982 -1.074 . . . . 0.0 110.948 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB3' ' CG ' ' A' ' 47' ' ' HIS . . . -158.2 46.32 0.34 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 109.842 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.961 HG21 HD13 ' A' ' 45' ' ' ILE . 90.7 m -135.47 134.13 39.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 111.242 -178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.648 ' HB3' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -127.71 151.9 48.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.5 -0.75 . . . . 0.0 109.313 179.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 16.0 p90 -142.46 166.01 25.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.967 . . . . 0.0 110.609 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.1 p -155.49 134.54 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 109.779 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.67 132.73 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -89.06 109.22 20.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.17 43.58 2.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.876 . . . . 0.0 110.362 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.7 -162.94 18.1 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' CB ' HD11 ' A' ' 62' ' ' ILE . 14.1 p-10 -142.16 16.59 2.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -1.156 . . . . 0.0 110.3 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.1 9.71 36.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.99 22.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 110.122 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.607 HD11 ' CB ' ' A' ' 59' ' ' ASP . 14.9 mt -57.09 -25.61 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.053 -1.029 . . . . 0.0 109.196 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.96 -27.97 47.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 109.32 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.804 ' O ' HD11 ' A' ' 85' ' ' ILE . . . -85.21 -44.73 6.14 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' HG22 ' A' ' 134' ' ' VAL . . . 148.16 33.76 0.05 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.755 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.8 pp -129.33 108.01 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.969 -1.312 . . . . 0.0 110.368 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.5 p -131.14 66.89 1.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.916 -1.115 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 39.37 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.838 -0.539 . . . . 0.0 112.305 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.13 55.03 0.65 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.731 -1.224 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.419 ' CG ' ' HB3' ' A' ' 56' ' ' ALA . 8.1 p-10 -175.55 163.67 2.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.257 -1.143 . . . . 0.0 109.926 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 73' ' ' ILE . 2.4 tm? -117.53 121.02 39.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 110.302 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 73' ' ' ILE . 3.0 tm? -97.71 149.37 22.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.426 -0.796 . . . . 0.0 110.188 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.986 ' N ' HD13 ' A' ' 72' ' ' LEU . 31.5 mm -130.9 117.29 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 52' ' ' TYR . 11.3 p -118.58 121.02 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.623 ' HB2' HG12 ' A' ' 131' ' ' VAL . 22.1 m-20 -81.21 103.27 10.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.022 -1.048 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.444 ' HA ' ' CA ' ' A' ' 129' ' ' GLY . 83.8 p -89.31 101.25 13.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' CB ' ' HB1' ' A' ' 50' ' ' ALA . . . -175.48 -41.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 110.075 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 79' ' ' THR . 3.0 mt -110.99 170.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.506 ' N ' HG22 ' A' ' 78' ' ' ILE . 99.7 m -97.54 147.47 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.25 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.749 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -94.49 -148.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.023 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -142.03 148.37 38.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.453 ' NE2' ' HD2' ' A' ' 102' ' ' ARG . 96.1 m-70 -60.87 142.23 56.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.219 -0.926 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.77 39.99 7.89 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -156.63 149.56 23.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -1.121 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.804 HD11 ' O ' ' A' ' 64' ' ' GLY . 12.0 tt -65.62 92.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.749 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.0 m -130.91 158.84 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.42 -0.8 . . . . 0.0 110.072 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 87' ' ' ILE . 1.3 tp -89.64 122.33 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.69 168.6 11.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.348 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.64 13.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 110.357 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 124' ' ' THR . 4.9 p -152.72 126.15 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 110.048 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 53.15 25.41 4.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.327 -0.858 . . . . 0.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.9 30.43 10.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -102.32 160.59 14.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -1.184 . . . . 0.0 110.346 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -134.17 93.47 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.274 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 1.0 OUTLIER -115.02 164.03 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.825 . . . . 0.0 110.111 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.747 HG11 ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -124.86 -148.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.295 -179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 109' ' ' PRO . 3.6 tttp 67.49 167.73 0.24 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.347 -0.846 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -81.07 126.51 31.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.354 -0.841 . . . . 0.0 110.168 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.703 ' H ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -122.62 151.07 41.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 101' ' ' LEU . 1.6 pt20 -117.12 127.81 54.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.226 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.657 HD21 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -126.16 -16.74 5.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.861 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.518 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.36 -56.69 0.96 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.88 -1.137 . . . . 0.0 110.636 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -62.42 -52.72 2.32 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 N-CA-C 109.143 -1.137 . . . . 0.0 109.143 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 m -150.94 152.89 34.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.733 -0.605 . . . . 0.0 109.634 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.838 HG11 ' H ' ' A' ' 122' ' ' GLU . 30.4 m -77.27 100.92 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.39 137.46 20.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 110.476 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.492 HD21 ' HG3' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -137.47 140.85 41.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.454 -0.778 . . . . 0.0 109.984 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.55 HD13 ' C ' ' A' ' 115' ' ' SER . 1.7 tp -146.1 76.63 12.32 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.051 -1.03 . . . . 0.0 111.032 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG3' HD21 ' A' ' 107' ' ' LEU . 2.5 Cg_endo -68.95 -151.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.206 1.108 . . . . 0.0 109.334 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.428 ' CB ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 68.72 155.89 0.13 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 21.4 t-20 -98.29 -81.14 0.44 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.2 p -84.24 -37.84 21.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.91 55.16 2.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 53.9 p90 -66.74 127.17 31.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.821 . . . . 0.0 111.112 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 108' ' ' ILE . 35.9 m -125.46 93.25 45.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.469 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.544 ' N ' HD13 ' A' ' 108' ' ' ILE . 3.1 Cg_exo -60.37 128.26 25.59 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.189 1.099 . . . . 0.0 110.997 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.2 tp -140.23 123.39 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.9 t -81.08 143.07 32.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 110.119 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.684 HG21 HD23 ' A' ' 125' ' ' LEU . 2.9 mp -95.77 169.81 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.515 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.2 m -54.99 -175.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 110.031 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.4 t -68.11 81.69 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.344 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.838 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.9 OUTLIER 53.36 58.66 5.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.1 -81.73 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.39 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.717 ' O ' HD22 ' A' ' 125' ' ' LEU . 1.4 m -148.43 81.7 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.109 -0.994 . . . . 0.0 110.581 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 124' ' ' THR . 1.4 mm? -128.36 108.2 10.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.138 -0.976 . . . . 0.0 110.258 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -146.75 155.28 42.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.153 -0.967 . . . . 0.0 110.61 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.87 153.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.417 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.43 -57.98 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.457 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 76' ' ' SER . . . -97.95 -148.01 23.15 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 130' ' ' VAL . 11.0 p -148.58 17.31 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -1.209 . . . . 0.0 110.93 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 132' ' ' ILE . 7.1 p -172.47 166.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.902 -1.124 . . . . 0.0 111.409 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 72' ' ' LEU . 2.6 mp -150.11 72.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' B' ' 137' ' ' ALA . 49.4 m170 -66.71 122.54 17.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.503 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.548 HG22 ' HA3' ' A' ' 65' ' ' GLY . 48.8 t -90.07 129.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 110.157 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.566 HG13 HG22 ' B' ' 135' ' ' VAL . 52.3 t -112.83 97.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.097 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.27 107.24 16.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' B' ' 133' ' ' HIS . . . -70.1 109.49 4.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.12 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.77 103.66 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.182 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.229 0.538 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' B' ' 27' ' ' PRO . 1.1 m-85 -64.29 -52.36 54.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 26' ' ' PHE . 3.0 Cg_endo -62.73 -155.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.942 0 O-C-N 122.785 0.887 . . . . 0.0 110.606 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.42 ' O ' ' N ' ' B' ' 30' ' ' ALA . 0.4 OUTLIER -147.54 155.34 45.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 110.218 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.09 75.18 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.313 1.165 . . . . 0.0 110.635 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 28' ' ' SER . . . 51.28 -172.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.3 114.66 14.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.02 -51.04 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.08 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 52.72 63.45 2.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.24 77.89 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.287 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.41 145.36 20.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.274 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.83 -150.15 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 110.053 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -52.74 3.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.092 -1.005 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.655 ' O ' HG23 ' B' ' 38' ' ' ILE . 6.3 tp -155.21 85.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 110.391 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.412 ' OD1' ' ND2' ' B' ' 41' ' ' ASN . 4.3 t0 -89.98 65.4 6.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.96 . . . . 0.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.847 HD21 HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -50.16 -48.94 53.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.637 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.699 ' HA ' HD13 ' A' ' 40' ' ' LEU . 9.7 p30 -51.03 -41.32 59.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 5.0 tt0 -89.92 -16.65 29.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 109.904 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -65.3 -64.75 0.79 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 110.259 -179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.629 HD23 HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -90.38 -18.19 25.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.983 HD13 HG21 ' B' ' 51' ' ' THR . 3.6 mt -143.47 -141.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.047 -1.033 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.457 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.9 mt-30 -168.16 -84.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.695 -1.253 . . . . 0.0 109.683 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HB3' ' B' ' 50' ' ' ALA . 0.3 OUTLIER -47.53 105.15 0.46 Allowed Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.451 -0.781 . . . . 0.0 110.401 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.16 -13.87 41.82 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 122.944 0.971 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 3.3 m -116.04 31.26 6.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.996 -1.065 . . . . 0.0 110.909 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.519 ' HB3' ' CG ' ' B' ' 47' ' ' HIS . . . -158.34 46.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.009 -1.057 . . . . 0.0 109.873 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.983 HG21 HD13 ' B' ' 45' ' ' ILE . 91.0 m -135.73 134.11 38.72 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 111.215 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.642 ' HB3' HG13 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -127.78 151.82 48.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.712 . . . . 0.0 109.274 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.451 ' HB3' ' CD1' ' B' ' 73' ' ' ILE . 16.8 p90 -142.38 165.67 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.044 -1.035 . . . . 0.0 110.709 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.414 ' O ' HG13 ' B' ' 54' ' ' VAL . 8.2 p -155.31 134.6 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.376 -0.828 . . . . 0.0 109.785 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.407 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.77 132.76 44.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.061 -1.024 . . . . 0.0 109.995 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 66' ' ' ILE . . . -89.02 109.19 20.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 110.394 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.19 43.62 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.35 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.63 -163.13 18.41 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.61 ' CB ' HD11 ' B' ' 62' ' ' ILE . 14.2 p-10 -142.02 16.75 2.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 110.262 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.46 10.18 35.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.36 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.432 ' HG2' ' CG2' ' B' ' 96' ' ' VAL . 0.0 OUTLIER -154.22 22.09 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 110.111 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.61 HD11 ' CB ' ' B' ' 59' ' ' ASP . 15.3 mt -57.3 -25.8 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.075 -1.016 . . . . 0.0 109.179 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.71 -28.11 45.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.452 -0.78 . . . . 0.0 109.317 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.794 ' O ' HD11 ' B' ' 85' ' ' ILE . . . -85.03 -44.88 6.14 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' B' ' 134' ' ' VAL . . . 148.18 33.79 0.05 OUTLIER Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.714 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.558 ' O ' HD12 ' B' ' 66' ' ' ILE . 1.8 pp -129.4 108.13 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.313 . . . . 0.0 110.271 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.3 p -131.31 66.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.984 -1.073 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 39.43 96.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.738 -0.601 . . . . 0.0 112.242 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.98 55.14 0.65 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.267 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.427 ' CG ' ' HB3' ' B' ' 56' ' ' ALA . 7.9 p-10 -175.67 163.5 2.88 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -1.18 . . . . 0.0 109.902 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.741 HD11 HD11 ' B' ' 73' ' ' ILE . 2.3 tm? -117.4 120.86 39.45 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 110.334 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.961 HD13 ' N ' ' B' ' 73' ' ' ILE . 3.0 tm? -97.56 149.13 22.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.551 -0.718 . . . . 0.0 110.21 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.961 ' N ' HD13 ' B' ' 72' ' ' LEU . 31.1 mm -130.6 117.35 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.642 HG13 ' HB3' ' B' ' 52' ' ' TYR . 11.3 p -118.59 120.89 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.636 ' HB2' HG12 ' B' ' 131' ' ' VAL . 21.6 m-20 -80.99 103.28 10.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.993 -1.067 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' CA ' ' B' ' 129' ' ' GLY . 83.5 p -89.36 101.29 13.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -175.63 -40.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.498 HG22 ' N ' ' B' ' 79' ' ' THR . 2.9 mt -111.19 170.72 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.498 ' N ' HG22 ' B' ' 78' ' ' ILE . 99.6 m -97.48 147.6 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.199 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -94.79 -148.43 0.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 0.0 110.014 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -141.9 148.76 39.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 109.807 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.2 m-70 -61.12 142.15 56.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.89 40.01 7.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -156.71 149.44 23.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.419 -1.048 . . . . 0.0 109.437 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.794 HD11 ' O ' ' B' ' 64' ' ' GLY . 11.9 tt -65.57 92.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.125 -0.985 . . . . 0.0 110.008 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.714 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -130.87 158.87 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.805 . . . . 0.0 109.956 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.57 ' O ' HG23 ' B' ' 87' ' ' ILE . 1.2 tp -89.62 122.22 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 110.027 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.893 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.61 168.3 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.37 134.14 13.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.322 -0.862 . . . . 0.0 110.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 124' ' ' THR . 4.6 p -152.57 122.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.457 -0.777 . . . . 0.0 110.086 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 53.9 26.91 6.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.315 -0.866 . . . . 0.0 110.773 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.09 32.91 8.51 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.456 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 16.4 mm-40 -105.31 163.34 12.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -1.181 . . . . 0.0 110.175 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -135.3 94.87 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.527 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.893 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 6.9 p -113.15 160.66 17.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.524 -0.735 . . . . 0.0 109.806 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.725 HG11 ' HA3' ' B' ' 64' ' ' GLY . 1.0 OUTLIER -124.67 -149.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.962 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 65.29 178.57 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.318 -0.864 . . . . 0.0 110.297 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -90.69 129.08 36.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.363 -0.835 . . . . 0.0 110.312 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.75 ' CB ' HD12 ' B' ' 107' ' ' LEU . 1.5 pt? -122.38 149.97 43.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 110.355 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.4 mt-30 -116.89 127.28 54.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -0.937 . . . . 0.0 109.253 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.688 HD23 ' O ' ' B' ' 100' ' ' GLN . 19.1 mt -126.45 -15.93 5.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.958 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.511 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -76.46 -56.18 1.53 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.932 -1.105 . . . . 0.0 110.359 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.6 Cg_endo -63.04 -53.54 1.52 Allowed 'Trans proline' 0 C--N 1.321 -0.88 0 N-CA-C 109.165 -1.129 . . . . 0.0 109.165 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 2.1 m -151.25 154.88 37.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.764 -0.585 . . . . 0.0 109.609 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.751 HG11 ' H ' ' B' ' 122' ' ' GLU . 35.9 m -78.48 100.58 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.052 -1.03 . . . . 0.0 110.119 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -149.23 139.27 22.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.173 -0.955 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.75 HD12 ' CB ' ' B' ' 99' ' ' LEU . 1.2 tp -139.82 146.76 39.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.402 -0.811 . . . . 0.0 110.065 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.551 HD11 ' N ' ' B' ' 115' ' ' SER . 1.5 tp -149.72 76.67 8.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.129 -0.982 . . . . 0.0 110.838 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' B' ' 107' ' ' LEU . 2.6 Cg_endo -67.61 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.271 1.143 . . . . 0.0 109.551 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.414 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 68.37 154.9 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.256 -0.902 . . . . 0.0 110.871 178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.412 ' CB ' ' HB ' ' B' ' 62' ' ' ILE . 22.0 t-20 -97.63 -79.6 0.46 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.495 -0.753 . . . . 0.0 109.729 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -83.48 -38.74 21.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.084 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.52 55.36 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 50.7 p90 -62.84 123.39 18.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.659 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.551 ' N ' HD11 ' B' ' 108' ' ' ILE . 42.9 m -115.58 93.97 38.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.419 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.2 Cg_exo -59.99 121.61 10.09 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 O-C-N 123.182 1.096 . . . . 0.0 110.713 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 117' ' ' ILE . 1.0 OUTLIER -140.08 128.87 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.282 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 10.3 t -88.85 154.11 20.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 110.134 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.66 HG21 HD23 ' B' ' 125' ' ' LEU . 2.8 mp -105.48 168.39 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.525 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.2 m -55.35 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 37.6 t -67.53 81.34 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.182 -0.949 . . . . 0.0 110.34 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.751 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.9 OUTLIER 53.42 58.97 4.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.153 -0.967 . . . . 0.0 110.162 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.42 -81.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.37 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.704 ' O ' HD22 ' B' ' 125' ' ' LEU . 1.4 m -148.41 81.88 1.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.115 -0.99 . . . . 0.0 110.533 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 124' ' ' THR . 1.4 mm? -128.49 108.5 10.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -146.99 155.52 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.594 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.1 153.4 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.283 -0.886 . . . . 0.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -95.33 -58.08 2.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.859 . . . . 0.0 110.441 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' B' ' 76' ' ' SER . . . -97.89 -148.07 23.25 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.643 HG22 ' O ' ' B' ' 130' ' ' VAL . 10.9 p -148.6 17.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -1.198 . . . . 0.0 110.931 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.725 ' C ' HD12 ' B' ' 132' ' ' ILE . 7.3 p -172.55 166.69 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.964 -1.085 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.846 HG23 HD11 ' B' ' 72' ' ' LEU . 2.6 mp -150.26 72.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.456 ' CD2' ' HA ' ' A' ' 137' ' ' ALA . 50.5 m170 -66.9 122.52 17.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 110.502 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.532 HG22 ' HA3' ' B' ' 65' ' ' GLY . 50.7 t -90.1 129.84 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.408 -0.808 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 135' ' ' VAL . 52.1 t -113.03 97.83 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.31 107.08 16.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.0 110.235 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 133' ' ' HIS . . . -70.02 109.65 4.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 4.2 tpt -118.73 103.63 9.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 110.323 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.162 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.298 0.57 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -144.32 107.92 4.86 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.855 . . . . 0.0 110.091 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.11 -26.42 75.64 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 O-C-N 122.946 0.972 . . . . 0.0 110.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.8 m 52.56 69.07 2.57 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.432 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.09 -46.88 14.0 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.314 1.166 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -169.38 -67.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 110.243 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.49 83.86 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -144.44 123.06 12.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.297 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 52.64 58.57 5.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.285 -0.885 . . . . 0.0 110.342 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.46 72.89 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 110.195 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.69 93.46 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.112 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 53.42 -149.25 0.41 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.58 146.51 49.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.066 -1.021 . . . . 0.0 110.192 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.5 tt -163.28 50.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -90.51 64.22 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' B' ' 40' ' ' LEU . 1.1 tp -52.04 -45.26 64.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.702 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.941 ' HA ' HD22 ' B' ' 40' ' ' LEU . 7.7 p-10 -55.04 -40.51 70.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 110.2 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.95 -11.16 45.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.19 -0.944 . . . . 0.0 111.692 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -102.87 -33.0 9.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.771 -1.206 . . . . 0.0 110.367 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' B' ' 44' ' ' LEU . 2.2 mp -95.27 -15.29 23.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.897 HD11 HD13 ' B' ' 40' ' ' LEU . 12.2 mt -111.63 175.75 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.869 -1.145 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' H ' HG22 ' A' ' 45' ' ' ILE . 26.6 mm100 -116.5 -18.07 10.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.208 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -119.87 154.82 55.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.091 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.96 -54.22 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.329 1.173 . . . . 0.0 110.352 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.9 m -143.44 60.04 1.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.843 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -150.19 44.46 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.846 . . . . 0.0 110.053 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.844 HG21 HG23 ' A' ' 45' ' ' ILE . 36.0 m -134.05 138.15 45.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 110.898 -178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.65 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -113.68 153.09 29.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.503 -0.748 . . . . 0.0 109.87 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HE2' HG23 ' B' ' 38' ' ' ILE . 5.6 p90 -142.19 162.68 34.87 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.145 -0.972 . . . . 0.0 110.051 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.516 HG12 HD22 ' A' ' 72' ' ' LEU . 8.3 p -155.54 137.27 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.892 . . . . 0.0 110.148 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' CE ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -72.57 128.92 37.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.702 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.609 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -78.53 101.74 7.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 110.426 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.4 t -136.43 58.33 1.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -179.99 -140.67 4.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' HA ' HG13 ' A' ' 62' ' ' ILE . 8.9 p-10 -161.7 27.81 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.352 -1.087 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 p -79.52 -13.11 59.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.412 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.42 ' HG2' HD11 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -160.89 45.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.058 . . . . 0.0 110.289 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.981 HD12 ' ND2' ' A' ' 111' ' ' ASN . 26.4 mt -53.17 -26.39 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.919 -1.113 . . . . 0.0 108.203 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 3.1 p30 -51.3 -32.4 24.84 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.143 0.973 . . . . 0.0 108.589 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.846 ' HA2' HD11 ' A' ' 85' ' ' ILE . . . -75.61 -39.14 35.59 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.09 38.6 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.08 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 72' ' ' LEU . 1.7 pp -128.81 98.69 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -1.156 . . . . 0.0 110.302 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -125.82 67.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.857 -1.152 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 t0 42.19 65.65 0.86 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.673 -0.642 . . . . 0.0 111.578 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.72 49.64 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.107 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' OD1' ' CB ' ' A' ' 56' ' ' ALA . 3.6 p30 -173.02 177.21 2.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.14 -1.212 . . . . 0.0 110.38 179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.709 HD11 HD11 ' B' ' 44' ' ' LEU . 2.1 tm? -126.62 126.94 44.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.242 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 66' ' ' ILE . 8.2 tt -97.19 150.24 21.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.372 -0.83 . . . . 0.0 110.658 -179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.962 HD11 HD11 ' B' ' 44' ' ' LEU . 18.7 mm -140.14 104.4 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.058 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.8 p -102.8 157.21 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.711 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.836 ' HB2' HG12 ' A' ' 131' ' ' VAL . 1.1 m-20 -110.11 98.22 7.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.878 -1.139 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.447 ' HA ' ' HA2' ' A' ' 129' ' ' GLY . 63.4 p -80.41 101.51 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.59 -56.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.42 158.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.372 -0.83 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.26 114.89 26.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.866 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' A' ' 130' ' ' VAL . . . -61.16 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.19 146.86 31.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.187 -0.946 . . . . 0.0 109.803 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 96.7 m-70 -57.88 144.24 39.68 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 110.416 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.21 34.78 10.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -148.99 154.93 40.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -1.104 . . . . 0.0 109.491 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 132' ' ' ILE . 5.5 tt -75.15 74.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.841 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.775 HG11 ' HB1' ' A' ' 80' ' ' ALA . 24.6 m -103.84 170.98 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.405 -0.81 . . . . 0.0 110.22 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.7 tp -89.59 124.14 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.786 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.42 143.08 27.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.77 122.05 28.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 124' ' ' THR . 5.9 p -152.56 128.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.456 -0.778 . . . . 0.0 109.928 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 53.92 22.48 3.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.363 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.26 33.47 7.64 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -105.68 164.49 11.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 19.5 m-85 -157.7 95.28 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 110.055 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.1 p -136.35 149.92 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.392 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.791 HG11 ' CA ' ' A' ' 64' ' ' GLY . 6.7 t -86.13 126.9 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.785 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 109' ' ' PRO . 2.0 tppt? -174.31 138.69 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.974 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -76.4 108.67 9.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 108.907 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.796 HD12 HD21 ' A' ' 101' ' ' LEU . 1.5 pt? -122.31 154.35 37.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.124 -0.985 . . . . 0.0 111.575 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 101' ' ' LEU . 13.7 mt-30 -118.73 128.68 54.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD21 HD12 ' A' ' 99' ' ' LEU . 24.3 mt -123.95 -11.39 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 110.859 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.521 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 1.4 mpt_? -76.29 -57.81 1.32 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.857 -1.152 . . . . 0.0 109.982 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -63.18 -57.8 0.36 Allowed 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 108.65 -1.327 . . . . 0.0 108.65 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -152.24 150.9 30.3 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 105' ' ' VAL . 26.7 m -72.94 102.12 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.645 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -138.85 139.3 38.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 111.327 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 tp -118.6 156.58 28.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.137 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -150.01 104.33 3.18 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 111.5 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 97' ' ' LYS . 2.8 Cg_endo -66.97 147.05 79.53 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 N-CA-C 108.624 -1.337 . . . . 0.0 108.624 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.542 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -124.26 -24.52 4.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.654 -1.279 . . . . 0.0 111.38 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.981 ' ND2' HD12 ' A' ' 62' ' ' ILE . 1.5 t-20 -53.62 -94.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.776 -1.202 . . . . 0.0 110.145 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.1 p -125.56 -21.25 4.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.817 -1.177 . . . . 0.0 110.873 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.85 60.31 5.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 109.934 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 49.6 p90 -62.4 121.01 12.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 110.237 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -162.15 81.86 1.78 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.865 . . . . 0.0 109.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.11 108.54 0.58 Allowed 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.272 1.143 . . . . 0.0 110.206 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 tt -131.55 153.9 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.451 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.5 t -95.52 142.34 27.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.297 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 125' ' ' LEU . 3.7 mt -82.02 172.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.871 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.558 ' O ' HG21 ' A' ' 105' ' ' VAL . 1.9 t -58.61 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.186 -0.946 . . . . 0.0 110.26 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.9 64.11 0.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.306 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' CA ' HG11 ' A' ' 105' ' ' VAL . 2.9 tt0 52.57 45.22 29.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.74 -80.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.135 -0.978 . . . . 0.0 110.091 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 90' ' ' VAL . 10.2 m -141.62 81.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.5 OUTLIER -128.22 97.49 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -146.52 147.71 31.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 0.0 110.325 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 87' ' ' ILE . 32.1 t -72.59 153.42 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.469 -0.769 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.5 -32.18 10.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.419 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 76' ' ' SER . . . -122.7 -143.07 6.33 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.798 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 13.0 p -149.46 15.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.132 -1.216 . . . . 0.0 111.183 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.836 HG12 ' HB2' ' A' ' 75' ' ' ASP . 11.7 p -172.71 170.42 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.92 -1.113 . . . . 0.0 111.165 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 85' ' ' ILE . 1.9 mp -148.49 85.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.689 ' CE1' ' HB1' ' B' ' 137' ' ' ALA . 0.3 OUTLIER -71.78 118.33 14.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 110.307 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 64' ' ' GLY . 43.0 t -91.79 131.31 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.149 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.863 HG13 HG22 ' B' ' 135' ' ' VAL . 40.4 t -111.77 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.562 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -86.46 111.16 20.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.375 -0.828 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.668 ' HB1' ' CE1' ' B' ' 133' ' ' HIS . . . -61.27 104.88 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -0.855 . . . . 0.0 109.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.412 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.5 OUTLIER -104.77 102.83 12.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.609 ' HB2' HG23 ' B' ' 131' ' ' VAL . 17.2 ttm180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.293 0.568 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -125.26 170.71 8.71 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 -48.84 9.28 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 O-C-N 123.232 1.122 . . . . 0.0 110.414 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.69 173.64 7.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 113.34 1.78 Allowed 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.349 1.183 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.99 155.51 4.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.18 44.74 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.28 -41.53 89.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -154.93 86.43 1.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 0.0 110.048 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 53.2 t -86.29 80.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 110.269 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -170.06 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 110.206 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.33 -60.45 1.92 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.144 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.49 80.36 0.14 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -0.886 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.689 HG23 ' HE2' ' A' ' 53' ' ' PHE . 4.5 mt -81.78 84.77 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -91.4 63.7 4.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.952 . . . . 0.0 109.957 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 1.024 HD23 HD23 ' A' ' 40' ' ' LEU . 1.2 tp -51.97 -44.5 64.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.466 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.926 ' HA ' HD22 ' A' ' 40' ' ' LEU . 7.7 p-10 -55.2 -40.48 70.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 110.132 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.92 -11.23 45.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.176 -0.953 . . . . 0.0 111.681 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -102.84 -32.84 9.59 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 0.0 110.391 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.989 HD23 HD23 ' A' ' 44' ' ' LEU . 2.1 mp -95.42 -15.32 23.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.585 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 40' ' ' LEU . 12.3 mt -111.59 175.72 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.924 -1.11 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.528 ' H ' HG22 ' B' ' 45' ' ' ILE . 26.3 mm100 -116.55 -17.7 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.222 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -120.21 154.93 56.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.188 -0.945 . . . . 0.0 110.039 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.04 -53.94 1.77 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.255 1.134 . . . . 0.0 110.326 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.8 m -143.78 59.99 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.849 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.786 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -150.19 44.56 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.403 -0.811 . . . . 0.0 109.989 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.857 HG21 HG23 ' B' ' 45' ' ' ILE . 35.4 m -134.06 138.08 45.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.128 -0.982 . . . . 0.0 110.853 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.654 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -113.51 153.06 29.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.99 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD13 ' B' ' 73' ' ' ILE . 5.5 p90 -142.23 162.7 34.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.066 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.502 HG12 HD22 ' B' ' 72' ' ' LEU . 8.3 p -155.59 137.38 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -0.955 . . . . 0.0 110.174 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.408 ' CE ' ' O ' ' B' ' 70' ' ' ASP . 0.0 OUTLIER -72.61 129.04 37.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.633 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.611 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -78.57 101.63 7.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.427 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -136.41 58.43 1.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.356 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.97 -140.81 4.37 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.458 ' HA ' HG13 ' B' ' 62' ' ' ILE . 8.9 p-10 -161.77 28.38 0.12 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.29 -1.124 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -79.99 -12.56 59.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.75 ' SD ' HG22 ' B' ' 95' ' ' THR . 0.0 OUTLIER -161.55 45.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.983 HD12 ' ND2' ' B' ' 111' ' ' ASN . 30.0 mt -53.33 -26.08 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.011 -1.056 . . . . 0.0 108.243 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' B' ' 110' ' ' MET . 3.1 p30 -51.63 -32.52 29.42 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.075 0.94 . . . . 0.0 108.587 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.831 ' HA2' HD11 ' B' ' 85' ' ' ILE . . . -75.62 -39.06 35.75 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.18 38.83 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.771 ' CG2' HD12 ' B' ' 72' ' ' LEU . 1.7 pp -128.75 98.91 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -1.128 . . . . 0.0 110.336 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.3 t -126.07 67.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 110.508 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t0 42.13 65.6 0.86 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.742 -0.599 . . . . 0.0 111.562 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.91 49.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.426 ' OD1' ' CB ' ' B' ' 56' ' ' ALA . 3.7 p30 -173.04 177.18 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.247 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 44' ' ' LEU . 2.1 tm? -126.39 127.09 44.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.771 HD12 ' CG2' ' B' ' 66' ' ' ILE . 8.2 tt -97.37 150.3 21.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.37 -0.832 . . . . 0.0 110.659 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.969 HD11 HD11 ' A' ' 44' ' ' LEU . 18.6 mm -140.22 104.47 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.149 -0.969 . . . . 0.0 110.023 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.654 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.8 p -102.99 157.17 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -0.85 . . . . 0.0 109.653 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.799 ' HB2' HG12 ' B' ' 131' ' ' VAL . 1.1 m-20 -110.08 98.36 7.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.974 -1.079 . . . . 0.0 110.386 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' B' ' 129' ' ' GLY . 61.6 p -80.49 101.43 9.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.768 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.786 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.54 -56.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.169 -0.957 . . . . 0.0 110.365 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.48 158.3 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -89.25 115.01 26.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.876 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.799 ' HB2' ' HA ' ' B' ' 130' ' ' VAL . . . -61.22 -153.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 110.318 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -145.31 146.97 31.84 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.167 -0.958 . . . . 0.0 109.916 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.485 ' CE1' ' HB2' ' B' ' 101' ' ' LEU . 96.4 m-70 -57.89 144.2 39.9 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 110.3 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.49 34.22 10.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' B' ' 98' ' ' LYS . 28.5 m-20 -148.45 155.79 41.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 109.69 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.859 ' O ' HD13 ' B' ' 132' ' ' ILE . 5.2 tt -75.71 74.04 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.133 -0.979 . . . . 0.0 109.704 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.768 HG11 ' HB1' ' B' ' 80' ' ' ALA . 24.0 m -103.64 170.99 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.571 -0.706 . . . . 0.0 110.351 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.523 ' O ' HG23 ' B' ' 87' ' ' ILE . 6.7 tp -89.63 124.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.855 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.54 142.46 27.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.163 -0.961 . . . . 0.0 110.245 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.0 121.9 28.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.52 -0.737 . . . . 0.0 110.31 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 124' ' ' THR . 5.9 p -152.74 128.98 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.395 -0.816 . . . . 0.0 110.078 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 52.62 22.81 2.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 110.507 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.5 8.36 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 11.9 mt-10 -103.12 158.42 16.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.212 -1.169 . . . . 0.0 110.35 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.25 100.87 3.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.869 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.75 HG22 ' SD ' ' B' ' 61' ' ' MET . 2.2 p -145.43 154.01 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.013 . . . . 0.0 111.014 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.757 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -91.27 127.1 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.549 -0.719 . . . . 0.0 109.634 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' B' ' 109' ' ' PRO . 3.0 mttt -173.74 138.75 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.158 -0.964 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' B' ' 84' ' ' ASP . 0.6 OUTLIER -75.73 108.22 8.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 108.914 179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.721 HD12 HD21 ' B' ' 101' ' ' LEU . 1.6 pt? -122.04 154.4 37.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.973 -1.079 . . . . 0.0 111.678 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.688 ' O ' HD23 ' B' ' 101' ' ' LEU . 2.2 mt-30 -119.05 131.73 55.98 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.736 HD13 ' O ' ' B' ' 125' ' ' LEU . 23.7 mt -128.09 -9.41 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.143 -0.973 . . . . 0.0 111.146 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 1.0 OUTLIER -79.36 -59.7 0.58 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.806 -1.184 . . . . 0.0 109.939 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.5 Cg_endo -62.98 -53.66 1.49 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 N-CA-C 108.402 -1.422 . . . . 0.0 108.402 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 1.1 m -151.18 150.79 31.05 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' B' ' 119' ' ' ILE . 12.6 p -84.91 103.03 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 110.031 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.536 ' CA ' HD12 ' B' ' 119' ' ' ILE . 64.2 mt-30 -144.22 146.77 32.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.967 -1.083 . . . . 0.0 111.13 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.423 ' HB2' HD11 ' B' ' 119' ' ' ILE . 6.4 tp -116.66 156.13 27.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.559 -0.713 . . . . 0.0 109.676 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.679 HD13 ' C ' ' B' ' 108' ' ' ILE . 0.0 OUTLIER -145.25 102.88 4.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.974 -1.079 . . . . 0.0 111.172 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.507 ' HG3' ' CZ ' ' B' ' 114' ' ' TYR . 2.9 Cg_endo -68.08 136.91 39.28 Favored 'Trans proline' 0 N--CA 1.483 0.88 0 N-CA-C 108.665 -1.321 . . . . 0.0 108.665 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.538 ' HB2' ' HB3' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -109.94 -29.17 8.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.857 -1.152 . . . . 0.0 111.247 -178.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.983 ' ND2' HD12 ' B' ' 62' ' ' ILE . 2.2 t-20 -54.94 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.768 -1.207 . . . . 0.0 109.81 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.0 p -175.28 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.067 -1.02 . . . . 0.0 110.488 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.11 -77.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.091 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' B' ' 109' ' ' PRO . 34.1 p90 -144.07 172.43 12.9 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -0.947 . . . . 0.0 110.266 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 49.6 m -64.52 160.62 50.46 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.48 148.38 93.11 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.257 1.135 . . . . 0.0 110.596 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 1.8 tt -140.56 153.56 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 110.377 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 118' ' ' THR . 7.5 t -87.62 151.14 23.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.028 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.788 ' HB ' HG22 ' B' ' 105' ' ' VAL . 3.2 mt -94.73 168.75 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 110.243 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.527 ' N ' HG22 ' B' ' 119' ' ' ILE . 1.8 t -59.23 -161.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.443 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 65.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 110.294 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 52.04 44.96 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 0.0 110.465 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.5 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.616 ' O ' HG23 ' B' ' 90' ' ' VAL . 10.6 m -141.76 81.63 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.736 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.5 OUTLIER -128.25 97.18 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -146.22 147.77 31.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.068 -1.02 . . . . 0.0 110.33 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.457 HG13 ' O ' ' B' ' 87' ' ' ILE . 30.8 t -72.68 153.24 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 110.33 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.38 -32.22 10.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.388 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' B' ' 76' ' ' SER . . . -122.65 -142.94 6.31 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.799 ' HA ' ' HB2' ' B' ' 80' ' ' ALA . 13.1 p -149.67 15.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.126 -1.22 . . . . 0.0 111.156 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.799 HG12 ' HB2' ' B' ' 75' ' ' ASP . 11.7 p -172.87 170.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.894 -1.129 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.859 HD13 ' O ' ' B' ' 85' ' ' ILE . 1.9 mp -148.54 85.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.668 ' CE1' ' HB1' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -72.02 118.69 15.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 64' ' ' GLY . 42.4 t -92.05 131.38 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 110.156 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.863 HG22 HG13 ' A' ' 135' ' ' VAL . 40.5 t -111.75 97.34 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.057 -1.027 . . . . 0.0 109.534 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -86.5 111.12 20.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 110.209 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.689 ' HB1' ' CE1' ' A' ' 133' ' ' HIS . . . -61.27 104.8 0.43 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 0.0 110.097 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.444 ' HG3' HG21 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -104.64 102.89 12.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.264 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 131' ' ' VAL . 17.3 ttm180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.236 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.253 0.549 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -157.88 82.77 2.88 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.34 177.12 0.88 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.306 1.161 . . . . 0.0 110.548 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 t -162.78 84.14 1.5 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.43 109.98 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.28 1.147 . . . . 0.0 110.483 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.41 59.25 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.282 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.77 -153.92 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -135.88 162.27 33.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.11 -0.993 . . . . 0.0 110.208 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 74.4 m-85 -101.54 132.19 47.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.179 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 34' ' ' VAL . 27.0 m -59.67 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.98 178.93 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.118 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.19 -64.97 1.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.15 108.05 3.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -157.3 39.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.14 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -89.1 73.95 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.955 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.027 HD11 HD11 ' B' ' 45' ' ' ILE . 1.2 mm? -53.83 -43.15 69.18 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.278 -0.889 . . . . 0.0 110.396 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.44 ' HA ' ' HG ' ' B' ' 40' ' ' LEU . 17.6 p-10 -52.79 -41.78 64.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.228 -0.92 . . . . 0.0 110.225 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG3' ' HG2' ' A' ' 46' ' ' GLN . 5.6 tt0 -88.71 -19.03 26.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 109.029 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' B' ' 53' ' ' PHE . 0.0 OUTLIER -61.44 -65.67 0.66 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' B' ' 44' ' ' LEU . 0.7 OUTLIER -79.49 -33.55 42.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.119 -0.988 . . . . 0.0 110.684 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.999 HD11 HD11 ' B' ' 40' ' ' LEU . 0.8 OUTLIER -123.16 -141.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' ILE . 1.3 mt-30 -174.9 32.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.652 -1.28 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 44.6 m170 -117.86 143.89 33.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.351 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.25 -30.18 64.1 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 O-C-N 123.11 1.058 . . . . 0.0 110.308 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.99 46.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 110.141 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -131.16 37.18 3.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 0.0 109.945 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 45' ' ' ILE . 95.7 m -130.82 123.9 30.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.175 -0.953 . . . . 0.0 110.886 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.683 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.54 24.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.752 . . . . 0.0 109.619 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.526 ' CD2' ' CD1' ' B' ' 43' ' ' LEU . 1.5 p90 -143.86 170.19 16.37 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.957 -1.09 . . . . 0.0 110.536 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.66 136.66 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 109.83 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 134.07 44.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.13 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HB1' ' CA ' ' A' ' 66' ' ' ILE . . . -92.5 100.81 13.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.51 52.9 1.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.69 -140.2 2.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.736 ' CB ' HD11 ' A' ' 62' ' ' ILE . 3.4 p30 -174.16 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -1.165 . . . . 0.0 110.298 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.96 -26.91 15.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.312 -0.868 . . . . 0.0 110.301 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.0 mtm -134.69 50.48 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.213 -0.929 . . . . 0.0 109.771 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.8 HD12 ' CG ' ' A' ' 111' ' ' ASN . 47.0 mt -71.66 -10.56 14.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.503 -0.748 . . . . 0.0 110.626 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' ' HE1' ' A' ' 110' ' ' MET . 20.2 p30 -50.54 -22.79 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.619 ' O ' HG11 ' A' ' 96' ' ' VAL . . . 170.45 29.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.246 -1.454 . . . . 0.0 111.265 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.646 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -129.52 -69.35 0.12 Allowed Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.745 -1.444 . . . . 0.0 109.743 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 66' ' ' ILE . 2.6 pp -129.0 129.64 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -1.129 . . . . 0.0 110.964 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 62' ' ' ILE . 77.3 p -132.1 65.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 110.709 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 67' ' ' SER . 35.6 t0 27.67 99.35 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.75 57.29 0.98 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.75 153.32 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -1.102 . . . . 0.0 109.724 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.81 HD13 ' N ' ' A' ' 72' ' ' LEU . 3.3 tm? -108.73 139.86 42.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 71' ' ' LEU . 5.5 tt -106.45 135.51 47.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.795 ' N ' HD23 ' A' ' 72' ' ' LEU . 13.1 mt -120.9 98.44 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 109.34 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' TYR . 14.5 p -98.47 156.42 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.829 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -115.6 97.2 6.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.712 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 94.8 p -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.246 -0.909 . . . . 0.0 109.672 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.68 -59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.127 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 79' ' ' THR . 2.4 mp -100.35 168.22 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.0 m -105.92 121.66 44.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.971 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -61.8 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.55 149.39 48.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.455 ' HE1' HD12 ' A' ' 101' ' ' LEU . 89.2 m-70 -59.34 139.26 57.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.34 40.76 6.79 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' VAL . 9.2 m-20 -150.31 146.23 26.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.373 -1.074 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 85' ' ' ILE . 3.4 tt -66.25 72.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.891 HG11 ' HB1' ' A' ' 80' ' ' ALA . 32.1 m -115.23 163.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.913 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -89.71 130.23 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 95' ' ' THR . . . -89.41 160.62 16.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . . . -144.69 125.48 14.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.355 -0.841 . . . . 0.0 110.746 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' HB2' ' A' ' 93' ' ' GLU . 3.8 p -152.98 121.52 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.493 -0.754 . . . . 0.0 109.718 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 54.9 20.76 3.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.203 -0.936 . . . . 0.0 110.674 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.5 6.4 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.241 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 5.7 mt-10 -104.38 164.02 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.083 -1.245 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 29.4 m-85 -139.39 85.29 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.543 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 109' ' ' PRO . 2.7 m -92.38 158.94 15.8 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.177 -0.952 . . . . 0.0 109.699 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 64' ' ' GLY . 1.9 t -136.77 103.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.948 -1.095 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG3' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER 172.02 178.47 0.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -75.88 89.5 2.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.312 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 88' ' ' ALA . 1.4 pt? -84.05 154.25 23.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 111.168 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.88 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -136.85 137.89 40.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.525 -0.734 . . . . 0.0 109.247 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.88 HD23 ' O ' ' A' ' 100' ' ' GLN . 22.8 mt -133.47 -15.48 2.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.975 . . . . 0.0 111.246 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -81.53 -60.76 0.4 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.409 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.6 Cg_endo -61.79 -54.94 1.28 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 N-CA-C 108.692 -1.311 . . . . 0.0 108.692 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.73 146.48 25.78 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.857 HG11 ' H ' ' A' ' 122' ' ' GLU . 27.0 m -79.62 100.31 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.024 -1.047 . . . . 0.0 109.832 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -135.89 145.45 46.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 110.856 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HG ' HG21 ' A' ' 95' ' ' THR . 19.3 tp -144.83 153.67 41.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.59 -0.694 . . . . 0.0 109.572 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.637 ' O ' HG23 ' A' ' 108' ' ' ILE . 6.8 tp -134.91 69.51 71.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 111.208 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.739 ' HB3' HG23 ' A' ' 95' ' ' THR . 2.8 Cg_endo -71.11 105.36 1.69 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.32 1.168 . . . . 0.0 109.359 178.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.497 ' HE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.21 159.83 0.99 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.703 -1.248 . . . . 0.0 112.437 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.8 ' CG ' HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -97.54 -78.64 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.5 p -108.19 -22.37 12.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.698 -0.626 . . . . 0.0 109.794 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.23 69.49 10.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 108.926 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 53.4 p90 -61.38 121.06 11.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.716 0.77 . . . . 0.0 111.247 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 108' ' ' ILE . 12.2 m -130.44 87.64 49.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.464 -0.772 . . . . 0.0 109.597 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.0 107.12 0.33 Allowed 'Trans proline' 0 C--N 1.32 -0.938 0 O-C-N 123.276 1.145 . . . . 0.0 110.463 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 tp -123.33 152.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -102.36 148.24 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 125' ' ' LEU . 3.2 mt -68.43 -84.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.019 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.8 t -157.0 -67.02 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.98 -1.075 . . . . 0.0 110.228 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.2 t -174.78 62.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.857 ' H ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER 54.32 59.81 3.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.863 . . . . 0.0 109.823 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.92 -73.48 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 110.6 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.624 ' O ' HD22 ' A' ' 125' ' ' LEU . 93.3 m -147.11 84.69 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.003 . . . . 0.0 110.551 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -139.18 117.5 11.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.238 -0.914 . . . . 0.0 109.883 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -146.67 158.19 43.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 88' ' ' ALA . 97.7 t -71.68 153.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 13.2 t80 -85.48 -59.27 2.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 110.505 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -119.88 -149.93 8.49 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 130' ' ' VAL . 8.8 p -135.92 -2.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.079 -1.248 . . . . 0.0 111.856 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -125.85 152.58 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.66 -1.275 . . . . 0.0 110.872 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 132' ' ' ILE . 3.8 mp -145.2 59.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -0.775 . . . . 0.0 108.95 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' B' ' 137' ' ' ALA . 0.7 OUTLIER -77.31 112.05 13.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.807 -179.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 134' ' ' VAL . 23.5 m -85.7 119.32 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.608 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.734 HG22 HG13 ' B' ' 135' ' ' VAL . 48.7 t -99.55 104.84 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.105 -0.997 . . . . 0.0 110.622 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 99.68 8.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG ' ' B' ' 133' ' ' HIS . . . -61.55 104.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.459 ' HB3' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -113.17 102.75 10.67 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 110.002 179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.499 ' O ' HD13 ' B' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.212 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.171 0.51 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 52.68 77.43 0.45 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.881 . . . . 0.0 110.337 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.5 -65.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.367 1.193 . . . . 0.0 110.643 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 16.7 m -69.11 154.9 94.54 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.94 . . . . 0.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.73 82.2 0.11 Allowed 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.262 1.138 . . . . 0.0 110.52 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.46 150.53 43.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.316 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.27 84.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -93.52 98.1 10.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 110.3 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.62 58.67 5.03 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 110.114 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.97 152.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.77 131.86 44.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -67.94 -67.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 110.326 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.18 0.76 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 0.0 110.112 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' B' ' 38' ' ' ILE . 0.8 OUTLIER -154.61 33.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.123 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -87.14 76.51 9.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.631 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.999 HD11 HD11 ' A' ' 45' ' ' ILE . 1.2 mm? -53.02 -43.5 66.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 0.0 110.396 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 17.4 p-10 -53.18 -41.87 65.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.109 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 46' ' ' GLN . 5.5 tt0 -88.66 -18.52 27.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.151 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -61.91 -65.63 0.66 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.629 -0.669 . . . . 0.0 110.477 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.942 HD23 HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -79.62 -33.14 41.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 0.0 110.596 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 1.027 HD11 HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -123.56 -142.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 120.921 -1.112 . . . . 0.0 109.874 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.44 ' H ' HG22 ' B' ' 45' ' ' ILE . 1.2 mt-30 -174.81 32.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.667 -1.27 . . . . 0.0 110.53 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ALA . 44.8 m170 -117.93 144.0 33.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.21 -30.53 64.51 Favored 'Trans proline' 0 N--CA 1.483 0.91 0 O-C-N 123.05 1.026 . . . . 0.0 110.208 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.76 46.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -131.09 37.09 3.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.687 HG21 HG12 ' B' ' 45' ' ' ILE . 94.6 m -130.78 123.89 30.18 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 110.932 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.682 ' O ' HG12 ' B' ' 74' ' ' VAL . 0.7 OUTLIER -113.34 155.62 24.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 0.0 109.633 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.532 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 1.5 p90 -143.91 170.03 16.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.011 -1.056 . . . . 0.0 110.42 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.59 136.57 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.299 -0.876 . . . . 0.0 109.853 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.68 133.92 44.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.959 . . . . 0.0 110.143 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' B' ' 66' ' ' ILE . . . -92.31 100.66 13.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 110.22 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -129.2 52.74 1.94 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 110.226 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.4 -140.16 2.83 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.72 ' CB ' HD11 ' B' ' 62' ' ' ILE . 3.4 p30 -173.95 33.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' B' ' 110' ' ' MET . 0.9 OUTLIER -93.08 -30.21 15.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 109.981 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.439 ' HG2' HD11 ' B' ' 108' ' ' ILE . 40.6 mtm -131.68 57.68 1.76 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 0.0 109.317 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.72 HD11 ' CB ' ' B' ' 59' ' ' ASP . 38.3 mt -78.67 -10.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 110.171 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 64' ' ' GLY . 20.3 p30 -50.67 -24.29 3.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.998 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.798 ' O ' HG11 ' B' ' 96' ' ' VAL . . . 171.66 32.29 0.03 OUTLIER Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.208 -1.472 . . . . 0.0 111.302 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.657 ' O ' HD12 ' B' ' 72' ' ' LEU . . . -131.37 -69.89 0.1 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.328 -1.415 . . . . 0.0 109.759 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.709 ' O ' HD12 ' B' ' 66' ' ' ILE . 2.6 pp -129.09 129.88 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -1.097 . . . . 0.0 110.843 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 68' ' ' ASP . 77.2 p -132.22 65.19 1.58 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 110.663 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' B' ' 67' ' ' SER . 35.4 t0 27.68 99.38 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.73 57.4 0.98 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -175.92 153.11 1.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -1.122 . . . . 0.0 109.713 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.799 HD13 ' N ' ' B' ' 72' ' ' LEU . 3.3 tm? -108.45 139.55 43.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.301 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.799 ' N ' HD13 ' B' ' 71' ' ' LEU . 5.5 tt -106.22 135.5 47.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.444 -0.785 . . . . 0.0 110.238 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.794 ' N ' HD23 ' B' ' 72' ' ' LEU . 12.9 mt -120.76 98.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.095 -1.003 . . . . 0.0 109.47 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.682 HG12 ' O ' ' B' ' 52' ' ' TYR . 14.5 p -98.59 156.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 0.0 109.929 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.806 ' N ' HG12 ' B' ' 131' ' ' VAL . 0.7 OUTLIER -115.47 97.24 6.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.784 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' B' ' 77' ' ' ALA . 90.5 p -78.37 100.7 6.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.665 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.66 -60.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 0.0 110.101 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.454 HG22 ' N ' ' B' ' 79' ' ' THR . 2.4 mp -100.07 168.1 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.374 -0.828 . . . . 0.0 110.182 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' HG22 ' B' ' 78' ' ' ILE . 56.9 m -105.73 121.57 44.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.878 . . . . 0.0 109.972 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.869 ' HB1' HG11 ' B' ' 86' ' ' VAL . . . -61.79 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.246 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -136.72 149.28 47.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.939 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.418 ' HE1' HD12 ' B' ' 101' ' ' LEU . 89.1 m-70 -59.12 139.52 56.8 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.174 -0.954 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.98 41.15 6.79 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' B' ' 86' ' ' VAL . 9.4 m-20 -150.86 145.17 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -1.107 . . . . 0.0 109.395 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.666 HG23 ' O ' ' B' ' 85' ' ' ILE . 3.5 tt -65.24 73.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.775 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.869 HG11 ' HB1' ' B' ' 80' ' ' ALA . 29.7 m -115.91 163.46 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.396 -0.815 . . . . 0.0 109.958 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.46 HG21 HG21 ' B' ' 74' ' ' VAL . 0.4 OUTLIER -89.85 129.92 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.969 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.98 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.43 160.38 16.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.369 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' B' ' 128' ' ' PHE . . . -144.27 125.7 14.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.737 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' B' ' 93' ' ' GLU . 4.0 p -152.9 126.52 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.497 -0.752 . . . . 0.0 109.931 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.68 22.2 2.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.294 -0.879 . . . . 0.0 110.495 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.77 31.5 8.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 1.5 mm-40 -100.68 156.25 17.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.112 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -134.26 79.03 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.465 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.98 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 80.5 p -96.12 173.55 7.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.996 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.798 HG11 ' O ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -130.62 -158.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.831 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.554 ' H ' HG12 ' B' ' 96' ' ' VAL . 0.0 OUTLIER 63.82 -180.0 0.16 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.957 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HG2' ' N ' ' B' ' 84' ' ' ASP . 4.4 mttt -79.32 134.06 36.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.514 -0.741 . . . . 0.0 111.201 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.762 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.86 145.36 48.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.445 -0.784 . . . . 0.0 109.784 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.686 ' O ' HD23 ' B' ' 101' ' ' LEU . 6.9 mt-30 -119.85 130.32 54.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.221 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 125' ' ' LEU . 13.8 mt -125.74 -13.43 6.43 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 110.741 -178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.09 -60.99 0.2 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 120.926 -1.109 . . . . 0.0 110.887 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.8 Cg_endo -62.8 -50.13 4.46 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 N-CA-C 108.912 -1.226 . . . . 0.0 108.912 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 105' ' ' VAL . 3.2 m -150.17 173.68 13.64 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.675 HG23 ' O ' ' B' ' 105' ' ' VAL . 34.5 m -108.56 100.55 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.942 -1.099 . . . . 0.0 111.252 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 100' ' ' GLN . 13.0 pt20 -132.39 150.74 52.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.237 -0.914 . . . . 0.0 109.122 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' B' ' 88' ' ' ALA . 14.7 tp -134.71 156.3 49.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.987 -1.07 . . . . 0.0 112.702 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.591 ' O ' HG23 ' B' ' 108' ' ' ILE . 2.9 tt -3.94 127.57 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.481 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 97' ' ' LYS . 2.3 Cg_endo -73.33 -30.49 10.21 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 120.879 1.053 . . . . 0.0 109.97 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 75.54 148.42 0.1 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.593 -0.692 . . . . 0.0 109.866 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -45.67 -92.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.524 -0.735 . . . . 0.0 111.111 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.3 p -119.94 -1.56 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.825 -1.172 . . . . 0.0 110.67 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.61 -85.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -143.7 147.92 34.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.046 -1.034 . . . . 0.0 110.316 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' B' ' 116' ' ' PRO . 1.7 m -50.54 169.3 0.21 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.335 -0.853 . . . . 0.0 110.441 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' B' ' 115' ' ' SER . 3.4 Cg_exo -54.66 152.92 25.83 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.06 1.032 . . . . 0.0 109.98 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 15.1 tt -120.3 155.11 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.124 -0.985 . . . . 0.0 110.818 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' B' ' 105' ' ' VAL . 9.7 t -86.65 147.74 25.76 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' B' ' 125' ' ' LEU . 32.7 mm -78.91 -84.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.946 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -162.93 -65.41 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 109.964 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.4 t -175.46 64.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.809 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.645 ' H ' HG11 ' B' ' 105' ' ' VAL . 0.0 OUTLIER 52.65 59.98 4.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.174 -0.954 . . . . 0.0 109.941 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.16 -73.04 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.217 -0.927 . . . . 0.0 110.567 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.63 ' O ' HD22 ' B' ' 125' ' ' LEU . 94.1 m -147.36 84.51 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.129 -0.982 . . . . 0.0 110.653 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.839 ' O ' HD13 ' B' ' 101' ' ' LEU . 0.3 OUTLIER -139.05 118.6 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 109.898 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -147.16 158.37 43.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.003 . . . . 0.0 110.734 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.489 HG22 HD21 ' B' ' 99' ' ' LEU . 94.8 t -72.17 153.29 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.403 -0.811 . . . . 0.0 110.173 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' B' ' 89' ' ' ALA . 13.4 t80 -85.5 -59.06 2.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.502 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' B' ' 75' ' ' ASP . . . -120.02 -149.95 8.47 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.485 HG22 ' O ' ' B' ' 130' ' ' VAL . 8.9 p -135.98 -2.13 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -1.208 . . . . 0.0 111.818 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.806 HG12 ' N ' ' B' ' 75' ' ' ASP . 1.1 p -126.06 152.61 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.634 -1.291 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.691 ' N ' HD12 ' B' ' 132' ' ' ILE . 3.8 mp -145.23 59.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.456 -0.778 . . . . 0.0 108.967 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 137' ' ' ALA . 0.7 OUTLIER -77.36 111.66 13.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 110.788 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 134' ' ' VAL . 23.8 m -85.37 119.05 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.734 HG13 HG22 ' A' ' 135' ' ' VAL . 48.9 t -99.42 104.88 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 110.683 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 99.68 8.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.502 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 133' ' ' HIS . . . -61.56 104.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.443 ' HB3' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -113.16 102.74 10.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.957 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.486 ' O ' HD13 ' A' ' 132' ' ' ILE . 18.8 ttt180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.226 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.22 0.533 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.03 78.87 0.72 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.41 169.8 6.14 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.311 1.164 . . . . 0.0 110.565 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 31' ' ' ALA . 30.6 t -149.14 74.69 9.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.48 -29.16 88.07 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 O-C-N 123.3 1.158 . . . . 0.0 110.593 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.65 81.23 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.918 . . . . 0.0 110.259 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' HB2' ' OG ' ' A' ' 28' ' ' SER . . . -105.65 107.96 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.336 -0.852 . . . . 0.0 110.165 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -134.58 -62.16 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 t80 53.05 89.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.24 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.29 61.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.905 . . . . 0.0 110.347 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.65 78.17 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.83 -53.78 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 110.222 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -174.86 142.83 0.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.912 . . . . 0.0 109.973 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -167.24 60.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.717 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 43' ' ' LEU . 9.2 t0 -90.31 74.4 7.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.76 ' CG ' HD12 ' B' ' 45' ' ' ILE . 0.1 OUTLIER -48.37 -44.16 34.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.244 -0.91 . . . . 0.0 110.734 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.704 ' HA ' HD22 ' B' ' 40' ' ' LEU . 8.5 p30 -54.42 -45.66 73.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.15 -0.969 . . . . 0.0 109.965 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 tp60 -88.02 -8.82 55.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -0.843 . . . . 0.0 109.765 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 71' ' ' LEU . 0.0 OUTLIER -73.23 -70.18 0.38 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.338 -0.851 . . . . 0.0 110.546 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 43' ' ' LEU . 0.8 OUTLIER -82.54 -30.6 29.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.989 -1.069 . . . . 0.0 110.196 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.907 HD13 HG21 ' A' ' 51' ' ' THR . 43.0 mt -123.55 -179.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.566 ' H ' HG22 ' A' ' 45' ' ' ILE . 13.3 mt-30 -155.4 23.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.716 -1.24 . . . . 0.0 110.923 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.34 146.82 35.07 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.63 -33.95 85.48 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 122.973 0.986 . . . . 0.0 110.004 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.0 p -175.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.422 -0.799 . . . . 0.0 109.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 77' ' ' ALA . . . -126.16 35.27 4.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.078 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.907 HG21 HD13 ' A' ' 45' ' ' ILE . 26.0 m -141.87 120.2 12.31 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.194 -0.941 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HB2' HG13 ' A' ' 74' ' ' VAL . 6.1 m-85 -109.02 157.75 18.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 108.917 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.525 ' HB3' HD13 ' A' ' 73' ' ' ILE . 11.1 p90 -143.47 163.34 33.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.89 -1.131 . . . . 0.0 111.607 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 72' ' ' LEU . 7.3 p -155.92 140.64 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 132.53 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.994 -1.066 . . . . 0.0 110.418 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 66' ' ' ILE . . . -88.49 113.09 23.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.2 59.0 1.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.182 -0.948 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.24 -135.65 2.0 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' CA ' HD11 ' A' ' 62' ' ' ILE . 12.4 p-10 -175.84 34.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.335 -1.097 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -111.08 -39.63 4.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.974 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.75 ' H ' HD11 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -100.03 30.76 3.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.518 HD11 ' CA ' ' A' ' 59' ' ' ASP . 8.2 mt -56.68 -25.07 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.224 -0.923 . . . . 0.0 109.138 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 85' ' ' ILE . 20.0 p30 -52.24 -29.77 24.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 109.673 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.551 ' CA ' HG11 ' A' ' 96' ' ' VAL . . . -87.92 -41.77 6.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' C ' HD23 ' A' ' 72' ' ' LEU . . . 141.95 38.74 0.08 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.255 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.75 HD11 ' H ' ' A' ' 61' ' ' MET . 1.6 pp -126.27 98.5 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -1.229 . . . . 0.0 110.49 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 t -126.88 66.77 1.27 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.987 -1.071 . . . . 0.0 109.977 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 35.46 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.262 0.553 . . . . 0.0 112.1 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.04 52.75 0.41 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -175.38 167.61 3.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -1.12 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.719 HD11 HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -113.37 123.78 50.9 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.056 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 73' ' ' ILE . 1.2 tm? -87.31 130.74 34.49 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.006 -1.059 . . . . 0.0 109.727 -179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' HB ' ' A' ' 131' ' ' VAL . 3.4 p -82.51 105.6 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.885 0.85 . . . . 0.0 111.039 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.2 98.62 11.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.08 -1.012 . . . . 0.0 109.8 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.0 p -93.48 101.83 14.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -176.11 -42.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.196 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.47 159.88 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -111.73 128.75 56.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 110.225 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.669 ' CB ' HG11 ' A' ' 86' ' ' VAL . . . -106.07 -156.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.287 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.45 166.92 24.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -52.4 143.05 15.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.543 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.16 27.47 36.9 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG13 ' A' ' 86' ' ' VAL . 71.0 m-20 -137.17 120.82 17.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -1.102 . . . . 0.0 109.877 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.679 HG21 HD12 ' A' ' 132' ' ' ILE . 14.8 tt -53.9 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 110.271 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 130' ' ' VAL . 33.3 m -137.92 -169.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.414 -0.804 . . . . 0.0 109.907 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.2 tp -101.52 117.81 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.205 -0.934 . . . . 0.0 110.384 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.979 ' HB3' ' OG1' ' A' ' 95' ' ' THR . . . -89.61 165.51 14.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 109.889 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.03 132.63 13.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.91 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 124' ' ' THR . 3.5 p -152.38 120.67 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.646 -0.659 . . . . 0.0 109.625 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 55.36 25.13 7.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.685 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.98 33.53 7.28 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 2.4 mm-40 -106.96 164.34 12.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -1.182 . . . . 0.0 110.499 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 93' ' ' GLU . 46.9 m-85 -141.43 105.71 4.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.979 ' OG1' ' HB3' ' A' ' 88' ' ' ALA . 11.3 p -119.51 162.02 19.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.551 HG11 ' CA ' ' A' ' 64' ' ' GLY . 2.3 t -136.45 101.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 110.366 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' NZ ' HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -178.48 -179.94 0.71 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.228 -0.92 . . . . 0.0 110.192 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -82.71 89.76 6.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.85 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 107' ' ' LEU . 1.9 pt? -86.58 154.41 21.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.311 -0.868 . . . . 0.0 110.845 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.928 ' O ' HD23 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -135.21 130.12 34.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.928 HD23 ' O ' ' A' ' 100' ' ' GLN . 13.9 mt -131.3 -6.16 3.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 111.214 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -75.76 -59.48 1.19 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.872 -1.142 . . . . 0.0 110.335 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 102' ' ' ARG . 2.4 Cg_endo -62.52 -51.65 3.12 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 N-CA-C 108.73 -1.296 . . . . 0.0 108.73 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -151.11 160.4 43.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.757 HG22 ' HB ' ' A' ' 119' ' ' ILE . 13.1 p -87.69 100.11 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 110.034 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -140.31 147.27 39.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 110.424 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -143.96 137.67 27.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.487 -0.758 . . . . 0.0 110.25 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.469 HD13 ' C ' ' A' ' 115' ' ' SER . 0.3 OUTLIER -146.83 78.34 10.7 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.133 -0.979 . . . . 0.0 110.802 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HG3' ' CG2' ' A' ' 95' ' ' THR . 2.6 Cg_endo -70.46 -153.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.225 1.118 . . . . 0.0 110.205 179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 110' ' ' MET . 4.3 mmm 64.22 176.42 0.18 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 62' ' ' ILE . 13.6 t-20 -125.47 -82.94 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.42 -0.8 . . . . 0.0 110.162 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 p -69.76 -42.08 74.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.173 -0.954 . . . . 0.0 109.907 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.2 57.82 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 114' ' ' TYR . 46.5 p90 -62.55 119.47 9.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.448 -0.783 . . . . 0.0 110.933 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.469 ' C ' HD13 ' A' ' 108' ' ' ILE . 72.1 m -125.56 84.07 60.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.468 -0.77 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.96 126.39 21.52 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.294 1.155 . . . . 0.0 110.852 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 117' ' ' ILE . 1.7 tp -134.29 128.56 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 118' ' ' THR . 8.8 t -85.54 151.44 23.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.853 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.757 ' HB ' HG22 ' A' ' 105' ' ' VAL . 3.5 mt -109.81 168.95 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 110.089 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.5 m -57.41 -166.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.623 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.03 68.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.872 . . . . 0.0 110.303 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 52.48 62.61 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -73.29 0.27 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 110.032 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.664 ' O ' HD22 ' A' ' 125' ' ' LEU . 92.7 m -142.75 81.59 1.74 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.908 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 119' ' ' ILE . 1.1 mm? -128.36 97.56 4.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.235 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.22 149.84 34.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.142 -0.974 . . . . 0.0 110.423 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 87' ' ' ILE . 53.6 t -84.81 148.65 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 110.495 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.67 -34.42 10.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 110.04 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -165.66 -155.28 8.58 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.888 HG13 HG12 ' A' ' 86' ' ' VAL . 6.4 t -125.68 140.93 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.24 . . . . 0.0 110.168 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' A' ' 74' ' ' VAL . 2.0 p -132.19 92.57 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.491 -0.755 . . . . 0.0 110.374 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' B' ' 138' ' ' MET . 1.1 tt -146.75 15.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 120.709 -1.244 . . . . 0.0 110.102 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.786 ' NE2' ' HB1' ' B' ' 137' ' ' ALA . 1.3 m80 -72.58 108.98 5.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.592 -1.317 . . . . 0.0 108.846 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.91 125.59 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.098 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.929 HG13 HG22 ' B' ' 135' ' ' VAL . 40.2 t -117.44 97.89 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.89 98.7 9.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 108.827 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.797 ' HB1' ' NE2' ' B' ' 133' ' ' HIS . . . -80.35 104.26 10.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 111.261 -178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.895 ' O ' HG23 ' B' ' 132' ' ' ILE . 14.4 mtm -127.32 141.07 51.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.457 -0.777 . . . . 0.0 109.358 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' ' CG1' ' B' ' 130' ' ' VAL . 11.6 ptt180 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.968 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.245 0.545 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.83 68.65 6.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 110.157 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.58 -47.46 11.4 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.339 1.178 . . . . 0.0 110.567 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 3.6 t -142.5 79.7 15.19 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.203 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -21.98 73.33 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.314 1.165 . . . . 0.0 110.531 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.89 7.37 44.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 110.718 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.61 80.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.957 -1.089 . . . . 0.0 110.318 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.08 24.91 0.49 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 110.32 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' B' ' 34' ' ' VAL . 16.1 t80 -152.64 -55.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' B' ' 33' ' ' TYR . 97.0 t -128.43 116.7 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.271 -0.893 . . . . 0.0 110.245 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.3 -62.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.321 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -112.62 -64.3 1.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.209 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.32 -44.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.672 ' O ' HG23 ' B' ' 38' ' ' ILE . 2.0 tt -164.14 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' B' ' 43' ' ' LEU . 8.9 t0 -90.16 69.07 7.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.765 ' CG ' HD12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -49.1 -42.43 39.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.277 -0.89 . . . . 0.0 110.347 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' A' ' 40' ' ' LEU . 8.4 p30 -55.53 -45.59 77.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' B' ' 45' ' ' ILE . 1.6 tp60 -88.07 -8.66 55.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.369 -0.832 . . . . 0.0 109.653 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.719 HD22 HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.42 -70.19 0.38 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.291 -0.881 . . . . 0.0 110.524 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -82.59 -30.4 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.965 -1.084 . . . . 0.0 110.108 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.926 HD13 HG21 ' B' ' 51' ' ' THR . 42.3 mt -123.82 179.99 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 0.0 109.137 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.549 ' H ' HG22 ' B' ' 45' ' ' ILE . 13.5 mt-30 -155.3 23.29 0.42 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.727 -1.233 . . . . 0.0 110.873 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -110.06 146.82 34.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.872 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.55 -34.06 86.01 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 O-C-N 123.107 1.056 . . . . 0.0 109.993 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 14.8 p -175.28 50.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.917 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 77' ' ' ALA . . . -126.3 35.18 4.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 110.097 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.926 HG21 HD13 ' B' ' 45' ' ' ILE . 26.0 m -141.72 120.27 12.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 110.931 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.657 ' HB2' HG13 ' B' ' 74' ' ' VAL . 6.1 m-85 -109.06 157.72 18.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 108.962 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' PHE . . . . . 0.539 ' HB3' HD13 ' B' ' 73' ' ' ILE . 11.1 p90 -143.52 163.19 33.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.924 -1.11 . . . . 0.0 111.579 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' B' ' 72' ' ' LEU . 7.1 p -155.76 140.66 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 132.38 43.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.941 -1.099 . . . . 0.0 110.409 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' B' ' 66' ' ' ILE . . . -88.35 113.15 23.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 110.335 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -136.36 58.91 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.247 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.92 -135.39 1.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.545 ' CA ' HD11 ' B' ' 62' ' ' ILE . 12.4 p-10 -176.15 34.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.337 -1.096 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 111' ' ' ASN . 0.2 OUTLIER -111.25 -39.29 4.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.855 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' MET . . . . . 0.738 ' H ' HD11 ' B' ' 66' ' ' ILE . 0.6 OUTLIER -100.38 30.39 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.545 HD11 ' CA ' ' B' ' 59' ' ' ASP . 8.1 mt -56.81 -24.41 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.32 -0.862 . . . . 0.0 109.075 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.597 ' O ' HD11 ' B' ' 85' ' ' ILE . 15.1 p30 -52.98 -29.33 28.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.314 -0.866 . . . . 0.0 109.617 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.55 ' CA ' HG11 ' B' ' 96' ' ' VAL . . . -88.16 -41.44 6.22 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.638 ' C ' HD23 ' B' ' 72' ' ' LEU . . . 141.77 38.84 0.08 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.179 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.738 HD11 ' H ' ' B' ' 61' ' ' MET . 1.6 pp -126.16 98.39 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -1.182 . . . . 0.0 110.362 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.2 t -126.81 66.73 1.26 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.052 -1.03 . . . . 0.0 110.057 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 35.47 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.257 0.551 . . . . 0.0 112.135 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.23 52.67 0.41 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -175.44 167.58 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 0.0 109.785 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -113.17 123.84 51.16 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.061 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.734 HD13 ' N ' ' B' ' 73' ' ' ILE . 1.2 tm? -87.26 130.62 34.52 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.734 ' N ' HD13 ' B' ' 72' ' ' LEU . 20.9 mm -124.91 100.21 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 109.671 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' B' ' 131' ' ' VAL . 3.4 p -82.5 105.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.878 0.847 . . . . 0.0 111.027 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.32 98.64 11.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.012 . . . . 0.0 109.828 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.2 p -93.44 101.81 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.255 -0.903 . . . . 0.0 110.267 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -176.19 -42.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.48 159.58 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.141 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -111.49 128.86 56.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.178 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.672 ' CB ' HG11 ' B' ' 86' ' ' VAL . . . -106.25 -156.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.341 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 1.9 m -145.4 166.91 24.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.464 ' CD2' ' HD3' ' B' ' 102' ' ' ARG . 92.6 m-70 -52.39 142.81 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.534 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.28 27.69 35.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASP . . . . . 0.519 ' O ' HG13 ' B' ' 86' ' ' VAL . 71.1 m-20 -137.55 120.6 16.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -1.136 . . . . 0.0 109.791 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.683 HG21 HD12 ' B' ' 132' ' ' ILE . 14.4 tt -54.01 98.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . 0.916 HG12 HG13 ' B' ' 130' ' ' VAL . 33.2 m -137.98 -169.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.435 -0.791 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.833 ' O ' HG13 ' B' ' 127' ' ' VAL . 1.2 tp -101.41 117.9 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.953 ' HB3' ' OG1' ' B' ' 95' ' ' THR . . . -89.52 165.16 14.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.69 132.38 14.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.121 -0.987 . . . . 0.0 111.04 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 124' ' ' THR . 3.8 p -152.55 122.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.6 -0.687 . . . . 0.0 109.738 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 54.45 24.48 5.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.342 -0.849 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.42 33.41 7.19 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HB2' ' CG1' ' B' ' 90' ' ' VAL . 2.5 mt-10 -107.82 164.5 12.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.258 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -144.18 98.73 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' THR . . . . . 0.953 ' OG1' ' HB3' ' B' ' 88' ' ' ALA . 41.4 p -110.91 163.66 13.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' VAL . . . . . 0.55 HG11 ' CA ' ' B' ' 64' ' ' GLY . 4.4 t -136.45 94.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.115 -0.99 . . . . 0.0 110.932 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.471 ' HD3' ' HB2' ' B' ' 63' ' ' ASP . 19.7 tptt -174.94 172.01 2.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 109.702 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.46 116.83 17.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 110.022 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.765 HD23 ' H ' ' B' ' 99' ' ' LEU . 2.2 pt? -122.32 152.57 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 110.596 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' GLN . . . . . 0.865 ' O ' HD23 ' B' ' 101' ' ' LEU . 1.4 mp0 -124.58 131.61 53.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.266 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.865 HD23 ' O ' ' B' ' 100' ' ' GLN . 15.0 mt -128.58 -13.68 4.77 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.159 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' B' ' 103' ' ' PRO . 7.2 mpt_? -70.36 -59.78 3.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.782 -1.199 . . . . 0.0 110.041 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' B' ' 102' ' ' ARG . 2.4 Cg_endo -62.73 -50.67 3.85 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 N-CA-C 108.927 -1.22 . . . . 0.0 108.927 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 101' ' ' LEU . 2.4 m -151.37 154.91 37.58 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.752 HG21 ' O ' ' B' ' 120' ' ' SER . 35.7 m -84.08 99.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 105' ' ' VAL . 3.2 mm100 -139.18 135.18 33.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.608 HD12 ' CB ' ' B' ' 99' ' ' LEU . 2.8 tp -134.98 145.14 47.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . 0.537 HD13 ' C ' ' B' ' 115' ' ' SER . 0.6 OUTLIER -152.78 78.51 6.08 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.177 -0.952 . . . . 0.0 110.821 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.459 ' HG3' ' CG2' ' B' ' 95' ' ' THR . 2.5 Cg_endo -68.02 -150.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' B' ' 60' ' ' SER . 4.3 mmt 66.57 164.09 0.19 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.091 -1.005 . . . . 0.0 110.957 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . 0.514 ' HB3' HD12 ' B' ' 62' ' ' ILE . 13.0 t30 -126.01 -66.91 0.9 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.463 -0.773 . . . . 0.0 109.67 178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 7.5 p -79.77 -43.59 22.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -90.26 59.25 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . 0.48 ' O ' ' CD2' ' B' ' 114' ' ' TYR . 52.9 p90 -62.37 127.25 30.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.433 -0.792 . . . . 0.0 111.006 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.537 ' C ' HD13 ' B' ' 108' ' ' ILE . 8.1 m -133.78 84.43 44.4 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.554 -0.716 . . . . 0.0 109.259 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.473 ' N ' HD13 ' B' ' 108' ' ' ILE . 3.1 Cg_exo -58.02 131.58 44.4 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.407 1.214 . . . . 0.0 111.09 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.404 HG23 ' O ' ' B' ' 117' ' ' ILE . 0.7 OUTLIER -140.15 132.74 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 110.158 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -88.49 151.4 22.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' B' ' 125' ' ' LEU . 3.5 mt -105.57 169.32 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.199 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.752 ' O ' HG21 ' B' ' 105' ' ' VAL . 1.9 m -58.86 -164.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.141 -0.974 . . . . 0.0 109.929 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.42 67.74 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.634 ' CA ' HG11 ' B' ' 105' ' ' VAL . 18.7 tt0 53.12 62.49 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -73.41 0.26 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.65 ' O ' HD22 ' B' ' 125' ' ' LEU . 92.2 m -142.82 81.58 1.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.98 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.8 ' HB3' HD13 ' B' ' 101' ' ' LEU . 1.1 mm? -128.18 98.07 4.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.134 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -146.42 149.73 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.066 -1.021 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.833 HG13 ' O ' ' B' ' 87' ' ' ILE . 55.0 t -84.82 148.58 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.343 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.69 -34.69 10.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.288 -0.882 . . . . 0.0 109.914 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' GLY . . . . . 0.607 ' O ' HG22 ' B' ' 87' ' ' ILE . . . -165.33 -155.09 8.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.916 HG13 HG12 ' B' ' 86' ' ' VAL . 6.4 t -125.78 140.96 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.069 -1.254 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' B' ' 74' ' ' VAL . 1.9 p -132.22 92.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.555 -0.716 . . . . 0.0 110.327 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' MET . 1.1 tt -146.77 15.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.769 -1.207 . . . . 0.0 110.179 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' HIS . . . . . 0.797 ' NE2' ' HB1' ' A' ' 137' ' ' ALA . 1.3 m80 -72.68 109.0 5.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.549 -1.345 . . . . 0.0 108.815 177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.91 125.63 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 135' ' ' VAL . 40.0 t -117.51 97.72 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.71 98.77 9.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 108.819 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . 0.786 ' HB1' ' NE2' ' A' ' 133' ' ' HIS . . . -80.43 104.35 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 111.313 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 15.0 mtm -127.4 141.18 51.75 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.588 -0.695 . . . . 0.0 109.304 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 11.7 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 stop_ save_